Text

Transmittal of 2007 Annual Radioactive Effluent Release Report & Rev. 5 to Offsite Dose Calculation Manual
	ML081270225
Person / Time
Site:	Byron
Issue date:	04/30/2008
From:	Hoots D; Exelon Generation Co, Exelon Nuclear
To:	; Document Control Desk, Office of Nuclear Reactor Regulation
References
	BYRON 2008-0032, FOIA/PA-2010-0209
	Download: ML081270225 (346)
	v • d • e

Exelon.

Exelon Generation Company, LLC Byron Station www.exe]onicorp.com Nuclear 4450 North German Church Road Byron, IL61010-9794 April 30, 2008 10 CFR 50.36a LTR: BYRON 2008-0032 File: 1.10.0101 United States Nuclear Regulatory Commission ATTN: Document Control Desk Washington, DC 20555-0001 Byron Station, Units 1 and 2 Facility Operating License Nos. NPF-37 and NPF-66 NRC Docket Nos. STN 50-454 and STN 50-455

Subject:

2007 Annual Radioactive Effluent Release Report Enclosed is the Annual Radioactive Effluent Release Report for Byron Station. This report is being submitted in accordance with 10 CFR 50.36(a)(2), "Technical specifications on effluents from nuclear power reactors," and includes a summary of radiological liquid and gaseous effluents and solid waste released from the site from January 2007, through December 2007. Also enclosed is the current Revision 5 of the Byron Station Offsite Dose Calculation Manual (ODCM), the Byron ODCM, Revision 5 Change Document and Technical Requirements Manual Chapters 3.11 and 3.12.

If you have any questions regarding this information, please contact W. Grundmann, Regulatory Assurance Manager, at (815) 406-2800.

Respectfully, David M. Hoots Site Vice President Byron Nuclear Generating Station DMH/JG/TH/vym Attachment ~LfS Attachment

BYRON NUCLEAR POWER STATION ANNUAL RADIOLOGICAL EFFLUENT RELEASE REPORT (ARERR) 2007

BYRON NUCLEAR POWER STATION UNIT 1/2 DOCKET NUMBER STN-50-454/455 RADIOACTIVE EFFLUENT RELEASE REPORT January 2007 THROUGH December 2007 Supplemental Information Regulatory Limits

a. Fission and activation gases:

Tech Spec Whole Body = 500 mrem/year Skin = 3000 mrem/year 10CFR50 Gamma = 5 mrad/quarter; 10 mrad/year Beta = 10 mrad/quarter; 20 mrad/year

b. Iodine: (summed with particulate, see below)

c. Particulates with half-lives > 8 days:

Tech Spec Organ = 1500 mrem/year 10CFR50 Organ = 7.5 mrem/quarter; 15 mrem/year

d. Liquid Effluents:

10CFR50 Whole Body = 1.5 mrem/quarter; 3 mrem year Organ = 5 mrem/quarter; 10 mrem/year

e. Total Effective Dose Equivalent:

10CFR20 TEDE = 100 mrem/year

2. Maximum Permissible Concentration

a. Fission and Activation Gases: 10CFR20 Appendix B Table 2

b. Iodine: 10CFR20 Appendix B Table 2

c. Particulates: 10CFR20 Appendix B Table 2

d. Liquid Effluents: 10 X 10CFR20 Appendix B Table 2

3. Average Energy: This item is not applicable. Release rates are calculated using an isotopic mix rather than average energy.

4. Measurements and Approximations of Total Radioactivity

a. Fission and Activation Gases: Prior to release, the isotopic content is determined. Released activity is calculated using volume of release, which is determined by the change in tank or containment pressure. Additional methods of calculation utilize historical data and assign an isotopic mix, which is representative of normal vent stack isotopics.

b. Particulate, Tritium and Iodine sampling media for the plant vent stacks are collected and isotopically analyzed weekly for the plant vent stacks.

Page 2 of 88

BYRON NUCLEAR POWER STATION UNIT 1/2 DOCKET NUMBER STN-50-454/455 RADIOACTIVE EFFLUENT RELEASE REPORT January 2007 THROUGH December 2007 Supplemental Information

c. Liquid effluents: Isotopic analysis is performed on each batch release prior to its release. Total release activity is calculated using volume of release. Total tritium activity released is calculated from the highest of a monthly circulating water blowdown composite activity or a sum of the input composite activities.

d. Analysis results that are less than the lower limit of detection (<LLD) are reported in units of Ci/ml unless otherwise noted. All LLD values are listed in Attachment A.

5. Batch Releases:

a. Liquid:

1. Number of batch releases = 91

2. Total time period for batch releases = 13,700 minutes

3. Maximum time period for a batch release = 450 minutes

4. Average time period for a batch release = 151 minutes

5. Minimum time period for a batch release = 27 minutes

6. Average stream flow during periods of release of effluent into a flowing stream = 250.63 m 3/sec, based on information from the U.S. Geological Survey Byron Gauging Station.

b. Gaseous:

1. Number of batch releases = 284

2. Total time period for batch releases = 41,800 minutes

3. Maximum time period for a batch release = 14,900 minutes

4. Average time period for batch releases = 147 minutes

5. Minimum time period for a batch release = 4 minutes

6. Abnormal Releases:

a. Liquid - None

b. Gaseous- None

7. 2007 Radiological Groundwater Protection Program (RGPP) Results Summary:

In 2007, the 22 Radiological Groundwater Protection Program (RGPP) monitoring wells were sampled in April and October for tritium. Of the twenty-two wells sampled in April 2007, four contained levels of tritium above the lower limit of detection (LLD) of 200 pCi/L. They were: AR-2 (548 pCi/L), AR-3 (327 pCi/L), AR-4 (3050 pCi/L), and AR-11 (1820 pCi/L). None of these wells showed significant change from previous results, and the dose consequences from tritium present in these wells is negligible. Of the twenty-two wells sampled in October 2007, four contained levels of tritium above the LLD of 200 pCi/L. They were: AR-2 (383 pCi/L), AR-3 (965 pCi/L), AR-4 (2890 pCi/L), and AR-1 1 (1300 pCi/L).

Since well AR-3 showed a measurable increase over the April 2007 result, it was reanalyzed with a result of 1110 pCi/L tritium. Well AR-3 was sampled again in November 2007 with a result of 1180 pCi/L. Along with elevated tritium, a corresponding increase in level was observed in the AR-3 well.

The tritium increase is believed to be a result of heavy late-summer rains that introduced pre-existing tritium that was present in the soil to the water table in the area of the well. After discussions with the Exelon Environmental Hydrologist, a monthly tritium monitoring frequency was established for Well AR-Page 3 of 88

3 beginning in January 2008. As of this writing, the tritium in Well AR-3 has decreased, and is now almost back to original levels.

8. Addendum 2006 Radiological Groundwater Protection Program (RGPP) Implementation In 2006, Exelon instituted a comprehensive program to evaluate the impact of station operations on groundwater in the vicinity of Byron Nuclear Generating Station. This evaluation involved numerous station personnel and contractor support personnel. At Byron, 17 permanent groundwater monitoring wells were installed in 2006. Of these new monitoring locations none were assigned to the station's Radiological Environmental Monitoring Program (REMP). During that time period, 370 analyses were performed on 175 samples from 22 locations. The monitoring was conducted in two phases. Phase 1 of the monitoring was part of a comprehensive study initiated by Exelon to determine whether groundwater or surface water at and in the vicinity of Byron Nuclear Generating Station had been adversely impacted by any releases of radionuclides.

Phase 1 was conducted by Conestoga-Rovers and Associates (CRA) and the conclusions were made available to state and federal regulators as well as the public on an Exelon web site. Phase 2 of the RGPP was conducted by Exelon corporate and station personnel to initiate follow up of Phase 1 and begin long-term monitoring at groundwater locations selected during Phase 1. In assessing the data gathered for this report, it was concluded that the operation of Byron Nuclear Generating Station had no adverse radiological impact on the environment, and there are no known active releases into the groundwater at Byron Nuclear Generating Station.

Gamma-emitting radionuclides associated with licensed plant operations were not detected at concentrations greater than their respective Lower Limits of Detection (LLDs) as specified in the Offsite Dose Calculation Manual (ODCM) in any of the groundwater. In the case of tritium, Exelon specified that its laboratories achieve a lower limit of detection 10 times lower than that required by federal regulation.

Strontium-89/90 was not detected in any of the groundwater samples tested.

Tritium was not detected in any of the groundwater samples at concentrations greater than the United States Environmental Protection Agency (USEPA) drinking water standard (and the Nuclear Regulatory Commission Reporting Limit) of 20,000 pCi/L. Low levels of tritium were detected at concentrations greater than the LLD of 200 pCi/L in 4 of 22 groundwater samples. The tritium concentrations ranged from 200 +/- 96 pCi/L to 4,080 +/- 463 pCi/L. The tritium that was detected in groundwater at the Byron Station was near the Circ Water Blowdown vaults (#2, #3, & #4), along the blowdown line located west of the station.

All Circ Water Blowdown vaults were plugged and coated to prevent any leakage of water from the vaults to the groundwater. Leakage detection systems have been installed in the Circ Water Blowdown vaults to monitor leakage during liquid release evolutions. Liquid release procedures have been revised to include a walk down of the Circ Water Blowdown vaults prior to and directly after a liquid release to check for the presence of water in the blowdown vaults. Any water found in the vaults is pumped out of the vaults and disposed of according to the NPDES permit.

The source of tritium in the groundwater at the well locations was the effect of leakage from the blowdown vacuum breakers prior to sealing the vaults. Since the dose consequences from the concentrations of tritium detected in the groundwater are negligible, and the volume, duration, and historical time frames of the leakage are unknown, the discovery of tritium in the groundwater was not characterized as an abnormal release, and was not reported as such in the 2006 ARERR. Analytical results for RGPP wells from Phase 1 and Phase 2 monitoring are reported in the 2006 AREOR.

Page 4 of 88

BYRON NUCLEAR POWER STATION UNIT 1/2 DOCKET NUMBER STN-50-454/455 RADIOACTIVE EFFLUENT RELEASE REPORT January 2007 THROUGH December 2007 SOLID RADIOACTIVE WASTE FOR BURIAL 1 ST QUARTER 2007 DISPOSITION OF MATERIAL MODE OF DESTINATION VOLUME CURIES*

DATE (DESCRIPTION, CLASS, TYPE AND TRANSPORT PER PER SOLIDIFYING AGENT) SHIPMENT SHIPMENT RADIOACTIVE MATERIAL, LOW SPECIFIC ACTIVITY 6.12E+01 2.00 E-01 EXCLUSIVE-USE WampumPA.

217/07 (LSA-I), 7, UN2912, CLASS A, GENERAL DESIGN PACKAGE (GDP), 20' METAL BOXES (2), NONE 3/28/07 RADIOACTIVE MATERIAL, LOW SPECIFIC ACTIVITY (LSA-I), 7, UN2912, CLASS A, GENERAL DESIGN EXCLUSIVE-USE Oak Ridge, TN 6.12E+01 1.61E-01 PACKAGE, 20' METAL BOXES (2), NONE Quarterly Totals Number of 2 1.22E+02 3.61 E-01 Shipments:

Calculated using measured ratios CUBIC M CURIES Page 5 of 88

BYRON NUCLEAR POWER STATION UNIT 1/2 DOCKET NUMBER STN-50-454/455 RADIOACTIVE EFFLUENT RELEASE REPORT January 2007 THROUGH December 2007 SOLID RADIOACTIVE WASTE FOR BURIAL 2 ND QUARTER 2007 DISPOSITION OF MATERIAL MODEOF VOLUME CURIES*

DATE (DESCRIPTION, CLASS, TYPE TRANSPORT DESTINATION PER PER AND SOLIDIFYING AGENT) SHIPMENT SHIPMENT RADIOACTIVE MATERIAL, LOW SPECIFIC ACTIVITY (LSA-II), 7, UN3321, CLASS A, EXCLUSIVE-USE Oak Ridge, TN 6.12E+01 5.57E-01 4/18/07 GENERAL DESIGN PACKAGE, 20' METAL BOXES (2), NONE RADIOACTIVE MATERIAL, LOW SPECIFIC 4/26/07 ACTIVITY (LSA-II), 7, UN3321, CLASS A, EXCLUSIVE-USE Oak Ridge, TN 6.12E+01 3.02E-01 GENERAL DESIGN PACKAGE, 20' METAL BOXES (2), NONE RADIOACTIVE MATERIAL, LOW SPECIFIC 5/09/07 ACTIVITY (LSA-II), 7, UN3321, CLASS C, EXCLUSIVE-USE Barnwell, SC 1.75E+00 1.18E+01 GENERAL DESIGN PACKAGE, CASK, NONE RADIOACTIVE MATERIAL, LOW SPECIFIC 6/19/07 ACTIVITY (LSA-II), 7, UN3321, CLASS A, EXCLUSIVE-USE Oak Ridge, TN 5.80E+01 1.01E-01 GENERAL DESIGN PACKAGE, 20' METAL BOXES (2), NONE RADIOACTIVE MATERIAL, LOW SPECIFIC 6/19/07 ACTIVITY (LSA-II), 7, UN3321, CLASS A, EXCLUSIVE-USE Oak Ridge, TN 2.90E+01 3.34E-01 GENERAL DESIGN PACKAGE, 20' METAL BOX, NONE Number of Quarterly Totals Shipments: 5 2.11 E+02 1.31 E+01

Calculated using measured ratios CUBIC M CURIES Page 6 of 88

BYRON NUCLEAR POWER STATION UNIT 1/2 DOCKET NUMBER STN-50-454/455 RADIOACTIVE EFFLUENT RELEASE REPORT January 2007 THROUGH December 2007 SOLID RADIOACTIVE WASTE FOR BURIAL 3 RD QUARTER 2007 DISPOSITION DATE (DECRIPION OF MATERIAL CLAS, YPE MODE OF VOLUME VLM CURIES*

UIS DATE (DESCRIPTION, CLASS, TYPE TRANSPORT DESTINATION PER PER AND SOLIDIFYING AGENT) SHIPMENT SHIPMENT RADIOACTIVE MATERIAL, LOW SPECIFIC 7/06/07 ACTIVITY (LSA-II), 7, UN3321, CLASS A, US EXCLUSIVE-USE CliveUT 4.67E+00 4.98E+00 DOT 7A, TYPE A, CASK, NONE RADIOACTIVE MATERIAL, LOW SPECIFIC 7/17/07 ACTIVITY (LSA-II), 7, UN3321, CLASS A, US EXCLUSIVE-USE Clive, UT 4.53E+00 1.05E+01 DOT 7A, TYPE A, CASK, NONE RADIOACTIVE MATERIAL, EXCEPTED 7/24/07 PACKAGE LIMITED QUANTITY OF MATERIAL, EXCLUSIVE-USE Oak Ridge, TN 1.17E+01 3.05E-04 7, UN291 0, CLASS A, GENERAL DESIGN PACKAGE, 20' METAL BOX, NONE RADIOACTIVE MATERIAL, LOW SPECIFIC 7/25/07 ACTIVITY (LSA-I), 7, UN2912, CLASS A, EXCLUSIVE-USE Oak Ridge, TN 5.10E+01 1.37E-02 GENERAL DESIGN PACKAGE, 20' METAL E BOXES (2), NONE RADIOACTIVE MATERIAL, LOW SPECIFIC 9/27/07 ACTIVITY (LSA-II), 7, UN3321, CLASS A, EXCLUSIVE-USE Oak Ridge, TN 6.12E+01 1.04E-01 GENERAL DESIGN PACKAGE, 20' METAL BOXES (2), NONE Number of QuarterlyTotals Shipments: 1.33E+02 1.56E+01

Calculated using measured ratios CUBIC M CURIES Page 7 of 88

BYRON NUCLEAR POWER STATION UNIT 1/2 DOCKET NUMBER STN-50-454/455 RADIOACTIVE EFFLUENT RELEASE REPORT January 2007 THROUGH December 2007 SOLID RADIOACTIVE WASTE FOR BURIAL 4 TH QUARTER 2007 DISPOSITION DATE (DECRIPION OF MATERIAL CLAS, YPE MODE OF VOLUME VLM CURIES*

UIS DATE (DESCRIPTION, CLASS, TYPE TRANSPORT DESTINATION PER PER AND SOLIDIFYING AGENT) SHIPMENT SHIPMENT RADIOACTIVE MATERIAL, LOW SPECIFIC 10/08/07 ACTIVITY (LSA-I), 7, UN2912, CLASS A, Oak Ridge, TN 9.23E+00 4.62E-03 GENERAL DESIGN PACKAGE, 20' METAL BOX, EXCLUSIVE-USE NONE RADIOACTIVE MATERIAL, LOW SPECIFIC 11/28/07 ACTIVITY (LSA-II), 7, UN3321, CLASS B, TYPE EXCLUSIVE-USE Barnwell, SC 2.63E+00 4.19E+01 B(U) PACKAGE, CASK, NONE RADIOACTIVE MATERIAL, TYPE B(U) 12/5/07 PACKAGE, 7, UN2916, CLASS C, TYPE B(U) EXCLUSIVE-USE Barnwell, SC 2.63E+00 2.11E+02 PACKAGE, CASK, NONE RADIOACTIVE MATERIAL, TYPE B(U) 12/12/07 PACKAGE, 7, UN2916, CLASS C, TYPE B(U) EXCLUSIVE-USE Barnwell, SC 2.63E+00 3.38E+02 PACKAGE, CASK, NONE Quarterly Totals Numbernof 4 1.71 E+01 5.91E+02 Shipments:

Calculated using measured ratios CUBIC M CURIES Page 8 of 88

BYRON NUCLEAR POWER STATION UNIT 1/2 DOCKET NUMBER STN-50-454/455 RADIOACTIVE EFFLUENT RELEASE REPORT January 2007 THROUGH December 2007 Process Control Program (PCP) for Radioactive Wastes RW-AA-100, Rev 4 was revised to Rev 5 in 2007. All changes were minor or administrative changes in nature.

The following changes were made:

" Step 2.8 under Terms and Definitions: added "compression dewatering" to definition of Liquid Waste Processing Systems. Compression dewatering is a NUKEM technology for dewatering liners.

" Step 2.11 under Terms and Definitions: added "Oil Dry absorbent material added to a container to absorb liquids" to definition of Waste Streams

" Step 3.1 under Responsibilities: added "to implement" at end of statement to clarify the step

" Step 4.6.1 under Procedure and Process Reviews: added description to state that changes are required to be approved under LS-AA-106, which is the Plant Operations Review Committee (PORC) procedure.

" Step 4.6.3 under Procedure and Process Reviews: deleted because it is covered under step 4.6.1

" Step 4.6.3 under Procedure and Process Reviews: formerly step 4.6.4 in rev 4, this step was revised to add "as applicable to your station" for cask manual procedures and "other" to vendor waste processing/operating procedures in order to be inclusive of all stations.

" Step 6.2.9 under References (source documents): changed from RN-AA-1006, which was in error, to RM-AA- 102-106.

Page 9 of 88

BYRON NUCLEAR POWER STATION UNIT 1/2 DOCKET NUMBER STN-50-454/455 RADIOACTIVE EFFLUENT RELEASE REPORT January 2007 THROUGH December 2007 Error Analysis The following is an estimate of the errors associated with effluent monitoring and analysis. The estimate is calculated using the square root of the sum of the squares methodology.

1. Gaseous Effluents Qme=3.33%

RM=N/A ECe=5%

Stdcse/Smplcse=5%

gme=N/A Total error = 7.8%

2. Liquid Effluents Qme=3.33%

RM=N/A ECe=N/A Stdcse/Smplcse=5%

qme=2.22%

Total error = 6.4%

3. Waste Resin Qme=10.0%

RM=N/A ECe=5%

Stdcse/Smplcse=5%

gme=1.0%

Total error = 12.3%

4. DAW, Mechanical Filters, and Contaminated Metal Qme=10.0%

RM=N/A ECe=N/A Stdcse/Smplcse=5%

qme=N/A Instrument calibration error = 10%

Total error = 11.2%

Page 10 of 88

BYRON NUCLEAR POWER STATION UNIT 1/2 DOCKET NUMBER STN-50-454/455 RADIOACTIVE EFFLUENT RELEASE REPORT January 2007 THROUGH December 2007 A. Meteorological and environmental impact information is reported in the Station Annual Radiological Environmental Operating Report as required by Technical Specification 5.6.2.

B. No limits were exceeded in liquid hold up tanks as stated in Technical Specification 5.5.12 or in waste gas decay tanks as stated in Technical Specification 5.5.12.

C. There were no irradiated fuel shipments during this period.

D. REMP second quarter composite surface water sample from point BY-12, Rock River downstream of the plant liquid effluent discharge, had a tritium result of 964 pCi/L. Although this result is well below the reportable limit of 30,000 pCi/L, tritium is not typically observed above the detection limit in this sample under normal operating conditions. The positive tritium result was likely due to the increase in liquid releases performed during the refueling outage in March/April 2007.

E. There were no elevated releases. All releases are considered vent or ground level releases.

F. There were no plant effluent radiation release monitors that exceeded LCOAR time limits.

G. Attached are Offsite Dose Calculations for January through December of 2007.

Page 11 of 88

SOLID RADIOACTIVE WASTE FOR BURIAL Estimated Solid Waste Composition 2007 Resins, Filters, Evap Bottoms Dry Active Waste Other Waste (Oil) 2007 3rd Q in rtpr 2007 4th Quarter 2007 4th Quarter Volume (m3) 20.9 Volume (m3) 2.63 Volume (m3) 9.23 Class A Class B Class A Nuclide % Abund Curies uCVml Nuclide % Adund Curies uCvml % Abund Curies uCi/ml H-3 26.551 4.1OE+00 1.96E-01 H-3 4.346 1.82E+00 6.92E-01 H-3 99.855 4.61E-03 4.99E-04 C-14 0.214 3.31E-02 1.58E-03 C-14 0.580 2.43E-01 9.24E-02 C-14 0.001 2.47E-08 2.68E-09 CR-51 1.315 2.03E-01 9.71E-03 MN-54 1.232 5.17E-01 1.97E-01 FE-55 0.030 1.37E-06 1.48E-07 MN-54 0.690 1.07E-01 5.12E-03 FE-55 2.791 1.17E+00 4.45E-01 CO-60 0.025 1.16E-06 1.26E-07 FE-55 5.517 8.52E-01 4.08E-02 CO-57 0.241 1.01E-01 3.84E-02 NI-59 0.001 6.54E-08 7.09E-09 FE-59 0.104 1.61E-02 7.70E-04 CO-58 2.565 1.08E+00 4.11E-01 NI-63 0.034 1.55E-06 1.68E-07 CO-57 0.405 6.25E-02 2.99E-03 CO-60 8.799 3.69E+00 1.40E+00 SR-90 0.002 8.76E-08 9.49E-09 CO-58 48.325 7.47E+00 3.57E-01 NI-59 0.323 1.36E-01 5.17E-02 TC-99 0.000 2.18E-08 2.36E-09 CO-60 4.932 7.62E-01 3.65E-02 NI-63 59.303 2.49E+01 9.47E+00 1-129 0.000 1.74E-11 1.89E-12 NI-59 0.295 4.55E-02 2.18E-03 ZN-65 0.099 4.17E-02 1.59E-02 CS-137 0.022 1.02E-06 1.11E-07 NI-63 6.930 1.07E+00 5.12E-02 SR-90 0.015 6.16E-03 2.34E-03 CE-144 0.029 1.35E-06 1.46E-07 ZN-65 0.012 1.83E-03 8.76E-05 NB-95 0.021 8.98E-03 3.41E-03 PU-238 0.000 2.73E-09 2.96E-10 SR-90 0.019 2.86E-03 1.37E-04 TC-99 0.039 1.63E-02 6.20E-03 PU-239 0.000 1.20E-09 1.30E-10 ZR-95 0.154 2.38E-02 1.14E-03 SB-125 0.313 1.31E-01 4.98E-02 PU-241 0.001 2.34E-08 2.54E-09 ZR-97 0.000 6.21 E-49 2.97E-50 1-129 0.000 5.59E-05 2.13E-05 AM-241 0.000 7.43E-10 8.05E-11 NB-95 0.307 4.74E-02 2.27E-03 CS-134 7.683 3.22E+00 1.22E+00 CM-242 0.000 1.65E-09 1.79E-10 MO-99 0.000 1.43E-40 6.84E-42 CS-137 11.486 4.82E+00 1.83E+00 CM-243 0.0001 1.68E-09 1.82E-10 TC-99 0.004 5.84E-04 2.79E-05 CE-144 0.047 1.95E-02 7.41E-03 RU-103 0.006 9.42E-04 4.51E-05 PU-238 0.000 9.27E-05 3.52E-05 AG-110M 0.005 7.96E-04 3.81E-05 PU-239 0.000 4.1OE-05 1.56E-05 SN-113 0.009 1.31E-03 6.27E-05 PU-241 0.116 4.86E-02 1.85E-02 SB-122 0.000 1.01E-16 4.83E-18 AM-241 0.000 2.55E-05 9.70E-06 SB-124 0.009 1.35E-03 6.46E-05 CM-242 0.000 5.15E-05 1.96E-05 SB-125 1.586 2.45E-01 1.17E-02 CM-243 0.000 3.OOE-05 1.14E-05 TE-123M 0.007 1.02E-03 4.88E-05 TE-125M 0.042 6.56E-03 3.14E-04 TE-132 0.000 2.36E-35 1.13E-36 1-129 0.000 1.21E-05 5.79E-07 XE-133 0.000 2.53E-23 1.21E-24 CS-134 0.544 8.40E-02 4.02E-03 CS-137 1.087 1.68E-01 8.04E-03 CE-144 0.879 1.36E-01 6.51E-03 PU-238 0.000 1.64E-05 7.85E-07 PU-239 0.000 7.24E-06 3.46E-07 PU-241 0.053 8.22E-03 3.93E-04 AM-241 0.000 3.34E-05 1.60E-06 CM-242 0.000 5.98E-06 2.86E-07 CM-243 0.000 1.OOE-05 4.78E-07 Page 12 of 88

Attachment A, 2007 Radioactive Effluent Release Report 2007 Lower Limits of Detection (LLD's)

Gaseous Liquid Nuclide LLD (CVml) Nuclide LLD (CVml)

H3 6.25E-14 H3 2.50E-12 Ar4l 5.97E-13 Na24 2.29E-14 Cr51 4.12E-18 Cr51 3.92E-13 Mn54 5.50E-19 Mn54 5.47E-14 Co58 7.84E-19 Fe55 8.94E-13 Fe59 2.52E-18 Co57 3.55E-14 Co60 3.28E-19 Co58 7.88E-14 Zn65 1.47E-18 Fe59 1.88E-13 Br82 7.73E-19 Co60 1.14E-13 Kr85m 1.60E-13 Zn65 9.87E-14 Kr87 4.20E-13 Sr85 5.28E-14 Kr88 7.07E-13 Sr89 4.11E-14 Sr89 3.47E-20 Sr-90 6.48E-1 5 Sr-90 1.82E-21 Sr92 2.81 E-14 Mo99 3.00E-19 Nb95 5.16E-14 1131 7.15E-19 Zr95 8.67E-14 Xe131m 8.03E-12 Mo99 3.47E-14 1133 6.58E-19 Agl1Om 4.57E-14 Xe133 8.51 E-13 Sb122 5.68E-14 Xe133m 1.72E-12 Te123m 3.76E-14 Cs134 8.95E-19 Sb124 5.75E-14 1135 3.95E-18 Sb125 1.12E-13 Xe135 2.25E-13 Te125m 9.51E-12 Cs137 7.36E-19 Sb126 3.95E-14 Xe138 9.69E-13 1131 5.01E-14 Ba140 2.48E-18 1132 7.01 E-14 La140 4.10E-19 Te132 3.51 E-14 Ce141 5.97E-19 1133 5.34E-14 Ce144 2.92E-18 Xe133 1.45E-13 Gross Alpha 2.79E-19 Cs134 7.73E-14 Xe 135 4.12E-14 Cs137 6.09E-14 Bal40 1.78E-13 Lal40 7.41 E-14 Ce141 6.61 E-14 Ce144 2.49E-13 Gross Alpha 9.51 E-14 Page 13 of 88

EFFLUENT AND WASTE DISPOSAL REPORT TABLE 1A GASEOUS EFFLUENTS - SUMMATION OF ALL RELEASES Unit 1 2007 REPORT FOR 2007 Units QTR 1 QTR 2 QTR 3 QTR 4 YEAR Fission and Activation Gases

1. Total Release Ci 2.18E-01 2.99E-02 2.20E-02 4.27E-02 3.12E-01

2. Avg. Release Rate uCi/sec 2.80E-02 3.80E-03 2.77E-03 5.37E-03 9.89E-03 Iodine-131

1. Total Release Ci 0.OOE+00 3.33E-06 8.48E-06 1.30E-05 2.49E-05

2. Avg. Release Rate uCi/sec 0.00E+00 4.24E-07 1.07E-06 1.64E-06 7.90E-07 Particulates Half Life >= 8 days

1. Total Release Ci 7.09E-07 0.00E+00 0.OOE+00 9.30E-07 1.64E-06

2. Avg. Release Rate uCi/sec 9.12E-08 0.OOE+00 0.00E+00 1.17E-07 5.20E-08 Others

1. Total Release Ci 1.02E-06 0.OOE+00 0.OOE+00 0.00E+00 1.02E-06

2. Avg. Release Rate uCi/sec 1.31E-07 0.OOE+00 0.OOE+00 0.OOE+00 3.23E-08 Tritium

1. Total Release Ci 2.39E+00 6.41E+00 5.15E+00 8.65E+00 2.26E+01

2. Avg. Release Rate uCi/sec 3.07E-01 8.15E-01 6.48E-01 1.09E+00 7.17E-01 Page 14 of 88

EFFLUENT AND WASTE DISPOSAL REPORT TABLE IC GASEOUS EFFLUENTS - GROUND RELEASES - CONTINUOUS MODE Unit 1 2007 REPORT FOR 2007 Units QTR 1 QTR 2 QTR 3 QTR 4 YEAR Fission and Activation Gases XE-133 Ci 1. 59E-01 0. 00E+00 0. OOE+00 1.05E-02 1.70E-01 Totals for Period... Ci 1. 59E-01 0. OOE+00 0. OOE+00 1.05E-02 1.70E-01 Iodines 1-131 Ci 0. OOE+00 3.33E-06 8. 48E-06 1.30E-05 2.49E-05 1-132 Ci 0. OOE+00 0. OOE+00 0. OOE+00 1. 05E-04 1. 05E-04 1-133 Ci 5. 46E-06 2. IE-05 4. 72E-05 6. lE-05 1.35E-04 Totals for Period... Ci 5. 46E-06 2. 43E-05 5.57E-05 1.79E-04 2. 65E-04 Particulates Half Life >= 8 dayE CS-136 Ci 0. OOE+00 0. OOE+00 0. OOE+00 9. 30E-07 9. 30E-07 SN-113 Ci 7. 09E-07 0. OOE+00 0. OOE+00 0 . OOE+00 7. 09E-07 Totals for Period... Ci 7. 09E-07 0 . OOE+00 0. OOE+00 9. 30E-07 1. 64E-06 Others BR-82 Ci 1. 02E-06 0. OOE+00 0. OOE+00 0. OOE+00 1. 02E-06 Totals for Period... Ci 1. 02E-06 0. OOE+00 0 . OOE+00 0.OOE+00 1. 02E-06 Tritium H-3 Ci 2.39E+00 6. 41E+00 5. 15E+00 8. 65E+00 2 .26E+01 Totals for Period... Ci 2.39E+00 6.41E+00 5. 15E+00 8. 65E+00 2 .26E+01 Page 15 of 88

EFFLUENT AND WASTE DISPOSAL REPORT TABLE IC GASEOUS EFFLUENTS - GROUND RELEASES - BATCH MODE Unit 1 2007 REPORT FOR 2007 Units QTR 1 QTR 2 QTR 3 QTR 4 YEAR Fission and Activation Gases AR-41 Ci 0. 00E+00 0. OOE+00 9. 37E-04 0 OOE+00 9.37E-04 KR-85 Ci 2. 71E-03 1. 06E-03 0. OOE+00 0 OOE+00 3.77E-03 KR-85M Ci 0. OOE+00 9. 14E-06 0. OOE+00 0.OOE+00 9. 14E-06 XE-131M Ci 0. OOE+00 0. OOE+00 0. OOE+00 1. 93E-04 1. 93E-04 XE-133 Ci 5. 57E-02 2. 80E-02 1. 86E-02 3. 17E-02 1.34E-01 XE-133M Ci 1. 82E-05 7 .72E-05 0. OOE+00 4. 70E-05 1.42E-04 XE-135 Ci 3. 50E-06 7. 53E-04 4. 13E-04 2 .23E-04 1.39E-03 XE-138 Ci 0. OOE+00 0. OOE+00 2 . lOE-03 0.OOE+00 2.10E-03 Totals for Period... Ci 5.84E-02 2.99E-02 2.21E-02 3.22E-02 1.43E-01 Iodines

- No Nuclide Activities 8 a Particulates Half Life >= 8 days

- No Nuclide Activities **

Others

- No Nuclide Activities **

Tritium

- No Nuclide Activities Page 16 of 88

EFFLUENT AND WASTE DISPOSAL REPORT TABLE 2A LIQUID EFFLUENTS - SUMMATION OF ALL RELEASES Unit 1 2007 REPORT FOR 2007 Units QTR 1 QTR 2 QTR 3 QTR 4 YEAR Fission and Activation Gases

1. Total Release Ci 3.13E-03 4.64E-03 2.02E-03 3.28E-03 1.31E-02

2. Avg. Diluted Conc. uCi/ml 1.18E-09 1.59E-09 5.66E-10 8.89E-10 1.02E-09 Tritium

1. Total Release Ci 4.81E+02 1.61E+02 1.43E+02 5.87E+02 1.37E+03

2. Avg. Diluted Conc. uCi/ml 1.81E-04 5.53E-05 4.01E-05 1.59E-04 1.07E-04 Dissolved and Entrained Gases

1. Total Release Ci 6.47E-04 7.02E-05 0.00E+00 4.59E-04 1.18E-03

2. Avg. Diluted Conc. uCi/ml 2.43E-10 2.41E-11 0.OOE+00 1.24E-10 9.22E-11 Volume of liquid waste liters 2.66E+09 2.91E+09 3.57E+09 3.69E+09 1.28E+10 Volume of dil. water liters 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 Page 17 of 88

EFFLUENT AND WASTE DISPOSAL REPORT TABLE 2A - Rock River LIQUID EFFLUENTS - SUMMATION BY RELEASE POINT Unit 1 2007 REPORT FOR 2007 Units QTR 1 QTR 2 QTR 3 QTR 4 YEAR Fission and Activation Gases

1. Total Release Ci 3.13E-03 4.64E-03 2.01E-03 3.28E-03 1.31E-02

2. Avg. Diluted Conc. uCi/ml 2.85E-06 4.14E-06 2.89E-06 3.97E-06 3.50E-06 Tritium

1. Total Release Ci 4.70E+02 1.44E+02 1.18E+02 3.58E+02 1.09E+03

2. Avg. Diluted Conc. uCi/ml 4.27E-01 1.29E-01 1.70E-01 4.33E-01 2.91E-01 Dissolved and Entrained Gases

1. Total Release Ci 6.47E-04 7.02E-05 0.00E+00 4.59E-04 1.18E-03

2. Avg. Diluted Conc. uCi/ml 5.88E-07 6.27E-08 0.00E+00 5.55E-07 3.16E-07 Volume of liquid waste liters 1.10E+06 1.12E+06 6.95E+05 8.27E+05 3.74E+06 Volume of dil. water liters 0.00E+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 Page 18 of 88

EFFLUENT AND WASTE DISPOSAL REPORT TABLE 2A - Circulating Water Blowdown LIQUID EFFLUENTS - SUMMATION BY RELEASE POINT Unit 1 2007 REPORT FOR 2007 Units QTR 1 QTR 2 QTR 3 QTR 4 YEAR Fission and Activation Gases

1. Total Release Ci 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00

2. Avg. Diluted Conc. uCi/ml 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Tritium

1. Total Release Ci 1.03E+01 1.73E+01 2.55E+01 2.28E+02 2.81E+02

2. Avg. Diluted Conc. uCi/ml 3.87E-06 5.95E-06 7.14E-06 6.18E-05 2.20E-05 Dissolved and Entrained Gases

1. Total Release Ci 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00

2. Avg. Diluted Conc. uCi/ml 0.00E+00 0.OOE+00 0.OOE+00 0.00E+00 0.OOE+00 Volume of liquid waste liters 2.66E+09 2.91E+09 3.57E+09 3.69E+09 1.28E+10 Volume of dil. water liters 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.OOE+00 Page 19 of 88

EFFLUENT AND WASTE DISPOSAL REPORT TABLE 2B LIQUID EFFLUENTS - CONTINUOUS MODE Unit 1 2007 REPORT FOR 2007 Units QTR 1 QTR 2 QTR 3 QTR 4 YEAR Fission and Activation Gases

- No Nuclide Activities **

Tritium H-3 Ci 1. 03E+01 1.73E+01 2. 55E+01 2 .28E+02 2 .81E+02 Totals for Period... Ci 1. 03E+01 1.73E+01 2. 55E+01 2 .28E+02 2 .81E+02 Dissolved and Entrained Gases

- No Nuclide Activities **

Page 20 of 88

EFFLUENT AND WASTE DISPOSAL REPORT TABLE 2B LIQUID EFFLUENTS - BATCH MODE Unit 1 2007 REPORT FOR 2007 Units QTR 1 QTR 2 QTR 3 QTR 4 YEAR Fission and Activation Gases CO-57 Ci 0. 00E+00 5.27E-06 8.30E-07 9.27E-06 1. 54E-05 CO-58 Ci 1. 29E-03 3 .72E-03 1. 02E-03 1 .01E-03 7 .04E-03 CO-60 Ci 1.40E-04 7. OOE-04 1. 31E-04 3. 31E-04 1. 30E-03 CR-51 Ci 0. 00E+00 1.17E-04 0. OOE+00 0 . OOE+00 1. 17E-04 FE-59 Ci 0. OOE+00 2 .28E-05 0. OOE+00 0. OOE+00 2 .28E-05 MN-54 Ci 0. OOE+00 2.01E-05 0. OOE+00 1.46E-05 3. 46E-05 NB-95 Ci 0 . OOE+00 1.45E-05 6. 32E-06 3. 13E-06 2. 40E-05 SB-125 Ci 0 . OOE+00 3. 59E-05 7. 72E-06 0 OOE+00 4 36E-05 SB-126 Ci 0. OOE+00 0. OOE+00 0. OOE+00 1.28E-06 1. 28E-06 SR-85 Ci 1.50E-06 0. OOE+00 0. OOE+00 0 OOE+00 1. 50E-06 TE-123M Ci 5.36E-06 5. 24E-06 2. 74E-06 0. OOE+00 1. 33E-05 TE-125M Ci 1.69E-03 0. OOE+00 8. 46E-04 1. 91E-03 4 .45E-03 Totals for Period... Ci 3.13E-03 4.64E-03 2.01E-03 3.28E-03 1.31E-02 Tritium H-3 Ci 4.70E+02 1.44E+02 1.18E+02 3.58E+02 1.09E+03 Totals for Period... Ci 4.70E+02 1.44E+02 1.18E+02 3.58E+02 1.09E+03 Dissolved and Entrained Gases KR-85 Ci 3.44E-04 0. OOE+00 0. OOE+00 0 . OOE+00 3.44E-04 XE-133 Ci 9. 41E-05 7. 02E-05 0. OOE+00 4.59E-04 6.23E-04 XE-135M Ci 2.09E-04 0. OOE+00 0. OOE+00 0 . OOE+00 2.09E-04 Totals for Period... Ci 6.47E-04 7.02E-05 0.OOE+00 4.59E-04 1.18E-03 Page 21 of 88

EFFLUENT AND WASTE DISPOSAL REPORT TABLE lA GASEOUS EFFLUENTS - SUMMATION OF ALL RELEASES Reg Guide 1.21 - Unit 2 All Gas REPORT FOR 2007 Units QTR 1 QTR 2 QTR 3 QTR 4 YEAR Fission and Activation Gases

1. Total Release Ci 1.67E-01 3.15E-02 0.OOE+00 4.40E-02 2.43E-01

2. Avg. Release Rate uCi/sec 2.15E-02 4.01E-03 0.OOE+00 5.54E-03 7.71E-03 Iodine-131

1. Total Release Ci 7.95E-07 1.88E-07 8.19E-07 8.24E-07 2.63E-06

2. Avg. Release Rate uCi/sec 1.02E-07 2.39E-08 1.03E-07 1.04E-07 8.34E-08 Particulates Half Life >= 8 days

1. Total Release Ci 0.OOE+00 0.OOE+00 4.16E-04 0.00E+00 4.16E-04

2. Avg. Release Rate uCi/sec 0.00E+00 0.OOE+00 5.23E-05 0.OOE+00 1.32E-05 Tritium

1. Total Release Ci 1.71E+01 7.70E+00 6.48E+00 1.13E+01 4.25E+01

2. Avg. Release Rate uCi/sec 2.20E+00 9.79E-01 8.15E-01 1.42E+00 1.35E+00 Page 22 of 88

EFFLUENT AND WASTE DISPOSAL REPORT TABLE IC GASEOUS EFFLUENTS - GROUND RELEASES - CONTINUOUS MODE Unit 2 2007 REPORT FOR 2007 Units QTR 1 QTR 2 QTR 3 QTR 4 YEAR Fission and Activation Gases XE-133 Ci 1. 59E-01 0 .00E+00 0. OOE+00 2.49E-02 1. 84E-01 Totals for Period... Ci 1. 59E-01 0 .OOE+00 0. OOE+00 2. 49E-02 1.84E-01 Iodines 1-131 Ci 7. 95E-07 1.88E-07 8.19E-07 8. 24E-07 2. 63E-06 1-133 Ci 0. 00E+00 0. 00E+00 4. 97E-06 1.44E-05 1.93E-05 Totals for Period... Ci 7. 95E-07 1.88E-07 5. 79E-06 1. 52E-05 2. 19E-05 Particulates Half Life >= 8 days TE-125M Ci 0.OOE+00 0 . OOE+00 4. 16E-04 0. OOE+00 4.16E-04 Totals for Period... Ci 0.00E+00 0. OOE+00 4. 16E-04 0. OOE+00 4. 16E-04 Tritium H-3 Ci 1.71E+01 7. 70E+00 6. 48E+00 1. 13E+01 4 .25E+01 Totals for Period... Ci 1.71E+01 7. 70E+00 6 . 48E+00 1. 13E+01 4.25E+01 Page 23 of 88

EFFLUENT AND WASTE DISPOSAL REPORT TABLE IC GASEOUS EFFLUENTS - GROUND RELEASES - BATCH MODE Unit 2 2007 REPORT FOR 2007 Units QTR 1 QTR 2 QTR 3 QTR 4 YEAR Fission and Activation Gases AR-41 Ci 5.28E-04 0.00E+00 0.00E+00 2.80E-03 3.33E-03 KR-85 Ci 2.71E-03 1.06E-03 0.00E+00 0.00E+00 3.77E-03 KR-85M Ci 0.00E+00 9.14E-06 0.00E+00 0.00E+00 9.14E-06 XE-131M Ci 0.00E+00 0.00E+00 0.00E+00 1.93E-04 1.93E-04 XE-133 Ci 4.84E-03 8.78E-03 0.00E+00 1.60E-02 2.97E-02 XE-133M Ci 1.82E-05 7.72E-05 0.00E+00 4.70E-05 1.42E-04 XE-135 Ci 3.50E-06 2.17E-02 0.OOE+00 0.00E+00 2.97E-02 Totals for Period... Ci 8.10E-03 3.16E-02 0.00E+00 1.90E-02 5.88E-02 Iodines

- No Nuclide Activities ** .......

Particulates Half Life >= 8 days

- No Nuclide Activities ** ........

Tritium

- No Nuclide Activities **

Page 24 of 88

EFFLUENT AND WASTE DISPOSAL REPORT TABLE 2A LIQUID EFFLUENTS - SUMMATION OF ALL RELEASES Unit 2 2007 REPORT FOR 2007 Units QTR 1 QTR 2 QTR 3 QTR 4 YEAR Fission and Activation Gases

1. Total Release Ci 3.13E-03 4.64E-03 2.02E-03 3.28E-03 1.31E-02

2. Avg. Diluted Conc. uCi/ml 1.18E-09 1.59E-09 5.66E-10 8.89E-10 1.02E-09 Tritium

1. Total Release Ci 4.81E+02 1.61E+02 1.43E+02 5.87E+02 1.37E+03

2. Avg. Diluted Conc. uCi/ml 1.81E-04 5.53E-05 4.01E-05 1.59E-04 1.07E-04 Dissolved and Entrained Gases

1. Total Release Ci 6.47E-04 7.02E-05 0.OOE+00 4.59E-04 1.18E-03

2. Avg. Diluted Conc. uCi/ml 2.43E-10 2.41E-11 0.OOE+00 1.24E-10 9.22E-11 Volume of liquid waste liters 2.66E+09 2.91E+09 3.57E+09 3.69E+09 1.28E+10 Volume of dil. water liters 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Page 25 of 88

EFFLUENT AND WASTE DISPOSAL REPORT TABLE 2A - Rock River LIQUID EFFLUENTS - SUMMATION BY RELEASE POINT Unit 2 2007 REPORT FOR 2007 Units QTR 1 QTR 2 QTR 3 QTR 4 YEAR Fission and Activation Gases

1. Total Release Ci 3.13E-03 4.64E-03 2.01E-03 3.28E-03 1.31E-02

2. Avg. Diluted Conc. uCi/ml 2.85E-06 4.14E-06 2.89E-06 3.97E-06 3.50E-06 Tritium

1. Total Release Ci 4.70E+02 1.44E+02 1.18E+02 3.58E+02 1.09E+03

2. Avg. Diluted Conc. uCi/ml 4.27E-01 1.29E-01 1.70E-01 4.33E-01 2.91E-01 Dissolved and Entrained Gases

1. Total Release Ci 6.47E-04 7.02E-05 0.00E+00 4.59E-04 1.18E-03

2. Avg. Diluted Conc. uCi/ml 5.88E-07 6.27E-08 0.00E+00 5.55E-07 3.16E-07 Volume of liquid waste liters 1.10E+06 1.12E+06 6.95E+05 8.27E+05 3.74E+06 Volume of dil. water liters 0.OOE+00 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 Page 26 of 88

EFFLUENT AND WASTE DISPOSAL REPORT TABLE 2A - Circulating Water Blowdown LIQUID EFFLUENTS - SUMMATION BY RELEASE POINT Unit 2 2007 REPORT FOR 2007 Units QTR 1 QTR 2 QTR 3 QTR 4 YEAR Fission and Activation Gases

1. Total Release Ci 0.OOE+00 0.00E+00 0.00E+00 0.00E+00 0.OOE+00

2. Avg. Diluted Conc. uCi/ml 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.OOE+00 Tritium

1. Total Release Ci 1.03E+01 1.73E+01 2.55E+01 2.28E+02 2.81E+02

2. Avg. Diluted Conc. uCi/ml 3.87E-06 5.95E-06 7.14E-06 6.18E-05 2.20E-05 Dissolved and Entrained Gases

1. Total Release Ci 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 0.00E+00

2. Avg. Diluted Conc. uCi/ml 0.00E+00 0.OOE+00 0.00E+00 0.00E+00 0.00E+00 Volume of liquid waste liters 2.66E+09 2.91E+09 3.57E+09 3.69E+09 1.28E+10 Volume of dil. water liters 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.00E+00 Page 27 of 88

EFFLUENT AND WASTE DISPOSAL REPORT TABLE 2B LIQUID EFFLUENTS - CONTINUOUS MODE Unit 2 2007 REPORT FOR 2007 Units QTR 1 QTR 2 QTR 3 QTR 4 YEAR Fission and Activation Gases

- No Nuclide Activities **

Tritium H-3 Ci 1. 03E+01 1. 73E+01 2.55E+01 2 .28E+02 2.81E+02 Totals for Period... Ci 1. 03E+01 1. 73E+01 2 . 55E+01 2 .28E+02 2.81E+02 Dissolved and Entrained Gases

- No Nuclide Activities **

Page 28 of 88

EFFLUENT AND WASTE DISPOSAL REPORT TABLE 2B LIQUID EFFLUENTS - BATCH MODE Unit 2 2007 REPORT FOR 2007 Units QTR 1 QTR 2 QTR 3 QTR 4 YEAR Fission and Activation Gases CO-57 Ci 0. 00E+00 5. 27E-06 8. 30E-07 9 . 27E-06 1. 54E-05 CO-58 Ci 1. 29E-03 3. 72E-03 1. 02E-03 1. 01E-03 7. 04E-03 CO-60 Ci 1. 40E-04 7 OOE-04 1. 31E-04 3 .31E-04 1 .30E-03 CR-51 Ci 0. 00E+00 1. 17E-04 0. OOE+00 0 . OOE+00 1. 17E-04 FE-59 Ci 0. 00E+00 2 28E-05 0. OOE+00 0 . OOE+00 2 .28E-05 MN-54 Ci 0. 00E+00 2 01E-05 0. OOE+00 1.46E-05 3 .46E-05 NB-95 Ci 0. OOE+00 1. 45E-05 6 32E-06 3. 13E-06 2. 40E-05 SB-125 Ci 0. OOE+00 3 59E-05 7. 72E-06 0 . OOE+00 4 .36E-05 SB-126 Ci 0. OOE+00 0. OOE+00 0. OOE+00 1. 28E-06 1 .28E-06 SR-85 Ci 1. 50E-06 0. OOE+00 0. OOE+00 0. OOE+00 1. 50E-06 TE-123M Ci 5. 36E-06 5.24E-06 2. 74E-06 0. OOE+00 1.33E-05 TE-125M Ci 1. 69E-03 0. OOE+00 8. 46E-04 1.91E-03 4. 45E-03 Totals for Period... Ci 3.13E-03 4.64E-03 2.01E-03 3.28E-03 1.31E-02 Tritium H-3 Ci 4. 70E+02 1. 44E+02 1. 18E+02 3 .58E+02 1. 09E+03 Totals for Period... Ci 4. 70E+02 1 .44E+02 1. 18E+02 3 .58E+02 1. 09E+03 Dissolved and Entrained Gases KR-85 Ci 3.44E-04 0 .OOE+00 0. OOE+00 0. OOE+00 3.44E-04 XE-133 Ci 9.41E-05 7. 02E-05 0. OOE+00 4. 59E-04 6. 23E-04 XE-135M Ci 2. 09E-04 0. OOE+00 0. OOE+00 0. OOE+00 2.09E-04 Totals for Period... Ci 6. 47E-04 7. 02E-05 0. OOE+00 4. 59E-04 1.18E-03 Page 29 of 88

GASEOUS RELEASE AND DOSE

SUMMARY

REPORT - BY UNIT (Composite Critical Receptor - Limited Analysis)

Release ID ............. 1 All Gas Release Types Period Start Date .... : 01/01/2007 00:00 Period End Date ...... :.01/01/2008 00:00 Period Duration (min): 5.256E+05 Coefficient Type ..... : Historical Unit .................. : 1 RELEASE DATA Total Release Duration (minutes) ...................................... 5.565E+05 Total Release Volume (cf) ............................................. 6.455E+10 Average Release Flowrate (cfm) ........................................ 1.160E+05 Average Period Flowrate (cfm) .......................................... 1.228E+05 NUCLIDE DATA Average EC Nuclide uCi uCi/cc Ratio EC AR-41 9.37E+02 5.13E-13 5.13E-05 1.00E-08 KR-85M 9.14E+00 5.OOE-15 5.OOE-08 1.00E-07 KR-85 3.77E+03 2.06E-12 2.95E-06 7.OOE-07 XE-131M 1.93E+02 1.05E-13 5.27E-08 2.OOE-06 XE-133M 1.42E+02 7.79E-14 1.30E-07 6.OOE-07 XE-133 2.93E+05 1.60E-10 3.21E-04 5.OOE-07 XE-135 1.39E+03 7.62E-13 1.09E-05 7.OOE-08 XE-138 2.10E+03 1.15E-12 5.74E-05 2.OOE-08 F&AG 3.02E+05 1.65E-10 4.44E-04 1-131 2.49E+01 1.36E-14 6.80E-05 2.OOE-10 1-132 1.05E+02 5.72E-14 2.86E-06 2.OOE-08 1-133 1.35E+02 7.37E-14 7.37E-05 1.OOE-09 Iodine 2.64E+02 1.44E-13 1.45E-04 BR-82 1.02E+00 5.58E-16 1.12E-07 5.OOE-09 Other 1.02E+00 5.58E-16 1.12E-07 H-3 2.26E+07 1.24E-08 1.24E-01 1.OOE-07 H-3 2.26E+07 1.24E-08 1.24E-01 SN-113 7.09E-01 3.88E-16 4.85E-07 8.OOE-10 CS-136 9.30E-01 5.09E-16 5.66E-07 9.OOE-10 P>=8 1.64E+00 8.97E-16 1.05E-06 Page 30 of 88

GASEOUS RELEASE AND DOSE

SUMMARY

REPORT - BY UNIT (Composite Critical Receptor - Limited Analysis)

Release ID ............. 1 All Gas Release Types Period Start Date .... :.01/01/2007 00:00 Period End Date ...... :.01/01/2008 00:00 Period Duration (min): 5.256E+05 Coefficient Type ..... :.Historical Unit ................. 1 NUCLIDE DATA Average EC Nuclide uCi uCi/cc Ratio EC Total 2.29E+07 1.25E-08 1.24E-01 Page 31 of 88

GASEOUS RELEASE AND DOSE

SUMMARY

REPORT - BY UNIT (Composite Critical Receptor - Limited Analysis)

Release ID ............. 1 All Gas Release Types Period Start Date .... :.01/01/2007 00:00 Period End Date ...... :.01/01/2008 00:00 Period Duration (min): 5.256E+05 Coefficient Type ..... : Historical Unit .................. 1 MAXIMUM I&P DOSE FOR PERIOD Limit Organ Age Dose Limit Limit Percent Type Type Group Organ (mrem) Period (mrem) of Limit Admin Any Orgzan INFANT THYROID 8.67E-03 31-day 2.25E-01 3.85E+00 Quarter 5.63E+00 1.54E-01 Annual 1.13E+01 7.70E-02 T.Spec Any Org*an INFANT THYROID 8.67E-03 31-day 3. OOE-01 2 . 89E+00 Quarter 7 . 50E+00 1.16E-01 Annual 1. 50E+01 5. 78E-02 Receptor ................... 5 Composite Crit. Receptor - IP Distance (meters) ......... 0.0 Compass Point ........... : 0.0 Critical Pathway ........ : 3 Grs/Goat/Milk (GMILK)

Major Contributors ...... :.0.0 % or greater to total Nuclide Percentage H-3 1. 68E+01 1-131 7 . 92E+01 1-132 3. 09E-03 1-133 4. OOE+00 CS-136 1.92E-04 Page 32 of 88

GASEOUS RELEASE AND DOSE

SUMMARY

REPORT - BY UNIT (Composite Critical Receptor - Limited Analysis)

Release ID ............ 1 All Gas Release Types Period Start Date .... 01/01/2007 00:00 Period End Date ....... 01/01/2008 00:00 Period Duration (min): 5.256E+05 Coefficient Type ...... Historical Unit .................

==PERIOD ORGAN DOSE BY AGE GROUP AND PATHWAY (mrem)

Age/Path Bone Liver Thyroid Kidney Lung GI-Lli Skin TB AGPD 1.23E-07 1. 23E-07 1.23E-07 1. 23E-07 1.23E-07 1. 23E-07 0. OOE+00 1 23E-07 AINHL 2. 78E-08 2.32E-04 2.40E-04 2 .32E-04 2 .32E-04 2 .32E-04 0. OOE+00 2 32E-04 AVEG 2 77E-07 4.16E-04 5.36E-04 4. 16E-04 4. 15E-04 4. 16E-04 0. OOE+00 4. 16E-04 AGMILK 1. 21E-06 2.88E-04 7.99E-04 2 .89E-04 2. 86E-04 2. 87E-04 0. OOE+00 2 87E-04 ACMEAT 3 31E-08 5. 98E-05 7. 46E-05 5. 98E-05 5. 97E-05 5. 97E-05 0. OOE+00 5. 97E-05 ACMILK 9. 69E-07 1.42E-04 5.67E-04 1. 43E-04 1.40E-04 1.41E-04 0. OOE+00 1. 41E-04 TGPD 1. 23E-07 1. 23E-07 1.23E-07 1 .23E-07 1. 23E-07 1.23E-07 0. OOE+00 1. 23E-07 TINHL 3. 90E-08 2.34E-04 2.45E-04 2 34E-04 2.34E-04 2 .34E-04 0. OOE+00 2 34E-04 TVEG 2. 63E-07 4.76E-04 5.76E-04 4. 76E-04 4.75E-04 4. 75E-04 0. OOE+00 4. 76E-04 TGMILK 2. 20E-06 3.76E-04 1.18E-03 3. 78E-04 3.72E-04 3. 73E-04 0. OOE+00 3. 74E-04 TCMEAT 2. 75E-08 3.56E-05 4.64E-05 3. 56E-05 3. 56E-05 3. 56E-05 0. OOE+00 3 56E-05 TCMILK 1. 75E-06 1. 85E-04 8. 60E-04 1. 87E-04 1.83E-04 1. 83E-04 0. OOE+00 1. 84E-04 CGPD 1. 23E-07 1.23E-07 1.23E-07 1. 23E-07 1.23E-07 1.23E-07 0. OOE+00 1. 23E-07 CINHL 5 .29E-08 2. 06E-04 2 .20E-04 2. 06E-04 2.06E-04 2. 06E-04 0. OOE+00 2 06E-04 CVEG 4. 89E-07 7 .39E-04 8. 92E-04 7. 39E-04 7.38E-04 7 .38E-04 0. OOE+00 7. 38E-04 CGMILK 5 30E-06 5.96E-04 2 .21E-03 5. 99E-04 5. 90E-04 5. 90E-04 0. OOE+00 5. 93E-04 CCMEAT 5. 08E-08 4. 32E-05 5. 94E-05 4. 32E-05 4. 31E-05 4. 31E-05 0. OOE+00 4 32E-05 CCMILK 4 25E-06 2.94E-04 1. 64E-03 2. 96E-04 2. 89E-04 2. 90E-04 0. OOE+00 2. 92E-04 IGPD 1.23E-07 1.23E-07 1.23E-07 1. 23E-07 1.23E-07 1.23E-07 0. OOE+00 1. 23E-07 IINHL 4 .20E-08 1.19E-04 1.31E-04 1. 19E-04 1. 19E-04 1. 19E-04 0. OOE+00 1. 19E-04 IGMILK 1. 10E-05 9. 09E-04 4. 82E-03 9. lOE-04 8. 95E-04 8. 96E-04 0. OOE+00 9. OIE-04 ICMILK 8. 86E-06 4. 50E-04 3.71E-03 4. 51E-04 4.39E-04 4.39E-04 0. OOE+00 4. 43E-04 TOTALS --

ADULT 2. 64E-06 1.14E-03 2. 22E-03 1.14E-03 1. 13E-03 1.13E-03 0. OOE+00 1.14E-03 TEEN 4.40E-06 1.31E-03 2. 91E-03 1.31E-03 1. 30E-03 1. 30E-03 0. OOE+00 1.30E-03 CHILD 1. 03E-05 1. 88E-03 5. 01E-03 1. 88E-03 1. 87E-03 1. 87E-03 0. OOE+00 1. 87E-03 INFANT 2. OOE-05 1.48E-03 8. 67E-03 1.48E-03 1. 45E-03 1.45E-03 0. OOE+00 1.46E-03 AGE GROUP / PATHWAY DESCRIPTIONS Abbreviation Age Group Pathway AGPD ADULT Ground Plane Deposition (GPD)

AINHL ADULT Inhalation (INHL)

AVEG ADULT Vegetation (VEG)

AGMILK ADULT Grs/Goat/Milk (GMILK)

ACMEAT ADULT Grs/Cow/Meat (CMEAT)

ACMILK ADULT Grs/Cow/Milk (CMILK)

TGPD TEEN Ground Plane Deposition (GPD)

TINHL TEEN Inhalation (INHL)

Page 33 of 88

GASEOUS RELEASE AND DOSE

SUMMARY

REPORT - BY UNIT (Composite Critical Receptor - Limited Analysis)

Release ID ............. 1 All Gas Release Types Period Start Date .... :.01/01/2007 00:00 Period End Date ...... .. 01/01/2008 00:00 Period Duration (min): 5.256E+05 Coefficient Type ..... : Historical Unit .................. 1 AGE GROUP / PATHWAY DESCRIPTIONS Abbreviation Age Group Pathway TVEG TEEN Vegetation (VEG)

TGMILK TEEN Grs/Goat/Milk (GMILK)

TCMEAT TEEN Grs/Cow/Meat (CMEAT)

TCMILK TEEN Grs/Cow/Milk (CMILK)

CGPD CHILD Ground Plane Deposition (GPD)

CINHL CHILD Inhalation (INHL)

CVEG CHILD Vegetation (VEG)

CGMILK CHILD Grs/Goat/Milk (GMILK)

CCMEAT CHILD Grs/Cow/Meat (CMEAT)

CCMILK CHILD Grs/Cow/Milk (CMILK)

IGPD INFANT Ground Plane Deposition (GPD)

IINHL INFANT Inhalation (INHL)

IGMILK INFANT Grs/Goat/Milk (GMILK)

ICMILK INFANT Grs/Cow/Milk (CMILK)

Page 34 of 88

GASEOUS RELEASE AND DOSE

SUMMARY

REPORT - BY UNIT (Composite Critical Receptor - Limited Analysis)

Release ID.............. 1 All Gas Release Types Period Start Date .... :.01/01/2007 00:00 Period End Date....... 01/01/2008 00:00 Period Duration (min): 5.256E+05 Coefficient Type ..... : Historical Unit .................. 1 MAXIMUM NG DOSE FOR PERIOD Limit Dose Limit Limit Percent Type Dose Type (mrad) Period (mrad) of Limit Admin Gamma 7. 80E-06 31-day 1.50E-01 5.20E-03 Quarter 3. 75E+00 2.08E-04 Annual 7 . 50E+00 1.04E-04 Admin Beta 4.73E-06 31-day 3.OOE-01 1.58E-03 Quarter 7 . 50E+00 6.31E-05 Annual 1. 50E+01 3.16E-05 T.Spec Gamma 7.80E-06 31-day 2 . OOE-01 3.90E-03 Quarter 5 . OOE+00 1.56E-04 Annual 1. OOE+01 7.80E-05 Receptor ................... 4 Composite Crit. Receptor - NG Distance (meters) ......... 0.0 Compass Point ............. 0.0 Major Contributors ...... :.0.0 % or greater to total Nuclide Percentage AR-41 6.49E+00 KR-85M 8.37E-03 KR-85 4.82E-02 XE-131M 2.24E-02 XE-133M 3.47E-02 XE-133 7.70E+01 XE-135 1.99E+00 XE-138 1.44E+01 T. Spec Beta 4.73E-06 31-day 4. OOE-01 1.18E-03 Quarter 1. OOE+01 4. 73E-05 Annual 2 . OOE+01 2.37E-05 Receptor ................... 4 Composite Crit. Receptor - NG Distance (meters) ....... : 0.0 Compass Point ............. 0.0 Major Contributors ...... :.0.0 % or greater to total Nuclide Percentage AR-41 9.26E-01 Page 35 of 88

GASEOUS RELEASE AND'DOSE

SUMMARY

REPORT - BY UNIT (Composite Critical Receptor - Limited Analysis)

Release ID ............. 1 All Gas Release Types Period Start Date .... :.01/01/2007 00:00 Period End Date ...... .. 01/01/2008 00:00 Period Duration (min): 5.256E+05 Coefficient Type ..... : Historical Unit .................. : 1 Major Contributors ...... : 0.0 % or greater to total Nuclide Percentage KR-85M 5.42E-03 KR-85 2.21E+00 XE-131M 6.45E-02 XE-133M 6.35E-02 XE-133 9.27E+01 XE-135 1.03E+00 XE-138 3.OOE+00 Page 36 of 88

LIQUID RELEASE AND DOSE

SUMMARY

REPORT

(PERIOD BASIS - BY UNIT)------

Release ID .............. 1 All Liquid Releases Period Start Date ..... 01/01/2007 00:00 Period End Date ....... :.01/01/2008 00:00 Period Duration (mins): 5.256E+05 Unit ................... 1 MULTIPLE RELEASE POINT MESSAGE Undiluted and Diluted Flowrate(s) and Concentration(s) cannot be combined.

RELEASE DATA Total Release Duration (minutes) ..................................... 5.847E+05 Total Undiluted Volume Released (gallons) ............................ NA Average Undiluted Flowrate (gpm) ..................................... NA Total Dilution Volume (gallons) ...................................... NA Average Dilution Flowrate (gpm) ....................................... NA NUCLIDE DATA Nuclide uCi CO-57 1.54E+01 SB-125 4.36E+01 TE-123M 1.33E+01 SB-126 1.28E+00 CR-51 1.17E+02 MN-54 3.46E+01 FE-59 2.28E+01 CO-58 7.04E+03 CO-60 1.30E+03 NB-95 2.40E+01 TE-125M 4.45E+03 Gamma 1.31E+04 KR-85 3.44E+02 XE-133 6.23E+02 XE-135M 2.09E+02 D&EG 1.18E+03 SR-85 1.50E+00 H-3 1.37E+09 Beta 1.37E+09 Total 1.37E+09 Page 37 of 88

LIQUID RELEASE AND DOSE

SUMMARY

REPORT

(PERIOD BASIS - BY UNIT)------

Release ID .............. 1 All Liquid Releases Period Start Date ..... .. 01/01/2007 00:00 Period End Date ....... .. 01/01/2008 00:00 Period Duration (mins): 5.256E+05 Unit .................. 1 Receptor ................. 0 Liquid Receptor PERMIT ORGAN DOSE BY AGE GROUP AND PATHWAY (mrem)

Age/Path Bone Liver Thyroid Kidney Lung GI-Lli Skin TB APWtr 3.87E-06 2.13E-02 2.13E-02 2.13E-02 2. 13E-02 2 14E-02 0. OOE+00 2. 13E-02 AFWFSp 4.43E-03 5. 72E-02 5. 65E-02 7. 32E-02 5. 52E-02 9. 44E-02 0. OOE+00 5. 66E-02 TPWtr 3.86E-06 1. 50E-02 1.50E-02 1. 50E-02 1.50E-02 1. 51E-02 0. OOE+00 1. 50E-02 TFWFSp 4.82E-03 4. 46E-02 4. 37E-02 4. 24E-02 4.24E-02 7. 16E-02 0. OOE+00 4. 39E-02 CPWtr 1.15E-05 2. 88E-02 2. 88E-02 2. 88E-02 2.88E-02 2. 89E-02 0. OOE+00 2. 88E-02 CFWFSp 6.19E-03 3.71E-02 3. 68E-02 3 51E-02 3. 51E-02 4. 64E-02 0. OOE+00 3 68E-02 IPWtr 1.52E-05 2 . 83E-02 2. 83E-02 2 83E-02 2. 83E-02 2. 83E-02 0. OOE+00 2. 83E-02 TOTALS- -------------------------------------

ADULT 4.43E-03 7.85E-02 7.78E-02 9.45E-02 7.65E-02 1.16E-01 0.OOE+00 7.79E-02 TEEN 4.82E-03 5.96E-02 5.87E-02 5.74E-02 5.74E-02 8.67E-02 0.OOE+00 5.89E-02 CHILD 6.20E-03 6.60E-02 6.57E-02 6.39E-02 6.39E-02 7.52E-02 0.OOE+00 6.57E-02 INFANT 1.52E-05 2.83E-02 2.83E-02 2.83E-02 2.83E-02 2.83E-02 0.OOE+00 2.83E-02

==AGE GROUP / PATHWAY DESCRIPTIONS Abbreviation Age Group Pathway APWtr ADULT Potable Water (PWtr)

AFWFSp ADULT Fresh Water Fish - Sport (FFSP)

TPWtr TEEN Potable Water (PWtr)

TFWFSp TEEN Fresh Water Fish - Sport (FFSP)

CPWtr CHILD Potable Water (PWtr)

CFWFSp CHILD Fresh Water Fish - Sport (FFSP)

IPWtr INFANT Potable Water (PWtr)

Page 38 of 88

LIQUID RELEASE AND DOSE

SUMMARY

REPORT (PERIOD BASIS - BY UNIT)------

Release ID .............. 1 All Liquid Releases Period Start Date ..... :.01/01/2007 00:00 Period End Date ....... .. 01/01/2008 00:00 Period Duration (mins): 5.256E+05 Unit ................... 1 Receptor ................. 0 Liquid Receptor PERMIT ORGAN DOSE BY AGE GROUP AND NUCLIDE (mrem)

Agegroup Bone Liver Thyroid Kidney Lung GI-Lli Skin TB ADULT H-3 0.OOE+00 7.65E-02 7.65E-02 7.65E-02 7.65E-02 7.65E-02 0.OOE+00 7.65E-02 CR-51 0.OOE+00 0.OOE+00 3.46E-08 1.28E-08 7.68E-08 1.46E-05 0.OOE+00 5.79E-08 MN-54 0.OOE+00 5.87E-05 0.OOE+00 1.75E-05 0.OOE+00 1.80E-04 0.OOE+00 1.12E-05 FE-59 9.19E-06 2.16E-05 0.OOE+00 0.OOE+00 6.04E-06 7.20E-05 0.OOE+00 8.28E-06 CO-58 0.OOE+00 2.45E-04 0.OOE+00 0.OOE+00 0.OOE+00 4.96E-03 0.OOE+00 5.48E-04 CO-60 0.OOE+00 1.30E-04 0.OOE+00 0.OOE+00 0.OOE+00 2.44E-03 0.OOE+00 2.87E-04 NB-95 4.14E-06 2.31E-06 0.OOE+00 2.28E-06 0.OOE+00 1.40E-02 0.OOE+00 1.24E-06 TE-125M 4.42E-03 1.60E-03 1.33E-03 1.80E-02 0.OOE+00 1.76E-02 0.OOE+00 5.92E-04 TEEN H-3 0.OOE+00 5.74E-02 5.74E-02 5.74E-02 5.74E-02 5.74E-02 0.OOE+00 5.74E-02 CR-51 0.OOE+00 0.OOE+00 3.32E-08 1.31E-08 8.52E-08 1.OOE-05 0.OOE+00 5.97E-08 MN-54 0.OOE+00 5.77E-05 0.OOE+00 1.72E-05 0.OOE+00 1.18E-04 0.OOE+00 1.14E-05 FE-59 9.47E-06 2.21E-05 0.OOE+00 0.OOE+00 6.97E-06 5.23E-05 0.OOE+00 8.53E-06 CO-58 0.OOE+00 2.43E-04 0.OOE+00 0.OOE+00 0.OOE+00 3.35E-03 0.OOE+00 5.60E-04 CO-60 0.OOE+00 1.30E-04 0.OOE+00 0.OOE+00 0.OOE+00 1.69E-03 0.OOE+00 2.93E-04 NB-95 4.17E-06 2.31E-06 0.OOE+00 2.24E-06 0.OOE+00 9.90E-03 0.OOE+00 1.27E-06 TE-125M 4.81E-03 1.73E-03 1.34E-03 0.OOE+00 0.OOE+00 1.42E-02 0.OOE+00 6.43E-04 CHILD H-3 0.OOE+00 6.39E-02 6.39E-02 6.39E-02 6.39E-02 6.39E-02 0.OOE+00 6.39E-02 CR-51 0.OOE+00 0.OOE+00 3.54E-08 9.67E-09 6.46E-08 3.38E-06 0.OOE+00 6.38E-08 MN-54 0.OOE+00 4.52E-05 0.OOE+00 1.27E-05 0.OOE+00 3.79E-05 0.OOE+00 1.20E-05 FE-59 1.15E-05 1.87E-05 0.OOE+00 0.OOE+00 5.41E-06 1.94E-05 0.OOE+00 9.29E-06 CO-58 0.OOE+00 1.96E-04 0.OOE+00 0.OOE+00 0.OOE+00 1.14E-03 0.OOE+00 5.99E-04 CO-60 0.OOE+00 1.06E-04 0.OOE+00 0.OOE+00 0.OOE+00 5.89E-04 0.OOE+00 3.14E-04 NB-95 4.93E-06 1.92E-06 0.OOE+00 1.80E-06 0.OOE+00 3.55E-03 0.OOE+00 1.37E-06 TE-125M 6.18E-03 1.68E-03 1.74E-03 0.OOE+00 0.OOE+00 5.96E-03 0.OOE+00 8.24E-04 INFANT H-3 0.OOE+00 2.83E-02 2.83E-02 2.83E-02 2.83E-02 2.83E-02 0.OOE+00 2.83E-02 CR-51 0.OOE+00 0.OOE+00 1.57E-10 3.43E-11 3.06E-10 7.02E-09 0.OOE+00 2.41E-10 MN-54 0.OOE+00 1.OOE-07 0.OOE+00 2.22E-08 0.OOE+00 3.68E-08 0.OOE+00 2.27E-08 FE-59 1.02E-07 1.78E-07 0.OOE+00 0.OOE+00 5.27E-08 8.52E-08 0.OOE+00 7.03E-08 CO-58 0.OOE+00 3.69E-06 0.OOE+00 0.OOE+00 0.OOE+00 9.20E-06 0.OOE+00 9.20E-06 CO-60 0.OOE+00 2.05E-06 0.OOE+00 0.OOE+00 0.OOE+00 4.87E-06 0.OOE+00 4.83E-06 NB-95 1.47E-10 6.04E-11 0.OOE+00 4.33E-11 0.OOE+00 5.10E-08 0.OOE+00 3.49E-11 TE-125M 1.51E-05 5.04E-06 5.07E-06 0.OOE+00 0.OOE+00 7.18E-06 0.OOE+00 2.04E-06 Page 39 of 88

LIQUID RELEASE AND DOSE

SUMMARY

REPORT

(PERIOD BASIS - BY UNIT)------

Release ID .............. 1 All Liquid Releases Period Start Date ..... .. 01/01/2007 00:00 Period End Date ......... 01/01/2008 00:00 Period Duration (mins): 5.256E+05 Unit ................... 1 Receptor ................. 0 Liquid Receptor MAXIMUM DOSE F OR PERIOD Limit Organ Age Dose Limit Limit Percent Type Type Group Organ (mrem) Period (mrem) of Limit Admin Any Organ ADULT GILLI 1.16E-01 31-day 1. 50E-01 7.72E+01 Quarter 3. 75E+00 3.09E+00 Annual 7.50E+00 1.54E+00 Admin Tot Body ADULT TBODY 7.79E-02 31-day 4. 50E-02 1.73E+02 Quarter 1. 13E+00 6.93E+00 Annual 2 .25E+00 3.46E+00 T.Spec Any Organ ADULT GILLI 1.16E-01 31-day 2. OOE-01 5.79E+01 Quarter 5. OOE+00 2.32E+00 Annual 1. OOE+01 1.16E+00 Critical Pathway .......... 1 Fresh Water Fish - Sport (FFSP Major Contributors ...... .. 0.0 % or greater to total Nuclide Percentage H-3 6.61E+01 CR-51 1 .26E-02 MN-54 1.55E-01 FE-59 6.22E-02 CO-58 4.28E+00 CO-60 2. 11E+00 NB-95 1.21E+01 TE-125M 1. 52E+01 T.Spec Tot Body ADULT TBODY 7.79E-02 31-day 6. OOE-02 1.30E+02 Quarter 1. 50E+00 5. 20E+00 Annual 3 . OOE+00 2 . 60E+00 Critical Pathway ......... : 1 Fresh Water Fish - Sport (FFSP Major Contributors ...... 0.0 % or greater to total Nuclide Percentage H-3 9.81E+01 CR-51 7.43E-05 MN-54 1.44E-02 FE-59 1.06E-02 CO-58 7.04E-01 Page 40 of 88

LIQUID RELEASE AND DOSE

SUMMARY

REPORT (PERIOD BASIS - BY UNIT)

Release ID ............... 1 All Liquid Releases Period Start Date ..... .. 01/01/2007 00:00 Period End Date ......... 01/01/2008 00:00 Period Duration (mins): 5.256E+05 Unit ................... 1 Receptor ............... 0 Liquid Receptor Major Contributors ....... .0.0 % or greater to total Nuclide Percentage CO-60 3.68E-01 NB-95 1.59E-03 TE-125M 7.59E-01 Page 41 of 88

GASEOUS RELEASE AND DOSE

SUMMARY

REPORT - BY UNIT (Composite Critical Receptor - Limited Analysis)

Release ID ............ : 1 All Gas Release Types Period Start Date .... 01/01/2007 00:00 Period End Date ...... 01/01/2008 00:00 Period Duration (min): 5.256E+05 Coefficient Type ..... : Historical Unit .................. : 2 RELEASE DATA Total Release Duration (minutes) ...................................... 5.618E+05 Total Release Volume (cf) ............................................. 8.415E+10 Average Release Flowrate (cfm) ........................................ 1.498E+05 Average Period Flowrate (cfm) ......................................... 1.601E+05 NUCLIDE DATA Average EC Nuclide uCi uCi/cc Ratio EC AR-41 3.33E+03 1.40E-12 1.40E-04 1.OOE-08 KR-85M 9.14E+00 3.84E-15 3.84E-08 1.OOE-07 KR-85 3.77E+03 1.58E-12 2.26E-06 7.OOE-07 XE-131M 1.93E+02 8.09E-14 4.05E-08 2.OOE-06 XE-133M 1.42E+02 5.98E-14 9.96E-08 6.OOE-07 XE-133 2.03E+05 8.52E-11 1.70E-04 5.OOE-07 XE-135 2.16E+04 9.07E-12 1.30E-04 7.OOE-08 F&AG 2.32E+05 9.74E-11 4.42E-04 1-131 2.63E+00 1.10E-15 5.51E-06 2.OOE-10 1-133 1.93E+01 8.lIE-15 8.11E-06 1.00E-09 Iodine 2.20E+01 9.21E-15 1.36E-05 H-3 4.25E+07 1.78E-08 1.78E-01 1.OOE-07 H-3 4.25E+07 1.78E-08 1.78E-01 TE-125M 4.16E+02 1.75E-13 1.75E-04 1.00E-09 P>=8 4.16E+02 1.75E-13 1.75E-04 Total 4.28E+07 1.79E-08 1.79E-01 Page 42 of 88

GASEOUS RELEASE AND DOSE

SUMMARY

REPORT - BY UNIT (Composite Critical Receptor - Limited Analysis)

Release ID ............. 1 All Gas Release Types Period Start Date .... 01/01/2007 00:00 Period End Date ...... :.01/01/2008 00:00 Period Duration (min): 5.256E+05 Coefficient Type ..... : Historical Unit .................. 2 MAXIMUM I&P DOSE FOR PERIOD Limit Organ Age Dose Limit Limit Percent Type Type Group Organ (mrem) Period (mrem) of Limit Admin Any Orgjan CHILD THYROID 3.86E-03 31-day 2.25E-01 1.72E+00 Quarter 5.63E+00 6.87E-02 Annual 1.13E+01 3.43E-02 T.Spec Any Organ CHILD THYROID 3.86E-03 31-day 3. OOE-01 1. 29E+00 Quarter 7 .50E+00 5. 15E-02 Annual 1. 50E+01 2. 58E-02 Receptor .............. 5 Composite Crit. Receptor - IP Distance (meters) ..... 0.0 Compass Point ......... . 0.0 Critical Pathway ...... .. 2 Vegetation (VEG)

Major Contributors .... 0.0 % or greater to total Nuclide Percentage H-3 9.09E+01 TE-125M 3.64E-01 1-131 8.17E+00 1-133 5.94E-01 Page 43 of 88

GASEOUS RELEASE AND DOSE

SUMMARY

REPORT - BY UNIT (Composite Critical Receptor - Limited Analysis)

Release ID.............. 1 All Gas Release Types Period Start Date ...... 01/01/2007 00:00 Period End Date........ 01/01/2008 00:00 Period Duration (min): 5.256E+05 Coefficient Type ........Historical Unit...................... 2 PERIOD ORGAN DOSE BY AGE GROUP AND PATHWAY (mrem)

Age/Path Bone Liver Thyroid Kidney Lung GI-Lli Skin TB AGPD 8. 82E-08 8. 82E-08 8. 82E-08 8. 82E-08 8. 82E-08 8. 82E-08 0. OOE+00 8. 82E-08 AINHL 2 .36E-08 4.36E-04 4. 37E-04 4.36E-04 4. 37E-04 4. 36E-04 0. OOE+00 4. 36E-04 AVEG 4. 83E-06 7. 83E-04 7. 96E-04 8. OIE-04 7. 81E-04 8. OIE-04 0. OOE+00 7. 82E-04 AGMILK 2.19E-07 5.38E-04 5. 93E-04 5.39E-04 5. 38E-04 5. 39E-04 0. OOE+00 5. 38E-04 ACMEAT 1.78E-05 1.19E-04 1. 19E-04 1. 85E-04 1. 12E-04 1.83E-04 0. OOE+00 1. 15E-04 ACMILK 9.10E-07 2. 64E-04 3 10E-04 2.67E-04 2 64E-04 2.67E-04 0. OOE+00 2. 64E-04 TGPD 8. 82E-08 8. 82E-08 8. 82E-08 8. 82E-08 8. 82E-08 8. 82E-08 0. OOE+00 8. 82E-08 TINHL 3. 36E-08 4. 39E-04 4. 41E-04 4.39E-04 4. 43E-04 4.40E-04 0. OOE+00 4. 39E-04 TVEG 7.40E-06 8. 97E-04 9. 07E-04 8. 94E-04 8. 94E-04 9. 16E-04 0. OOE+00 8. 95E-04 TGMILK 4. OOE-07 7. 01E-04 7. 87E-04 7. 01E-04 7 OOE-04 7. 01E-04 0. OOE+00 7 OOE-04 TCMEAT 1.51E-05 7. 24E-05 7. 23E-05 6. 69E-05 6 69E-05 1. 11E-04 0. OOE+00 6. 89E-05 TCMILK 1. 68E-06 3.44E-04 4. 16E-04 3.44E-04 3. 43E-04 3.48E-04 0. OOE+00 3 .44E-04 CGPD 8. 82E-08 8. 82E-08 8. 82E-08 8. 82E-08 8. 82E-08 8. 82E-08 0. OOE+00 8. 82E-08 CINHL 4. 63E-08 3. 88E-04 3 90E-04 3. 88E-04 3 .91E-04 3. 88E-04 0 . OOE+00 3. 88E-04 CVEG 1. 75E-05 1.39E-03 1. 41E-03 1.39E-03 1. 39E-03 1.41E-03 0 OOE+00 1. 39E-03 CGMILK 9. 76E-07 1. lIE-03 1. 28E-03 1.l1E-03 1.l1E-03 1.l1E-03 0. OOE+00 1. lE-03 CCMEAT 2. 83E-05 8. 88E-05 9. 08E-05 8. 11E-05 8. 11E-05 1. 08E-04 0. OOE+00 8. 49E-05 CCMILK 4. 11E-06 5.45E-04 6. 90E-04 5.45E-04 5.44E-04 5. 48E-04 0. OOE+00 5. 45E-04 IGPD 8. 82E-08 8. 82E-08 8. 82E-08 8. 82E-08 8. 82E-08 8. 82E-08 0. OOE+00 8. 82E-08 IINHL 3. 33E-08 2 .23E-04 2. 25E-04 2. 23E-04 2 .26E-04 2.23E-04 0. OOE+00 2. 23E-04 IGMILK 2. 02E-06 1. 69E-03 2. lIE-03 1. 69E-03 1. 68E-03 1.68E-03 0. OOE+00 1. 68E-03 ICMILK 8. 42E-06 8.29E-04 1. 18E-03 8. 26E-04 8. 25E-04 8. 29E-04 0. OOE+00 8. 27E-04 TOTALS----------------------

ADULT 2. 39E-05 2.14E-03 2 .25E-03 2.23E-03 2.13E-03 2.23E-03 0. OOE+00 2. 13E-03 TEEN 2. 46E-05 2.45E-03 2.62E-03 2.45E-03 2.45E-03 2.52E-03 0. OOE+00 2.45E-03 CHILD 5. lE-05 3. 53E-03 3. 86E-03 3.51E-03 3.51E-03 3.56E-03 0. OOE+00 3. 52E-03 INFANT 1.06E-05 2.74E-03 3.51E-03 2.73E-03 2.73E-03 2.74E-03 0. OOE+00 2. 73E-03 AGE GROUP / PATHWAY DESCRIPTIONS Abbreviation Age Group Pathway AGPD ADULT Ground Plane Deposition (GPD)

AINHL ADULT Inhalation (INHL)

AVEG ADULT Vegetation (VEG)

AGMILK ADULT Grs/Goat/Milk (GMILK)

ACMEAT ADULT Grs/Cow/Meat (CMEAT)

ACMILK ADULT Grs/Cow/Milk (CMILK)

TGPD TEEN Ground Plane Deposition (GPD)

TINHL TEEN Inhalation (INHL)

Page 44 of 88

GASEOUS RELEASE AND DOSE

SUMMARY

REPORT - BY UNIT (Composite Critical Receptor - Limited Analysis)

Release ID............. 1 All Gas Release Types Period Start Date .... 01/01/2007 00:00 Period End Date ....... 01/01/2008 00:00 Period Duration (min): 5.256E+05 Coefficient Type ...... Historical Unit .................

=== AGE GROUP / PATHWAY DESCRIPTIONS Abbreviation Age Group Pathway TVEG TEEN Vegetation (VEG)

TGMILK TEEN Grs/Goat/Milk (GMILK)

TCMEAT TEEN Grs/Cow/Meat (CMEAT)

TCMILK TEEN Grs/Cow/Milk (CMILK)

CGPD CHILD Ground Plane Deposition (GPD)

CINHL CHILD Inhalation (INHL)

CVEG CHILD Vegetation (VEG)

CGMILK CHILD Grs/Goat/Milk (GMILK)

CCMEAT CHILD Grs/Cow/Meat (CMEAT)

CCMILK CHILD Grs/Cow/Milk (CMILK)

IGPD INFANT Ground Plane Deposition (GPD)

IINHL INFANT Inhalation (INHL)

IGMILK INFANT Grs/Goat/Milk (GMILK)

ICMILK INFANT Grs/Cow/Milk (CMILK)

Page 45 of 88

GASEOUS RELEASE AND DOSE

SUMMARY

REPORT - BY UNIT (Composite Critical Receptor - Limited Analysis)

Release ID ............. 1 All Gas Release Types Period Start Date .... :.01/01/2007 00:00 Period End Date ...... .. 01/01/2008 00:00 Period Duration (min): 5.256E+05 Coefficient Type ..... : Historical Unit .................. 2 MAXIMUM NG DOSE FOR PERIOD Limit Dose Limit Limit Percent Type Dose Type (mrad) Period (mrad) of Limit Admin Gamma 8.37E-06 31-day 1. 50E-01 5.58E-03 Quarter 3. 75E+00 2.23E-04 Annual 7. 50E+00 1. 12E-04 Admin Beta 4.06E-06 31-day 3.OOE-01 1.35E-03 Quarter 7. 50E+00 5.42E-05 Annual 1. 50E+01 2.71E-05 T.Spec Gamma 8.37E-06 31-day 2. OOE-01 4.18E-03 Quarter 5. OOE+00 1.67E-04 Annual 1. OOE+01 8.37E-05 Receptor ................ :4 Composite Crit. Receptor - NG Distance (meters) ....... 0.0 Compass Point ........... 0.0 Major Contributors ...... 0.0 % or greater to total Nuclide Percentage AR-41 2.14E+01 KR-85M 7.79E-03 KR-85 4.49E-02 XE-131M 2.09E-02 XE-133M 3.23E-02 XE-133 4.97E+01 XE-135 2.88E+01 T. Spec Beta 4.06E-06 31-day 4. OOE-01 1.02E-03 Quarter 1. OOE+01 4. 06E-05 Annual 2 . OOE+01 2. 03E-05 Receptor ................... 4 Composite Crit. Receptor - NG Distance (meters) ......... 0.0 Compass Point ............ : 0.0 Major Contributors ...... :.0.0 % or greater to total Nuclide Percentage AR-41 3.83E+00 KR-85M 6.32E-03 Page 46 of 88

GASEOUS RELEASE AND DOSE

SUMMARY

REPORT - BY UNIT (Composite Critical Receptor - Limited Analysis)

Release ID ............. 1 All Gas Release Types Period Start Date .... .. 01/01/2007 00:00 Period End Date ...... .. 01/01/2008 00:00 Period Duration (min): 5.256E+05 Coefficient Type ..... : Historical Unit .................. 2 Major Contributors ...... : 0.0 % or greater to total Nuclide Percentage KR-85 2.58E+00 XE-131M 7.51E-02 XE-133M 7.39E-02 XE-133 7.48E+01 XE-135 1.86E+01 Page 47 of 88

LIQUID RELEASE AND DOSE

SUMMARY

REPORT

(PERIOD BASIS - BY UNIT)-------

Release ID .............. 1 All Liquid Releases Period Start Date ..... :.01/01/2007 00:00 Period End Date ......... 01/01/2008 00:00 Period Duration (mins): 5.256E+05 Unit .................... 2 MULTIPLE RELEASE POINT MESSAGE Undiluted and Diluted Flowrate(s) and Concentration(s) cannot be combined.

RELEASE DATA Total Release Duration (minutes) ..................................... 5.847E+05 Total Undiluted Volume Released (gallons) ............................ NA Average Undiluted Flowrate (gpm) ..................................... NA Total Dilution Volume (gallons) ...................................... NA Average Dilution Flowrate (gpm) ............................... ....... NA

=== NUCLIDE DATA Nuclide uCi CO-57 1.54E+01 SB-125 4.36E+01 TE-123M 1.33E+01 SB-126 1.28E+00 CR-51 1.17E+02 MN-54 3.46E+01 FE-59 2.28E+01 CO-58 7.04E+03 CO-60 1.30E+03 NB-95 2.40E+01 TE-125M 4.45E+03 Gamma 1.31E+04 KR-85 3.44E+02 XE-133 6.23E+02 XE-135M 2.09E+02 D&EG 1.18E+03 SR-85 1.50E+00 H-3 1.37E+09 Beta 1.37E+09 Total 1.37E+09 Page 48 of 88

LIQUID RELEASE AND DOSE

SUMMARY

REPORT

(PERIOD BASIS - BY UNIT)------

Release ID ............... 1 All Liquid Releases Period Start Date ..... 01/01/2007 00:00 Period End Date ......... 01/01/2008 00:00 Period Duration (mins): 5.256E+05 Unit .. .................. 2 Receptor ............... : 0 Liquid Receptor PERMIT ORGAN DOSE BY AGE GROUP AND PATHWAY (mrem)

Age/Path Bone Liver Thyroid Kidney Lung GI-Lli Skin TB APWtr 3.87E-06 2.13E-02 2.13E-02 2.13E-02 2.13E-02 2.14E-02 0.OOE+00 2.13E-02 AFWFSp 4.43E-03 5.72E-02 5.65E-02 7.32E-02 5.52E-02 9.44E-02 0.OOE+00 5.66E-02 TPWtr 3.86E-06 1.50E-02 1.50E-02 1.50E-02 1.50E-02 1.51E-02 0.OOE+00 1.50E-02 TFWFSp 4.82E-03 4.46E-02 4.37E-02 4.24E-02 4.24E-02 7.16E-02 0.OOE+00 4.39E-02 CPWtr 1.15E-05 2.88E-02 2.88E-02 2.88E-02 2.88E-02 2.89E-02 0.OOE+00 2.88E-02 CFWFSp 6.19E-03 3.71E-02 3.68E-02 3.51E-02 3.51E-02 4.64E-02 0.OOE+00 3.68E-02 IPWtr 1.52E-05 2.83E-02 2.83E-02 2.83E-02 2.83E-02 2.83E-02 0.OOE+00 2.83E-02

TOTALS- -------------------------------------

ADULT 4.43E-03 7.85E-02 7.78E-02 9.45E-02 7.65E-02 1.16E-01 0.OOE+00 7.79E-02 TEEN 4.82E-03 5.96E-02 5.87E-02 5.74E-02 5.74E-02 8.67E-02 0.OOE+00 5.89E-02 CHILD 6.20E-03 6.60E-02 6.57E-02 6.39E-02 6.39E-02 7.52E-02 0.OOE+00 6.57E-02 INFANT 1.52E-05 2.83E-02 2.83E-02 2.83E-02 2.83E-02 2.83E-02 0.OOE+00 2.83E-02 AGE GROUP / PATHWAY DESCRIPTIONS Abbreviation Age Group Pathway APWtr ADULT Potable Water (PWtr)

AFWFSp ADULT Fresh Water Fish - Sport (FFSP)

TPWtr TEEN Potable Water (PWtr)

TFWFSp TEEN Fresh Water Fish - Sport (FFSP)

CPWtr CHILD Potable Water (PWtr)

CFWFSp CHILD Fresh Water Fish - Sport (FFSP)

IPWtr INFANT Potable Water (PWtr)

Page 49 of 88

LIQUID RELEASE AND DOSE

SUMMARY

REPORT

(PERIOD BASIS - BY UNIT)------

Release ID ............... 1 All Liquid Releases Period Start Date ..... .. 01/01/2007 00:00 Period End Date ......... 01/01/2008 00:00 Period Duration (mins): 5.256E+05 Unit ...................... 2 Receptor ................. : 0 Liquid Receptor PERMIT ORGAN DOSE BY AGE GROUP AND NUCLIDE (mrem) ----------

Agegroup Bone Liver Thyroid Kidney Lung GI-Lli Skin TB ADULT H-3 0.OOE+00 7.65E-02 7.65E-02 7.65E-02 7.65E-02 7.65E-02 0.OOE+00 7.65E-02 CR-51 0.OOE+00 0.OOE+00 3.46E-08 1.28E-08 7.68E-08 1.46E-05 0.OOE+00 5.79E-08 MN-54 0.OOE+00 5.87E-05 0.OOE+00 1.75E-05 0.OOE+00 1.80E-04 0.OOE+00 1.12E-05 FE-59 9.19E-06 2.16E-05 0.OOE+00 0.OOE+00 6.04E-06 7.20E-05 0.OOE+00 8.28E-06 CO-58 0.OOE+00 2.45E-04 0.OOE+00 0.OOE+00 0.OOE+00 4.96E-03 0.OOE+00 5.48E-04 CO-60 0.00E+00 1.30E-04 0.OOE+00 0.OOE+00 0.OOE+00 2.44E-03 0.OOE+00 2.87E-04 NB-95 4.14E-06 2.31E-06 0.OOE+00 2.28E-06 0.OOE+00 1.40E-02 0.OOE+00 1.24E-06 TE-125M 4.42E-03 1.60E-03 1.33E-03 1.80E-02 0.OOE+00 1.76E-02 0.OOE+00 5.92E-04 TEEN H-3 0.OOE+00 5.74E-02 5.74E-02 5.74E-02 5.74E-02 5.74E-02 0.OOE+00 5.74E-02 CR-51 0.OOE+00 0.OOE+00 3.32E-08 1.31E-08 8.52E-08 1.OOE-05 0.OOE+00 5.97E-08 MN-54 0.OOE+00 5.77E-05 0.OOE+00 1.72E-05 0.OOE+00 1.18E-04 0.OOE+00 1.14E-05 FE-59 9.47E-06 2.21E-05 0.OOE+00 0.OOE+00 6.97E-06 5.23E-05 0.OOE+00 8.53E-06 CO-58 0.OOE+00 2.43E-04 0.OOE+00 0.OOE+00 0.OOE+00 3.35E-03 0.OOE+00 5.60E-04 CO-60 0.OOE+00 1.30E-04 0.OOE+00 0.OOE+00 0.00E+00 1.69E-03 0.OOE+00 2.93E-04 NB-95 4.17E-06 2.31E-06 0.OOE+00 2.24E-06 0.00E+00 9.90E-03 0.00E+00 1.27E-06 TE-125M 4.81E-03 1.73E-03 1.34E-03 0.OOE+00 0.OOE+00 1.42E-02 0.OOE+00 6.43E-04 CHILD H-3 0.OOE+00 6.39E-02 6.39E-02 6.39E-02 6.39E-02 6.39E-02 0.OOE+00 6.39E-02 CR-51 0.OOE+00 0.OOE+00 3.54E-08 9.67E-09 6.46E-08 3.38E-06 0.OOE+00 6.38E-08 MN-54 0.OOE+00 4.52E-05 0.00E+00 1.27E-05 0.00E+00 3.79E-05 0.00E+00 1.20E-05 FE-59 1.15E-05 1.87E-05 0.00E+00 0.00E+00 5.41E-06 1.94E-05 0.OOE+00 9.29E-06 CO-58 0.OOE+00 1.96E-04 0.OOE+00 0.OOE+00 0.00E+00 1.14E-03 0.00E+00 5.99E-04 CO-60 0.OOE+00 1.06E-04 0.00E+00 0.00E+00 0.OOE+00 5.89E-04 0.00E+00 3.14E-04 NB-95 4.93E-06 1.92E-06 0.OOE+00 1.80E-06 0.00E+00 3.55E-03 0.OOE+00 1.37E-06 TE-125M 6.18E-03 1.68E-03 1.74E-03 0.OOE+00 0.00E+00 5.96E-03 0.OOE+00 8.24E-04 INFANT H-3 0.00E+00 2.83E-02 2.83E-02 2.83E-02 2.83E-02 2.83E-02 0.00E+00 2.83E-02 CR-51 0.OOE+00 0.OOE+00 1.57E-10 3.43E-11 3.06E-10 7.02E-09 0.OOE+00 2.41E-10 MN-54 0.00E+00 1.00E-07 0.00E+00 2.22E-08 0.00E+00 3.68E-08 0.00E+00 2.27E-08 FE-59 1.02E-07 1.78E-07 0.OOE+00 0.OOE+00 5.27E-08 8.52E-08 0.00E+00 7.03E-08 CO-58 0.00E+00 3.69E-06 0.00E+00 0.00E+00 0.00E+00 9.20E-06 0.00E+00 9.20E-06 CO-60 0.00E+00 2.05E-06 0.00E+00 0.OOE+00 0.00E+00 4.87E-06 0.OOE+00 4.83E-06 NB-95 1.47E-10 6.04E-11 0.00E+00 4.33E-11 0.00E+00 5.10E-08 0.OOE+00 3.49E-11 TE-125M 1.51E-05 5.04E-06 5.07E-06 0.00E+00 0.00E+00 7.18E-06 0.OOE+00 2.04E-06 Page 50 of 88

LIQUID RELEASE AND DOSE

SUMMARY

REPORT

(PERIOD BASIS - BY UNIT)------

Release ID .............. 1 All Liquid Releases Period Start Date ..... .. 01/01/2007 00:00 Period End Date ....... .. 01/01/2008 00:00 Period Duration (mins): 5.256E+05 Unit .................... 2 Receptor ................. : 0 Liquid Receptor MAXIMUM DOSE FOR PERIOD-------------------------------

Limit Organ Age Dose Limit Limit Percent Type Type Group Organ (mrem) Period (mrem) of Limit Admin Any Organ ADULT GILLI 1.16E-01 31-day 1. 50E-01 7.72E+01 Quarter 3. 75E+00 3.09E+00 Annual 7. 50E+00 1.54E+00 Admin Tot Body ADULT TBODY .7.79E-02 31-day 4. 50E-02 1.73E+02 Quarter 1. 13E+00 6.93E+00 Annual 2 .25E+00 3.46E+00 T.Spec Any Organ ADULT GILLI 1.16E-01 31-day 2. OOE-01 5.79E+01 Quarter 5. OOE+00 2.32E+00 Annual 1. OOE+01 1.16E+00 Critical Pathway .......... 1 Fresh Water Fish - Sport (FFSP Major Contributors ....... .0.0 % or greater to total Nuclide Percentage H-3 6.61E+01 CR-51 1.26E-02 MN-54 1. 55E-01 FE-59 6. 22E-02 CO-58 4.28E+00 CO-60 2. 11E+00 NB-95 1.21E+01 TE-125M 1. 52E+01 T.Spec Tot Body ADULT TBODY 7.79E-02 31-day 6. OOE-02 1.30E+02 Quarter 1. 50E+00 5.20E+00 Annual 3 .OOE+00 2.60E+00 Critical Pathway .......... 1 Fresh Water Fish - Sport (FFSP Major Contributors ...... 0.0 % or greater to total Nuclide Percentage H-3 9.81E+01 CR-51 7.43E-05 MN-54 1.44E-02 FE-59 1.06E-02 CO-58 7.04E-01 Page 51 of 88

LIQUID RELEASE AND DOSE

SUMMARY

REPORT

(PERIOD BASIS - BY UNIT)

Release ID ............... 1 All Liquid Releases Period Start Date ..... .. 01/01/2007 00:00 Period End Date ......... 01/01/2008 00:00 Period Duration (mins): 5.256E+05 Unit .. .................. 2 Receptor ................. : 0 Liquid Receptor Major Contributors ....... .0.0 % or greater to total Nuclide Percentage CO-60 3.68E-01 NB-95 1.59E-03 TE-125M 7.59E-01 Page 52 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT LIQUID DOSE

SUMMARY

Unit 1 2007 Report for: 2007 Unit Range - From: 1 To: 1 Liquid Receptor PERIOD DOSE BY ORGAN AND AGE GROUP (mrem) QUARTER 1 Agegrp Bone Liver Thyroid Kidney Lung GI-LLI Skin TB ADULT 2.42E-03 4.79E-02 4.76E-02 5.67E-02 4.69E-02 5.82E-02 0.00E+00 4.74E-02 TEEN 2.63E-03 3.62E-02 3.59E-02 3.52E-02 3.52E-02 4.41E-02 0.OOE+00 3.57E-02 CHILD 3.38E-03 4.02E-02 4.01E-02 3.92E-02 3.92E-02 4.28E-02 0.00E+00 3.98E-02 INFANT 8.24E-06 1.74E-02 1.74E-02 1.74E-02 1.74E-02 1.74E-02 0.OOE+00 1.74E-02 SITE DOSE LIMIT ANALYSIS QUARTER 1 Age Dose Limit Max % of Quartr - Limit Group Organ (mrem) (mrem) Limit Qtr 1 - Admin. Any Organ ADULT GILLI 5. 82E-02 3.75E+0 0 1.55E+00 Qtr 1 - Admin. Total Body ADULT TBODY 4. 74E-02 1. 13E+0 0 4.21E+00 Qtr 1 - T.Spc. Any Organ ADULT GILLI 5.82E-02 5.OOE+00 1.16E+00 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 8. 05E+01 CO-58 2. 25E+00 CO-60 6.47E-01 TE-125M 1. 66E+01 Qtr 1 - T.Spc. Total Body ADULT TBODY 4.74E-02 1.50E+00 3.16E+00 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 9.89E+01 CO-58 3.05E-01 CO-60 9.33E-02 TE-125M 6.83E-01 Page 53 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT LIQUID DOSE

SUMMARY

Unit 1 2007 Report for: 2007 Unit Range - From: 1 To: 1 Liquid Receptor PERIOD DOSE BY ORGAN AND AGE GROUP (mrem) QUARTER 2 Agegrp Bone Liver Thyroid Kidney Lung GI-LLI Skin TB ADULT 4.67E-05 4.08E-02 3.98E-02 3.99E-02 3.98E-02 9.01E-02 0.00E+00 4.16E-02 TEEN 4.79E-05 3.09E-02 2.99E-02 2.99E-02 2.99E-02 6.50E-02 0.00E+00 3.17E-02 CHILD 5.79E-05 3.41E-02 3.33E-02 3.33E-02 3.33E-02 4.57E-02 0.00E+00 3.53E-02 INFANT 4.08E-07 1.47E-02 1.47E-02 1.47E-02 1.47E-02 1.48E-02 0.00E+00 1.48E-02 SITE DOSE LIMIT ANALYSIS QUARTER 2 Age Dose Limit Max % of Quartr - Limit Group Organ (mrem) (mrem) Limit Qtr 2 - Admin. Any Organ ADULT GILLI 9.01E-02 3.75E+00 2.40E+00 Qtr 2 - Admin. Total Body ADULT TBODY 4.16E-02 1.13E+00 3.70E+00 Qtr 2 - T.Spc. Any Organ ADULT GILLI 9.01E-02 5.00E+00 1.80E+00 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 4. 42E+01 CR-51 6.45E-02 MN-54 4. 62E-01 FE-59 3.19E-01 CO-58 1. 16E+01 CO-60 5. 81E+00 NB-95 3.75E+01 Qtr 2 - T.Spc. Total Body ADULT TBODY 4.16E-02 1.50E+00 2.78E+00 Critical-Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 9.56E+01 CR-51 5.55E-04 MN-54 6.22E-02 FE-59 7.93E-02 CO-58 2.77E+00 CO-60 1.48E+00 NB-95 7.19E-03 Page 54 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT LIQUID DOSE

SUMMARY

Unit 1 2007 Report for: 2007 Unit Range - From: 1 To: 1 Liquid Receptor PERIOD DOSE BY ORGAN AND AGE GROUP (mrem) QUARTER 3 Agegrp Bone Liver Thyroid Kidney Lung GI-LLI Skin TB ADULT 4.78E-03 3.67E-02 3.62E-02 4.99E-02 3.52E-02 6.97E-02 0.00E+00 3.61E-02 TEEN 5.00E-03 2.80E-02 2.75E-02 2.64E-02 2.64E-02 5.21E-02 0.00E+00 2.74E-02 CHILD 6.26E-03 3.10E-02 3.08E-02 2.94E-02 2.94E-02 3.93E-02 0.00E+00 3.06E-02 INFANT 3.31E-05 1.30E-02 1.30E-02 1.30E-02 1.30E-02 1.30E-02 0.00E+00 1.30E-02 SITE DOSE LIMIT ANALYSIS QUARTER 3 Age Dose Limit Max % of Quartr - Limit Group Organ (mrem) (mrem) Limit Qtr 3 - Admin. Any Organ ADULT GILLI 6.97E-02 3.75E+00 1.86E+00 Qtr 3 - Admin. Total Body ADULT TBODY 3.61E-02 1.13E+00 3.21E+00 Qtr 3 - T.Spc. Any Organ ADULT GILLI 6.97E-02 5.OOE+00 1.39E+00 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 5.04E+01 FE-55 3. 97E-02 CO-58 4.45E+00 CO-60 1.52E+00 SR-89 1.77E-02 SR-90 3.64E-02 NB-95 2.28E+01 TE-125M 2.07E+01 Qtr 3 - T.Spc. Total Body ADULT TBODY 3.61E-02 1.50E+00 2.41E+00 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 9.73E+01 FE-55 3.12E-02 CO-58 9. 50E-01 CO-60 3.44E-01 SR-89 6.13E-03 SR-90 5.61E-02 NB-95 3.89E-03 TE-125M 1.34E+00 Page 55 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT LIQUID DOSE

SUMMARY

Unit 1 2007 Report for: 2007 Unit Range - From: 1 To: 1 Liquid Receptor PERIOD DOSE BY ORGAN AND AGE GROUP (mrem) QUARTER 4 Agegrp Bone Liver Thyroid Kidney Lung GI-LLI Skin TB ADULT 3.73E-03 3.78E-02 3.75E-02 4.78E-02 3.67E-02 5.23E-02 0.00E+00 3.73E-02 TEEN 3.89E-03 2.88E-02 2.83E-02 2.75E-02 2.75E-02 3.96E-02 0.00E+00 2.82E-02 CHILD 4.86E-03 3.18E-02 3.17E-02 3.06E-02 3.07E-02 3.55E-02 0.00E+00 3.14E-02 INFANT 2.70E-05 1.36E-02 1.36E-02 1.36E-02 1.36E-02 1.36E-02 0.00E+00 1.36E-02 SITE DOSE LIMIT ANALYSIS QUARTER 4 Age Dose Limit Max % of Quartr - Limit Group Organ (mrem) (mrem) Limit Qtr 4 - Admin. Any Organ ADULT GILLI 5.23E-02 3.75E+00 1.40E+00 Qtr 4 - Admin. Total Body ADULT TBODY 3.73E-02 1.13E+00 3.31E+00 Qtr 4 - T.Spc. Any Organ ADULT GILLI 5.23E-02 5.OOE+00 1.05E+00 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 7.00E+01 MN-54 2.09E-01 FE-55 4.50E-02 CO-58 1.97E+00 CO-60 1.72E+00 SR-89 2.01E-02 SR-90 4.12E-02 NB-95 5.04E+00 TE-125M 2.09E+01 Qtr 4 - T.Spc. Total Body ADULT TBODY 3.73E-02 1.50E+00 2.48E+00 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 9.83E+01 MN-54 1.83E-02 FE-55 2.57E-02 CO-58 3.05E-01 CO-60 2.83E-01 SR-89 5.05E-03 SR-90 4.62E-02 NB-95 6.27E-04 TE-125M 9.87E-01 Page 56 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT LIQUID DOSE

SUMMARY

Unit 1 2007 Report for: 2007 Unit Range - From: 1 To: 1 Liquid Receptor PERIOD DOSE BY ORGAN AND AGE GROUP (mrem) ANNUAL 2007 ==---

Agegrp Bone Liver Thyroid Kidney Lung GI-LLI Skin TB ADULT 1.13E-02 1.63E-01 1.62E-01 1.97E-01 1.59E-01 2.41E-01 0.OOE+00 1.62E-01 TEEN 1.19E-02 1.24E-01 1.22E-01 1.19E-01 1.19E-01 1.81E-01 0.OOE+00 1.23E-01 CHILD 1.50E-02 1.37E-01 1.37E-01 1.33E-01 1.33E-01 1.57E-01 0.OOE+00 1.37E-01 INFANT 6.74E-05 5.88E-02 5.88E-02 5.88E-02 5.88E-02 5.89E-02 0.OOE+00 5.89E-02 SITE DOSE LIMIT ANALYSIS ANNUAL 2007 Age Dose Limit Max % of Annual - Limit Group Organ (mrem) (mrem) Limit 2007 - Admin. Any Organ ADULT GILLI 2.41E-01 7.50E+00 3 .22E+00 2007 - Admin. Total Body ADULT TBODY 1.62E-01 2.25E+00 7.20E+00 2007 - T.Spc. Any Organ ADULT GILLI 2.41E-01 1.OOE+01 2.41E+00 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 6.59E+01 CR-51 1.26E-02 MN-54 1.56E-01 FE-55 1.97E-02 FE-59 6.25E-02 CO-58 4.30E+00 CO-60 2.12E+00 SR-89 8.80E-03 SR-90 1.80E-02 NB-95 1.21E+01 TE-125M 1.53E+01 2007 - T.Spc. Total Body ADULT TBODY 1.62E-01 3.OOE+00 5.40E+00 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 9.81E+01 CR-51 7.48E-05 MN-54 1.45E-02 FE-55 1.19E-02 FE-59 1.07E-02 CO-58 7.08E-01 CO-60 3.70E-01 Page 57 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT Nuclide Percentage SR-89 2.34E-03 SR-90 2.15E-02 NB-95 1.60E-03 TE-125M 7.64E-01 Page 58 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT GASEOUS DOSE

SUMMARY

Unit 1 2007 Report for: 2007 Unit Range - From: 1 To: 1 I&P DOSE LIMIT ANALYSIS QUARTER 1 Age Dose Limit Max % of Quartr - Limit Group Organ (mrem) (mrem) Limit Qtr 1 - Admin. Any Organ CHILD THYROID 1.71E-03 5.63E+()0 3.04E-02 Qtr 1 - Admin. Total Body CHILD TBODY 1.61E-03 5.25E+()0 3.06E-02 Qtr 1 - T.Spc. Any Organ CHILD THY ROID 1.71E-03 7.50E+00 2.28E-02 Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compas s Point: NA Critical Pathway: Vegetation (VEG)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 9.40E+01 1-131 5.58E+00 1-133 3.79E-01 Qtr 1 - T.Spc. Total Body CHILD TBO DY 1.61E-03 7.50E+00 2.14E-02 Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compas s Point: NA Critical Pathway: Vegetation (VEG)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 1.OOE+02 1-131 1.03E-02 1-133 9.20E-04 Page 59 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT GASEOUS DOSE

SUMMARY

Unit 1 2007 Report for: 2007 Unit Range - From: 1 To: 1 NG DOSE LIMIT ANALYSIS QiUARTER 1 Dose Limit Max % of Quartr - Limit (mrad) (mrad) Limit Qtr 1 - Admin. Gamma 8.05E-06 3. 75E+00 2.15E-04 Qtr 1 - Admin. Beta 5.84E-06 7.50E+00 7. 79E-05 Qtr 1 - T.Spc. Gamma 8.05E-06 5.OOE+00 1.61E-04 Receptor: 4 Composite Crit. Receptor - NG Distance: 0.00 (meters) Compass Point: NA Nuclide Percentage AR-41 3.54E+00 KR-85 6.72E-02 XE-135 9.68E-03 XE-133M 8.60E-03 XE-133 9.64E+01 Qtr 1 - T.Spc. Beta 5.84E-06 1.OOE+01 5.84E-05 Receptor: 4 Composite Crit. Receptor - NG Distance: 0.00 (meters) Compass Point: NA Nuclide Percentage AR-41 4.22E-01 KR-85 2.58E+00 XE-135 4.20E-03 XE-133M 1.32E-02 XE-133 9.70E+01 Page 60 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT GASEOUS DOSE

SUMMARY

Unit 1 2007 Report for: 2007 Unit Range - From: 1 To: 1 I&P DOSE LIMIT ANALYSIS UARTER 2 Age Dose Limit Max % of Quartr - Limit Group Organ (mrem) (mrem) Limit Qtr 2 - Admin. Any Organ INFANT THYROID 1. 93E-03 5.63E+C10 3.44E-02 Qtr 2 - Admin. Total Body CHILD TBODY 1. 17E-03 5.25E+C10 2.22E-02 Qtr 2 - T.Spc. Any Organ INFANT THYROID 1.931 -03 7.50E+00 2.58E-02 Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compass Point: NA Critical Pathway: Grs/Goat/Milk (GMILK)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 4.69E+01 1-131 5.03E+01 1-133 2.79E+00 Qtr 2 - T.Spc. Total Body CHILD TBO DY 1.17E-03 7.50E+00 1.55E-02 Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compas s Point: NA Critical Pathway: Vegetation (VEG)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 9.99E+01 1-131 6.29E-02 1-133 4.88E-03 Page 61 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT GASEOUS DOSE

SUMMARY

Unit 1 2007 Report for: 2007 Unit Range - From: 1 To: 1 NG DOSE LIMIT ANALYSIS QUARTER 2 Dose Limit Max % of Quartr - Limit (mrad) (mrad) Limit Qtr 2 - Admnin. Gamma 3.25E-06 3.75E+00 8.67E-05 Qtr 2 - Admin. Beta 1.40E-06 7.50E+00 1.86E-05 Qtr 2 - T.Spc. Gamma 3.25E-06 5.00E+00 6.50E-05 Receptor: 4 Composite Crit. Receptor - NG Distance: 0.00 (meters) Compass Point: NA Nuclide Percentage KR-85 6.52E-02 KR-85M 4.01E-02 XE-135 7.66E+01 XE-133M 9.01E-02 XE-133 2.32E+01 Qtr 2 - T.Spc. Beta 1.40E-06 1.OOE+01 1.40E-05 Receptor: 4 Composite Crit. Receptor - NG Distance: 0.00 (meters) Compass Point: NA Nuclide Percentage KR-85 4.22E+00 KR-85M 3.67E-02 XE-135 5.61E+01 XE-133M 2.33E-01 XE-133 3.94E+01 Page 62 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT GASEOUS DOSE

SUMMARY

Unit 1 2007 Report for: 2007 Unit Range - From: 1 To: 1 I&P DOSE LIMIT ANALYSIS QUARTER 3 Age Dose Limit Max % of Quartr - Limit Group Organ (mrem) (mrem) Limit Qtr 3 - Admin. Any Organ INFANT THYROID 3.45E-03 5.63E+00 6.14E-02 Qtr 3 - Admin. Total Body CHILD TBODY 9.69E-04 5.25E+00 1.85E-02 Qtr 3 - T.Spc. Any Organ INFANT THYROID 3.45E-03 7.50E+00 4.61E-02 Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compass Point: NA Critical Pathway: Grs/Goat/Milk (GMILK)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 2.16E+01 TE-125M 8.42E-02 1-131 7.44E+01 1-133 3.89E+00 Qtr 3 - T.Spc. Total Body CHILD TBO'DY 9.69]E-04 7.50E+00 1.29E-02 Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compas s Point: NA Critical Pathway: Vegetation (VEG)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 9.91E+01 TE-125M 6.93E-01 1-131 2.00E-01 1-133 1.46E-02 Page 63 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT GASEOUS DOSE

SUMMARY

Unit 1 2007 Report for: 2007 Unit Range - From: 1 To: 1 NG DOSE LIMIT ANALYSIS QUARTER 3 Dose Limit Max % of Quartr - Limit (mrad) (mrad) Limit Qtr 3 - Admin. Gamma 2.05E-06 3.75E+00 5.48E-05 Qtr 3 - Admin. Beta 4.79E-07 7.50E+00 6.38E-06 Qtr 3 - T.Spc. Gamma 2.051E-06 5.OOE+00 4.11E-05 Receptor: 4 Composite Crit. Receptor - NG Distance: 0.00 (meters) Compass Point: NA Nuclide Percentage AR-41 2.46E+01 XE-138 5.46E+01 XE-135 2.24E+00 XE-133 1.85E+01 Qtr 3 - T.Spc. Beta 4.791E-07 1.OOE+01 4.79E-06 Receptor: 4 Composite Crit., Receptor - NG Distance: 0.00 (meters) Compass Point: NA Nuclide Percentage AR-41 9.16E+00 XE-138 2.97E+01 XE-135 3.03E+00 XE-133 5.81E+01 Page 64 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT GASEOUS DOSE

SUMMARY

Unit 1 2007 Report for: 2007 Unit Range - From: 1 To: 1 I&P DOSE LIMIT ANALYSIS QUARTER 4 Age Dose Limit Max % of Quartr - Limit Group Organ (mrem) (mrem) Limit Qtr 4 - Admin. Any Organ INFANT THYROID 5.31E-03 5.63E+0 0 9.43E-02 Qtr 4 - Admin. Total Body CHILD TBODY 1.65E-03 5.25E+0 0 3.14E-02 Qtr 4 - T.Spc. Any Organ INFANT THYROID 5.31E-03 7.50E+00 7.08E-02 Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compass Point: NA Critical Pathway: Grs/Goat/Milk (GMILK)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 2.41E+01 1-131 7.22E+01 1-132 5.05E-03 1-133 3.66E+00 CS-136 3.14E-04 Qtr 4 - T.Spc. Total Body CHILD TBODY 1.65E-03 7.50E+00 2.20E-02 Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compass Point: NA Critical Pathway: Vegetation (VEG)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 9.98E+01 1-131 1.76E-01 1-132 1.lIE-03 1-133 1.24E-02 CS-136 5.06E-02 Page 65 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT GASEOUS DOSE

SUMMARY

Unit 1 2007 Report for: 2007 Unit Range - From: 1 To: 1 NG DOSE LIMIT ANALYSIS QUARTER 4 Dose Limit Max % of Quartr - Limit (mrad) (mrad) Limit Qtr 4 - Admnin. Gamma 3.24E-06 3. 75E+00 8. 65E-05 Qtr 4 - Admiin. Beta 1.39E-06 7. 50E+00 1. 86E-05 Qtr 4 - T.Spc. Gamma 3.241 -06 5.OOE+00 6.49E-05 Receptor: 4 Composite Crit. Receptor - NG Distance: 0.00 (meters) Compass Point: NA Nuclide Percentage AR-41 4.65E+01 XE-135 7.67E-01 XE-133M 5.49E-02 XE-131M 1.08E-01 XE-133 5.25E+01 Qtr 4 - T.Spc. Beta 1.39:E~-06 1.OOE+01 1.39E-05 Receptor: 4 Composite Crit. Receptor - NG Distance: 0.00 (meters) Compass Point: NA Nuclide Percentage AR-41 9.40E+00 XE-135 5.62E-01 XE-133M i142E-01 XE-131M 4.38E-01 XE-133 8.95E+01 Page 66 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT GASEOUS DOSE

SUMMARY

Unit 1 2007 Report for: 2007 Unit Range - From: 1 To: 1 I&P DOSE LIMIT ANALYSIS ANNUAL 2007 Age Dose Limit Max % of Annual - Limit Group Organ (mrem) (mrem) Limit 2007 - Admin. Any Organ INFANT THYROID 1.22E-02 1.13E+01 1.08E-01 2007 - Admin. Total Body CHILD TBODY 5.39E-03 1.05E+01 5.13E-02 2007 - T.Spc. Any Organ INFANT THYROID 1.22E-02 1.50E+01 8.12E-02 Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compass Point: NA Critical Pathway: Grs/Goat/Milk (GMILK)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 3 .44E+01 TE-125M 2 39E-02 1-131 6.24E+01 1-132 2 .20E-03 1-133 3 .25E+00 CS-136 1 37E-04 2007 - T.Spc. Total Body CHILD TBO DY 5.39]E-03 1.50E+01 3.59E-02 Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compas s Point: NA Critical Pathway: Vegetation (VEG)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 9. 97E+01 TE-125M 1 .25E-01 1-131 1. 06E-01 1-132 3. 40E-04 1-133 7. 74E-03 CS-136 1. 55E-02 Page 67 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT GASEOUS DOSE

SUMMARY

Unit 1 2007 Report for: 2007 Unit Range - From: 1 To: 1 NG DOSE LIMIT ANALYSIS ANNUAL 2007 Dose Limit Max % of Annual - Limit (mrad) (mrad) Limit 2007 - Admin. Gamma 1.66E-05 7.50E+00 2 .21E-04 2007 - Admin. Beta 9.11E-06 1.50E+01 6 . 08E-05 2007 - T.Spc. Gamma 1.66]E-05 1.OOE+01 1.66E-04 Receptor: 4 Composite Crit. Receptor - NG Distance: 0.00 (meters) Compass Point: NA Nuclide Percentage AR-41 1.39E+01 KR-85 4.53E-02 XE-138 6.76E+00 KR-85M 7.86E-03 XE-135 1.54E+01 XE-133M 3.26E-02 XE-131M 2.10E-02 XE-133 6.38E+01 2007 - T.Spc. Beta 9.11JE-06 2.OOE+01 4.56E-05 Receptor: 4 Composite Crit. Receptor - NG Distance: 0.00 (meters) Compass Point: NA Nuclide Percentage AR-41 2.19E+00 KR-85 2.30E+00 XE-138 1.56E+00 KR-85M 5.63E-03 XE-135 8.85E+00 XE-133M 6.60E-02 XE-131M 6.70E-02 XE-133 8.50E+01 Page 68 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT Unit 1 2007 Report for: 2007 Unit Range - From: 1 To: 1 MAXIMUM DOSE ANALYSIS ANNUAL 2007 Age Dose Dose Type Group Organ (mrem)

Any Organ ADULT GILLI 2.451E-01 Liquid Receptor: 0 Liquid Receptor Gaseous Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compass Point: NA Liquid Dose: 2.41E-01 % of Total: 9.85E+01 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors 0% or greater to total)

Nuclide Percentage H-3 6 .59E+01 CR-51 1. 26E-02 MN-54 1. 56E-01 FE-55 1. 97E-02 FE-59 6 .25E-02 CO-58 4. 30E+00 CO-60 2 .12E+00 SR-89 8. 80E-03 SR-90 1. 80E-02 NB-95 1. 21E+01 TE-125M 1 .53E+01 Gaseous Dose: 3.36E-03 % of Total: 1.37E+00 Critical Pathway: Vegetation (VEG)

Major Contributors 0% or greater to total)

Nuclide Percentage H-3 9. 71E+01 TE-125M 2 .81E+00 1-131 2. 91E-02 1-132 4. 80E-04 1-133 1. 10E-02 CS-136 2. 14E-03

==MAXIMUM DOSE ANALYSIS---------------- -= ANNUAL 2007 Age Dose Dose Type Group Organ (mrem)

Total Body ADULT TBODY 1.651E-01 Liquid Receptor: 0 Liquid Receptor Gaseous Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compass Point: NA Page 69 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT Liquid Dose: 1.62E-01 % of Total: 9.82E+01 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors 0% or greater to total)

Nuclide Percentage H-3 9.81E+01 CR-51 7.48E-05 MN-54 1.45E-02 FE-55 1.19E-02 FE-59 1.07E-02 CO-58 7.08E-01 CO-60 3.70E-01 SR-89 2.34E-03 SR-90 2.15E-02 NB-95 1.60E-03 TE-125M 7.64E-01 Gaseous Dose: 3.27E-03 % of Total: 1.98E+00 Critical Pathway: Vegetation (VEG)

Major Contributors 0% or greater to total)

Nuclide Percentage H-3 9.98E+01 TE-125M 9.88E-02 1-131 6.30E-02 1-132 5.27E-04 1-133 4.84E-03 CS-136 1.12E-02 Page 70 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT LIQUID DOSE

SUMMARY

Unit 2 2007 Report for: 2007 Unit Range - From: 2 To: 2 Liquid Receptor PERIOD DOSE BY ORGAN AND AGE GROUP (mrem) QUARTER 1 Agegrp Bone Liver Thyroid Kidney Lung GI-LLI Skin TB ADULT 2.42E-03 4.79E-02 4.76E-02 5.67E-02 4.69E-02 5.82E-02 0.OOE+00 4.74E-02 TEEN 2.63E-03 3.62E-02 3.59E-02 3.52E-02 3.52E-02 4.41E-02 0.00E+00 3.57E-02 CHILD 3.38E-03 4.02E-02 4.01E-02 3.92E-02 3.92E-02 4.28E-02 0.OOE+00 3.98E-02 INFANT 8.24E-06 1.74E-02 1.74E-02 1.74E-02 1.74E-02 1.74E-02 0.00E+00 1.74E-02 SITE DOSE LIMIT ANALYSIS QUARTER 1 Age Dose Limit Max % of Quartr - Limit Group Organ (mrem) (mrem) Limit Qtr 1 - Admin. Any Organ ADULT GILLI 5.82E-02 3.75E+00 1.55E+00 Qtr 1 - Admin. Total Body ADULT TBODY 4.74E-02 1.13E+00 4.21E+00 Qtr 1 - T.Spc. Any Organ ADULT GILLI 5.82E-02 5.00E+00 1.16E+00 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 8.05E+01 CO-58 2.25E+00 CO-60 6.47E-01 TE-125M 1.66E+01 Qtr 1 - T.Spc. Total Body ADULT TBODY 4.74E-02 1.50E+00 3.16E+00 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors ( 0% or greater to total)

Nuclide' Percentage H-3 9.89E+01 CO-58 3.05E-01 CO-60 9.33E-02 TE-125M 6.83E-01 Page 71 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT LIQUID DOSE

SUMMARY

Unit 2 2007 Report for: 2007 Unit Range - From: 2 To: 2 Liquid Receptor PERIOD DOSE BY ORGAN AND AGE GROUP (mrem) QUARTER 2 Agegrp Bone Liver Thyroid Kidney Lung GI-LLI Skin TB ADULT 4.67E-05 4.08E-02 3.98E-02 3.99E-02 3.98E-02 9.01E-02 0.00E+00 4.16E-02 TEEN 4.79E-05 3.09E-02 2.99E-02 2.99E-02 2.99E-02 6.50E-02 0.OOE+00 3.17E-02 CHILD 5.79E-05 3.41E-02 3.33E-02 3.33E-02 3.33E-02 4.57E-02 0.OOE+00 3.53E-02 INFANT 4.08E-07 1.47E-02 1.47E-02 1.47E-02 1.47E-02 1.48E-02 0.OOE+00 1.48E-02 SITE DOSE LIMIT ANALYSIS QUARTER 2 Age Dose Limit Max % of Quartr - Limit Group Organ (mrem) (mrem) Limit Qtr 2 - Admin. Any Organ ADULT GILLI 9.01E-02 3.75E+00 2.40E+00 Qtr 2 - Admin. Total Body ADULT TBODY 4.16E-02 1.13E+00 3.70E+00 Qtr 2 - T.Spc. Any Organ ADULT GILLI 9.01E-02 5.OOE+00 1.80E+00 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 4. 42E+01 CR-51 6. 45E-02 MN-54 4.62E-01 FE-59 3.19E-01 CO-58 1. 16E+01 CO-60 5. 81E+00 NB-95 3.75E+01 Qtr 2 - T.Spc. Total Body ADULT TBODY 4.16E-02 1.50E+00 2.78E+00 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 9.56E+01 CR-51 5.55E-04 MN-54 6.22E-02 FE-59 7.93E-02 CO-58 2.77E+00 CO-60 1.48E+00 NB-95 7.19E-03 Page 72 of 88

40CFRI90 URANIUM FUEL CYCLE DOSE REPORT LIQUID DOSE

SUMMARY

Unit 2 2007 Report for: 2007 Unit Range - From: 2 To: 2 Liquid Receptor PERIOD DOSE BY ORGAN AND AGE GROUP (mrem) QUARTER 3 Agegrp Bone Liver Thyroid Kidney Lung GI-LLI Skin TB ADULT 4.78E-03 3.67E-02 3.62E-02 4.99E-02 3.52E-02 6.97E-02 0.OOE+00 3.61E-02 TEEN 5.OOE-03 2.80E-02 2.75E-02 2.64E-02 2.64E-02 5.21E-02 0.00E+00 2.74E-02 CHILD 6.26E-03 3.10E-02 3.08E-02 2.94E-02 2.94E-02 3.93E-02 0.00E+00 3.06E-02 INFANT 3.31E-05 1.30E-02 1.30E-02 1.30E-02 1.30E-02 1.30E-02 0.OOE+00 1.30E-02 SITE DOSE LIMIT ANALYSIS QUARTER 3 Age Dose Limit Max % of Quartr - Limit Group Organ (mrem) (mrem) Limit Qtr 3 - Admin. Any Organ ADULT GILLI 6.97E-02 3.75E+00 1.86E+00 Qtr 3 - Admin. Total Body ADULT TBODY 3.61E-02 1.13E+00 3.21E+00 Qtr 3 - T.Spc. Any Organ ADULT GILLI 6.97E-02 5.OOE+00 1.39E+00 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 5.04E+01 FE-55 3.97E-02 CO-58 4.45E+00 CO-60 1.52E+00 SR-89 1.77E-02 SR-90 3.64E-02 NB-95 2.28E+01 TE-125M 2.07E+01 Qtr 3 - T.Spc. Total Body ADULT TBODY 3.61E-02 1.50E+00 2.41E+00 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 9.73E+01 FE-55 3.12E-02 CO-58 9.50E-01 CO-60 3.44E-01 SR-89 6.13E-03 SR-90 5.61E-02 NB-95 3.89E-03 TE-125M 1.34E+00 Page 73 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT LIQUID DOSE

SUMMARY

Unit 2 2007 Report for: 2007 Unit Range - From: 2 To: 2 Liquid Receptor PERIOD DOSE BY ORGAN AND AGE GROUP (mrem) QUARTER 4 Agegrp Bone Liver Thyroid Kidney Lung GI-LLI Skin TB ADULT 3.73E-03 3.78E-02 3.75E-02 4.78E-02 3.67E-02 5.23E-02 0.OOE+00 3.73E-02 TEEN 3.89E-03 2.88E-02 2.83E-02 2.75E-02 2.75E-02 3.96E-02 0.OOE+00 2.82E-02 CHILD 4.86E-03 3.18E-02 3.17E-02 3.06E-02 3.07E-02 3.55E-02 0.OOE+00 3.14E-02 INFANT 2.70E-05 1.36E-02 1.36E-02 1.36E-02 1.36E-02 1.36E-02 0.OOE+00 1.36E-02 SITE DOSE LIMIT ANALYSIS QUARTER 4 Age Dose Limit Max % of Quartr - Limit Group Organ (mrem) (mrem) Limit Qtr 4 - Admin. Any Organ ADULT GILLI 5.23E-02 3.75E+00 1.40E+00 Qtr 4 - Admin. Total Body ADULT TBODY 3.73E-02 1.13E+00 3.31E+00 Qtr 4 - T.Spc. Any Organ ADULT GILLI 5.23E-02 5.OOE+00 1.05E+00 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 7.OOE+01 MN-54 2.09E-01 FE-55 4.50E-02 CO-58 1.97E+00 CO-60 1.72E+00 SR-89 2.01E-02 SR-90 4.12E-02 NB-95 5.04E+00 TE-125M 2.09E+01 Qtr 4 - T.Spc. Total Body ADULT TBODY 3.73E-02 1.50E+00 2.48E+00 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 9.83E+01 MN-54 1.83E-02 FE-55 2.57E-02 CO-58 3.05E-01 CO-60 2.83E-01 SR-89 5.05E-03 SR-90 4.62E-02 NB-95 6.27E-04 TE-125M 9.87E-01 Page 74 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT LIQUID DOSE

SUMMARY

Unit 2 2007 Report for: 2007 Unit Range - From: 2 To: 2 Liquid Receptor PERIOD DOSE BY ORGAN AND AGE GROUP (mrem) ANNUAL 2007 ==---

Agegrp Bone Liver Thyroid Kidney Lung GI-LLI Skin TB ADULT 1.13E-02 1.63E-01 1.62E-01 1.97E-01 1.59E-01 2.41E-01 0.OOE+00 1.62E-01 TEEN 1.19E-02 1.24E-01 1.22E-01 1.19E-01 1.19E-01 1.81E-01 0.OOE+00 1.23E-01 CHILD 1.50E-02 1.37E-01 1.37E-01 1.33E-01 1.33E-01 1.57E-01 0.OOE+00 1.37E-01 INFANT 6.74E-05 5.88E-02 5.88E-02 5.88E-02 5.88E-02 5.89E-02 0.OOE+00 5.89E-02 SITE DOSE LIMIT ANALYSIS ANNUAL 2007 Age Dose Limit Max % of Annual - Limit Group Organ (mrem) (mrem) Limit 2007 - Admin. Any Organ ADULT GILLI 2.41E-01 7.50E+00 3. 22E+00 2007 - Admin. Total Body ADULT TBODY 1.62E-01 2.25E+00 7. 20E+00 2007 - T.Spc. Any Organ ADULT GILLI 2.41E-01 1.OOE+01 2.41E+00 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 6 59E+01 CR-51 1 26E-02 MN-54 1. 56E-01 FE-55 1. 97E-02 FE-59 6. 25E-02 CO-58 4 .30E+00 CO-60 2. 12E+00 SR-89 8. 80E-03 SR-90 1. 80E-02 NB-95 1. 21E+01 TE-125M 1. 53E+01 2007 - T.Spc. Total Body ADULT TBODY 1.62E-01 3.OOE+00 5.40E+00 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 9. 81E+01 CR-51 7.48E-05 MN-54 1.45E-02 FE-55 1. 19E-02 FE-59 1. 07E-02 CO-58 7. 08E-01 CO-60 3.70E-01 Page 75 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT Nuclide Percentage SR-89 2.34E-03 SR-90 2.15E-02 NB-95 1.60E-03 TE-125M 7.64E-01 Page 76 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT GASEOUS DOSE

SUMMARY

Unit 2 2007 Report for: 2007 Unit Range - From: 2 To: 2 I&P DOSE LIMIT ANALYSIS QUARTER 1 Age Dose Limit Max % of Quartr - Limit Group Organ (mrem) (mrem) Limit Qtr 1 - Admin. Any Organ CHILD THYROID 1.71E-03 5.63E+00 3.04E-02 Qtr 1 - Admin. Total Body CHILD TBODY 1.61E-03 5.25E+00 3. 06E-02 Qtr 1 - T.Spc. Any Organ CHILD THY ROID 1.71E-03 7.50E+00 2.28E-02 Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compas s Point: NA Critical Pathway: Vegetation (VEG)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 9.40E+01 1-131 5. 58E+00 1-133 3. 79E-01 Qtr 1 - T.Spc. Total Body CHILD TBO DY 1.611E-03 7.50E+00 2.14E-02 Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compas s Point: NA Critical Pathway: Vegetation (VEG)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 1.OOE+02 1-131 1.03E-02 1-133 9.20E-04 Page 77 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT GASEOUS DOSE

SUMMARY

Unit 2 2007 Report for: 2007 Unit Range - From: 2 To: 2 NG DOSE LIMIT ANALYSIS QUARTER 1 Dose Limit Max % of Quartr - Limit (mrad) (mrad) Limit Qtr 1 - Admin. Gamma 8.05E-06 3.75E+00 2.15E-04 Qtr 1 - Admin. Beta 5.84E-06 7.50E+00 7.79E-05 Qtr 1 - T.Spc. Gamma 8.05]E-06 5.OOE+00 1.61E-04 Receptor: 4 Composite Crit. Receptor - NG Distance: 0.00 (meters) Compass Point: NA Nuclide Percentage AR-41 3.54E+00 KR-85 6.72E-02 XE-135 9.68E-03 XE-133M 8.60E-03 XE-133 9.64E+01 Qtr 1 - T.Spc. Beta 5.84]E-06 1.OOE+01 5.84E-05 Receptor: 4 Composite Crit. Receptor - NG Distance: 0.00 (meters) Compass Point: NA Nuclide Percentage AR-41 4.22E-01 KR-85 2.58E+00 XE-135 4.20E-03 XE-133M 1.32E-02 XE-133 9.70E+01 Page 78 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT GASEOUS DOSE

SUMMARY

Unit 2 2007 Report for: 2007 Unit Range - From: 2 To: 2 I&P DOSE LIMIT ANALYSIS QUARTER 2 Age Dose Limit Max % of Quartr - Limit Group Organ (mrem) (mrem) Limit Qtr 2 - Admin. Any Organ INFANT THYROID 1.93E-03 5.63E+00 3.44E-02 Qtr 2 - Admin. Total Body CHILD TBODY 1.17E-03 5.25E+00 2.22E-02 Qtr 2 - T.Spc. Any Organ INFANT THYROID 1.93]E-03 7.50E+00 2.58E-02 Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compass Point: NA Critical Pathway: Grs/Goat/Milk (GMILK)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 4.69E+01 1-131 5.03E+01 1-133 2.79E+00 Qtr 2 - T.Spc. Total Body CHILD TBODY 1.17E-03 7.50E+00 1.55E-02 Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compass Point: NA Critical Pathway: Vegetation (VEG)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 9.99E+01 1-131 6.29E-02 1-133 4.88E-03 Page 79 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT GASEOUS DOSE

SUMMARY

Unit 2 2007 Report for: 2007 Unit Range - From: 2 To: 2 NG DOSE LIMIT ANALYSIS QUARTER 2 Dose Limit Max % of Quartr - Limit (mrad) (mrad) Limit Qtr 2 - Admin. Gamma 3.25E-06 3.75E+00 8.67E-05 Qtr 2 - Admin. Beta 1.40E-06 7.50E+00 1.86E-05 Qtr 2 - T.Spc. Gamma 3.25:E-06 5.OOE+00 6.50E-05 Receptor: 4 Composite Crit. Receptor - NG Distance: 0.00 (meters) Compass Point: NA Nuclide Percentage KR-85 6.52E-02 KR-85M 4.01E-02 XE-135 7.66E+01 XE-133M 9.01E-02 XE-133 2.32E+01 Qtr 2 - T.Spc. Beta 1.40E-06 1.OOE+01 1.40E-05 Receptor: 4 Composite Crit. Receptor - NG Distance: 0.00 (meters) Compass Point: NA Nuclide Percentage KR-85 4.22E+00 KR-85M 3.67E-02 XE-135 5.61E+01 XE-133M 2.33E-01 XE-133 3.94E+01 Page 80 of 88

40CFRI90 URANIUM FUEL CYCLE DOSE REPORT GASEOUS DOSE

SUMMARY

Unit 2 2007 Report for: 2007 Unit Range - From: 2 To: 2 I&P DOSE LIMIT ANALYSIS QUARTER 3 Age Dose Limit Max % of Quartr - Limit Group Organ (mrem) (mrem) Limit Qtr 3 - Admin. Any Organ INFANT THYROID 3.45E-( 03 5.63E+C10 6.14E-02 Qtr 3 - Admin. Total Body CHILD TBODY 9. 69E-( )4 5.25E+C10 1.85E-02 Qtr 3 - T.Spc. Any Organ INFANT THYROID 3.45 E-03 7.50E+00 4.61E-02 Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compass Point: NA Critical Pathway: Grs/Goat/Milk (GMILK)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 2.16E+01 TE-125M 8.42E-02 1-131 7.44E+01 1-133 3.89E+00 Qtr 3 - T.Spc. Total Body CHILD TBO DY 9.69]E-04 7.50E+00 1.29E-02 Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compas s Point: NA Critical Pathway: Vegetation (VEG)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 9.91E+01 TE-125M 6.93E-01 1-131 2.OOE-01 1-133 1.46E-02 Page 81 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT GASEOUS DOSE

SUMMARY

Unit 2 2007 Report for: 2007 Unit Range - From: 2 To: 2 NG DOSE LIMIT ANALYSIS QUARTER 3 Dose Limit Max % of Quartr - Limit (mrad) (mrad) Limit Qtr 3 - Admin. Gamma 2.05E-06 3.75E+00 5.48E-05 Qtr 3 - Admin. Beta 4.79E-07 7.50E+00 6.38E-06 Qtr 3 - T.Spc. Gamma 2.05E-06 5.00E+00 4.11E-05 Receptor: 4 Composite Crit. Receptor - NG Distance: 0.00 (meters) Compass Point: NA Nuclide Percentage AR-41 2.46E+01 XE-138 5.46E+01 XE-135 2.24E+00 XE-133 1.85E+01 Qtr 3 - T.Spc. Beta 4.79E-07 1.OOE+01 4.79E-06 Receptor: 4 Composite Crit. Receptor - NG Distance: 0.00 (meters) Compass Point: NA Nuclide Percentage AR-41 9.16E+00 XE-138 2.97E+01 XE-135 3.03E+00 XE-133 5.81E+01 Page 82 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT GASEOUS DOSE

SUMMARY

Unit 2 2007 Report for: 2007 Unit Range - From: 2 To: 2 I&P DOSE LIMIT ANALYSIS QUARTER 4 Age Dose Limit Max % of Quartr - Limit Group Organ (mrem) (mrem) Limit Qtr 4 - Admin. Any Organ INFANT THYROID 5.31E-03 5.63E+0 0 9.43E-02 Qtr 4 - Admin. Total Body CHILD TBODY 1.65E-03 5.25E+0 0 3.14E-02 Qtr 4 - T.Spc. Any Organ INFANT THYROID 5.31E-03 7.50E+00 7.08E-02 Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compass Point: NA Critical Pathway: Grs/Goat/Milk (GMILK)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 2.41E+01 1-131 7.22E+01 1-132 5. 05E-03 1-133 3. 66E+00 CS-136 3.14E-04 Qtr 4 - T.Spc. Total Body CHILD TBO)DY 1.65E-03 7.50E+00 2.20E-02 Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compas s Point: NA Critical Pathway: Vegetation (VEG)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 9.98E+01 1-131 1.76E-01 1-132 1.l1E-03 1-133 1.24E-02 CS-136 5.06E-02 Page 83 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT GASEOUS DOSE

SUMMARY

Unit 2 2007 Report for: 2007 Unit Range - From: 2 To: 2 NG DOSE LIMIT ANALYSIS QUARTER 4 Dose Limit Max % of Quartr - Limit (mrad) (mrad) Limit Qtr 4 - Admin. Gamma 3.24E-0 '6 3.75E+00 8. 65E-05 Qtr 4 - Admin, Beta 1.39E-0 '6 7.50E+00 1.86E-05 Qtr 4 - T.Spc, Gamma 3.24E-06 5.OOE+00 6.49E-05 Receptor: 4 Composite Crit. Receptor - NG Distance: 0.00 (meters) Compass Point: NA Nuclide Percentage AR-41 4.65E+01 XE-135 7.67E-01 XE-133M 5.49E-02 XE-131M 1.08E-01 XE-133 5.25E+01 Qtr 4 - T.Spc, Beta 1.39E-06 1.OOE+01 1.39E-05 Receptor: 4 Composite Crit. Receptor - NG Distance: 0.00 (meters) Compass Point: NA Nuclide Percentage AR-41 9.40E+00 XE-135 5.62E-01 XE-133M 1.42E-01 XE-131M 4.38E-01 XE-133 8.95E+01 Page 84 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT GASEOUS DOSE

SUMMARY

Unit 2 2007 Report for: 2007 Unit Range - From: 2 To: 2 I&P DOSE LIMIT ANALYSIS ANNUAL 2007 Age Dose Limit Max % of Annual - Limit Group Organ (mrem) (mrem) Limit 2007 - Admin. Any Organ INFANT THYROID 1.22E-02 1.13E+01 1. 08E-01 2007 - Admin. Total Body CHILD TBODY 5.39E-03 1.05E+01 5. 13E-02 2007 - T.Spc. Any Organ INFANT THYROID 1.22E-02 1.50E+01 8. 12E-02 Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compass Point: NA Critical Pathway: Grs/Goat/Milk (GMILK)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 3 .44E+01 TE-125M 2 .39E-02 1-131 6. 24E+01 1-132 2 .20E-03 1-133 3 .25E+00 CS-136 1. 37E-04 2007 - T.Spc. Total Body CHILD TBODY 5.39E-03 1.50E+01 3.59E-02 Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compass Point: NA Critical Pathway: Vegetation (VEG)

Major Contributors ( 0% or greater to total)

Nuclide Percentage H-3 9. 97E+01 TE-125M 1. 25E-01 1-131 1. 06E-01 1-132 3. 40E-04 1-133 7 .74E-03 CS-136 1. 55E-02 Page 85 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT GASEOUS DOSE

SUMMARY

Unit 2 2007 Report for: 2007 Unit Range - From: 2 To: 2 NG DOSE LIMIT ANALYSIS ANNUAL 2007 Dose Limit Max % of Annual - Limit (mrad) (mrad) Limit 2007 - Admin. Gamma 1.66E-05 7.50E+00 2.21E-04 2007 - Admin. Beta 9.11E-06 1.50E+01 6. 08E-05 2007 - T.Spc. Gamma 1.66E-05 l.00E+01 1.66E-04 Receptor: 4 Composite Crit. Receptor - NG Distance: 0.00 (meters) Compass Point: NA Nuclide Percentage AR-41 1.39E+01 KR-85 4.53E-02 XE-138 6.76E+00 KR-85M 7. 86E-03 XE-135 1. 54E+01 XE-133M 3. 26E-02 XE-131M 2.10E-02 XE-133 6. 38E+01 2007 - T.Spc. Beta 9.11E-06 2.OOE+01 4.56E-05 Receptor: 4 Composite Crit. Receptor - NG Distance: 0.00 (meters) Compass Point: NA Nuclide Percentage AR-41 2.19E+00 KR-85 2.30E+00 XE-138 1.56E+00 KR-85M 5.63E-03 XE-135 8.85E+00 XE-133M 6.60E-02 XE-131M 6.70E-02 XE-133 8.50E+01 Page 86 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT Unit 2 2007 Report for: 2007 Unit Range - From: 2 To: 2 MAXIMUM DOSE ANALYSIS ANNUAL 2007 Age Dose Dose Type Group Organ (mrem)

Any Organ ADULT GILLI 2.45E-01 Liquid Receptor: 0 Liquid Receptor Gaseous Receptor: 5 Composite Crit. Receptor - IP Distance: 0.00 (meters) Compass Point: NA Liquid Dose: 2.41E-01 % of Total: 9.85E+01 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors 0% or greater to total)

Nuclide Percentage H-3 6.59E+01 CR-51 1.26E-02 MN-54 1.56E-01 FE-55 1.97E-02 FE-59 6.25E-02 CO-58 4.30E+00 CO-60 2.12E+00 SR-89 8.80E-03 SR-90 1.80E-02 NB-95 1.21E+01 TE-125M 1.53E+01 Gaseous Dose: 3.36E-03 % of Total: 1.37E+00 Critical Pathway: Vegetation (VEG)

Major Contributors 0% or greater to total)

Nuclide Percentage H-3 9.71E+01 TE-125M 2.81E+00 1-131 2.91E-02 1-132 4.80E-04 1-133 1.10E-02 CS-136 2.14E-03 MAXIMUM DOSE ANALYSIS ANNUAL 2007 Age Dose Dose Type Group Organ (mrem)

Total Body ADULT TBODY 1.65E-01 Liquid Receptor: 0 Liquid R eceptor Gaseous Receptor: 5 Composit .e Crit. RecE2ptor - IP Distance: 0.00 (meters) Comipass Point: NA Page 87 of 88

40CFR190 URANIUM FUEL CYCLE DOSE REPORT Liquid Dose: 1.62E-01 % of Total: 9.82E+01 Critical Pathway: Fresh Water Fish - Sport (FFSP)

Major Contributors 0% or greater to total)

Nuclide Percentage H-3 9.81E+01 CR-51 7.48E-05 MN-54 1.45E-02 FE-55 1.19E-02 FE-59 1.07E-02 CO-58 7.08E-01 CO-60 3.70E-01 SR-89 2.34E-03 SR-90 2.15E-02 NB-95 1.60E-03 TE-125M 7.64E-01 Gaseous Dose: 3.27E-03 % of Total: 1.98E+00 Critical Pathway: Vegetation (VEG)

Major Contributors 0% or greater to total)

Nuclide Percentage H-3 9.98E+01 TE-125M 9.88E-02 1-131 6.30E-02 1-132 5.27E-04 1-133 4.84E-03 CS-136 1.12E-02 Page 88 of 88

BYRON ODCM, REV. 5, CHANGE DOCUMENT ORIGINAL ODCM REVISED ODCM REASON Part I: Section 2.0 Controls and Removed All Effluent controls and Surveillance Requirements surveillances are in the TRM as part of the last revision. This should have been removed as part of the last revision since the Controls are tied to the RECS (Radiological Effluents Controls and Surveillances) portion of the ODCM/TRM. The RECS was moved solely to the TRM, previously the RECS were in the TRM and ODCM.

Figure 1-2 Site Boundary Removed Same as Figure 6-1 3.13 Meteorological Monitoring 3.13 Meteorological Monitoring Page number update due to Program found on page 1.3-3 Program found on page 1.3-2 removal of section 2.0 2.5.3 Waste Gas Decay Tank 2.5.3 Waste Gas Decay Tank Page number update due to Monitors found on page 11.2-7 Monitors found on page 11.2-8 removal of section 2.0 2.6.2 Containment Purge Effluent 2.6.2 Containment Purge Page number update due to Monitors found on page 11.2-8 Effluent Monitors found on removal of section 2.0 page 11.2-9 2.6.3 Waste Gas Decay Tank 2.6.3 Waste Gas Decay Tank Page number update due to Effluent Monitors found on page Effluent Monitors found on page removal of section 2.0 11.2-8 11.2-9 4.2.3 Time Averaged Dose from 4.2.3 Time Averaged Dose from Page number update due to Non-Noble Gas Radionuclides Non-Noble Gas Radionuclides removal of section 2.0 found on page 11.4-8 found on page 11.4-9 Figure 1-3 Restricted Area Figure 1-3 Restricted Area Page number update due to Boundary found on page 11.1-21 Boundary found on page 11.1- removal of Figure 1-2. Map

20. Removed "future" from needed update to reflect current "future radwaste storage conditions.

building" in the index.

Updated restricted area boundary and improved legibility.

Part I: 1.1 Actions shall be that Part I: Actions shall be that Changed word "Specification" to part of a Specification that part of a Requirement that "Requirement" to match the prescribes Required Actions to be prescribes Required Actions definition of Actions found in the taken under designated Conditions to be taken under designated Technical Requirements Manual within specified Completion times. Conditions within specified (TRM)

Completion times.

Part I: 1.5 Dose Equivalent 1-131 Part I: 1.5 Dose Equivalent I- Removed word "thyroid" and C:\Documents and Settings\BYRTF\Local Settings\Temporary Internet Files\0LK127\ODCM rev 5

BYRON ODCM, REV. 5, CHANGE DOCUMENT ORIGINAL ODCM REVISED ODCM REASON shall be that concentration of 1-131 131 shall be that concentration added "or Federal Guidance (microcuries/gram) that alone of 1-131 (microcuries/gram) that Report 11, "Limiting Values of would produce the same thyroid alone would produce the same Radionuclide Intake and Air dose as the quantity and isotopic thyroid dose as the quantity and Concentration and Dose mixture of 1-131, 1-132, 1-133, 1- isotopic mixture of 1-131, 1-132, Conversion Factors for 134, and 1-135 actually present. 1-133,1-134, and 1-135 actually Inhalation, Submersion and The thyroid dose conversion present. The dose conversion Ingestion," 1989, (Table 2.1, factors used for this calculation factors used for this calculation Exposure-to-Dose Conversion shall be those listed in Table III of shall be those listed in Table III Factors for Inhalation)" to match TID-14844, AEC, 1962. of TID-14844, AEC, 1962, the definition of Dose Equivalent "Calculation of Distance Factors "Calculation of Distance Factors 1-131 found in the Technical for Power and Test Reactor Sites, for Power and Test Reactor Requirements Manual (TRM)

"or those listed in Table E-7 of Sites, "or those listed in Table Regulatory Guide 1.109, Rev. 1, E-7 of Regulatory Guide 1.109, NRC, 1977, or ICRP 30, Rev. 1, NRC, 1977, or ICRP 30, Supplement to Part 1, pages 192- Supplement to Part 1, pages 212, Table Titled, "Committed 192-212, Table Titled, Dose Equivalent in Target Organs "Committed Dose Equivalent in or Tissues per Intake of Unit Target Organs or Tissues per Activity." Intake of Unit Activity", or Federal Guidance Report 11, "Limiting Values of Radionuclide Intake and Air Concentration and Dose Conversion Factors for Inhalation, Submersion and Ingestion," 1989, (Table 2.1, Exposure-to-Dose Conversion Factors for Inhalation).

Part I: 1.9 Mode shall correspond Part I: 1.9 Mode shall Removed "Technical to any one inclusive combination correspond to any one inclusive Specifications" and replaced of core reactivity condition, power combination of core reactivity with 'TRM Table T1.1-1" to level, average reactor coolant condition, power level, average match TRM wording for temperature, and reactor vessel reactor coolant temperature, definition of Mode.

head closure bolt tensioning and reactor vessel head closure specified in Technical bolt tensioning specified in TRM Specifications with fuel in the Table T1.1-1 with fuel in the reactor vessel, reactor vessel.

Part I: 1.14 Rated Thermal Power Part I: 1.14 Rated Thermal Removed "as defined in the shall be a total core heat transfer Power shall be a total core heat Technical Specifications" and rate to the reactor coolant as transfer rate to the reactor replaced with "3586.6 MWT" to defined in the Technical coolant 3586.6 MWT. match TRM wording for Specifications. definition of Rated Thermal Power.

Part I: 1.15 Radiological Effluent Part I: 1.15 Radiological Removed "Specifications" and Controls and Surveillances Effluent Controls and replaced with "Requirements (RECS) are in accordance with Surveillances (RECS) are in Manual (TRM)" to match TRM C:\Documents and Settings\BYRTF\Local Settings\Temporary Internet Files\OLK127\ODCM rev 5

BYRON ODCM, REV. 5, CHANGE DOCUMENT ORIGINAL ODCM REVISED ODCM REASON Byron Technical Specifications accordance with Byron wording for definition of and the Code of Federal Technical Requirements Manual Radiological Effluent Controls Regulations. (TRM) and the Code of Federal and Surveillances (RECS).

Regulations.

Part I: 1.16 Radiological Part I: 1.16 Radiological Removed "Specifications" and Environmental Monitoring Program Environmental Monitorin[g replaced with "Requirements (REMP) are in accordance with Pro-gram (REMP) are in Manual (TRM)" to match TRM Byron Technical Specifications accordance with Byron wording for definition of and the Code of Federal Technical Requirements Manual Radiological Environmental Regulations. (TRM) and the Code of Federal Monitoring Program (REMP).

Regulations.

Part I: 1.17 Site Boundary shall be Part I: 1.17 Site Boundary shall Removed "or property" and that line beyond which, the land or be that line beyond which, the changed "not" to "neither" to property is not owned, nor leased, land is neither owned, nor match TRM wording for nor otherwise controlled by the leased, nor otherwise controlled definition of Site Boundary.

licensee, by the licensee.

Part I: 1.24 Ventilation Exhaust Part I: 1.24 Ventilation Exhaust Replaced "absorbers" with Treatment System shall be any Treatment System shall be any "adsorbers" since it is the system designed and installed to system designed and installed correct terminology for the reduce gaseous radioiodine or to reduce gaseous radioiodine system.

radioactive material in particulate or radioactive material in form in effluents by passing particulate form in effluents by ventilation or vent exhaust gases passing ventilation or vent through charcoal absorbers and/or exhaust gases through charcoal HEPA filters for the purpose of adsorbers and/or HEPA filters removing iodines or particulates for the purpose of removing from the gaseous exhaust stream iodines or particulates from the prior to release to the gaseous exhaust stream prior to environment. Such a system is release to the environment.

not considered to have any effect Such a system is not considered on noble gas effluents, to have any effect on noble gas Engineered Safety Features effluents. Engineered Safety Atmospheric Cleanup Systems are Features Atmospheric Cleanup not considered VENTILATION Systems are not considered EXHAUST TREATMENT VENTILATION EXHAUST SYSTEM components. TREATMENT SYSTEM components.

Table 1-2, page 2 of 2 Compliance Table 1-2, page 2 of 2 Fixed typo from revision 4.

Matrix has typo in middle of table Compliance Matrix removed where column headings are extra column headings repeated.

Part I: Section 3.0 Surveillance Removed All Effluent controls and Requirements surveillances are in the TRM as part of the last revision. This should have been removed as part of the last revision since the Surveillances are tied to the RECS (Radiological Effluents Controls and Surveillances) portion of the ODCM/TRM. The RECS was moved solely to the C:\Documents and Settings\BYRTF\Local Settings\Temporary Internet Files\0LK127\ODCM rev 5

BYRON ODCM, REV. 5, CHANGE DOCUMENT ORIGINAL ODCM REVISED ODCM D REASON TRM, previously the RECS were in the TRM and ODCM.

Part I1: 1.1 Structure of the Part I1: 1.1 Structure of the Combined Radiological Effluent ODCM. Part I of the ODCM is ODCM. Part I of the ODCM is Controls with Radiological considered to be the Radiological considered to be the Environmental Monitoring Effluents Controls (RECS), and Radiological Effluents Controls Program and removed the word contains the former Radiological (RECS), and contains the "surveillances" to reflect Effluent Technical Specifications former Radiological Effluent updated ODCM structure.

that have been removed from the Technical Specifications that Technical Specifications. Part I is have been removed from the organized as follows: Definitions, Technical Specifications. Part I Radiological Effluent Controls and is organized as follows:

Surveillances, Radiological Definitions, Radiological Effluent Environmental Monitoring Controls and Radiological Program, Bases, Administrative Environmental Monitoring Requirements Program, Meteorological Monitoring Program, Bases, Administrative Requirements Part II Table 1-1 in liquid releases Part II Table 1-1 in liquid Corrected oversight from section there was not a TRM releases section added TRM revision 4 of ODCM.

section reference listed for Organ section 3.11 .d for Organ Dose(per reactor unit) Dose(per reactor unit)

Part I1: 2.4 A simplified HVAC and Part I1: 2.4 A simplified HVAC Added Figure 2-1 to end of gaseous effluent flow diagram is and gaseous effluent flow sentence. This was missing in provided in. diagram is provided in Figure 2- Rev 4 of ODCM.

1.

Part I1: 2.4 The principal release Part I1: 2.4 The principal Added Figure 2-1 to end of points for potentially radioactive release points for potentially sentence and removed word airborne effluents are the two radioactive airborne effluents "vent" to correct wording auxiliary building vent stacks are the two auxiliary building missing in Rev 4 of ODCM and (designated Vent Stack 1 and Vent vent stacks (designated Stack 1 correct terminology to match Stack 2 in ). and Stack 2 in Figure 2-1). that found in Figure 2-1.

Part II 2.4.2 The ventilation Part II 2.4.2 The ventilation Added Figure 2-1 to end of exhaust treatment systems are exhaust treatment systems are sentence. This was missing in shown in. shown in Figure 2-1. rev 4 of ODCM.

Part I1: Table 2-4 at bottom of Part I1: Table 2-4 at bottom of Typo from rev 4 of ODCM page words "Figure 2-1 Simplified page removed words "Figure 2-HVAC & Gaseous Effluent Flow 1 Simplified HVAC & Gaseous Diagram" Effluent Flow Diagram" Part II Figure 2-1 page 2 of 2 Part II Figure 2-1 page 2 of 2 Notes 4 and 5 were not included notes 4 and 5 removed notes 4 and 5 referenced anywhere on Figure 2-1 so they were removed Part II Figure 2-2 To U2 Part II Figure 2-2 To U2 Fixed typos found in Figure 2-2 Codensate Storage Tank and To Condensate Storage Tank and Primary Waste Storage Tank To Primary Water Storage Tank Part II 3.1.5 Cases in which Part II 3.1.5 Cases in which Added word "and" before "will" normally non-radioactive liquid normally non-radioactive liquid to fix grammar.

C:\Documents and Settings\BYRTF\Local Settings\Temporary Internet Files\OLK127\ODCM rev 5

BYRON ODCM, REV. 5, CHANGE DOCUMENT ORIGINAL ODCM REVISED ODCM REASON streams (such as the Services streams (such as the Services Water) are found to contain Water) are found to contain radioactive material are non- radioactive material are non-routine will be treated on a case routine and will be treated on a specific basis if and when this case specific basis if and when occurs, this occurs.

Part II 3.4.3 Aai(Fish)i Site-Specific Part II3.4.3 Aai(Fish)j Site-Specific Fixed description term for Dose Factor for Potable Water Dose Factor for Fish Ingestion equation since it is for Fish Pathway Pathway Ingestion pathway not potable water pathway Part II 4.2.2.1 Gamma Air Dose Part II 4.2.2.1 Gamma Air Dose Reg Guide 1.109 does not have term Mi Gamma air dose rate term Mi Gamma air dose rate a Table 3-1. The reference has factor per unit of radioactivity factor per unit of radioactivity been changed to Table B-1 of release rate for radionuclide i. See release rate for radionuclide i. Reg Guide 1.109.

Table 4-28 for Gamma Air Dose See Table 4-28 for Gamma Air conversion factors (From Table 3- Dose conversion factors (From 1 of Regulatory Guide 1.109) Table B-1 of Regulatory Guide 1.109)

Part II (page 11.4-6) TRM TSR Part II (page 11.4-6) TRM 3.11.g Removed "TSR" and "1" as 3.11 .g. 1 requires determination of requires determination of these are typos from rev 4 of cumulative and projected gamma cumulative and projected ODCM.

air dose contributions due to noble gamma air dose contributions gases for the current calendar due to noble gases for the quarter and the current calendar current calendar quarter and the year at least once per 31 days. current calendar year at least once per 31 days.

Part 114.2.2.2 Beta Air Dose term Part 114.2.2.2 Beta Air Dose Reg Guide 1.109 does not have Ni Beta Air Dose Conversion term Ni Beta Air Dose a Table 3-1. The reference has Factor Beta air dose rate per unit Conversion Factor Beta air been changed to Table B-1 of of radioactivity concentration for dose rate per unit of Reg Guide 1.109.

radionuclide i. See Table 4-28 radioactivity concentration for for Beta Air Dose conversion radionuclide i. See Table 4-28 factors (From Table 3-1 of for Beta Air Dose conversion Regulatory Guide 1.109) factors (From Table B-1 of Regulatory Guide 1.109)

Part 114.2.2.4 Skin Dose term Ki Part 114.2.2.4 Skin Dose term Ki Reg Guide 1.109 does not have Gamma Total Body Dose Gamma Total Body Dose a Table 3-1. The reference has Conversion Factor Gamma total Conversion Factor Gamma been changed to Table B-1 of body dose factor due to gamma total body dose factor due to Reg Guide 1.109.

emissions for noble gas gamma emissions for noble gas radionuclide i released from a radionuclide i released from a stack, vent or ground level release stack, vent or ground level point, respectively. See Table 4- release point, respectively. See 28 for Gamma total body dose Table 4-28 for Gamma total conversion factors. (From Table body dose conversion factors.

C:\Documents and Settings\BYRTF\Local Settings\Temporary Internet Files\0LK127\ODCM rev 5

BYRON ODCM, REV. 5, CHANGE DOCUMENT ORIGINAL ODCM REVISED ODCM REASON 3-1 of Regulatory Guide 1.109). (From Table B-1 of Regulatory Guide 1.109).

Part II 4.2.2.4 Skin Dose Note Part II 4.2.2.4 Skin Dose Note Removed word "if"for better that in the unlikely event that if that in the unlikely event that sentence structure.

beta air dose guideline is beta air dose guideline is exceeded, then the skin dose will exceeded, then the skin dose require evaluation, will require evaluation.

Part II 4.2.3 term Raipj Values of Part II 4.2.3 term Raipj Values of Table 4-8 does not provide Raipj Raipj are provided in Table 4-7 Raipj are provided in Table 4-7 values.

through Table 4-26. and Table 4-9 through Table 4-26.

Part II 4.2.3.4 Ingestion: Milk page Part II 4.2.3.4 Ingestion: Milk Corrected the descriptor for 11.4-16 Water Fraction The page 11.4-16 Water Fraction Water Fraction for Milk Ingestion fraction of total vegetation that is The fraction of total feed that is from total vegetation to total water. water. feed.

Part II 4.2.3.5 Ingestion: Meat Uaf Part II 4.2.3.5 Ingestion: Meat Corrected the units for meat Meat Consumption Rate [I/yr] Uaf Meat Consumption Rate consumption rate from I/yr to

[kg/yr] kg/yr.

Part II 4.2.3.5 Ingestion: Meat Part II 4.2.3.5 Ingestion: Meat Corrected the descriptor for Water Fraction for equation 4-16 Water Fraction for equation 4-16 Water Fraction for Meat The fraction of total vegetation that The fraction of total feed that is Ingestion from total vegetation is water. water. to total feed.

Part II Table 6-1 Airborne Part II Table 6-1 Airborne Increased radioiodine collection Radioiodine and Particulates Radioiodine and Particulates frequency from biweekly to Sampling or Collection Frequency Sampling or Collection weekly.

Continuous sampler operation with Frequency Continuous sampler particulate sample collection operation with particulate weekly, or more frequently if sample collection weekly, or required by dust loading, and more frequently if required by radioiodine canister collection dust loading, and radioiodine biweekly. canister collection weekly.

Part II Table 6-1 Direct Radiation Part II Table 6-1 Direct Included the actual sample ID's, Indicators-Other One at each Radiation Indicators- distance, location and sector airborne location given in part 1.a Other BY-01-1, 3.0 mi N (4.76 information instead of and 1.b km A), BY-01 -2, 3.0 mi N (4.76 referencing part 1.a and 1 .b. No km A), BY-04-1, 5.0 mi SE change to program. These are (7.98 km G), BY-04-2, 5.0 mi SE the same samples that were in (7.98 km G), BY-24-1, 0.6 mi part 1.a and 1 .b.

SW (1.03 km L), BY-24-2, 0.6 mi SW (1.03 km L), BY-06-1, 4.7 mi SSW (7.54 km K), BY 2, 4.7 mi SSW (7.54 km K), BY-21-1, 0.3 mi N (0.48 km A),BY-21-2, 0.3 mi N (0.48 km A), BY-22-1, 0.4 mi ESE (0.60 km F),

BY-22-2, 0.4 mi ESE (0.60 km F), BY-23-1, 0.6 mi S (0.95 km J), BY-23-2, 0.6 mi S (0.95 km J)

C:\Documents and Settings\BYRTF\Local Settings\Temporary Internet Files\0LK127\ODCM rev 5

BYRON ODCM, REV. 5, CHANGE DOCUMENT ORIGINAL ODCM REVISED ODCM REASON Part II Table 6-1 Direct Radiation Part II Table 6-1 Direct Included the actual sample ID's, Control One at each airborne Radiation Control BY-08-1, 6.8 distance, location and sector control location given in part 1.c. mi WNW (10.9 km P) and BY- information instead of.

08-2, 6.8 mi WNW (10.9 km P) referencing part 1 .c. No change to program. These are the same samples that were in part 1.c.

Part II Table 6-1 Waterborne Part II Table 6-1, Waterborne Added 3 ground/well indicator Ground/Well Indicators BY-14-1, Ground/Well Indicators BY-14-1, sample locations in 2 nd Q 2006.

3200 German Church Rd, 1.0 mi 3200 German Church Rd, 1.0 SSE (1.6km H), BY-18, McCoy mi SSE (1.6km H), BY-18, Farmstead, 0.7 mi SW (1.2km L), McCoy Farmstead, 0.7 mi SW BY-32, Wolford Well, 1.8 mi W (1.2km L), BY-32, Wolford Well, (2.9km N) 1.8 mi W (2.9km N), BY-35, Vancko Well, 2.0 mi WNW (3.22km P), BY-36, Blanchard Well, 1.0 mi NW (1.61km Q),

BY-37, Alexander Well, 1.80 mi WNW, (2.90km P)

Part II Table 6-1 Waterborne c. Part II Table 6-1 Waterborne Format change in table for Surface, d. Control, e. Sediment Surface a. Indicators, b. Control; consistency.

Sediment a. Indicators Part II Table 6-1 Ingestion a. Milk, Part II Table 6-1 Ingestion Milk, Format change in table for

b. Fish, c. Food Products Fish, Food Products consistency.

Part II Table 6-1 Ingestion Milk Part II Table 6-1 Ingestion Milk Added 1 milk indicator sample Indicators BY-20-1, R. Snodgrass, Indicators BY-20-1, R. location in January 2006.

Dairy Farm, 4.7 mi WSW (7.52 km Snodgrass, Dairy Farm, 4.7 mi M), BY-30, Don Roos Dairy, 5.3 mi WSW (7.52 km M), BY-30, Don SE (8.4 km G) Roos Dairy, 5.3 mi SE (8.4 km G), BY-38, D. Larson Goat Farm, 5.0 mi ENE (8.05 km D)

Part II Table 6-2 Surface Part II Table 6-2 Surface Included sediment-sample ID Water/Fish/Sediment Sampling Water/Fish/Sediment Sampling and location information in Locations BY-12, BY-29, BY-31 Locations BY-12, BY-29, BY-31, Table 6-2. This is not a new BY-34 sample and is not a change to the program, it was omitted in rev 4 of ODCM.

Part II Table 6-2 Milk Sampling Part II Table 6-2 Milk Sampling Added 1 milk sampling location Locations BY-20, BY-26, BY-30 Locations BY-20-1, BY-26-1, (BY-38) to the table. Corrected BY-30, BY-38 typos for locations BY-20-1 and BY-26-1.

Part II Table 6-2 Well Water Part II Table 6-2 Well Water Added 3 well water sampling Sampling Locations BY-1 4, BY-1 8, Sampling Locations BY-14-1, locations (BY-35, BY-36, BY-37)

BY-32 BY-18, BY-32, BY-35, BY-36, to the table. Corrected typo for BY-37 location BY-14-1.

C:\Documents and Settings\BYRTF\Local Settings\Temporary Internet Files\OLK12 7\ODCM rev 5

BYRON ODCM, REV. 5, CHANGE DOCUMENT ORIGINAL ODCM REVISED ODCM REASON Figure 6-3 Inner Ring & Outer Figure 6-3 Inner Ring & Outer BY-101-1 & BY-101-2 locations Ring TLD Locations Ring TLD Locations with sectors were not accurate. Sectors added and BY-101-1 & BY-101- added to enhance usefulness.

2 locations revised C:\Documents and Settings\BYRTF\Local Settings\Temporary Internet Files\OLK127\ODCM rev 5

CY-BY-1 70-301 Revision 5 INFORMATION USE ODCM TABLE OF CONTENTS PART I - RADIOLOGICAL EFFLUENT CONTROLS 1.0 D E FIN IT IO NS ....................................................................................... 1.1-1 3.11 RADIOLOGICAL EFFLUENT CONTROLS AND RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM .................................. 1.3-1 3.13 METEOROLOGICAL MONITORING PROGRAM ................................ 1.3-2 4 .0 B AS E S ................................................................................................ 1.4-1 5.0 ADMINISTRATIVE REQUIREMENTS .................................................. 1.5-1 PART II - ODCM

1.0 INTRODUCTION

- ODCM GENERAL INFORMATION ...................... 11.1-1 1.1 Structure of the ODCM .............................................................. 11.1-1 1.2 Regulations ............................................................................... 11.1-2 1.2.1 Code of Federal Regulations .......................................... 11.1-2 1.2.2 Radiological Effluent Technical Standards ..................... 11.1-4 1.2.3 Offsite Dose Calculation Manual .................................... 11.1-5 1.2.4 Overlapping Requirements ............................................. 11.1-5 1.2.5 Dose Receiver Methodology .......................................... 11.1-5 1.3 Offsite Dose Calculation Parameters ...................................... 11.1-10 1.4 References .............................................................................. 11.1-10 2.0 INSTRUMENTATION AND SYSTEMS ................................................ 11.2-1 2.1 Liquid Effluent System Description ........................................... 11.2-1 2.1.1 R elease Tanks ............................................................... 11.2-1 2.1.2 Turbine Building Fire and Oil Sump ................................ 11.2-1 2.1.3 Condensate Polisher Sump ............................................ 11.2-1 2.2 Liquid Effluent Radiation Monitors ............................................ 11.2-2 2.2.1 Liquid Radwaste Effluent Monitor ................................... 11.2-2 2.2.2 Station Blowdown Monitor .............................................. 11.2-2 2.2.3 Reactor Containment Fan Cooler (RCFC) and Essential Service Water (SX) Outlet Line Monitor .......... 11.2-2 2.2.4 Turbine Building Fire and Oil Sump Monitor ................... 11.2-2 2.2.5 Condensate Polisher Sump Monitor ............................... 11.2-2 2.2.6 Component Cooling Water Monitors .............................. 11.2-2 2.3 Liquid Radiation Effluent Monitors Alarm and Trip Setpo ints ................................................................................... 11.2-3 2.3.1 Station Blowdown Monitor .............................................. 11.2-3 2.3.2 Liquid Radwaste Effluent Monitor ................................... 11.2-3 2.3.3 Other Liquid Effluent Monitors ........................................ 11.2-5 2.3.4 Conversion Factors ........................................................ 11.2-6 Page 1 of 6

CY-BY-1 70-301 Revision 5 PART II - ODCM 2.3.5 Allocation of Effluent from Common Release Po ints ......................................................................... .... 11.2-6 2.3.6 Solidification of Wastes/Process Control Program ......................................................................... 11.2-6 2.4 Gaseous Effluent System Description ...................................... 11.2-6 2.4.1 Waste Gas Holdup System ........................................... 11.2-6 2.4.2 Ventilation Exhaust Treatment System ......................... 11.2-6 2.5 Gaseous Effluent Radiation Monitors ....................................... 11.2-7 2.5.1 Auxiliary Building Vent Effluent Monitors ....................... 11.2-7 2.5.2 Containment Purge Effluent Monitors ............. 11.2-7 2.5.3 Waste Gas Decay Tank Monitors ................................... 11.2-8 2.5.4 Gland Steam and Condenser Air Ejector Mo nito rs ......................................................................... 11.2-8 2.5.5 Radwaste Building Ventilation Monitor .......................... 11.2-8 2.6 Gaseous Effluent Monitor Alarm and Trip Setpoints ................. 11.2-8 2.6.1 Auxiliary Building Vent Effluent Monitors ........................ 11.2-8 2.6.2 Containment Purge Effluent Monitors ............................. 11.2-9 2.6.3 Waste Gas Decay Tank Effluent Monitors ...................... 11.2-9 2.6.4 Gaseous Effluent Release Limits ................................... 11.2-9 2.6.5 Release Mixture ........................................................... 11.2-10 2.6.6 Conversion Factors ..................................................... 11.2-10 2.6.7 HVAC Dilution Flow Rates ........................................... 11.2-10 2.6.8 Allocation of Effluents from Common Release Po ints ........................................................................... 11.2-10 2.6.9 Dose Projections for Batch Releases ........................... 11.2-10 3.0 LIQ UID EFFLU ENTS ........................................................................... 11.3-1 3.1 Liquid Effluent Releases - General Information ........................ 11.3-1 3.2 Liquid Effluent Concentrations .................................................. 11.3-2 3.3 Liquid Effluent Dose Calculation Requirements ........................ 11.3-4 3.4 Dose Methodology .................................................................... 11.3-4 3.5 Site Specific Dose Factors and Bioaccumulation F acto rs ..................................................................................... 11.3-7 4.0 GASEOUS EFFLUENTS ............................... 11.4-1 4.1 Gaseous Effluents - General Information ................................. 11.4-1 4.2 Gaseous Effluents - Dose and Dose Rate Calculation R equirem ents ........................................................................... 11.4-2 4.2.1 Instantaneous Dose Rates ............................................. 11.4-2 4.2.2 Time Averaged Dose from Noble Gas ............................ 11.4-5 4.2.3 Time Averaged Dose from Non-Noble Gas R adionuclides ................................................................. 11.4-9 Page 2 of 6

CY-BY-1 70-301 Revision 5 PART II - ODCM 5.0 TOTAL DOSE ...................................................................................... 11.5-1 5.1 Total Dose Calculation Requirements ....................................... 11.5-1 5.1.1 Total Effective Dose Equivalent Limits, 10CFR20 and 40CFR190 ............................................................... 11.5-1 5.1.2 Total Dose Calculation Methodology .............................. 11.5-1 5.2 Onsite Radwaste and Rad Material Storage Facilities .............. 11.5-2 5.2.1 Process Waste Storage Facilities ................................... 11.5-2 5.2.2 DAW Storage Facilities .................................................. 11.5-2 5.2.3 Replaced Steam Generator Storage Facilities ............... 11.5-2 5.2.4 ISFSI Facilities ............................................................... 11.5-2 5.3 Methodology ............................................................................. 11.5-2 5.4 Total D ose ................................................................................. 11.5-3 5.5 Compliance to Total Dose Limits .............................................. 11.5-4 5.5.1 Total Effective Dose Equivalent Limit - 10CFR20 Compliance .................................................................... 11.5-4 5.5.2 Dose to a Member of the Public in the Unrestricted Area .......................... 11.5-4 5.5.3 Dose to a Member of the Public in the Restricted A rea ................................................................................ 11.5-4 5.5.4 Total Dose Due to the Uranium Fuel Cycle (40CFR1 90) .................................................................... 11.5-5 5.6 When Compliance Assessment is Required ............................. 11.5-6 6.0 RADIOLOGICAL ENVIRONMENTAL MONITORING P R O G R A M.......................................................................................... 11.6-1 Page 3 of 6

CY-BY-1 70-301 Revision 5 ODCM TABLE OF CONTENTS LIST OF TABLES PART I - RADIOLOGICAL EFFLUENT CONTROLS Table 1-1 Frequency Notations ............................................................... 1.1-4 Table 1-2 Compliance Matrix ................................................................... 1.1-5 PART II - ODCM Table 1-1 Regulatory Dose Limit Matrix ................................................. 11.1-7 Table 1-2 Dose Assessment Receivers .................................................. 11.1-8 Table 1-3 Miscellaneous Dose Assessment Factors:

Environmental Parameters ................................................... 11.1-17 Table 1-4 Stable Element Transfer Data .............................................. 11.1-18 Table 2-1 Liquid Radioactive Effluent Monitors .................................... 11.2-11 Table 2-2 Gaseous Radioactive Effluent Monitors ............................... 11.2-12 Table 2-3 Assumed Composition of the Byron Station Noble Gas Effl uent ................................................................................. 11.2-13 Table 2-4 Assumed Composition of the Byron Station Liquid E fflue nt ................................................................................. 11.2-14 Table 3-1 Site Specific Potable Water Dose Factors for Adult Age G ro up ..................................................................................... 11.3-9 Table 3-2 Site Specific Potable Water Dose Factors for Teen Age G ro up ................................................................................... 11.3-11 Table 3-3 Site Specific Potable Water Dose Factors for Child Age G ro up ................................................................................... 11.3-13 Table 3-4 Site Specific Potable Water Dose Factors for Infant Age G ro up ................................................................................... 11.3-15 Table 3-5 Site Specific Fish Ingestion Dose Factors for Adult Age G ro up ................................................................................... 11.3-17 Table 3-6 Site Specific Fish Ingestion Dose Factors for Teen Age G ro up ................................................................................... 11.3-19 Table 3-7 Site Specific Fish Ingestion Dose Factors for Child Age G ro up ................................................................................... 11.3-2 1 Table 3-8 Bioaccumulation Factors (BF1 ) to be used in the Absence of Site-Specific Data .............................................. 11.3-23 Table 4-1 X/Q and D/Q Maxima at or Beyond the Unrestricted A rea Boundary ..................................................................... 11.4-18 Table 4-2 X/Q and D/Q Maxima at or Beyond the Restricted Area B oundary .............................................................................. 11.4-19 Table 4-3 Maximum Offsite Gamma-X/Q .............................................. 11.4-20 Table 4-4 X/Q and D/Q at the Nearest Resident Locations within 5 m ile s ..................................................................................... 11.4-2 1 Page 4 of 6

CY-BY-1 70-301 Revision 5 ODCM TABLE OF CONTENTS LIST OF TABLES PART II - ODCM Table 4-5 X/Q and D/Q at the Nearest Cow Milk Locations within 5 miles ..................................................................................... 11.4-22 Table 4-6 X/Q and D/Q at the Nearest Cow Milk Meat Locations w ithin 5 m iles ........................................................................ 11.4-23 Table 4-7 Ground Plane Dose Factors ................................................. 11.4-24 Table 4-8 External Dose Factors for Standing on Contaminated G ro u nd ................................................................................. 11.4-26 Table 4-9 Adult Inhalation Dose Factors .............................................. 11.4-29 Table 4-10 Teen Inhalation Dose Factors .............................................. 11.4-31 Table 4-11 Child Inhalation Dose Factors .............................................. 11.4-33 Table 4-12 Infant Inhalation Dose Factors .............................................. 11.4-35 Table 4-13 Adult Vegetation Dose Factors ............................................. 11.4-37 Table 4-14 Teen Vegetation Dose Factors ............................................. 11.4-39 Table 4-15 Child'Vegetation Dose Factors ............................................. 11.4-41 Table 4-16 Adult Grass-Cow-Milk Dose Factors .................................... 11.4-43 Table 4-17 Teen Grass-Cow-Milk Dose Factors ..................................... 11.4-45 Table 4-18 Child Grass-Cow-Milk Dose Factors .................................... 11.4-47 Table 4-19 Infant Grass-Cow-Milk Dose Factors .................................... 11.4-49 Table 4-20 Adult Grass-Goat-Milk Dose Factors .................................... 11.4-51 Table 4-21 Teen Grass-Goat-Milk Dose Factors .................................... 11.4-53 Table 4-22 Child Grass-Goat-Milk Dose Factors .................................... 11.4-55 Table 4-23 Infant Grass-Goat-Milk Dose Factors ................................... 11.4-57 Table 4-24 Adult Grass-Cow-Meat Dose Factors ................................... 11.4-59 Table 4-25 Teen Grass-Cow-Meat Dose Factors ................................... 11.4-61 Table 4-26 Child Grass-Cow-Meat Dose Factors ................................... 11.4-63 Table 4-27 Byron Station Characteristics ............................................... 11.4-65 Table 4-28 Dose Factors for Noble Gases ............................................. 11.4-66 Table 6-1 Radiological Environmental Monitoring Program .................... 11.6-2 Table 6-2 Latitude/Longitude Positions of REMP samples ................... 11.6-14 Page 5 of 6

CY-BY-1 70-301 Revision 5 ODCM TABLE OF CONTENTS LIST OF FIGURES PART I - RADIOLOGICAL EFFLUENT CONTROLS NONE PART II - ODCM Figure 1-1 Radiation Exposure Pathways to Humans ............................. 11.1-9 Figure 1-2 Removed - See Figure 6-1 ............................................................

Figure 1-3 Restricted Area Boundary .................................................... 11.1-20 Figure 2-1 Simplified HVAC & Gaseous Effluent Flow Diagram ............ 11.2-15 Figure 2-2 Simplified Liquid Radwaste Processing Diagram ................. 11.2-17 Figure 2-3 Liquid Release Flow Path ....................... 11.2-18 Figure 6-1 Onsite Air Sampling Locations and Site Boundary ............... 11.6-10 Figure 6-2 Offsite Air Sampling Locations ............................................. 11.6-11 Figure 6-3 Inner Ring & Outer Ring TLD Locations ............................... 11.6-12 Figure 6-4 Ingestion & Waterbome Exposure Pathway Sample Locatio ns .............................................................................. 11.6-13 Figure 6-5 Site Layout and Exclusion Area ............................................. 11.6-16 Page 6 of 6

CY-BY-1 70-301 Revision 5 RADIOLOGICAL EFFLUENTS CONTROLS FOR BYRON STATION UNITS 1 AND 2 REVISION 5

CY-BY-1 70-301 Revision 5 1.0 DEFINITIONS 1.1 ACTIONS shall be that part of a Requirement that prescribes Required Actions to be taken under I designated Conditions within specified Completion Times.

1.2 CHANNEL CALIBRATION shall be the adjustment, as necessary, of the channel so that it responds within the required range and accuracy to known inputs. The CHANNEL CALIBRATION shall encompass the entire channel, including the required sensor, alarm, interlock, display, and trip functions. Calibration of instrument channels with Resistance Temperature Detector (RTD) or thermocouple sensors may consist of an in place qualitative assessment of sensor behavior and normal calibration of the remaining adjustable devices in the channel. The CHANNEL CALIBRATION may be performed by means of any series of sequential, overlapping calibrations or total channel steps so that the entire channel is calibrated.

1.3 CHANNEL CHECK shall be the quantitative assessment, by observation, of channel behavior during operation. This determination shall include, where possible, comparison of the channel indication and status to other indications or status derived from independent instrument channels measuring the same parameter.

1.4 CHANNEL OPERATIONAL TEST (COT) shall be the injection of a simulated or actual signal into the channel as close to the sensor as practicable to verify the OPERABILITY of required alarm, interlock, display and trip functions. The COT shall include adjustments, as necessary, of the required alarm, interlock, and trip setpoints so that the setpoints are within the required range and accuracy.

1.5 DOSE EQUIVALENT 1-131 shall be that concentration of 1-131 (microcuries/gram) that alone would produce the same thyroid dose as the quantity and isotopic mixture of 1-131, 1-132, 1-133, I-134, and 1-135 actually present. The dose conversion factors used for this calculation shall be those listed in Table III of TID-14844, AEC, 1962. "Calculation of Distance Factors for Power and Test Reactor Sites," or those listed in Table E-7 of Regulatory Guide 1.109, Rev.1, NRC, 1977, or ICRP 30, Supplement to Part 1, pages 192-212, Table Titled, "Committed Dose Equivalent in Target Organs or Tissues per Intake of Unit Activity, or Federal Guidance Report 11, "Limiting Values of Radionuclide Intake and Air Concentration and Dose Conversion Factors for Inhalation, Submersion and Ingestion," 1989, (Table 2.1, Exposure-to-Dose Conversion Factors for Inhalation).

1.6 FREQUENCY - Table 1-1 provides the definitions of various frequencies for which surveillances, sampling, etc., are performed unless defined otherwise. The 25% variance shall not be applied to Operability Action statements. The bases to Improved Technical Specification 3.0.2 provide clarifications to this requirement.

1.7 IMMEDIATELY - When "immediately" is used as a completion time the Required Action should be pursued without delay and in a controlled manner.

1.8 MEMBER(S) OF THE PUBLIC shall include all persons who are not occupationally associated with the plant. This category does not include employees of the licensee, its contractors or vendors and persons who enter the site to service equipment or to make deliveries. This category does include persons who use portions of the site for recreational, occupational, or other purposes not associated with the plant.

1.9 MODE shall correspond to any one inclusive combination of core reactivity condition, power level, average reactor coolant temperature, and reactor vessel head closure bolt tensioning specified in TRM Table T1 .1-1 with fuel in the reactor vessel.

Page 1.1-1

CY-BY-1 70-301 Revision 5 1.10 OCCUPATIONAL DOSE means the dose received by an individual in the course of employment in which the individual's assigned duties involve exposure to radiation and/or to radioactive material from licensed and unlicensed sources of radiation, whether in the possession of the licensee or other person. Occupational dose does not include dose from background radiation, as a patient from medical practices, from voluntary participation in medical research programs, or as a member of the public.

1.11 A system, subsystem, train, component, or device shall be OPERABLE or have OPERABLITY when it is capable of performing its specified safety functions(s) and when all necessary attendant instrumentation, controls, normal or emergency electrical power, cooling and seal water, lubrication, and other auxiliary equipment that are required for the system, subsystem, train, component, or device to perform its specified safety function(s) are also capable of performing their related support function(s).

1.12 PROCESS CONTROL PROGRAM (PCP) shall contain the current formulas, sampling, analyses, tests, and determinations to be made to ensure that processing and packaging of solid radioactive wastes based on demonstrated processing of actual or simulated wet solid wastes will be accomplished in such a way as to assure compliance with 10 CFR Parts 20, 61, and 71, State regulations, burial ground requirements and other requirements governing the disposal of solid radioactive waste.

1.13 PURGE/PURGING shall be any controlled process of discharging air or gas from a confinement to maintain temperature, pressure, humidity, concentration or other operating condition, in such a manner that replacement air or gas is required to purify the confinement.

1.14 RATED THERMAL POWER shall be a total core heat transfer rate to the reactor coolant of 3586.6 MWT.

1.15 RADIOLOGICAL EFFLUENT CONTROLS AND SURVEILLANCES (RECS) are in accordance with Byron Technical Requirements Manual (TRM) and the Code of Federal Regulations.

1.16 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM (REMP) are in accordance with Byron Technical Requirements Manual (TRM) and the Code of Federal Regulations.

1.17 SITE BOUNDARY shall be that line beyond which, the land is neither owned, nor leased, nor otherwise controlled by the licensee.

1.18 SOLIDIFICATION shall be the conversion of wet wastes into a form that meets shipping and burial ground requirements.

1.19 SOURCE CHECK shall be the qualitative assessment of channel response when the channel sensor is exposed to a source of increased radioactivity.

1.20 THERMAL POWER shall be the total reactor core heat transfer rate to the reactor coolant.

1.21 TLCO-TECHNICAL LIMITING CONDITION FOR OPERATION Limiting Condition for Operation as listed in the TRM.

1.22 TECHNICAL REQUIREMENTS MANUAL (TRM) Chapter 3.11 contains the Radiological Effluent Controls and Surveillances (RECS). Chapter 3.12 contains the Radiological Environmental Monitoring Program (REMP).

1.23 UNRESTRICTED AREA means an area, access to which is neither limited nor controlled by the licensee.

Page 1.1-2

CY-BY-170-301 Revision 5 1.24 VENTILATION EXHAUST TREATMENT SYSTEM shall be any system designed and installed to reduce gaseous radioiodine or radioactive material in particulate form in effluents by passing ventilation or vent exhaust gases through charcoal adsorbers and/or HEPA filters for the purpose of removing iodines or particulates from the gaseous exhaust stream prior to the release to the environment. Such a system is not considered to have any effect on noble gas effluents.

Engineered Safety Features Atmospheric Cleanup Systems are not considered VENTILATION EXHAUST TREATMENT SYSTEM components.

1.25 VENTING shall be any controlled process of discharging air or gas from a confinement to maintain temperature, pressure, humidity, concentration or other operating condition, in such a manner that replacement air or gas is not provided or required during VENTING. Vent, used in system names, does not imply a VENTING process.

1.26 WASTE GAS HOLDUP SYSTEM shall be any system designed and installed to reduce radioactive gaseous effluents by collecting Reactor Coolant System off-gases from the Reactor Coolant System and providing for delay or holdup for the purpose of reducing the total radioactivity prior to release to the environment.

1.27 Definitions Peculiar to Estimating Dose to Members of the Public using the OFFSITE DOSE CALCULATION MANUAL (ODCM) Computer Program.

a. ACTUAL - ACTUAL refers to using known release data to project the dose to members of the public for the previous time period. This data is stored in the database and used to demonstrate compliance with the reporting requirements of the ODCM.

b. PROJECTED - PROJECTED refers to using known release data from the previous time period or estimated release data to forecast a future dose to members of the public. This data is not incorporated into the database.

Page 1.1-3

CY-BY-1 70-301 Revision 5 Table 1-1 FREQUENCY NOTATIONS*

Notation Frequency S - Shiftly At least once per 12 hours1.388889e-4 days 0.00333 hours 1.984127e-5 weeks 4.566e-6 months D - Daily At least once per 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months W - Weekly At least once per 7 days B- Biweekly At least once every 14 days M - Monthly At least once per 31 days Q - Quarterly At least once per 92 days SA - Semiannually At least once per 184 days A - Annually At least once per 366 days R - Refuel Cycle At least once per 18 months S/U - Startup Prior to each reactor startup N.A. Not applicable P - Prior Prior to each radioactive release

Each frequency requirement shall be performed within the specified time interval with the maximum allowable extension not to exceed 25% of the frequency interval. The 25% variance shall not be applied to Operability Action statements. The bases to ITS 3.0.2 provide clarifications to this requirement. These frequency notations do not apply to the Radiological Environmental Monitoring Program as described in TRM 3.12.

Page 1.1-4

CY-BY-1 70-301 Revision 5 Table 1-2 COMPLIANCE MATRIX ODC ODCM REC Technical Regulation Dose Component Limit Equation Specification 10 CFR 50 1. Gamma air dose and beta air dose due to 4-4 3.11.g 5.5.4.h Appendix I airborne radioactivity in effluent plume. 4-5

a. Total body and skin dose due to airborne 4-6 N/A N/A radioactivity in effluent plume are 4-7 reported only if certain gamma and beta air dose criteria are exceeded.

2. Dose for all organs and all four age groups 4-8 3.11.h 5.5.4.i due to iodines and particulates in effluent plume. All pathways are considered.

3. Dose for all organs and all four age groups 3-3 3.1 1.d 5.5.4.d due to radioactivity in liquid effluents.

10 CFR 20 1. Total Dose, totaling all external dose 5-2 5.5.4.c components (direct, ground and plume shine) and internal dose (all pathways, both airborne and liquid-borne).

40 CFR 190 1. Total body dose due to direct dose, 5-1 3.11 .k 5.5.4.j (now by ground and plume shine from all sources at a reference, station.

also part of 10 CFR 20) 2. Organ doses to an adult due to all 3-3 pathways. 4-8 Technical 1. "Instantaneous" total body, skin and organ 4-1 3.11 .f 5.5.4.g Specifications dose rates to a child due to radioactivity in 4-2 airborne effluents. For the organ dose, only 4-3 inhalation is considered.

2. "Instantaneous" concentration limits for liquid effluents. 3-1 3.11.c 5.5.4.b Technical 1. Radioactive Effluent Release Report NA 5.2 5.6.2 Specifications I I Page 1.1-5

CY-BY-1 70-301 Revision 5 Table 1-2 Page 2 of 2 COMPLIANCE MATRIX Regulation Component Limit ODCM TRM Technical

_ Equation Specification 10CFR50 Appendix I 1. Implement Environmental Monitoring Program. N/A 3.12.a N/A Section IV.B.2 10CFR50 Appendix I 1. Land Use Census N/A 3.12.b N/A Section IV.B.3 10CFR50 Appendix I 1. Interlaboratory Comparison Program N/A 3.12.c N/A Section IV.B.2 10CFR50 Appendix I Section IV.B.2 1. Annual Radiological Environmental Operating N/A 5.1 5.6.2 and Technical Report Specifications Page 1.1-6

CY-BY-1 70-301 Revision 5 NOTE: 3.0.5 through 3.10 Not Used 3.11 Radiological Effluent Controls and Radiological Environmental Monitoring Program NOTE: SEE TRM Chapter 3.11 for Radiological Effluents Controls and Surveillances (RECS) and TRM Chapter 3.12 for Radiological Environmental Monitoring Program (REMP).

Page 1.3-1

CY-BY-1 70-301 Revision 5 3.13 METEOROLOGICAL MONITORING PROGRAM 3.13.1 METEOROLOGICAL MONITORING Meteorological parameters are measured in the vicinity of each nuclear power station in order to provide data for calculating radiation doses due to airborne effluent radioactivity. Some nuclear power stations' Technical Specifications state applicable requirements (typically under the subheading, "Meteorological Instrumentation," in the instrumentation section). Regulatory guidance is given in Regulatory Guide 1.23 (Reference 5). Wind speed, wind direction and the temperature gradient are measured using instruments at two or more elevations on a meteorological tower at each Exelon Nuclear station. The elevations are chosen to provide meteorological data representative of the elevations of the airborne releases from the station. The Annual Radiological Environmental Operating Report

includes a summary of meteorological data collected over the reporting year. These data are used to calculate optional isopleths of radiation dose and radioactivity concentration.

3.13.2 METEOROLOGICAL CONTRACTOR The meteorological contractor operates and maintains the meteorological tower instrumentation at each nuclear power station. The contractor collects and analyzes the data and issues periodic reports. The contractor prepares the meteorological data summary required for the Annual Radiological Environmental Operating Report (AREOR) and also computes and plots isopleths included in the AREOR.

Page 1.3-2

CY-BY-1 70-301 Revision 5 4.0 BASES 4.1 RADIOACTIVE LIQUID EFFLUENT MONITORING INSTRUMENTATION (TRM 3.11 .a)

The radioactive liquid effluent instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in liquid effluents during actual or potential releases of liquid effluents. The alarm/trip setpoints for these instruments shall be calculated and adjusted in accordance with the methodology and parameters in the ODCM to ensure that the alarm/trip will occur prior to exceeding 10 times the EFFLUENT CONCENTRATION values specified in Appendix B, Table 2, Column 2 to 10 CFR 20. The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63 and 64 of Appendix A to 10 CFR Part 50. The purpose of tank level indicating devices is to assure the detection and control of leaks that if not controlled could potentially result in the transport of radioactive materials to UNRESTRICTED AREAS.

4.2 RADIOACTIVE GASEOUS EFFLUENT MONITORING INSTRUMENTATION (TRM 3.11 .b)

The radioactive gaseous effluent instrumentation is provided to monitor and control, as applicable, the releases of radioactive materials in gaseous effluents during actual or potential releases of gaseous effluents. The alarm/trip setpoints for these instruments shall be calculated and adjusted in accordance with the methodology and parameters in the ODCM to ensure that the alarm/trip will occur prior to exceeding the limits of 10 CFR Part 20. The OPERABILITY and use of this instrumentation is consistent with the requirements of General Design Criteria 60, 63 and 64 of Appendix A to 10 CFR Part 50.

4.3 LIQUID EFFLUENT CONCENTRATION (TRM 3.11 .c)

This Control is provided to ensure that the concentration of radioactive materials released in liquid waste effluents to UNRESTRICTED AREAS will be less than 10 times the EFFLUENT CONCENTRATION values specified in Appendix B, Table 2, Column 2 to 10 CFR 20. The Control provides operational flexibility for releasing liquid effluents in concentrations to follow the Section II.A and II.C design objectives of Appendix I to 10 CFR Part 50. This limitation provides reasonable assurance that the levels of radioactive materials in bodies of water in UNRESTRICTED AREAS will result in exposures within (1) the Section II.A design objectives of Appendix I, 10 CFR Part 50, to a MEMBER OF THE PUBLIC and (2) the restrictions authorized by 10 CFR Part 20.1301(e). The concentration limit for the dissolved or entrained noble gases is based upon the assumption that Xe-1 33 is the controlling radionuclide and its EFFLUENT CONCENTRATION in air (submersion) was converted to an equivalent concentration in water. This control does not affect the requirement to comply with the annual limitations of 10 CFR Part 20.1301(a).

This Control applies to the release of radioactive materials in liquid effluents from all units at the site.

The required detection capabilities for radioactive materials in liquid waste samples are tabulated in terms of the lower limits of detection (LLDs). Detailed discussion of the LLD and other detection limits can be found in Currie, L.A., "Lower Limit of Detection: Definition and Elaboration of a Proposed Position for Radiological Effluent and Environmental Measurements," NUREG/CR-4007 (September 1984), and in the HASL Procedures Manual, HASL-300 (revised annually).

Page 1.4-1

CY-BY-1 70-301 Revision 5 4.4 DOSE FROM LIQUID EFFLUENTS (TRM 3.11.d)

This Control is provided to implement the requirements of Sections II.A, III.A and IV.A of Appendix 1,10 CFR Part 50. The Control statement implements the guides set forth in Section lI.A of Appendix I. The Action statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in liquid effluents will be kept "as low as is reasonably achievable." Also, for fresh water sites with drinking water supplies that can be potentially affected by plant operations, there is reasonable assurance that the operation of the facility will not result in radionuclide concentrations in the finished drinking water that are in excess of the requirements of 40 CFR Part 141. The dose calculation methodology and parameters in the ODCM implement the requirements in Section III.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated.

The equations specified in the ODCM for calculating the doses due to the actual release rates of radioactive materials in liquid effluents are consistent with the methodology provided in Regulatory Guide 1.109, "Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I,"Revision 1, October 1977 and Regulatory Guide 1.113, "Estimating Aquatic Dispersion of Effluents from Accidental and Routine Reactor Releases for the Purpose of Implementing Appendix I,"April 1977.

This Control applies to the release of liquid effluents from each reactor at the site. For units with shared radwaste treatment systems, the liquid effluents from the shared system are proportioned among the units sharing that system.

4.5 LIQUID RADWASTE TREATMENT SYSTEM (TRM 3.11 .e)

The OPERABILITY of the Liquid Radwaste Treatment System ensures that this system will be available for use whenever liquid effluents require treatment prior to release to the environment. The requirement that the appropriate portions of this system be used, when specified, provides assurance that the releases of radioactive materials in liquid effluents will be kept "as low as is reasonably achievable". This Control implements the requirements of 10 CFR Part 50.36a, General Design Criterion 60 of Appendix A to 10 CFR Part 50 and the design objective given in Section II.D of Appendix Ito 10 CFR part 50. The specified limits governing the use of appropriate portions of the liquid radwaste treatment system were specified as a suitable fraction of the dose design objectives set forth in Section II.A of Appendix 1,10 CFR Part 50, for liquid effluents.

This Control applies to the release of liquid effluents from each reactor at the site. For units with shared radwaste treatment systems, the liquid effluents from the shared system are proportioned among the units sharing that system.

Page 1.4-2

CY-BY-1 70-301 Revision 5 4.6 GASEOUS EFFLUENTS DOSE RATES'(TRM 3.11 .f)

This Control provides reasonable assurance that radioactive material discharged in gaseous effluents will not result in the exposure of a MEMBER OF THE PUBLIC in an UNRESTRICTED AREA, either at or beyond the SITE BOUNDARY in excess of the design objectives of Appendix I to 10 CFR Part 50. This Control is provided to ensure that gaseous effluents from all units on the site will be appropriately controlled. It provides operational flexibility for releasing gaseous effluents to satisfy the Section II.A and II.C design objectives of Appendix I to 10 CFR Part 50. For MEMBERS OF THE PUBLIC who may at times be within the SITE BOUNDARY, the occupancy of that MEMBER OF THE PUBLIC will usually be sufficiently low to compensate for the reduced atmospheric dispersion of gaseous effluents relative to that for the SITE BOUNDARY. Examples of calculations for such MEMBERS OF THE PUBLIC, with the appropriate occupancy factors, shall be given in the ODCM. The specified release rate limits restrict, at all times, the corresponding dose rates above background to a MEMBER OF THE PUBLIC at or beyond the SITE BOUNDARY to less than or equal to 500 mrem/year to the total body or to less than or equal to 3000 mrem/year to the skin. These release rate limits also restrict, at all times, the corresponding thyroid dose rate above background to a child via the inhalation pathway to less than or equal to 1500 mrem/year. This Control does not affect the requirement to comply with the annual limitations of 10 CFR 20.1301(a).

This Control applies to the release of gaseous effluents from all units at the site.

The required detection capabilities for radioactive materials in gaseous waste samples are tabulated in terms of the lower limits of detection (LLDs). Detailed discussion of the LLD and other detection limits can be found in Currie, L.A., "Lower Limit of Detection: Definition and Elaboration of a Proposed Position for Radiological Effluent and Environmental Measurements," NUREG/CR-4007 (September 1984), and in the HASL Procedures Manual, HASL-300 (revised annually).

4.7 DOSE FROM NOBLE GASES (TRM 3.1 1.a)

This Control is provided to implement the requirements of Sections lI.B, III.A and IV.A of Appendix I, 10 CFR Part 50. The Control statements implement the guides set forth in Section II.B of Appendix I. The Action statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive material in gaseous effluents will be kept "as low as is reasonably achievable." The Surveillance Requirements implement the requirements in Section III.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated.

The dose calculation methodology and parameters established in the ODCM for calculating the doses due to the actual release rates of radioactive noble gases in gaseous effluents are consistent with the methodology provided in Regulatory Guide 1.109, "Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision 1, October 1977 and Regulatory Guide 1.111, "Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water Cooled Reactors,"

Revision 1, July 1977. The ODCM equations provided for determining the air doses at and beyond the SITE BOUNDARY are based upon the historical average atmospheric conditions.

This Control applies to the release of gaseous effluents from each reactor at the site. For units with shared radwaste treatment systems, the gaseous effluents from the shared system are proportioned among the units sharing that system.

Page 1.4-3

CY-BY-1 70-301 Revision 5 4.8 DOSE FROM IODINE-1 31, TRITIUM, AND RADIOACTIVE MATERIAL IN PARTICULATE FORM (TRM 3.11 .h)

This Control is provided to implement the requirements of Sections II.C, III.A and IV.A of Appendix I, 10 CFR Part 50. The Controls are the guides set forth in Section II.C of Appendix I. The Action statements provide the required operating flexibility and at the same time implement the guides set forth in Section IV.A of Appendix I to assure that the releases of radioactive materials in gaseous effluents will be kept "as low as is reasonably achievable." The ODCM calculational methods specified in the Surveillance Requirements implement the requirements in Section III.A of Appendix I that conformance with the guides of Appendix I be shown by calculational procedures based on models and data, such that the actual exposure of a MEMBER OF THE PUBLIC through appropriate pathways is unlikely to be substantially underestimated.

The ODCM calculational methodology and parameters for calculating the doses due to the actual release rates of the subject materials are consistent with the methodology provided in Regulatory Guide 1.109, "Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50, Appendix I," Revision 1, October 1977 and Regulatory Guide 1.111, "Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water-Cooled Reactors," Revision 1, July 1977. These equations also provide for determining the actual doses based upon the historical average atmospheric conditions. The release rate controls for Iodine-1 31, Tritium, and radionuclides in particulate form with half-lives greater than 8 days are dependent upon the existing radionuclide pathways to man, in the areas at and beyond the SITE BOUNDARY. The pathways that were examined in the development of these calculations were: 1) individual inhalation of airborne radionuclides, 2) deposition of radionuclides onto green leafy vegetation with subsequent consumption by man, 3) deposition onto grassy areas where milk animals and meat producing animals graze with consumption of the milk and meat by man, and 4) deposition on the ground with subsequent exposure of man.

This Control applies to the release of gaseous effluents from each reactor at the site. For units with shared radwaste treatment systems, the gaseous effluents from the shared systems are proportioned among the units sharing that system.

4.9 GASEOUS RADWASTE TREATMENT SYSTEM (TRM 3.11 .i)

The OPERABILITY of the Gaseous Radwaste Treatment System ensures that the system will be available for use whenever gaseous effluents require treatment prior to release of the environment. The requirement that the appropriate portions of these systems be used, when specified, provides reasonable assurance that the release of radioactive materials in gaseous effluents will be kept "as low as is reasonably achievable." This Control implements the requirements of 10 CFR Part 50.36a, General Design Criterion 60 of Appendix A to 10 CFR Part 50, and the design objectives given in Section II.D of Appendix I to 10 CFR Part 50.

The specified limits governing the use of appropriate portions of the systems were specified as a suitable fraction of the dose design objectives set forth in Sections II.B and II.C of Appendix I, 10 CFR Part 50, for gaseous effluents.

This Control applies to the release of gaseous effluents from each reactor at the site. For units with shared radwaste treatment systems, the gaseous effluents from the shared systems are proportioned among the units sharing that system.

Page 1.4-4

CY-BY-1 70-301 Revision 5 4.10 TOTAL DOSE (TRM 3.11.k)

This Control is provided to meet the dose limitations of 40 CFR Part 190 that have been incorporated into 10 CFR Part 20.1301(d). The Control requires the preparation and submittal of a Special Report whenever the calculated doses due to releases of radioactivity and to radiation from uranium fuel cycle sources exceed 25 mrems to the total body or any organ, except the thyroid, which shall be limited to less than or equal to 75 mrems.

For sites containing up to 4 reactors, it is highly unlikely that the resultant dose to a MEMBER OF THE PUBLIC will exceed the dose,limits of 40 CFR Part 190 if the individual reactors remain within twice the dose design objectives of Appendix I, and ifdirect radiation doses from the reactor units and outside storage tanks, etc., are kept small. The Special Report will describe a course of action that should result in the limitation of the annual dose to a MEMBER OF THE PUBLIC to within the 40 CFR Part 190 limits.

For the purposes of the Special Report, it may be assumed that the dose commitment to the MEMBER OF THE PUBLIC from other uranium fuel cycle sources is negligible, with the exception that dose contributions from other nuclear fuel cycle facilities at the same site or within a radius of 8 km must be considered. If the dose to any MEMBER OF THE PUBLIC is estimated to exceed the requirements of 40 CFR Part 190, submittal of the Special Report within 30 days with a request for a variance (provided the release conditions resulting in violation of 40 CFR Part 190 have not already been corrected), in accordance with the provisions of 40 CFR Part 190.11 and 10 CFR Part 20.2203(a)(4), is considered to be a timely request and fulfills the requirements of 40 CFR Part 190 until NRC staff action is completed.

Demonstration of compliance with the limits of 40 CFR Part 190 or with the design objectives of Appendix I to 10 CFR Part 50 will be considered to demonstrate compliance with the 0.1 rem limit of 10 CFR Part 20.1301.

4.11 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM (TRM 3.12)

The Radiological Environmental Monitoring Program required by this Control provides representative measurements of radiation and of radioactive materials in those exposure pathways and for those radionuclides that lead to the highest potential radiation exposures of MEMBERS OF THE PUBLIC resulting from the station operation.

This monitoring program implementsSection IV.B.2 of Appendix I to 10 CFR Part 50 and thereby supplements the Radiological Effluent Monitoring Program by verifying that the measurable concentrations of radioactive materials and levels of radiation are not higher than expected on the basis of the effluent measurements and the modeling of the environmental exposure pathways. Isotopes identified in REMP are compared to those identified in the applicable Annual Effluent Report. Program changes may be initiated based on these operational experiences.

The required detection capabilities for environmental sample analyses are tabulated in terms of the lower limits of detection (LLDs). The LLDs required by Table T3.12.a-3 are considered optimum for routine environmental measurements in industrial laboratories. It should be recognized that the LLD is defined as an a Drior (before the fact) limit representing the capability of a measurement system and not as an a posteriori (after the fact) limit for a particular measurement.

Detailed discussion of the LLD and other detection limits can be found in Currie, L.A., "Lower Limit of Detection: Definition and Elaboration of a Proposed Position for Radiological Effluent and Environmental Measurements," NUREG/CR-4007 (September 1984), and in the HASL Procedures Manual, HASL-300 (revised annually).

Page 1.4-5

CY-BY-1 70-301 Revision 5 4.12 LAND USE CENSUS (TRM 3.12.b)

This Control is provided to ensure that changes in the use of areas at and beyond the SITE BOUNDARY are identified and that modifications to the Radiological Environmental Monitoring Program are made if required by the results of this census. The best information from the door-to-door survey, from aerial survey or from consulting with local agricultural authorities shall be used. This census satisfies the requirements of Section IV.B.3 of Appendix I to 10 CFR Part 50. Restricting the census to gardens of greater than 50 m2 provides assurance that significant exposure pathways via leafy vegetables will be identified and monitored since a garden of this size is the minimum required to produce the quantity (26 kg/year) of leafy vegetables assumed in Regulatory Guide 1.109 for consumption by a child. To determine this minimum garden size, the following assumptions were made: 1) 20% of the garden was used for growing broad leaf vegetation (i.e., similar to lettuce and cabbage), and 2) a vegetation yield of 2 kg/m 2 .

4.13 INTERLABORATORY COMPARISON PROGRAM (TRM 3.12.c)

The requirement for participation in an approved Interlaboratory Comparison Program is provided to ensure that independent checks on the precision and accuracy of the measurements of radioactive material in environmental sample matrices are performed as part of the quality assurance program for environmental monitoring in order to demonstrate that the results are reasonably valid for the purposes of Section IV.B.2 of Appendix I to 10 CFR Part 50.

Page 1.4-6

CY-BY-1 70-301 Revision 5 5.0 ADMINISTRATIVE REQUIREMENTS 5.1 Annual Radiological Environmental Operatina Report*

Routine Annual Radiological Environmental Operating Report covering the operation of the Unit(s) during the previous calendar year shall be submitted prior to May 15 of each year.

The Annual Radiological Environmental Operating Report shall include summaries, interpretations, and an analysis of trends of the results of the radiological environmental surveillance activities for the report period, including a comparison with operational controls as appropriate, and with previous environmental surveillance reports, and an assessment of the observed impacts of the plant operation on the environment.

The Annual Radiological Environmental Operating Report shall include the-results of all radiological environmental samples and of all environmental radiation measurements taken during the period pursuant to the locations specified in the tables and figures in Part II Section 6 of the ODCM, as well as summarized and tabulated results of these analyses and measurements in the format of the table in the Radiological Assessment Branch Technical Position, Revision 1, November 1979. In the event that some individual results are not available for inclusion with the report, the report shall be submitted noting and explaining the reasons for the missing results. The missing data shall be submitted as soon as possible in a supplementary report.

The reports shall also include the following: a summary description of the Radiological Environmental Monitoring Program; legible maps covering all sampling locations keyed to a table giving distances and directions from the midpoint between the two units; reasons for not conducting the Radiological Environmental Monitoring Program as required by TLCO 3.12.a, a Table of Missed Samples and a Table of Sample Anomalies for all deviations from the sampling schedule of TRM Table T3.12.a-1; discussion of environmental sample measurements that exceed the reporting levels of TRM Table T3.12.a-2 but are not the result of plant effluents, discussion of all analyses in which the LLD required by TRM Table T3.12.a-3 was not achievable; result of the Land Use Census required by TRM TLCO 3.12.b; and the results of the licensee participation in an Interlaboratory Comparison Program and the corrective actions being taken if the specified program is not being performed as required by TRM TLCO 3.12.c.

The Annual Radiological Environmental Operating Report shall also include an annual summary of hourly meteorological data collected over the applicable year. This annual summary may be either in the form of an hour-by-hour listing on magnetic tape of wind speed, wind direction, atmospheric stability, and precipitation (if measured), or in the form of joint frequency distributions of wind speed, wind direction, and atmospheric stability. In lieu of submission with the Annual Radiological Environmental Operating Report, the licensee has the option of retaining this summary of required meteorological data on site in a file that shall be provided to the NRC upon request.

The Annual Radiological Environmental Operating Report shall also include an assessment of the radiation doses due to the radioactive liquid and gaseous effluents released from the Unit or Station during the previous calendar year. This report shall also include an assessment of the radiation doses to the most likely exposed MEMBER OF THE PUBLIC from reactor releases and other near-by uranium fuel cycle sources including doses from primary effluent pathways and direct radiation, for the previous calendar year. The assessment of radiation doses shall be performed in accordance with the methodology and parameters in the ODCM, and in compliance with 10CFR20 and 40 CFR Part 190, "Environmental Radiation Protection Standards for Nuclear Power Operation."

A single submittal may be made for a multiple unit station.

Page 1.5-1

CY-BY-1 70-301 Revision 5 5.2 Annual Radioactive Effluent Release Report**

Routine Annual Radioactive Effluent Release Reports covering the operation of the unit during the previous calendar year of operation shall be submitted prior to May I of the following year.

The Annual Radioactive Effluent Release Reports shall include a summary of the quantities of radioactive liquid and gaseous effluents and solid waste released from the unit as outlined in Regulatory Guide 1.21, "Measuring Evaluating, and Reporting Radioactivity in Solid Wastes and Releases of Radioactive Materials in Liquid and Gaseous Effluents from Light-Water-Cooled Nuclear Power Plants," Revision 1, June 1974, with data summarized on a quarterly basis following the format of Appendix B thereof.

For solid wastes, the format for Table 3 in Appendix B of the report shall be supplemented with three additional categories: class of solid wastes (as defined by 10 CFR Part 61), type of container (e.g.,

LSA, Type A, Type B, Large Quantity), and SOLIDIFICATION agent or absorbent (e.g., cement, urea formaldehyde).

The Annual Radioactive Effluent Release Reports shall include a list and description of unplanned releases from the site to UNRESTRICTED AREAS of radioactive materials in gaseous and liquid effluents made during the reporting period.

The Annual Radioactive Effluent Release Reports shall include any changes made during the reporting period to the PCP as well as any major changes to Liquid, Gaseous or Solid Radwaste Treatment Systems, pursuant to Part I Section 5.3.

The Annual Radioactive Effluent Release Reports shall also include the following: an explanation as to why the inoperability of liquid or gaseous effluent monitoring instrumentation was not corrected within the time specified in TRM TLCO 3.11 .a or TLCO 3.11 .b, respectively; and description of the events leading to liquid holdup tanks or gas storage tanks exceeding the limits of TS 5.5.12.

- A single submittal may be made for a multiple unit station. The submittal should combine those sections that are common to all units at the station; however, for units with separate radwaste systems, the submittal shall specify the releases of radioactive material from each unit.

Page 1.5-2

CY-BY-1 70-301 Revision 5 5.3 ODCM 5.3.1 The ODCM shall be submitted to the Commission following proper approval through station processes.

5.3.2 Licensee-initiated changes to the ODCM:

a. Shall be documented and records of reviews performed shall be retained as required by UFSAR Chapter 17. This documentation shall contain:

1. Sufficient information to support the change together with the appropriate analyses or evaluations justifying the changes(s); and

2. A determination that the change will maintain the level of radioactive effluent control required by 10 CFR Part 20, 40 CFR Part 190, 10 CFR 50.36a, and Appendix I to 10 CFR Part 50 and not adversely impact the accuracy or reliability of effluent, dose, or setpoint calculations.

b. Shall become effective after review and acceptance by the Independent Technical Review and PORC and the approval of the Plant Manager on the date specified by the Independent Technical Review and PORC.

c. Shall be submitted to the Commission in the form of the complete, legible copy of the entire ODCM, or updated pages if the Commission retains a controlled copy. If an entire copy of the ODCM is submitted, it shall be submitted as a part of or concurrent with the Annual Radioactive Effluent Release Report for the period of the report in which any change to the ODCM was made effective. Each change shall be identified by markings in the margin of the affected pages, clearly indicating the area of the page that was changed, and shall indicate the date (e.g., month/year) the change was implemented.

Page 1.5-3

CY-BY-1 70-301 Revision 5 5.4 Major Chanaies to Liquid and Gaseous Radwaste Treatment Systems***

Licensee-initiated major changes to the Radwaste Treatment Systems (liquid and gaseous):

a. Shall be reported to the Commission in the Annual Radioactive Effluent Release Report for the period in which the evaluation was reviewed by the Independent Technical Review and PORC.

The discussion of each change shall contain:

1) A summary of the evaluation that led to the determination that the change could be made in accordance with 10 CFR 50.59;

2) Sufficient detailed information to totally support the reason for the change without benefit of additional and supplemental information;

3) A detailed description of the equipment, components, and processes involved and the interfaces with other plant systems.

4) An evaluation of the change which shows the predicted releases of radioactive materials in liquid and gaseous effluents that differ from those previously predicted in the License application and amendments thereto;

5) An evaluation of the change, which shows the expected maximum exposures to a MEMBER OF THE PUBLIC in the UNRESTRICTED AREA and to the general population that differ from those previously estimated in the License application and amendments thereto;

6) A comparison of the predicted releases of radioactive materials, in liquid and gaseous effluents, to the actual releases for the period prior to when the changes are to be made;

7) An estimate of the exposure to plant operating personnel as a result of the change; and

8) Documentation of the fact that the change was reviewed and found acceptable by the Independent Technical Review and PORC.

b. Shall become effective upon review and acceptance by the Independent Technical Review and PORC.

'*Licensees may choose to submit the information called for in this standard as part of the annual FSAR update.

Page 1.5-4

CY-BY-1 70-301 Revision 5 OFFSITE DOSE CALCULATION MANUAL Byron Station Units I and 2 Revision 5

CY-BY-1 70-301 Revision 5

1.0 INTRODUCTION

- ODCM GENERAL INFORMATION The Offsite Dose Calculation Manual (ODCM) presents a discussion of the following:

The basic concepts applied in calculating offsite doses from plant effluents.

" The regulations and requirements for the ODCM and related programs.

" The methodology and parameters for the offsite dose calculations to assess impact on the environment and compliance with regulations.

The methodology detailed in this manual is intended for the calculation of radiation doses during routine (i.e., non-accident) conditions. The calculations are normally performed using a computer program. Manual calculations may be performed in lieu of the computer program.

The dose effects of airborne radioactivity releases predominately depend on meteorological conditions (wind speed, wind direction, and atmospheric stability). For airborne effluents, the dose calculations prescribed in this manual are based on historical average atmospheric conditions. This methodology is appropriate for estimating annual average dose effects and is stipulated in the Bases Section of the Radiological Effluents Controls (RECS).

1.1 Structure of the ODCM Part I of the ODCM is considered to be the Radiological Effluents Controls (RECS), and contains the former Radiological Effluent Technical Specifications that have been removed from the Technical Specifications.

Part I is organized as follows:

" Definitions

" Radiological Effluent Controls and Radiological Environmental Monitoring Program

" Meteorological Monitoring Program

Bases

" Administrative Requirements Page 11.1-1

CY-BY-1 70-301 Revision 5 Part IIof the ODCM is considered to be the Offsite Dose Calculation Manual (ODCM), and contains methods, equations, assumptions, and parameters for calculation of radiation doses from plant effluents. Part II is organized as follows:

Introduction

Instrumentation and Systems

Liquid Effluents

Gaseous Effluents

Total Dose

Radiological and Environmental Monitoring Program 1.2 Regulations This section serves to illustrate the regulations and requirements that define and are applicable to the ODCM. Any information provided in the ODCM concerning specific regulations are not a substitute for the regulations as found in the Code of Federal Regulations (CFR) or Technical Specifications.

1.2.1 Code of Federal Regulations Various sections of the Code of Federal Regulations (CFR) require nuclear power stations to be designed and operated in a manner that limits the radiation exposure to members of the public. These sections specify limits on offsite radiation doses and on effluent radioactivity concentrations and they also require releases of radioactivity to be "As Low As Reasonably Achievable". These requirements are contained in 10CFR20, 10CFR50 and 40CFR190. In addition, 40CFR141 imposes limits on the concentration of radioactivity in drinking water provided by the operators of public water systems.

S10OCFR20, Standards for Protection Against Radiation This revision of the ODCM addresses the requirements of 10CFR20.

The 10CFR20 dose limits are summarized in Table 1 - 1.

0 Design Criteria (Appendix A of 10CFR50)

Section 50.36 of 10CFR50 requires that an application for an operating license include proposed Technical Specifications. Final Technical Specifications for each station are developed through negotiation between the applicant and the NRC. The Technical Specifications are then issued as a part of the operating license, and the licensee is required to operate the facility in accordance with them.

Page 11.1-2

CY-BY-1 70-301 Revision 5 Section 50.34 of 10CFR50 states that an application for a license must state the principal design criteria of the facility. Minimum requirements are contained in Appendix A of 10CFR50.

ALARA Provisions (Appendix I of 10CFR50)

Sections 50.34a and 50.36a of 10CFR50 require that the nuclear plant design and the station RECS have provisions to keep levels of radioactive materials in effluents to unrestricted areas "As Low As Reasonably Achievable" (ALARA). Although 10CFR50 does not impose specific limits on releases, Appendix I of 10CFR50 does provide numerical design objectives and suggested limiting conditions for operation. According to Section I of Appendix I of 10CFR50, design objectives and limiting conditions for operation, conforming to the guidelines of Appendix I "shall be deemed a conclusive showing of compliance with the "As Low As Reasonably Achievable" requirements of 10CFR50.34a and 50.36a."

An applicant must use calculations to demonstrate conformance with the design objective dose limits of Appendix I. The calculations are to be based on models and data such that the actual radiation exposure of an individual is "unlikely to be substantially underestimated" (see 10CFR50 Appendix I, Section III.A.1).

The guidelines in Appendix I call for an investigation, corrective action and a report to the NRC whenever the calculated dose due to the radioactivity released in a calendar quarter exceeds one-half of an annual design objective. The guidelines also require a surveillance program to monitor releases, monitor the environment and identify changes in land use.

40CFR1 90, Environmental Radiation Protection Standards for Nuclear Power Operations Under an agreement between the NRC and the EPA, the NRC stipulated to its licensees in Generic Letter 79-041 that "Compliance with Radiological Effluent Technical Specifications (RETS), NUREG-0472 (Rev.2) for PWR's, implements the LWR provisions to meet 40CFR190". (See References 49 and 103.)

The regulations of 40CFR1 90 limit radiation doses received by members of the public as a result of operations that are part of the uranium fuel cycle. Operations must be conducted in such a manner as to provide reasonable assurance that the annual dose equivalent to any member of the public due to radiation and to planned discharges of radioactive materials does not exceed the following limits:

o 25 mrem to the total body o 75 mrem to the thyroid Page 11.1-3

CY-BY-1 70-301 Revision 5 o 25 mrem to any other organ An important difference between the design objectives of 10CFR50 and the limits of 40CFR1 90 is that 10CFR50 addresses only doses due to radioactive effluents. 40CFR190 limits doses due to effluents and to radiation sources maintained on site. See Section 1.2.4 for further discussion of the differences between the requirements of 10CFR50 Appendix I and 40CFR190.

40CFR141. National Primary Drinking Water Regulations The following radioactivity limits for community water systems were established in the July, 1976 Edition of 40CFR141:

o Combined Ra-226 and Ra-228: < 5 pCi/L.

o Gross alpha (particle activity including Ra-226 but excluding radon and uranium): < 15 pCi/L.

o The average annual concentration of beta particle and photon radioactivity from man-made radionuclides in drinking water shall not produce an annual dose equivalent to the total body or any internal organ greater than 4 mrem/yr.

The regulations specify procedures for determining the values of annual average radionuclide concentration that produce an annual dose equivalent of 4 mrem. Radiochemical analysis methods are also specified. The responsibility for monitoring radioactivity in a community water system falls on the supplier of the water. The Byron Station has requirements related to 40CFR141 in the RECS.

1.2.2 Radiological Effluent Technical Standards The Radiological Effluent Technical Standards (RETS) were formerly a subset of the Technical Specifications. They implement provisions of the Code of Federal Regulations aimed at limiting offsite radiation dose. The NRC published Standard RETS for PWRs (Reference 2) as guidance to assist in the development of technical specifications. These documents have undergone frequent minor revisions to reflect changes in plant design and evolving regulatory concerns. The RETS have been removed from the Technical Specifications and placed in the TRM as the RECS (see Reference 90). The RECS are similar but not identical to the guidance of the Standard Radiological Effluent Technical Specifications.

Page 11.1-4

CY-BY-1 70-301 Revision 5 1.2.3 .Offsite Dose Calculation Manual The NRC in Generic Letter 89-01 defines the ODCM as follows (not verbatim) (see Reference 90):

The Offsite Dose Calculation Manual (ODCM) shall contain the methodology and parameters used in the calculation of offsite doses resulting from radioactive gaseous and liquid effluents, in the calculation of gaseous and liquid effluent monitoring Alarm/Trip Setpoints, and in the conduct of the Radiological Environmental Monitoring Program. The ODCM shall also contain (1) the Radioactive Effluent Controls and Radiological Environmental Monitoring Programs and (2) descriptions of the Information that should be included in the Annual Radiological Environmental Operating and Annual Radioactive Effluent Release Reports.

Additional requirements for the content of the ODCM are contained throughout the text of the RECS.

1.2.4 Overlapping Requirements In 10CFR20, 10CFR50 and 40CFR190, there are overlapping requirements regarding offsite radiation dose and dose commitment to the total body. In 10CFR20.1301, the total effective dose equivalent (TEDE) to a member of the public is limited to 100 mrem per calendar year. In addition, Appendix I to 10CFR50 establishes design objectives on annual total body dose or dose commitment of 3 mrem per reactor for liquid effluents and 5 mrem per reactor for gaseous effluents (see 10CFR50 Appendix I, Sections II.A and II.B.2(a)). Finally, 40CFR190 limits annual total body dose or dose commitment to a member of the public to 25 mrem due to all uranium fuel cycle operations.

While these dose limits/design objectives appear to overlap, they are different and each is addressed separately by the RETS. Calculations are made and reports are generated to demonstrate compliance to all regulations. Refer to Table 1 - 1 and Table I - 2 for additional information regarding instantaneous effluent limits, design objectives and regulatory compliance.

1.2.5 Dose Receiver Methodology Table 1 - 2 lists the location of the dose recipient and occupancy factors, if applicable. Dose is assessed at the location in the unrestricted area where the combination of existing pathways and receptor age groups indicates the maximum potential exposures. The dose calculation Page 11.1-5

CY-BY-1 70-301 Revision 5 methodology is consistent with the methodology of Regulatory Guide 1.109 (Reference 6) and NUREG 0133 (Reference 14). Dose is therefore calculated to a maximum individual. The maximum individual is characterized as "maximum" with regard to food consumption, occupancy and other usage of the area in the vicinity of the plant site.

Such a "maximum individual" represents reasonable deviation from the average for the population in general. In all physiological and metabolic respects, the maximum individual is assumed to have those characteristics that represent averages for their corresponding age group. Thus, the dose calculated is very conservative compared to the

average" (or typical) dose recipient who does not go out of the way to maximize radioactivity uptakes and exposure.

Page 11.1-6

CY-BY-1 70-301 Revision 5 Table I - 1 Regulatory Dose Limit Matrix TRM DOSE TYPE DOSE LIMIT(s) Section REGULATION Airborne Releases: (quarterly) (annual) 10CFR50 App. la Gamma Dose to Air due to Noble Gas 5 mrad 10 mrad 3.11 .g Radionuclides (per reactor unit)

Beta Dose to Air Due to Noble Gas 10 mrad 20 mrad 3.11 .g Radionuclides (per reactor unit)

Organ Dose Due to Specified Non-Noble 7.5 mrem 15 mrem 3.11 .h Gas Radionuclides (per reactor unit)

Total Body and Skin Total Body 2.5 mrem 5 mrem N/A Dose (if air dose is exceeded) Skin 7.5 mrem 15 mrem N/A Technical Specifications Total Body Dose Rate Due to Noble Gas 500 mrem/yr 3.11 .f Radionuclides (instantaneous limit, per site)

Skin Dose Rate Due to Noble Gas 3,000 mrem/yr 3.11 .f Radionuclides (instantaneous limit, per site)

Organ Dose Rate Due to Specified Non- 1,500 mrem/yr 3.11 .f Noble Gas Radionuclides (instantaneous limit, per site)

Liquid Releases: (quarterly) (annual) 10CFR50 App. I' Whole (Total) Body Dose 1.5 mrem 3 mrem 3.1 1.d (per reactor unit)

Organ Dose (per reactor unit) 5 mrem 10 mrem 3.11 .d Technical Specifications The concentration of radioactivity in liquid Ten times the values effluents released to unrestricted areas listed in 10CFR20 3.11.c Appendix B; Table 2, Column 2, and note 5 below for Noble Gases Total Doses 1: ODCM Section II 10 CFR 20.1301 (a)(1) Total Effective Dose Equivalent 4 100 mrem/yr 5.5 10CFR20.1301 (d) Total Body Dose 25 mrem/yr 5.5 And 40CFR190 Thyroid Dose 75 mrem/yr 5.5 Other Organ Dose 25 mrem/yr 5.5 Other Limits ;:

40CFR141 Total Body Dose Due to Drinking Water 4 mrem/yr 3.4 From Public Water Systems Organ Dose Due to Drinking Water From 4 mrem/yr 3.4 Public Water Systems These doses are calculated considering all sources of radiation and radioactivity in effluents.

2 These limits are not directly applicable to nuclear power stations. They are applicable to the owners or operators of public water systems. However, the Byron RECS requires assessment of compliance with these limits.

3 Note that 10CFR50 provides design objectives, not limits.

4 Compliance with 10CFR20.1301(a)(1) is demonstrated by compliance with 40CFR190. Note that it may be necessary to address dose from on-site activity by members of the public as well.

s Kr-85m, Kr-85, Kr-87, Kr-88, Ar-41, Xe-131m, Xe-133m, Xe-133, Xe-135m and Xe-135 allowable concentration is 2E-4 pCi/ml computed from Equation 17 of ICRP Publication 2 adjusted for infinite cloud submersion in water, and R = 0.01 rem/wk, pw = 1.0 g/cm3, and PwIPt = 1.0.

Page 11.1-7

CY-BY-1 70-301 Revision 5 Table 1 - 2 Dose Assessment Receivers Location; Occupancy if Dose Component or Pathway Different than 100%

"Instantaneous" dose rates from Unrestricted area boundary location that airborne radioactivity results in the maximum dose rate "Instantaneous" concentration limits in Point where liquid effluents enter the liquid effluents unrestricted area Annual average concentration limits for Point where liquid effluents enter the liquid effluents unrestricted area Direct dose from contained sources Receiver spends part of this time in the controlled area and the remainder at his residence or fishing nearby; occupancy factor is considered and is site-specific.

Direct dose from airborne plume Receiver is at the unrestricted area boundary location that results in the maximum dose.

Dose due to radioiodines, tritium and Receiver is at the location in the particulates with half-lives greater than unrestricted area where the combination of 8 days for inhalation, ingestion of existing pathways and receptor age groups vegetation, milk and meat, and ground indicates the highest potential exposures.

plane exposure pathways.

Ingestion dose from drinking water The drinking water pathway is considered as an additive dose component in this assessment only if the public water supply serves the community immediately adjacent to the plant.

Ingestion dose from eating fish The receiver eats fish from the receiving body of water Total Organ Doses Summation of ingestion/inhalation doses Total Dose Summation of above data (Note it may also be necessary to address dose from on-site activity by members of the public.)

Figure 1 - 1 illustrates some of the potential radiation exposure pathways to humans due to routine operation of a nuclear power station.

Page 11.1-8

CY-BY-1 70-301 Revision 5 Figure 1 - I Radiation Exposure Pathways to Humans Page 11.1-9

CY-BY-170-301 Revision 5 1.3 Offsite Dose Calculation Parameters This section contains offsite dose calculation parameter factors, or values not specific only to one of the gas, liquid, or total dose chapters. Additional parameters are provided in the Sections 2, 4 and 5 of the ODCM.

10CFR50 Dose Commitment Factors With the exception of H-3, the dose commitment factors for 10CFR50 related calculations are exactly those provided in Regulatory Guide 1.109 (Reference 6). The following table lists the parameters and the corresponding data tables in the RG 1.109:

PATHWAY ADULT TEENAGER CHILD INFANT Inhalation RG 1.109: RG 1.109: RG 1.109: RG 1.109:

Table E-7 Table E-8 Table E-9 Table E-10 Ingestion RG 1.109: RG 1.109: RG 1.109: RG 1.109:

Table E-1 1 Table E-1 2 Table E-13 Table E-14 These tables are contained in Regulatory Guide 1.109 (Reference 6).

Each table (E-7 through E-14) provides dose factors for seven organs for each of 73 radionuclides, and Table E-5 lists Miscellaneous Dose Assessment Factors - Consumption Parameters. For radionuclides not found in these tables, dose factors will be derived from ICRP 2 (Reference

50) or NUREG-0172 (Reference 51). The values for H-3 are taken from NUREG-4013 (Reference 107).

1.4 REFERENCES

The references listed below were transferred from the previous ODCM revision that was common to all former Commonwealth Edison nuclear stations. The references not applicable to Byron have been deleted, however the numbering has been preserved for ease of reference management throughout the ODCM document; therefore, reference numbering is not sequential.

2. U.S. Nuclear Regulatory Commission, Standard Radiological Effluent Technical Specifications for Pressurized Water Reactors, NUREG-0472, Rev. 3, Draft, January 1983 (frequently revised).

4. U.S. Nuclear Regulatory Commission, Measuring, Evaluating, and Reporting Radioactivity in Solid Wastes and Releases of Radioactive Materials in Liquid Page 11.1-10

CY-BY-1 70-301 Revision 5 and Gaseous Effluents from Light-Water-Cooled Nuclear Power Plants, Regulatory Guide 1.21. Revision 1, June 1974.

5. U.S. Nuclear Regulatory Commission, Onsite Meteorological Programs,,

Regulatory Guide 1.23, Safety Guide 23, February 17, 1972.

6. U.S. Nuclear Regulatory Commission, Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purpose of Evaluating Compliance with 10 CFR Part 50 Appendix I, Regulatory Guide 1.109, Rev. 1, October 1977.

7. U.S. Nuclear Regulatory Commission, Methods for Estimating Atmospheric Transport and Dispersion of Gaseous Effluents in Routine Releases from Light-Water-Cooled Reactors, Regulatory Guide 1.111, Rev. 1, July 1977.

8. U.S. Nuclear Regulatory Commission, Calculation of Releases of Radioactive Materials in Gaseous and Liquid Effluents from Light-Water-Cooled Power Reactors, Regulatory Guide 1.112, Rev. 0-R, April 1976; reissued May 1977.

9. U.S. Nuclear Regulatory Commission, Estimating Aquatic Dispersion of Effluents from Accidental and Routine Reactor Releases for the Purpose of Implementing Appendix I, Regulatory Guide 1.113, Rev. 1, April 1977.

10. U.S. Nuclear Regulatory Commission, Programs for Monitoring Radioactivity in the Environs of Nuclear Power Plants, Regulatory Guide 4.1, Rev. 1, April 1975.

11. U.S. Nuclear Regulatory Commission, Preparation of Environmental Reports for Nuclear Power Stations, Regulatory Guide 4.2, Rev. 2, July 1976.

12. U.S. Nuclear Regulatory Commission, Environmental Technical Specifications for Nuclear Power Plants, Regulatory Guide 4.8, Rev. 1, December 1975. (See also the related Radiological Assessment Branch Technical Position, Rev. 1, November 1979.)

13. U.S. Nuclear Regulatory Commission, Quality Assurance for Radiological Monitoring Programs (Normal Operations)--Effluent Streams and the Environment, Regulatory Guide 4.15, Rev. 1, February 1979.

14. U.S. Nuclear Regulatory Commission, Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants, edited by J. S. Boegli et al.

NUREG-0133, October 1978.

15. U.S. Nuclear Regulatory Commission, XOQDOQ: Computer Pro-ram for the Meteorological Evaluation of Routine Effluent Releases at Nuclear Power Stations, J. F. Sagendorf et al. NUREG/CR-2919, PNL-4380, September 1982.

16. U.S. Nuclear Regulatory Commission, Radiological Assessment, edited by J. E.

Till and H. R. Meyer, NUREG/CR-3332, ORNL-5968, September 1983.

Page 11.1-11

CY-BY-1 70-301 Revision 5

17. U.S. Nuclear Regulatory Commission, Standard Review Plan, NUREG-0800, July 1981.

18. U.S. Atomic Energy Commission, Meteorology and Atomic Energy 1968, edited by D. H. Slade, TID-21940, July 1968.

19. U.S. Atomic Energy Commission, Plume Rise, G. A. Briggs, TID-25075, 1969.

20. U.S. Atomic Energy Commission, The Potential Radiological Implications of Nuclear Facilities in the Upper Mississippi River Basin in the Year 2000, WASH 1209, January 1973.

21. U.S. Atomic Energy Commission, HASL Procedures Manual, Health and Safety Laboratory, HASL-300 (revised annually).

22. U.S. Department of Energy, Models and Parameters for Environmental Radiolo-gical Assessments, edited by C. W. Miller, DOE/TIC-1 1468, 1984.

23. U.S. Department of Energy, Atmospheric Science and Power Production, edited by D. Randerson, DOE/TIC-27601, 1984.

24. U.S. Environmental Protection Agency, Workbook of Atmospheric Dispersion Estimates, D. B. Turner, Office of Air Programs Publication No. AP-26, 1970.

25. U.S. Environmental Protection Agency, 40CFR190 Environmental Radiation Protection Requirements for Normal Operations of Activities in the Uranium Fuel Cycle, Final Environmental Statement, EPA 520/4-76-016, November 1, 1976.

26. U.S. Environmental Protection Agency, Environmental Analysis of the Uranium Fuel Cycle, EPA-520/9-73-003-C, November 1973.

27. American Society of Mechanical Engineers, Recommended Guide for the Prediction of the Dispersion of Airborne Effluents, 1973.

28. Eisenbud, M., Environmental Radioactivity, 3rd Edition, (Academic Press, Orlando, FL, 1987).

29. Glasstone, S., and Jordan, W. H., Nuclear Power and Its Environmental Effects (American Nuclear Society, LaGrange Park, IL, 1980).

30. International Atomic Energy Agency, Generic Models and Parameters for Assessing the Environmental Transfer of Radionuclides from Routine Releases, Safety Series, No. 57, 1982.

31. National Council on Radiation Protection and Measurements, Radiological Assessment: Predicting the Transport, Bioaccumulation, and Uptake by Man of Radionuclides Released to the Environment, NCRP Report No. 76, March 15, 1984.

Page 11.1-12

CY-BY-1 70-301 Revision 5

32. American National Standards Institute, Guide to Samplina Airborne Radioactive Materials in Nuclear Facilities, ANSI N13.1-1969, February 19, 1969.

33. Institute of Electrical and Electronics Engineers, Specification and Performance of On-Site Instrumentation for Continuously Monitorinnq Radioactivity in Effluents, ANSI N13.10-1974, September 19,1974.

34. American National Standards Institute, Testing and Procedural Specifications for Thermoluminescence Dosimetry (Environmental Applications), ANSI N545-1975, August 20, 1975.

35. American Nuclear Insurers, Effluent Monitoring, ANI/MAELU Engineering Inspection Criteria for Nuclear Liability Insurance, Section 5.1, Rev. 2, October 24,1986.

36. American Nuclear Insurers, Environmental Monitoring, ANI/MAELU Engineering Inspection Criteria for Nuclear Liability Insurance, Section 5.2, Rev. 1, March 23, 1987.

37. American Nuclear Insurers, Environmental Monitoring Programs, ANI/MAELU Information Bulletin 86-1, June 9, 1986.

38. Cember, H., Introduction to Health Physics, 2nd Edition (Pergamon Press, Elmsford, NY 1983).

41. U.S. Nuclear Regulatory Commission, Branch Technical Position, Radiological Assessment Branch, Revision 1, November 1979. (This is a branch position on Regulatory Guide 4.8.)

43. U.S. Nuclear Regulatory Commission, Calculation of Releases of Radioactive Materials in Gaseous and Liquid Effluents from Pressurized Water Reactors (PWR-GALE Code), NUREG-0017, April 1976.

49. U.S. Nuclear Regulatory Commission, Methods for Demonstrating LWR Compliance with the EPA Uranium Fuel Cycle Standard (40 CFR Part 190),

NUREG-0543, February 1980.

50. International Commission on Radiological Protection, Report of Committee Two on Permissible Dose for Internal Radiation, Recommendations of the International Commission on Radiological Protection, ICRP Publication 2, 1959.

51. U.S. Nuclear Regulatory Commission, Aqe-Specific Radiation Dose Commitment Factors for a One-Year Chronic Intake, Battelle Pacific Northwest Laboratories, NUREG-0172, 1977.

Page 11.1-13

CY-BY-1 70-301 Revision 5

52. W. C. Ng, Transfer Coefficients for Prediction of the Dose to Man via the Foraqe-Cow-Milk Pathway from Radionuclides Released to the Biosphere, UCRL-51939.

53. E. C. Eimutis and M. G. Konicek, Derivations of Continuous Functions for the Lateral and Vertical Atmospheric Dispersion Coefficients, Atmospheric Environment 6, 859 (1972).

54. D. C. Kocher, Editor, Nuclear Decay Data for Radionuclides Occurring in Routine Releases from Nuclear Fuel Cycle Facilities, ORNL/NUREG/TM-1 02, August 1977.

55. R. L. Heath, Gamma-Ray Spectrum Catalog, Aerojet Nuclear Co., ANCR-1000-2, third or subsequent edition.

56. S. E. Thompson, Concentration Factors of Chemical Elements in Edible Aquatic Organisms, UCRL-50564, Rev. 1, 1972.

57. U.S. Nuclear Regulatory Commission, Instruction Concerning Risks from Occupational Radiation Exposure, Regulatory Guide 8.29, July 1981.

58. Dresden Nuclear Power Station, Radioactive Waste and Environmental Monitoring, Annual Report 1987, March 1988.

59. Reserved reference number

70. D. C. Kocher, Radioactivity Decay Data Tables, DOE/TIC-1 1026, 1981.

71. J. C. Courtney, A Handbook of Radiation Shielding Data, ANS/SD-76/14, July 1976.

75. Sargent & Lundy, METWRSUM, S&L Program Number 09.5.187-1.0.

76. Sargent & Lundy, Comments on CECo ODCM and List of S&L Calculations, Internal Office Memorandum, P. N. Derezotes to G. R. Davidson, November 23, 1988.

77. Sargent & Lundy, AZAP, A Computer Program to Calculate Annual Average Offsite Doses from Routine Releases of Radionuclides in Gaseous Effluents and Postaccident X/Q Values, S&L Program Number 09.8.054-1.7.

78. National Oceanic and Atmospheric Administration, A Program for Evaluating Atmospheric Dispersion from a Nuclear Power Station, J. F. Sagendorf, NOAA Technical Memorandum ERL ARL-42, Air Resources Laboratory, Idaho Falls, Idaho, May 1974.

79. G. P. Lahti, R. S. Hubner, and J. C. Golden, Assessment of Gamma-Ray Exposures Due to Finite Plumes, Health Physics 41,319 (1981).

Page 11.1-14

CY-BY-1 70-301 Revision 5

80. National Council of Radiation Protection and Measurements, Ionizinq Radiation Exposure of the Population of the United States, NCRP Report No. 93, September 1, 1987.

82. W. R. Van Pelt (Environmental Analysts, Inc.), Letter to J. Golden (ComEd) dated January 3, 1972.

84. U.S. Nuclear Regulatory Commission, Draft Generic Environmental Impact Statement on Uranium Milling, NUREG-051 1, April 1979.

85. U.S. Environmental Protection Agency, Environmental Analysis of the Uranium Fuel Cycle, Part I - Fuel Supply, EPA-520/9-73-003-B, October 1973.

86. U.S. Nuclear Regulatory Commission, Final Generic Environmental Statement on the Use of Recycle Plutonium in Mixed Oxide Fuel in Light Water Cooled Reactors, NUREG-0002, August 1976.

87. U.S. Nuclear Regulatory Commission, Demographic Statistics Pertaining to Nuclear Power Reactor Sites, NUREG-0348, Draft, December 1977.

88. Nuclear News 31, Number 10, Page 69 (August 1988).

89. General Electric Company, Irradiated Fuel Storage at Morris Operation, Operating Experience Report, January 1972 through December 1982, K. J. Eger, NEDO-20969B.

90. U.S. Nuclear Regulatory Commission, Generic Letter 89-01, "Guidance For The Implementation of Programmatic Controls For RETS In The Administrative Controls Section of Technical Specifications and the Relocation of Procedural Details of Current RETS to the Offsite Dose Calculation Manual or Process Control Program", January 1989.

92. NRC Safety Evaluation Report (SER)/Idaho Notional Engineering Laboratory Technical Evaluation Report (TER) of the Commonwealth Edison Offsite Dose Calculation Manual (ODCM), Revision O.A, December 2,1991.

95. U.S. Nuclear Regulatory Commission, Standards for Protection Against Radiation (10CFR20).

96. U.S. Nuclear Regulatory Commission, Licensing of Production and Utilization Facilities (10CFR50).

97. Federal Register, Vol. 57, No. 169, Monday, August 31, 1992, page 39358.

98. Miller, Charles W., Models and Parameters for Environmental Radiological Assessments, U.S. Dept. of Energy, DE8102754, 1984, pages 32, 33, 48, and 49.

Page 11.1-15

CY-BY-1 70-301 Revision 5

99. Kocher, D. C., "Dose-Rate Conversion Factors For External Exposure To Photons and Electrons", Health Physics Vol. 45, No. 3 (September), pp. 665-686, 1983.

100. U.S. Department of Health, Education and Welfare Public Health Service, Radiological Health Handbook, January 1970.

101. ODCM Bases and Reference Document, rev.0, November, 1998.

103. U.S. Nuclear Regulatory Commission, Generic Letter 79-041, September 17, 1979.

104. Federal Register, Vol. 56, No. 98, Tuesday, May 21, 1991, page 23374, column 3.

105. U.S. Nuclear Regulatory Commission, Offsite Dose Calculation Manual Guidance: Standard Radiological Effluent Controls for Pressurized Water Reactors, NUREG-1301, April 1991.

107. U.S. Nuclear Regulatory Commission, LADTAP II - Technical Reference and Users Guide, NUREG-4013, April 1986.

Page 11.1-16

CY-BY-1 70-301 Revision 5 Table I - 3 Miscellaneous Dose Assessment Factors: Environmental Parameters Parameter Value Comment Equation Basisa fq 0.76 4-11,4-12 A fL 1.0 4-11,4-12 A fp 1.0 4-13,4-15 A fs 1.0 4-13,4-15 A tb 262,800 30 years 4-9 C hrs tf 48 hrs Cow Milk Pathway 4-13 A tf 480*hrs Cow Meat Pathway 4-15 A th 1440 hrs 60 days for produce 4-11 A th 2160 hrs 90 days for produce 4-13, 4-15 A tL 24 hrs 1 day for leafy vegetables 4-11 A QF 50 4-13, 4-14, 4-15, B Kg/day 4-16 r 1.0 For lodines 4-11, 4-13, 4-15 A r 0.2 For Particulates 4-11, 4-13, 4-15 A Yn 0.7 2 4-13,4-15 A Kg/mn Ys 2.0 2 4-13,4-15 A Kg/m Yv 2.0 2 4-11 A Kg/M 0.0021 4-11, 4-13, 4-15 A hr-1 H- t-8 gm/m" Absolute Atmospheric Humidity 4-12, 4-14, 4-16 D aBasis key:

A: Reference 6, Table E-1 5.

B: Reference 6, Table E-3.

C: The parameter tb is taken as the midpoint of plant operating life (based upon an assumed 60 year plant operating lifetime).

D: Reference 14, Section 5.3.1.3.

Page 11.1-17

CY-BY-1 70-301 Revision 5 Table I - 4 Stable Element Transfer Data Ff FM(Cow)

Element Meat (dika) Milk (d/L) Reference H 1.2E-02 1.OE-02 6 Be 1.5E-03 3.2E-03 Footnote 1 C 3.1IE-02 1.2E-02 6 F 2.9E-03 1.4E-02 Footnote 2 Na 3.OE-02 4.OE-02 6 Mg 1.5E-03 3.2E-03 Footnote 1 Al 1.5E-02 1.3E-03 Footnote 3 P 4.6E-02 2.5E-02 6 CI 2.9E-03 1.4E-02 Footnote 2 Ar NA NA NA K 1.8E-02 7.2E-03 16 Ca 1.6E-03 1.1 E-02 16 Sc 2.4E-03 7.5E-06 Footnote 4 Ti 3.4E-02 5.OE-06 Footnote 5 V 2.8E-01 1.3E-03 Footnote 6 Cr 2.4E-03 2.2E-03 6 Mn 8.OE-04 2.5E-04 6 Fe 4.OE-02 1.2E-03 6 Co 1.3E-02 1.OE-03 6 Ni 5.3E-02 6.7E-03 6 Cu 8.OE-03 1.4E-02 6 Zn 3.OE-02 3.9E-02 6 Ga 1.5E-02 1.3E-03 Footnote 3 Ge 9.1 E-04 9.9E-05 Footnote 7 As 1.7E-02 5.OE-04 Footnote 8 Se 7.7E-02 1.OE-03 Footnote 9 Br 2.9E-03 2.2E-02 Ff Footnote 2 ;FM from Ref. 16 Kr NA NA NA Rb 3.1IE-02 3.OE-02 6 Sr 6.OE-04 8.OE-04 6 Y 4.6E-03 1.OE-05 6 Zr 3.4E-02 5.OE-06 6 Nb 2.8E-01 2.5E-03 6 Mo 8.OE-03 7.5E-03 6 Tc 4.OE-01 2.5E-02 6 Ru 4.OE-O1 1.OE-06 6 Rh 1.5E-03 1.OE-02 6 Pd 5.3E-.02 6.7E-03 Footnote 10 Cd 3.OE-02 2.OE-02 Footnote 11 In 1.5E-02 1.3E-03 Footnote 3 Sn 9.1 E-04 9.9E-05 Footnote 7 Sb 5.OE-03 2.OE-05 98 Ag 1.7E-02 5.OE-02 6 Te 7.7E-02 I.OE-03 6 I 2.9E-03 6.OE-03 6 Xe NA NA NA Cs 4.OE-03 1.2E-02 6 Ba 3.2E-03 4.OE-04 6 La 2.OE-04 5.OE-06 6 Ce 1.2E-03 1.OE-04 6 Pr 4.7E-03 5.OE-06 6 Nd 3.3E-03 5.OE-06 6 Page 11.1-18

CY-BY-1 70-301 Revision 5 Table I - 4 (Cont'd)

Stable Element Transfer Data Ff FM (Cow)

Element Meat (d/kq) Milk (d/L) Reference Pm 2.9E-04 2.OE-05 16 Sm 2.9E-04 2.OE-05 16 Eu 2.9E-04 2.OE-05 16 Gd 2.9E-04 2.OE-05 16 Dy 2.9E-04 2.OE-05 16 Er 2.9E-04 2.OE-05 16 Tm 2.9E-04 2.OE-05 16 Yb 2.9E-04 2.OE-05 16 Lu 2.9E-04 2.OE-05 16 Hf 3.4E-02 5.OE-06 Footnote 5 Ta 2.8E-01 1.3E-03 FM - Ref.16; Ff -Footnote 6 W 1.3E-03 5.OE-04 6 Re 1.OE-01 1.3E-03 FM- Ref.16; Ff-Footnote 12 Os 2.2E-01 6.OE-04 Footnote 13 Ir 7.3E-03 5.5E-03 Footnote 14 Pt 5.3E-02 6.7E-03 Footnote 10 Au 1.3E-02 3.2E-02 Footnote 15 Hg 3.OE-02 9.7E-06 FM - Ref.16; Ff -Footnote 11 TI 1.5E-02 1.3E-03 FM - Ref.16; Ff -Footnote 3 Pb 9.1 E-04 9.9E-05 98 Bi 1.7E-02 5.OE-04 98 Ra 5.5E-04 5.9E-04 98 Th 1.6E-06 5.OE-06 98 U 1.6E-06 1.2E-04 98 Np 2.OE-04 5.OE-06 6 Am 1.6E-06 2.OE-05 98 Notes:

1. NA = It Is assumed that noble gases are not deposited on the ground.

2. Elements listed are those considered for 10CFR20 assessment and compliance.

Footnotes:

There are numerous Ff and FM values that were not found in published literature. In these cases, the periodic table was used in conjunction with published values. The periodic table was used based on a general assumption that elements have similar characteristics when In the same column of the periodic table. The values of elements In the same column of the periodic table, excluding atomic numbers 58-71 and 90-103, were averaged then assigned to elements missing values located in the same column of the periodic table. This method was used for all columns where there were missing values except column 3A, where there was no data, hence, the average of column 2B and 4A were used.

1. Values obtained by averaging Reference 6 values of Ca, Sr, Ba and Ra.

2. Ff value obtained by assigning the Reference 6 value for I. Fm value obtained by averaging I (Ref. 6) and Br (Ref.16).

3. Ff values obtained by averaging Zn (Ref.6) and Pb (Ref. 98); there were no values for elements in the same column; an average is taken between values of columns 2B and 4A on the periodic table. FM values obtained by using the value for TI from Reference 16.

4. Values obtained by averaging Reference 6 values of Y and La.

5. Values obtained by assigning the Reference 6 value for Zr.

6. Ft values obtained from Ref. 6 value for Nb. FM values obtained by averaging values for Nb (Ref.6) and Ta (Ref. 16).

7. Values obtained from the Reference 6 values for Pb.

8. Values obtained from the Reference 6 values for Bi.

9. Values obtained from the Reference 6 values for Te.

10. Values obtained from the Reference 6 values for Ni.

11. Ff values obtained from Ref. 6 values for Zn. FM values obtained by averaging the Reference 6 values for Zn and Hg.

12. Values obtained by averaging Reference 6 values for Mn, Tc, Nd and Reference 98 value for U.

13. Values obtained by averaging Reference 6 values from Fe and Ru.

14. Values obtained by averaging Reference 6 values from Co and Rh.

15. Values obtained by averaging Reference 6 values from Cu and Ag.

Page 11.1-19

CY-BY-1 70-301 Revision 5 Gmian Chuarch Read

" Proessa Fladwaaso suta0 suUwv

.1 DAW BUng (Waroumm 0)

FtUMw DAW A 46 PaCk LoCaton OFFSITE DOSE CALCULATION NAHUAL R11(tgd Area UCundwy BYRON STATION F IGURE 1-3

n IMFlm FE"Kr RESTRICTED AREA BOUNOARY R

aft""c sALS Page 11.1-20

CY-BY-1 70-301 Revision 5 2.0 INSTRUMENTATION AND SYSTEMS 2.1 Liquid Effluents System Description A simplified liquid release flowpath diagram is provided in Figure 2-3.

A simplified liquid radwaste processing diagram is provided in Figure 2-2.

The liquid radwaste treatment system is designed and installed to reduce radioactive liquid effluents by collecting the liquids, providing for retention or holdup, and providing for treatment by demineralizer for the purpose of reducing the total radioactivity prior to release to the environment. The system is described in Chapter 11 of the Byron Updated Final Safety Analysis Report.

2.1.1 Release Tanks There are two radwaste release tanks (OWXOIT and OWX26T 30,000-gallon capacity each) that receive liquid waste before discharge to the Rock River.

2.1.2 Turbine Building Fire and Oil Sump The turbine building fire and oil sump receives water from selected turbine building sumps, the tendon tunnel sumps, and the diesel fuel oil storage sumps, all of which are normally non-radioactive but potentially contaminated. The effluent from this sump is monitored, and if radioactive contamination exceeds a predetermined level pump operation is automatically terminated. The water may then be sent to the liquid radwaste treatment system.

2.1.3 Condensate Polisher Sump The condensate polisher sump receives wastewater from the condensate polisher system, which is normally non-radioactive but potentially contaminated. The effluent from this sump is monitored and if radioactive contamination exceeds a predetermined level sump discharge is terminated and major condensate polisher inputs to the sump are automatically isolated. The water may then be sent to the liquid radwaste treatment system.

Page 11.2-1

CY-BY-1 70-301 Revision 5 2.2 Liquid Effluent Radiation Monitors Pertinent information on the Liquid Radioactive Effluent Monitors and associated control devices are shown in Table 2-1; additional information is provided in the Byron UFSAR Chapter 11.

2.2.1 Liquid Radwaste Effluent Monitor Monitor ORE-PRO01 is used to monitor all releases from the release tanks. On high alarm, the monitor automatically initiates closure of valves OWX-353 and OWX-869 to terminate the release.

2.2.2 Station Blowdown Monitor Monitor ORE-PR010 continuously monitors the recirculating water blowdown. No control device is initiated by this channel.

2.2.3 Reactor Containment Fan Cooler (RCFC) and Essential Service Water (SX) Outlet Line Monitors.

Monitors 1RE-PR002, 2RE-PROO2, 1 RE-PR003, and 2RE-PRO03 continuously monitor the RCFC and SX outlet lines. No control device is initiated by these channels.

2.2.4 Turbine Building Fire and Oil Sump Monitor Monitor ORE-PRO05 continuously monitors the fire and oil sump discharge. On high alarm the monitor automatically initiates an interlock to trip the discharge pumps, close valve 0OD030, and terminate the release.

2.2.5 Condensate Polisher Sump Monitor Monitor ORE-PRO41 continuously monitors the condensate polisher sump discharge. On high alarm, the monitor automatically initiates an interlock to trip the discharge pumps and terminate the release.

2.2.6 Component Cooling Water Monitors Monitors ORE-PRO09 (common), 1RE-PRO09 (Unit 1), and 2RE-PRO09 (Unit 2) continuously monitor the component cooling water heat exchanger outlets. On high alarm ORE-PRO09 initiates closure of both component cooling water surge tank (CCWST) vents, 1RE-PRO09 initiates closure of the Unit 1 Page 11.2-2

CY-BY-1 70-301 Revision 5 CCWST vent, and 2RE-PRO09 initiates closure of the Unit 2 CCWST vent.

2.3 Liquid Radiation Effluent Monitors Alarm and Trip Setpoints Alarm and trip setpoints of liquid effluent monitors at the principal release points are established to ensure that the limits of TRM Section 3.11 .a are not exceeded in the unrestricted area.

Setpoint calculations normally consist of identified release mixtures, dilution factors, conversion factors (detector sensitivity), maximum release flow rates, and conservatism factors.

2.3.1 Station Blowdown Monitor During release, the monitor setpoint is found by solving equation 2-1 P < Ccw + (1.50 x CT) x (Fr-max(FCW + Y'ma,)) (2-1)

P Release Setpoint [VCi/ml]

1.50 Factor to account for minor fluctuations in count rate CCW Concentration of activity in the circulating water blowdown at the time of discharge ("Background reading") [VCi/ml]

CT Analyzed activity in the release tank (excluding tritium)vCi/ml]

FCW Circulating Water Blowdown Rate [gpm]

Ftnax Maximum Release Tank Discharge Flow Rate [gpm]

The flow rate from the radwaste discharge tank The release mixture used for the setpoint determination is the radionuclide mix identified in the release tank grab sample isotopic analysis.

2.3.2 Liquid Radwaste Effluent Monitor During release, the setpoint is established at 1.5 times the analyzed tank activity plus the background reading. However, per procedure, the maximum discharge flow rate is limited to a value that will result in less than 50% of 10*ECL at the discharge point. (See Section 2.3.2.1)

Page 11.2-3

CY-BY-1 70-301 Revision 5 2.3.2.1 Radwaste Tank Discharge Flow Rate Prior to each batch release, a grab sample is obtained.

The results of the analysis of the waste sample determine the discharge rate of each batch as follows:

m=a 0.5(Fact/ / O

ECL d)) (2-2)

The summation is over radionuclides i.

Fn, Maximum Permitted Discharge Flow Rate [gpm]

The maximum permitted flow rate from the radwaste discharge tank based on radiological limits (not chemistry limits which may be more restrictive)

Fadct Circulating Water Blowdown Rate [gpm]

0 Concentration of Radionuclide i in the Release Tank [gCi/ml]

The concentration of radioactivity in the radwaste discharge tank based on measurements of a sample drawn from the tank.

ECL1 Effluent Concentration Limit [VCi/ml]

The concentration of radionuclide i given in Appendix B, Table 2, Column 2 to 10CFR20.1001 - 20.2402.

10 Multiplier 2.3.2.2 Release Mixture The release mixture used for the setpoint determination is the radionuclide mix identified in the release tank grab sample isotopic analysis.

2.3.2.3 Liquid Dilution Flow Rates Dilution flow rates are obtained from the main control board in the control room. If this information is unavailable, releases may continue for up to 30 days provided the dilution flow rates are estimated every 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months during the release, in accordance with TRM Table T 3.11.a-1.

Page 11.2-4

CY-BY-1 70-301 Revision 5 2.3.2.4 Projected Concentrations for Releases After determining F",ax 0 from Equation 2-2, RECS compliance is verified using Equations 2-3 and 2-4.

Cl = CT[F.ax/(Fra + FL)] (2-3)

{C* / 10

ECL } - 1 (2-4)

The summation is over radionuclides i.

Cia Concentration of Radionuclide i in the Unrestricted Area[RCi/mL]

The calculated concentration of radionuclide i in the unrestricted area as determined by Equation 2-3.

C, Concentration of Radionuclide i in the Release Tank [gCi/mL]

The concentration of radioactivity in the radwaste discharge tank based on measurements of a sample drawn from the tank.

ECLi Effluent Concentration Limit [RiCi/mI]

The concentration of radionuclide i given in Appendix B, Table 2, Column 2 to 10CFR20.1001 - 20.2402.

10 Multiplier Fa Maximum Release Tank Discharge Flow Rate [gpm]

d Fad Circulating Water Blowdown Rate [gpm]

2.3.3 Other Liquid Effluent Monitors For all other liquid effluent monitors, including ORE-PRO01 and ORE-PRO10 when not batch releasing, setpoints are determined such that the concentration limits do not exceed 10 times the ECL value given in Appendix B, Table 2, Column 2 to 10CFR20.1001 - 20.2402 in the unrestricted area. Release mixtures are based on a representative isotopic mixture of the waste stream or inputs to the waste stream, or defaulted to the mix listed in Table 2-4.

Page 11.2-5

CY-BY-1 70-301 Revision 5 2.3.4 Conversion Factors The readouts for the liquid effluent monitors are in gCi/ml. The cpm to gCi/ml conversion is determined for each monitor.

2.3.5 Allocation of Effluents from Common Release Points Radioactive liquid effluents released from either release tank (OWX01T or OWX26T) are comprised of contributions from both units. Under normal operating conditions, it is difficult to apportion the radioactivity between the units. Consequently, allocation is made evenly between units.

2.3.6 Solidification Of Waste/Process Control Program The process control program (PCP) contains the sampling, analysis, and formulation determination by which solidification of radioactive wastes from liquid systems is ensured.

2.4 Gaseous Effluents System Description A simplified HVAC and gaseous effluent flow diagram is provided in Figure 2-1. The principal release points for potentially radioactive airborne effluents are the two auxiliary building vent stacks (designated Stack 1 and Stack 2 in Figure 2-1). In the classification scheme of Section 4.1.4, each is classified as a vent release point. Engineered safety features atmospheric cleanup systems are not considered to be ventilation exhaust treatment system components.

2.4.1 Waste Gas Holdup System The waste gas holdup system is designed and installed to reduce radioactive gaseous effluents by collecting reactor coolant system off-gases from the reactor coolant system and providing for delay or holdup to reduce the total radioactivity by radioactive decay prior to release to the environment.

2.4.2 Ventilation Exhaust Treatment System Ventilation exhaust treatment systems are designed and installed to reduce gaseous radioiodine or radioactive material in particulate form in gaseous effluents by passing ventilation or vent exhaust gases through charcoal adsorbers and/or HEPA filters prior to release to the environment. Such a system is not considered to have any effect on noble gas effluents. The ventilation exhaust treatment systems are shown in Figure 2-1.

Page 11.2-6

CY-BY-1 70-301 Revision 5 Engineered safety features atmospheric cleanup systems are not considered to be ventilation exhaust treatment system components.

2.5 Gaseous Effluent Radiation Monitors Pertinent information on the Gaseous Effluent Radiation Monitors and associated control devices are shown in Table 2-2, additional information is provided in Byron UFSAR Chapter 11.

2.5.1 Auxiliary Building Vent Effluent Monitors Monitors 1 RE-PR028 (Unit 1) and 2RE-PRO28 (Unit 2) continuously monitor the final effluent from the auxiliary building vent stacks.

Both vent stack monitors feature automatic noble gas monitoring, isokinetic sampling, grab sampling, and sampling for iodine, particulate, and tritium.

These monitors perform no automatic isolation or control functions.

2.5.2 Containment Purge Effluent Monitors Monitors 1 RE-PRO01 (Unit 1) and 2RE-PRO01 (Unit 2) continuously monitor the effluent from the Unit 1 and Unit 2 containments, respectively. When airborne radioactivity in the containment purge effluent stream exceeds a specified level station personnel will follow established procedures to terminate the release by manually activating the containment purge valves. Additionally, the auxiliary building vent effluent monitors provide an independent, redundant means of monitoring the containment purge effluent.

These monitors perform no automatic isolation or control functions.

Monitors 1RE-AR011, 2RE-AR01 1, 1RE-AR01 2 and 2RE-AR012 continuously monitor the containment atmosphere for radioactive gas and particulates. On high alarm during a containment purge, these monitors will automatically terminate the purge.

Page 11.2-7

CY-BY-1 70-301 Revision 5 2.5.3 Waste Gas Decay Tank Monitors Monitors ORE-PRO02A and ORE-PRO02B continuously monitor the noble gas activity released from the gas decay tanks.

On high alarm, the monitors automatically initiate closure of the valve OGW104 thus terminating the release.

2.5.4 Gland Steam and Condenser Air Ejector Monitors Monitors 1 RE-PR027 and 2RE-PR027 continuously monitor the condenser air ejector gas from Units I and 2, respectively. This monitor performs no automatic isolation or control functions.

2.5.5 Radwaste Building Ventilation Monitor Monitor ORE-PR026 continuously monitors radioactivity in the radwaste building ventilation system. On high alarm, ORE-PR026 initiates isolation of the radwaste building ventilation system.

2.5.5.1 Miscellaneous Ventilation Monitors Monitor ORE-PRO03 continuously monitors radioactivity in the ventilation exhaust from the laboratory fume hoods. This monitor performs no automatic isolation or control functions.

2.6 Gaseous Effluent Monitor Alarm and Trip Setpoints 2.6.1 Auxiliary Building Vent Effluent Monitors The setpoints for the low range noble gas channel are conservatively established at 2.5% of the maximum permissible release rate for the high alarm and 0.25% of the maximum release rate for the alert alarm.

The setpoints for the high range noble gas channel are conservatively established at 50% of the maximum permissible release rate for the high alarm and 5% of the maximum release rate for the alert alarm.

Page 11.2-8

CY-BY-1 70-301 Revision 5 2.6.2 Containment Purge Effluent Monitors The setpoints are established at 1.25 times the containment noble gas activity during purge.

2.6.3 Waste Gas Decay Tank Effluent Monitors The setpoints are established at 1.25 times the analyzed waste gas tank activity during release.

2.6.4 Gaseous Effluent Release Limits Alarm and trip setpoints of gaseous effluent monitors are established to ensure that the release rate limits of TRM Section 3.11 .b are not exceeded. The release limits are found by solving Equations 2-5 and 2-6 for the total allowed release rate of vent releases, Qty.

WQ) Q, X:K, f, <500 mrem/yr (2-5)

Q f If{L (X/Q), + (1.11) M,(,JQ)T 1<3000 mremlyr (2-6)

The summations are over noble gas radionuclides i.

Fractional Radionuclide Composition The release rate of noble gas radionuclide i divided by the total release rate of all noble gas radionuclides.

Qtv Total Allowed Release Rate, Vent Release [jiCi/sec]

The total allowed release rate of all noble gas radionuclides released as vent releases.

The remaining parameters in Equation 2-5 have the same definitions as in Equation 4-1 of Part II Section 4. The remaining parameters in Equation 2-6 have the same definition as in Equation 4-2 of Part II Section 4.

Equation 2-5 is based on Equation 4-1 of Section 4 and the RECS restriction on whole body dose rate (500 mrem/yr) due to noble gases released in gaseous effluents (see Part II Section 4.2.1.1). Equation 2-6 is based on Equation 4-2 of Section 4 and the RECS restriction on skin dose rate (3000 mrem/yr) due to noble gases released in gaseous effluents (see Part II Section 4.2.1.2).

Page 11.2-9

CY-BY-1 70-301 Revision 5 Since the solution to Equation 2-6 is more conservative than the solution to Equation 2-5, the value of Equation 2-6 (1.02 x 107 RCi/sec) is used as the limiting noble gas release rate. During evolutions involving releases from the containment or waste gas decay tanks, the total station release rate is procedurally limited such that the maximum permissible release rate is not exceeded.

2.6.5 Release Mixture In the determination of alarm and trip setpoints, the radioactivity mixture in exhaust air is assumed to have the radionuclide composition of Table 2-3.

2.6.6 Conversion Factors.

The response curves used to determine the monitor count rates are based on the sensitivity to Xe-1 33 for conservatism.

2.6.7 HVAC Dilution Flow Rates The plant vent stack flow rates are obtained from the RM-1 1 (or equivalent) console in the control room. If the values cannot be obtained from RM-1 1 (or equivalent), flow rates can be estimated from the operating fan combinations.

2.6.8 Allocation of Effluents from Common Release Points Radioactive gaseous effluents released from the auxiliary building, miscellaneous ventilation systems and the gas decay tanks are comprised of contributions from both units. Consequently, allocation is made evenly between units.

2.6.9 Dose Projections for Batch Releases The 10CFR20 dose limits have been converted into a station administrative release rate limit using the methodology in the ODCM.

Compliance is verified prior to each release. Doses are calculated after purging the containment or venting the waste gas decay tanks.

Per procedure, representative samples are obtained and analyzed, and the doses calculated on a monthly basis to verify compliance with 10CFR50.

Page 11.2-10

CY-BY-1 70-301 Revision 5 Table 2-1 Liquid Radioactive Effluent Monitors Alarm 1 Setpoint Channel I Monitor Description Sampling Locations Effluent Control Functions Used Radwaste Release Common release point from Radwaste ORE-PRO01 Tank Monitor Release Tanks OWX01T, OWX26T I Radwaste release termination ] Yes Station Blowdown ORE-PRO10 Monitor Recirculating Water Blowdown None No 1 RE-PRO02 Reactor Containment I j 2RE-PRO02 Fan Cooler and 1RE-PR003 Essential Service Water 2RE-PRO03 Outlet Line Monitors I RCFC and SX outlet lines None No Turbine Building Fire Terminates release from ORE-PRO05 and Oil Sump Monitor J Fire and Oil Sump discharge Fire and Oil Sump j Yes Condensate Polisher Terminates release from ORE-PRO41 Sump Monitor Condensate Polisher Sump discharge Condensate Polisher Sump , Yes ORE-PRO09: CCW Heat Exchangers, ORE-PRO09: Closes both CCW surge common discharge tank vents I RE-PRO09: Unit 1 CCW Heat Exchanger 1RE-PRO09: Closes Unit 1 CCW ORE-PRO09 discharge surge tank vent 1RE-PRO09 Component Cooling 2RE-PRO09: Unit 2 CCW Heat Exchanger 2RE-PRO09: Closes Unit 2 CCW 2RE-PRO09 Water (CCW) Monitors discharge surge tank vent j Yes Page 11.2-11

CY-BY-1 70-301 Revision 5 Table 2-2 Gaseous Radioactive Effluent Monitors j Alarm Setpoint Channel Monitor Description Sampling Locations Effluent Control Functions Used I Final effluent from auxiliary building vent stack 1RE-PR028 Auxiliary Building Vent from Unit 1 (1RE-PR028) and 2RE-PR028 Effluent Monitors from Unit 2 (2RE-PR028) None Yes 1RE-PRO01 Containment Purge Effluent from Unit 1 Containment (1 RE-PRO01) 2RE-PRO01 Effluent Monitors Effluent from Unit 2 Containment (2RE-PRO01) None Yes 1RE-AR01 1 Unit I Containment (1RE-AR011, 1 RE-AR012) 2RE-AR01 1 Reactor Containment Unit 2 Containment (2RE-ARO1 1, 2RE-AR01 2) 1RE-AR01 2 Particulate and Gas Note: not effluent monitors, but have effluent 2RE-AR012 Monitors control functions Terminate containment purge Yes ORE-PRO02A Waste Gas Decay Tank Closes valve OGW104, ORE-PRO02B Monitors Release line from Waste Gas Decay Tanks terminates release Yes Gland Steam and Condenser Air Ejector (CAE) gas from Unit 1 1RE-PR027 Condenser Air Ejector (1 RE-PR027) and 2RE-PRO27 Monitors CAE gas from Unit 2 (2RE-PR027) None I No tT ORE-PR026 Radwaste Building Ventilation Radwaste Building Ventilation System

{

I Isolates Radwaste Building ventilation system Yes Laboratory Fume Hood ORE-PRO03 Exhaust Monitor Common line from laboraton fume hoods None No Page 11.2-12

CY-BY-1 70-301 Revision 5 Table 2-3 Assumed Composition of the Byron Station Noble Gas Effluent Isotope Percent of Effluent Ar-41 0.89 Kr-85m 0.18 Kr-85 24.9 Kr-87 0.04 Kr-88 0.28 Xe-131m 1.42 Xe-133m 0.57 Xe-133 71.1 Xe-1 35 0.53 Xe-138 0.04 Page 11.2-13

CY-BY-1 70-301 Revision 5 Table 2-4 Assumed Composition of the Byron Station Liquid Effluent Isotope Concentration Isotope Concentration (uCi/mi) (uCi/ml)

H-3 1.16E-05 Ag-1I0m 1.70E-11 Cr-51 2.39E-12 Te-127 5.40E-13 Mn-54 3.86E-11 Te-129m 1.78E-12 Fe-55 2.08E-12 Te-129 1.16E-12 Fe-59 1.35E-12 Te-131m 1.27E-12 Co-58 1.74E-10 Te-132 2.39E-11 Co-60 3.40E-10 1-130 4.24E-12 Br-83 6.59E-13 1-131 3.09E-09 Rb-86 1.81 E-12 1-132 6.95E-11 Sr-89 5.02E-13 1-133 1.43E-09 Zr-95 5.40E-1 1 1-135 1.66E-1 0 Nb-95 7.72E-11 Cs-134 1.08E-09 Mo-99 7.72E-11 Cs-136 2.66E-10 Tc-99m 8.88E-1 I Cs-1 37 1.35E-09 Ru-103 5.40E-12 Ce-144 2.01E-10 Ru-106 9.26E-11 Np-239 8.88E-13 Page 11.2-14

CY-BY-1 70-301 Revision 5

~A ELEV. 2000

~I - ABOVE GRADE STATEOF STATE O F ILUNOIS NTACO ILLINOIS 5PMONITOR H PURGE IMI N ,o STACK MONITOR 2RE-PR031

-- I--F-. -4Z- 1lRE-PooI1 F

.f0 (NOTE2)

N 0 CONTAINMENT UNIT 2 2RE-PR001 F 135,900 NONFILTERED F- ----- -- -- -- - -b.

AUXILLARY BUILDING H H G TANK VENTS FILTERED AUXILLARY-BUILDING TANK VENTS 'H G H VOLUME REDUCTION EQUIP VENTS

,* 9,230 SAMPLE ROOMS AND LABORATORIES LAUNDRY ORE-PROIS 9,000 OFFSITE DOSE CALCULATION MANUAL BYRON STATION Figure 2-1 SIMPLIFIED HVAC AND GASEOUS EFFLUENT FLOW DIAGRAM (SHEET 1 OF 2)

Page 11.2-15

CY-BY-1 70-301 Revision 5 UNIT 1 CONDENSOR HOGGING PUMP--------------- 2,500 DURING UNIT 1 STARTUP GLAND STEAM 1_400___H_1,432 CONDENSOR 1OEP02 '-'-

1RE-PR027I 6,000 (NOTE 3)

EJECTORI I TURBINE BUILDING OFFGAS FILTER UNIT I GENERAL AREA (ELEVATION 451 FEET)

UNIT 2 CONDENSOR 2,500 DURING UNIT 2 STARTUP STACK STACK HOGGING PUMP-----1 2 GLAND STEAM 1,400 I H COEESNSER2RE-PRO27 -(;p-F 0 32 STEAM JET AIR EJECTOR SOLID RADWASTE ORE-PR026 DRUMMING STATION 30E-PR140 4--- - ---------------- - I---

VOLUME REDUCTION r II H G G H ORE-PRO40 LEGEND NOTES

1. USED INTERMITTENTLY TO VENT CONTAINMENT DURING NORMAL OR FREQUENT FLOW PATH NORMAL OPERATION

-- - OCCASIONAL FLOW PATH 2. USED ONLY DURING POST ACCIDENT OPERATION

3. FILTER UNIT OPERATES ONLY WHEN HIGH RADIATION IS A CONTAIMENT ATMOSPHERE RADIATION DETECTED IN OFFGAS SYSTEM EFFLUENT DISCHARGE MONITOR C CHARCOAL FILTER F REFUELING G NOBLE GAS RADIATION MONITOR H HEPA FILTER M THREE-CHANNEL RADIATION MONITOR FOR PARTICULATE, OFFSITE DOSE CALCULATION MANUAL IODINE, AND NOBLE GAS (OFFLINE) BYRON STATION N NORMAL OPERATION P PARTICULATE MONITOR (OFFLINE) Figure 2-1 R HYDROGEN RECOMBINER SIMPLIFIED HVAC AND GASEOUS S NORMAL RANGE STACK RADIATION MONITOR EFFLUENT FLOW DIAGRAM (PARTICULATE, IODINE, AND NOBLE GAS) (SHEET 2 OF 2)

W WIDE-RANGE STACK NOBLE GAS RADIATION MONITOR Page 11.2-16

CY-BY-1 70-301 Revision 5 UNIT 1 UNIT 1 BLOWDOWN BLOWDOWN BLOWDOWN MIXED BED DEMINERALIZER PUI1NIPER DEMINERALIZER AFTER FILTER STEAM BLOWDOWN CONENAT STORAGE TANK GENERATOR NSER BLOWDOWN UNIT 2 UNIT 2 BLOWDOWN LOWDOWN BLOWDOWN BLOWDOWN MIXED BED DEMINERALIZER MONITOR UNIT 2 NIT2 R DEMINERAUZER "AFTR FILTER TANKS To UNIT 2 STEAM BLOWDOWN * = CONDENSATE GENERATOR [RELEASE RDENSER TANK 1STORAGE TANK BLOWDOWN I

Figure 2-2 Simplified Liquid Radwaste Processing Diagram Page 11.2-17

CY-BY-1 70-301 Revision 5 IRE-PR002 LEGEND W Liquid Radwaste Monito TF

NaturalDraftCooling Tower

~ Essential ServiceWater CoolingT ower Figure 2-3 Liquid Release Flow Path Page 11.2-18

CY-BY-1 70-301 Revision 5 3.0 LIQUID EFFLUENTS 3.1 Liquid Effluent Releases - General Information 3.1.1 The design objectives of 10CFR50, Appendix I and RECS provide the following limits on the dose to a member of the public from radioactive materials in liquid effluents released from each reactor unit to restricted area boundaries:

" During any calendar quarter, less than or equal to 1.5 mrem to the total body and less than or equal to 5 mrem to any organ.

During any calendar year, less than or equal to 3 mrem to the total body and less than or equal to 10 mrem to any organ.

3.1.2 The organ doses due to radioactivity in liquid effluents are also used as part of the 40CFR1 90 compliance and are included in the combination of doses to determine the total dose used to demonstrate 10CFR20 compliance. (See Section 5.0, Total Dose) 3.1.3 Dose assessments for 10CFR50 Appendix I compliance are made for four age groups (adult, teenager, child, infant) using NUREG 0133 (Reference 14) methodology and Regulatory Guide 1.109 (Reference 6) dose conversion factors.

3.1.4 To limit the consequences of tank overflow, Technical Specification 5.5.12 limits the quantity of radioactivity that may be stored in unprotected outdoor tanks to 10 Curies.

Unprotected tanks are tanks that are not surrounded by liners, dikes, or walls capable of holding the tank contents and that do not have tank overflows and surrounding area drains connected to the liquid radwaste treatment system.

The specific objective is to provide assurance that in the event of an uncontrolled release of a tank's contents, the resulting radioactivity concentrations beyond the unrestricted area boundary, at the nearest potable water supply and at the nearest surface water supply, will be less than the limits of 10CFR20 Appendix B, Table 2; Column 2.

3.1.5 Cases in which normally non-radioactive liquid streams (such as the Service Water) are found to contain radioactive material are non-routine and will be treated on a case specific basis if and when this occurs. Since the station has sufficient capacity to delay a liquid release for reasonable periods of time, it is expected that Page 11.3-1

CY-BY-1 70-301 Revision 5 planned releases will not take place under these circumstances.

Therefore, the liquid release setpoint calculations need not and do not contain provisions for treating multiple simultaneous release pathways.

3.1.6 Radioactive liquid effluents released from either release tank (OWX01 T or 0WX26T) are comprised of contributions from both units. Under normal operating conditions, it is difficult to apportion the radioactivity between the units. Consequently, allocation is made evenly between units.

3.2 Liquid Effluent Concentrations 3.2.1 One method of demonstrating compliance to the requirements of 10CFR20.1301 is to demonstrate that the annual average concentrations of radioactive material released in gaseous and liquid effluents do not exceed the values specified in 10CFR20 Appendix B, Table 2, Column 2. (See 10CFR 20.1302(b)(2).)

However, as noted in Section 5.5, this mode of 10CFR20.1301 compliance has not been elected.

As a means of assuring that annual concentration limits will not be exceeded, and as a matter of policy assuring that doses by the liquid pathway will be ALARA; RECS provides the following restriction:

"The concentration of radioactive material released in liquid effluents to unrestricted areas shall be limited to ten times the concentration values in Appendix B, Table 2, Column 2 to 10CFR20.1001-20.2402."

This also meets the requirement of Station Technical Specifications and RECS.

3.2.2 According to the footnotes to 10CFR20 Appendix B, Table 2, Column 2, if a radionuclide mix of known composition is released, the concentrations must be such that where the summation is over radionuclide i.

Page 11.3-2

CY-BY-1 70-301 Revision 5 C, Radioactivity Concentration in Liquid Effluents to the Unrestricted Area [gCi/ml]

Concentration of radionuclide i in liquid released to the unrestricted area.

ECLI Effluent Concentration Limit in Liquid Effluents Released to the Unrestricted Area [Ci/mI]

The allowable annual average concentration of radionuclide i in liquid effluents released to the unrestricted area. This concentration is specified in 10CFR20 Appendix B, Table 2, Column 2. Concentrations for noble gases are different and are specified in the stations' Technical Specifications and RECS.

10 Multiplier to meet the requirements of Technical Specifications.

If either the identity or concentration of any radionuclide in the mixture is not known, special rules apply. These are given in the footnotes in 10CFR20 Appendix B, Table 2, Column 2.

3.2.3 When radioactivity is released to the unrestricted area with liquid discharge from a tank (e.g., a radwaste discharge tank), the concentration of a radionuclide in the effluent is calculated as follows:

C, = C' Waste Flow (3-2)

Dilution Flow Ci Concentration in Liquid effluent to the unrestricted area.

[LCi/ml]

Concentration of radionuclide i in liquid released to the unrestricted area.

Cit Concentration in the Discharge Tank [gCi/ml]

Measured concentration of.radionuclide i in the discharge tank.

The RECS and Technical Specifications require a specified sampling and analysis program to assure that liquid radioactivity concentrations at the point of release are maintained within the required limits. To comply with this provision, samples are analyzed in accordance with the radioactive liquid waste (or effluent)

Page 11.3-3

CY-BY-1 70-301 Revision 5 sampling and analysis program in the TRM 3.11.c. Radioactivity concentrations in tank effluents are determined in accordance with Equation 3-2. Comparison with the Effluent Concentration Limit is made using Equation 3-1.

3.3 Liquid Effluent Dose Calculation Requirements 3.3.1 RECS require determination of cumulative and projected dose contributions from liquid effluents for the current calendar quarter and the current calendar year at least once per 31 days. (See TRM Chapter 3.11.)

For a release attributable to a processing or effluent system shared by more than one reactor unit, the dose due to an individual unit is obtained by proportioning the effluents among the units sharing the system. The allocation procedure is specified in section 3.1.6.

3.3.2 Operability and Use of the Liquid Radwaste Treatment System The design objectives of 10CFR50, Appendix I, RECS and Technical Specifications require that the liquid radwaste treatment system be operable and that appropriate portions be used to reduce releases of radioactivity when projected doses due to the liquid effluent from each reactor unit to restricted area boundaries exceed either of the following (see TRM Chapter 3.11, RECS);

0 0.06 mrem to the total body in a 31-day period.

0.2 mrem to any organ in a 31-day period.

3.4 Dose Methodology 3.4.1 Liquid Effluent Dose Method: General The dose from radioactive materials in liquid effluents considers the contributions for consumption of fish and potable water. All of these pathways are considered in the dose assessment unless demonstrated not to be present. While the adult is normally considered the maximum individual, the methodology provides for dose to be calculated for all four age groups. The dose to each organ (and to the total body) is calculated by the following expression:

91 =F tAalpjCi (3-3) p I Page 11.3-4

CY-BY-1 70-301 Revision 5 The summation is over exposure pathways p and radionuclides i.

DUq Organ and Total Body Dose Due to Liquid Effluents [mrem]

Dose to organ j (including total body) of age group a due to radioactivity in liquid effluents.

F Near Field Average Dilution Factor [dimensionless]

Dilution in the near field averaged over the period of interest.

Defined as:

F= Waste Flow (3-4)

Dilution Flow x Z Waste Flow Liquid Radioactive Waste Flow [gpm]

The average flow during disposal from the discharge structure release point into the receiving water body.

Dilution Flow Dilution Water Flow During Period of Interest [gpm]

Z Discharge Structure Mixing Factor [dimensionless]

Site-specific factor to account for the mixing effect of the discharge structure. The factor addresses the dilution that occurs in the near field between the discharge structure and the body of water containing the fish in the liquid ingestion pathway (See section 3.5.5.2).

At Duration of Release [hrs]

Ci Average Radionuclide Concentration [gCi/ml]

Average concentration of radionuclide i, in the undiluted liquid effluent during time period At.

Aaipj Site-Specific Liquid Dose Factor [(mrem/hr)/(Cil/ml)]

Site-specific dose factor for age group a, nuclide i, liquid pathway p and organ j. The pathways included are potable water and fish ingestion. Aaipj is defined for these pathways in the following sections. Values for Aaipj are provided in Part II Section 3.5 of this ODCM.

Page 11.3-5

CY-BY-1 70-301 Revision 5 3.4.2 Potable Water Pathway The site-specific potable water pathway dose factor is calculated by the following expression:

A.I(pw)j = ko{w DFLa.j (3-5)

Where:

AaI(pw)j Site-Specific Dose Factor for Potable Water Pathway

[(mrem/hr)/(iCi/ml)]

Site-specific potable water ingestion dose factor for age group a, nuclide i and organ j.

ko Conversion Constant (1.14E05) [(yr-pCi-ml)/(hr-gCi-I)]

Units constant to convert years to hours, pCi to laCi and liters to ml.

Uaw Potable Water Consumption Rate [l/yr]

Potable water consumption rate for age group a. Taken from Table E-5 of Regulatory Guide 1.109.

Dw Potable Water Dilution Factor [dimensionless]

Dilution factor from the nearfield area within one-quarter mile of the release point to the potable water intake (See section 3.5.5.1).

DFLaj Ingestion Dose Conversion Factor [mrem/pCi]

Ingestion dose conversion factor for age group a, nuclide i and organ j. Converts pCi ingested to mrem. Taken from Tables E-1 1 though E-14 of Regulatory Guide 1.109. The value for H-3 is taken from NUREG 4013 (Reference 107).

Page 11.3-6

CY-BY-1 70-301 Revision 5 3.4.3 Fish Ingestion Pathway The site-specific fish ingestion pathway dose factor is calculated by the following expression:

Aa1(FISh)j = koUFBF DFL.Q (3-6)

Where:

Aai(Fish)J Site-Specific Dose Factor for Fish Ingestion Pathway

[(mrem/hr)/(lCi/ml)]

Site-specific fish ingestion dose factor for age group a, nuclide i and organ j.

UaF Fish Consumption Rate [kg/yr]

Fish consumption rate for age group a. Taken from Table E-5 of Regulatory Guide 1.109.

BF, Bioaccumulation Factor [(pCi/kg)/(pCi/l)]

Bioaccumulation factor for nuclide i in fresh water fish.

Taken from Table 3-8.

All other terms have been previously defined.

3.4.4 Offsite doses due to projected releases of radioactive materials in liquid effluents are calculated using Equation 3-3. Projected radionuclide release concentrations are used in place of measured concentrations, C1.

3.5 Site Specific Dose Factors and Bioaccumulation Factors 3.5.1 There are no public potable water intakes on the Rock River downstream of the station.

3.5.2 There is no irrigation occurring on the Rock River downstream of the station.

3.5.3 Recreation includes one or more of the following: boating, water-skiing, swimming, and sport fishing.

Page 11.3-7

CY-BY-1 70-301 Revision 5 3.5.4 According to Section 2.4.1.2 and Figure 2.4-5 of the Byron Environmental Report, there are four downstream dams on the Rock River within approximately 50 miles of the station one at Oregon, one at Dixon and two at Sterling.

3.5.5 Water and Fish Ingestion Parameters 3.5.5.1 Dw= 10 (potable water dilution factor, dimensionless) 3.5.5.2 Z = 32 (discharge structure mixing factor, dimensionless) 3.5.6 Site-specific dose factors for potable water consumption are shown in Table 3-1 for adult, Table 3-2 for teen, Table 3-3 for child, and Table 3-4 for infant age groups. These tables include dose factors for the bone, liver, total body, thyroid, kidney, lung, and GI (lower large intestines).

3.5.7 Site-specific dose factors for fish ingestion are shown in Table 3-5 for adult, Table 3-6 for teen, and Table 3-7 for child age groups.

These tables include dose factors for the bone, liver, total body, thyroid, kidney, lung, and GI (lower large intestines).

Page 11.3-8

CY-BY-1 70-301 Revision 5 Table 3-1 Site Specific Potable Water Dose Factors for Adult Age Group Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 O.OOE+00 4.98E-01 4.98E-01 4.98E-01 4.98E-01 4.98E-01 4.98E-01 Na-24 1.41E+01 1.41E+01 1.41E+01 1.41E+01 1.41E+01 1.41E+01 1.41E+01 Cr-51 0.00E+00 O.OOE+00 2.21E-02 1.32E-02 4.88E-03 2.94E-02 5.57E+00 Mn-54 0.OOE+00 3.80E+01 7.26E+00 0.OOE+00 1.13E+01 0.OOE+00 1.17E+02 Mn-56 O.OOE+00 9.57E-01 1.70E-01 O.OOE+00 1.22E+00 O.OOE+00 3.05E+01 Fe-55 2.29E+01 1.58E+01 3.69E+00 O.OOE+00 O.OOE+00 8.82E+00 9.07E+00 Fe-59 3.61E+01 8.49E+01 3.25E+01 O.OOE+00 O.OOE+00 2.37E+01 2.83E+02 Co-58 O.OOE+00 6.20E+00 1.39E+01 0.00E+00 O.OOE+00 O.OOE+00 1.26E+02 Co-60 O.OOE+/-00 1.78E+01 3.93E+01 O.OOE+00 O.OOE+00 O.OOE+00 3.35E+02 Ni-63 1.08E+03 7.50E+01 3.63E+01 O.OOE+00 O.OOE+00 0.OOE+00 1.56E+01 Ni-65 4.39E+00 5.71E-01 2.60E-01 O.OOE+00 O.OOE+00 0.OOE+00 1.45E+01 Cu-64 O.OOE+00 6.93E-01 3.25E-01 O.OOE+00 1.75E+00 O.OOE+00 5.91E+01 Zn-65 4.03E+01 1.28E+02 5.79E+O1 O.OOE+00 8.57E+01 O.OOE+00 8.07E+01 Zn-69 8.57E-02 1.64E-01 1.14E-02 O.OOE+00 1.07E-01 O.OOE+00 2.46E-02 Br-83 O.OOE+00 O.OOE+00 3.35E-01 O.OOE+00 O.OOE+00 O.OOE+00 4.82E-01 Br-84 O.OOE+00 O.OOE+00 4.34E-01 O.OOE+00 O.OOE+00 O.OOE+00 3.40E-06 Br-85 O.OOE+0O 0.OOE+00 1.78E-02 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 Rb-86 O.OOE+00 1.76E+02 8.18E+01 O.OOE+00 O.OOE+00 O.OOE+00 3.46E+01 Rb-88 O.OOE+00 5.03E-01 2.67E-01 O.OOE+00 O.OOE+00 0.OOE+00 6.96E-12 Rb-89 O.OOE+00 3.34E-01 2.35E-01 O.OOE+00 O.OOE+00 0.OOE+00 1.94E-14 Sr-89 2.56E+03 O.OOE+00 7.36E+01 O.OOE+00 O.OOE+00 0.OOE+00 4.11E+02 Sr-90 7.25E+04 O.OOE+00 1.46E+03 O.OOE+00 O.OOE+00 O.OOE+00 1.82E+03 Sr-91 4.72E+01 O.OOE+00 1.91E+00 O.OOE+00 0.OOE+00 O.OOE+00 2.25E+02 Sr-92 1.79E+01 O.OOE+00 7.74E-01 O.OOE+00 O.OOE+00 0.OOE+00 3.55E+02 Y-90 8.01E-02 O.OOE+00 2.15E-03 0.OOE+00 O.OOE+00 O.OOE+00 8.49E+02 Y-91M 7.56E-04 O.OOE+00 2.93E-05 O.OOE+00 O.OOE+00 0.OOE+00 2.22E-03 Y-91 1.17E+00 O.OOE+00 3.14E-02 O.OOE+00 O.OOE+00 0.OOE+00 6.46E+02 Y-92 7.03E-03 O.OOE+00 2.06E-04 O.OOE+00 O.OOE+00 0.OOE+00 1.23E+02 Y-93 2.23E-02 O.OOE+00 6.16E-04 O.OOE+00 O.OOE+00 0.OOE+00 7.07E+02 Zr-95 2.53E-01 8.11 E-02 5.49E-02 O.OOE+00 1.27E-01 O.OOE+00 2.57E+02 Zr-97 1.40E-02 2.82E-03 1.29E-03 O.OOE+00 4.26E-03 O.OOE+00 8.74E+02 Nb-95 5.18E-02 2.88E-02 1.55E-02 0.OOE+00 2.85E-02 0.OOE+00 1.75E+02 Mo-99 O.OOE+00 3.59E+01 6.82E+00 0.OOE+00 8.12E+01 O.OOE+O0 8.31E+01 Tc- 99M 2.06E-03 5.81E-03 7.40E-02 0.OOE+00 8.82E-02 2.85E-03 3.44E+00 Tc-101 2.11E-03 3.05E-03 2.99E-02 0.OOE+00 5.48E-02 1.56E-03 9.15E-15 Ru-103 1.54E+00 O.OOE+00 6.63E-01 0.OOE+00 5.88E+00 O.OOE+00 1.80E+02 Ru-105 1.28E-01 O.OOE+00 5.06E-02 0.OOE+00 1.66E+00 O.OOE+00 7.84E+01 Ru-106 2.29E+01 O.OOE+00 2.90E+00 0.OOE+00 4.42E+01 O.OOE+00 1.48E+03 Ag-110M 1.33E+00 1.23E+00 7.32E-01 0.OOE+00 2.42E+00 0.OOE+00 5.03E+02 Te-125M 2.23E+01 8.08E+00 2.99E+00 6.71E+00 9.07E+01 O.OOE+00 8.90E+01 Page 11.3-9

CY-BY-1 70-301 Revision 5 Table 3-1 (continued)

Site Specific Potable Water Dose Factors for Adult Age Group Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Te-127M 5.63E+01 2.01E+01 6.87E+00 1.44E+01 2.29E+02 0.OOE+00 1.89E+02 Te-127 9.15E-01 3.29E-01 1.98E-01 6.78E-01 3.73E+00 0.OOE+00 7.22E+01 Te-129M 9.57E+01 3.57E+01 1.51E+01 3.29E+01 3.99E+02 0.OOE+00 4.82E+02 Te-129 2.61E-01 9.82E-02 6.37E-02 2.01E-01 1.10E+00 0.OOE+00 1.97E-01 Te-131M 1.44E+01 7.04E+00 5.87E+00 1.12E+01 7.13E+01 0.00E+00 6.99E+02 Te-131 1.64E-01 6.85E-02 5.18E-02 1.35E-01 7.18E-01 O.OOE+00 2.32E-02 Te-132 2.1OE+O1 1.36E+01 1.27E+01 1.50E+01 1.31E+02 0.OOE+00 6.42E+02 1-130 6.29E+00 1.86E+01 7.32E+00 1.57E+03 2.90E+01 0.00E+00 1.60E+01 1-131 3.46E+01 4.95E+01 2.84E+01 1.62E+04 8.49E+01 0.OOE+00 1.31E+01 1-132 1.69E+00 4.52E+00 1.58E+00 1.58E+02 7.20E+00 O.OOE+00 8.49E-01 1-133 1.18E+01 2.06E+01 6.27E+00 3.02E+03 3.59E+01 0.OOE+00 1.85E+01 1-134 8.82E-01 2.40E+00 8.57E-01 4.15E+01 3.81E+00 O.OOE+00 2.09E-03 1-135 3.69E+00 9.65E+00 3.56E+00 6.37E+02 1.55E+01 O.OOE+00 1.09E+01 Cs-134 5.18E+02 1.23E+03 1.O1E+03 O.OOE+00 3.99E+02 1.32E+02 2.16E+01 Cs-136 5.42E+01 2.14E+02 1.54E+02 0.OOE+00 1.19E+02 1.63E+01 2.43E+01 Cs-137 6.63E+02 9.07E+02 5.94E+02 0.OOE+00 3.08E+02 1.02E+02 1.76E+01 Cs-138 4.59E-01 9.07E-01 4.49E-01 0.OOE+00 6.67E-01 6.58E-02 3.87E-06 Ba-139 8.07E-01 5.75E-04 2.36E-02 O.OOE+00 5.38E-04 3.26E-04 1.43E+00 Ba-140 1.69E+02 2.12E-01 1.11E+01 0.OOE+00 7.22E-02 1.22E-01 3.48E+02 Ba-141 3.92E-01 2.96E-04 1.32E-02 O.OOE+00 2.75E-04 1.68E-04 1.85E-10 Ba-142 1.77E-01 1.82E-04 1.12E-02 0.OOE+00 1.54E-04 1.03E-04 2.50E-19 La-140 2.08E-02 1.05E-02 2.77E-03 0.OOE+00 O.OOE+00 O.OOE+00 7.70E+02 La-142 1.07E-03 4.84E-04 1.21E-04 O.OOE+00 0.00E+00 0.OOE+00 3.54E+00 Ce-141 7.79E-02 5.27E-02 5.98E-03 O.OOE+00 2.45E-02 0.00E+00 2.01E+02 Ce-143 1.37E-02 1.02E+01 1. 12E-03 0.OOE+00 4.47E-03 0.OOE+00 3.79E+02 Ce-144 4.06E+00 1.70E+00 2.18E-01 O.OOE+00 1.01E+00 O.OOE+00 1.37E+03 Pr-143 7.66E-02 3.07E-02 3.79E-03 0.OOE+00 1.77E-02 0.OOE+00 3.35E+02 Pr-144 2.50E-04 1.04E-04 1.27E-05 0.OOE+00 5.87E-05 0.OOE+00 3.60E- 11 Nd-147 5.23E-02 6.05E-02 3.62E-03 O.OOE+00 3.54E-02 0.OOE+00 2.90E+02 W-187 8.57E-01 7.17E-01 2.50E-01 0.OOE+00 O.OOE+00 O.OOE+00 2.35E+02 Np-239 9.90E-03 9.74E-04 5.37E-04 0.00E+00 3.04E-03 0.00E+00 2.00E+02 Notes:

1) Units are mrem/hr per tCi/ml.

Page 11.3-10

CY-BY-1 70-301 Revision 5 Table 3-2 Site Specific Potable Water Dose Factors for Teen Age Group Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 O.OOE+00 3.51E-01 3.51E-01 3.51E-01 3.51E-01 3.51E-01 3.51E-01 Na-24 1.34E+01 1.34E+01 1.34E+01 1.34E+01 1.34E+01 1.34E+01 1.34E+01 Cr-51 O.OOE+00 0.00E+00 2.09E-02 1.16E-02 4.59E-03 2.99E-02 3.52E+00 Mn-54 O.OOE+00 3.43E+01 6.80E+00 O.OOE+00 1.02E+01 0.OOE+00 7.03E+01 Mn-56 O.OOE+00 9.19E-01 1.63E-01 O.OOE+00 1.16E+00 0.OOE+00 6.05E+01 Fe-55 2.20E+01 1.56E+01 3.63E+00 O.OOE+00 O.OOE+00 9.88E+00 6.74E+00 Fe-59 3.41E+01 7.97E+01 3.08E+01 O.OOE+00 O.OOE+00 2.51E+O1 1.88E+02 Co-58 O.OOE+00 5.65E+00 1.30E+01 O.OOE+00 O.OOE+00 0.OOE+00 7.79E+01 Co-60 O.OOE+00 1.63E+01 3.68E+01 O.OOE+00 O.OOE+00 0.OOE+00 2.13E+02 Ni-63 1.03E+03 7.27E+01 3.49E+01 O.OOE+00 O.OOE+00 O.OOE+00 1.16E+01 Ni-65 4.35E+00 5.56E-01 2.53E-01 O.OOE+00 O.OOE+00 O.OOE+00 3.02E+01 Cu-64 O.OOE+00 6.69E-01 3.15E-01 O.OOE+00 1.69E+00 O.OOE+00 5.19E+01 Zn-65 3.35E+01 1.16E+02 5.42E+01 O.OOE+00 7.44E+01 O.OOE+00 4.92E+01 Zn-69 8.55E-02 1.63E-01 1.14E-02 O.OOE+00 1.06E-01 O.OOE+00 3.OOE-01 Br-83 O.OOE+00 0.OOE+00 3.34E-01 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+0O Br-84 O.OOE+00 O.OOE+00 4.20E-01 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Br-85 O.OOE+00 O.OOE+00 1.77E-02 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Rb-86 0.OOE+00 1.73E+02 8.14E+01 O.OOE+00 O.OOE+00 O.OOE+00 2.56E+01 Rb-88 0.OOE+00 4.95E-01 2.64E-01 O.OOE+00 O.OOE+00 O.OOE+00 4.24E-08 Rb-89 O.OOE+00 3.20E-01 2.26E-01 O.OOE+00 O.OOE+0O O.OOE+00 4.90E-10 Sr-89 2.56E+03 0.OOE+00 7.33E+01 O.OOE+00 O.OOE+0 O.OOE+00 3.05E+02 Sr-90 5.93E+04 0.OOE+00 1.19E+03 O.OOE+00 O.OOE+00 O.OOE+00 1.35E+03 Sr-91 4.69E+01 0.OOE+00 1.87E+00 O.OOE+00 O.OOE+0 0.OOE+00 2.13E+02 Sr-92 1.77E+01 0.OOE+00 7.56E-01 O.OOE+00 O.OOE+00 O.OOE+00 4.52E+02 Y-90 7.97E-02 O.OOE+00 2.15E-03 O.OOE+00 O.OOE+00 O.OOE+00 6.57E+02 Y-91M 7.50E-04 0.OOE+00 2.87E-05 O.OOE+00 O.OOE+00 O.OOE+00 3.54E-02 Y-91 1.17E+00 0.OOE+00 3.13E-02 O.OOE+00 O.OOE+00 O.OOE+00 4.79E+02 Y-92 7.03E-03 0.OOE+00 2.03E-04 O.OOE+00 O.OOE+00 O.OOE+00 1.93E+02 Y-93 2.23E-02 O.OOE+00 6.1OE-04 0.OOE+00 0.OOE+00 O.OOE+00 6.80E+02 Zr-95 2.40E-01 7.56E-02 5.20E-02 O.OOE+00 1.1IE-01 O.OOE+00 1.74E+02 Zr-97 1.38E-02 2.73E-03 1.26E-03 O.OOE+00 4.13E-03 O.OOE+00 7.38E+02 Nb-95 4.78E-02 2.65E-02 1.46E-02 0.OOE+00 2.57E-02 O.OOE+00 1.13E+02 Mo-99 0.OOE+00 3.51E+01 6.69E+00 O.OOE+00 8.02E+01 O.OOE+00 6.28E+01 Tc- 99M 1.93E-03 5.38E-03 6.98E-02 O.OOE+00 8.02E-02 2.99E-03 3.53E+00 Tc-101 2.09E-03 2.98E-03 2.92E-02 0.OOE+00 5.38E-02 1.81E-03 5.09E-10 Ru-103 1.48E+00 0.00E+00 6.34E-01 0.OOE+00 5.23E+00 O.OOE+00 1.24E+02 Ru-105 1.27E-01 0.OOE+00 4.92E-02 0.OOE+00 1.60E+00 0.OOE+00 1.02E+02 Ru-106 2.28E+01 O.OOE+00 2.87E+00 0.OOE+00 4.40E+01 0.OOE+00 1.09E+03 Ag-li0M 1.19E+00 1.13E+00 6.86E-01 0.OOE+00 2.15E+00 0.00E+00 3.17E+02 Te-125M 2.23E+01 8.02E+00 2.98E+00 6.22E+00 0.OOE+00 0.OOE+00 6.57E+01 Page 11.3-11

CY-BY-1 70-301 Revision 5 Table 3-2 (continued) I Site Specific Potable Water Dose Factors for Teen Age Group Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Te-127M 5.62E+01 1.99E+01 6.69E+00 1.34E+01 2.28E+02 0.OOE+00 1.40E+02 Te-127 9.19E-01 3.26E-01 1.98E-01 6.34E-01 3.72E+00 0.OOE+00 7.09E+01 Te-129M 9.48E+01 3.52E+01 1.50E+01 3.06E+01 3.97E+02 0.OOE+00 3.56E+02 Te-129 2.60E-01 9.71E-02 6.34E-02 1.86E-01 1.09E+00 0.OOE+00 1.42E+00 Te-131M 1.42E+01 6.80E+00 5.67E+00 1.02E+01 7.09E+01 0.OOE+00 5.46E+02 Te-131 1.62E-01 6.69E-02 5.07E-02 1.25E-01 7.09E-01 0.OOE+00 1.33E-02 Te-132 2.03E+01 1.28E+01 1.21E+01 1.35E+01 1.23E+02 0.OOE+00 4.07E+02 1-130 5.99E+00 1.73E+01 6.92E+00 1.41E+03 2.67E+01 0.OOE+00 1.33E+01 1-131 3.40E+01 4.76E+01 2.56E+01 1.39E+04 8.20E+01 O.OOE+00 9.42E+00 1-132 1.62E+00 4.24E+00 1.52E+00 1.43E+02 6.69E+00 0.OOE+00 1.85E+00 1-133 1.17E+01 1.98E+01 6.05E+00 2.77E+03 3.48E+01 O.OOE+00 1.50E+01 1-134 8.49E-01 2.25E+00 8.08E-01 3.75E+01 3.55E+00 0.OOE+00 2.97E-02 1-135 3.55E+00 9.13E+00 3.38E+00 5.87E+02 1.44E+01 O.OOE+00 1.O1E+01 Cs-134 4.87E+02 1.15E+03 5.31E+02 0.OOE+0O 3.64E+02 1.39E+02 1.42E+01 Cs-136 4.99E+01 1.97E+02 1.32E+02 0.OOE+00 1.07E+02 1.69E+01 1.58E+01 Cs-137 6.51E+02 8.66E+02 3.02E+02 0.OOE+00 2.95E+02 1.15E+02 1.23E+01 Cs-138 4.51E-01 8.66E-01 4.33E-01 O.OOE+0O 6.40E-01 7.44E-02 3.93E-04 Ba-139 8.08E-01 5.69E-04 2.35E-02 O.OOE+00 5.36E-04 3.92E-04 7.21E+00 Ba-140 1.65E+02 2.02E-01 1.06E+01 0.OOE+00 6.86E02 1.36E-01 2.55E+02 Ba-141 3.90E-01 2.91E-04 1.30E-02 0.OOE+00 2.70E-04 1.99E-04 8.31E-07 Ba-142 1.74E-01 1.74E-04 1.07E-02 0.OOE+0O 1.47E-04 1.16E-04 5.34E-13 La-140 2.02E-02 9.94E-03 2.65E-03 0.OOE+0O 0.OOE+00 0.OOE+00 5.71E+02 La-142 1.04E-03 4.62E-04 1.15E-04 0.OOE+0 0.OOE+0O 0.OOE+00 1.41E+01 Ce-141 7.73E-02 5.16E-02 5.93E-03 0.OOE+00 2.43E-02 O.OOE+00 1.48E+02 Ce-143 1.37E-02 9.94E+00 1.11E-03 0.OOE+00 4.46E-03 0.OOE+00 2.99E+02 Ce-144 4.05E+00 1.67E+00 2.17E-01 0.OOE+00 1.OOE+00 0.OOE+00 1.02E+03 Pr-143 7.62E-02 3.04E-02 3.79E-03 0.OOE+00 1.77E-02 0.OOE+00 2.51E+02 Pr-144 2.50E-04 1.02E-04 1.27E-05 0.OOE+00 5.87E-05 0.OOE+00 2.76E-07 Nd-147 5.45E-02 5.93E-02 3.55E-03 0.00E+00 3.48E-02 0.OOE+00 2.14E+02 W-187 8.49E-01 6.92E-01 2.42E-01 0.OOE+00 0.OOE+00 0.OOE+00 1.87E+02 Np-239 1.02E-02 9.65E-04 5.36E-04 0.OOE+00 3.03E-03 O.OOE+00 1.55E+02 Notes:

1) Units are mrem/hr per gCi/ml.

Page 11.3-12

CY-BY-1 70-301 Revision 5 Table 3-3 Site Specific Potable Water Dose Factors for Child Age Group Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 O.OOE+00 6.74E-01 6.74E-01 6.74E-01 6.74E-01 6.74E-01 6.74E-01 Na-24 3.37E+01 3.37E+01 3.37E+01 3.37E+01 3.37E+01 3.37E+01 3.37E+01 Cr-51 O.OOE+00 O.OOE+00 5.17E-02 2.87E-02 7.85E-03 5.24E-02 2.74E+00 Mn-54 O.OOE+00 6.22E+01 1.66E+01 O.OOE+00 1.74E+01 O.OOE+00 5.22E+01 Mn-56 O.OOE+00 1.94E+00 4.38E-01 O.OOE+00 2.35E+00 O.OOE+00 2.81E+02 Fe-55 6.69E+01 3.55E+01 1.1OE+01 O.OOE+00 O.OOE+0O 2.01E+01 6.57E+00 Fe-59 9.59E+01 1.55E+02 7.73E+01 O.OOE+00 O.OOE+0 4.50E+01 1.62E+02 Co-58 O.OOE+00 1.05E+01 3.20E+01 O.OOE+00 O.OOE+00 O.OOE+00 6.10E+01 Co-60 O.OOE+00 3.08E+01 9.07E+01 O.OOE+00 O.OOE+00 O.OOE+00 1.70E+02 Ni-63 3.13E+03 1.67E+02 1.06E+02 O.OOE+00 O.OOE+00 O.OOE+00 1.13E+01 Ni-65 1.29E+01 1.22E+00 7.09E-01 O.OOE+00 O.OOE+00 O.OOE+00 1.49E+02 Cu-64 O.OOE+00 1.42E+00 8.60E-01 O.OOE+00 3.44E+00 O.OOE+00 6.69E+01 Zn-65 7.97E+01 2.12E+02 1.32E+02 O.OOE+00 1.34E+02 O.OOE+00 3.73E+01 Zn-69 2.55E-01 3.68E-01 3.40E-02 O.OOE+00 2.23E-01 O.OOE+00 2.32E+01 Br-83 O.OOE+00 O.OOE+00 9.94E-01 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Br-84 O.OOE+00 O.OOE+00 1.15E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Br-85 O.OOE+00 O.OOE+00 5.30E-02 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Rb-86 O.OOE+00 3.90E+02 2.40E+02 O.OOE+00 O.OOE+00 O.OOE+00 2.51E+O1 Rb-88 O.OOE+00 1.10E+00 7.67E-01 O.OOE+00 O.OOE+00 O.OOE+00 5.42E-02 Rb-89 O.OOE+00 6.80E-01 6.05E-01 O.OOE+00 O.OOE+00 O.OOE+00 5.93E-03 Sr-89 7.67E+03 O.OOE+00 2.19E+02 O.OOE+00 O.OOE+00 O.OOE+00 2.97E+02 Sr-90 1.49E+05 O.OOE+00 2.99E+03 O.OOE+00 O.OOE+00 O.OOE+00 1.33E+03 Sr-91 1.40E+02 O.OOE+00 5.27E+00 O.OOE+00 O.OOE+00 O.OOE+00 3.08E+02 Sr-92 5.25E+01 O.OOE+00 2.1OE+00 O.OOE+00 O.OOE+00 O.OOE+00 9.94E+02 Y-90 2.39E-01 O.OOE+00 6.40E-03 O.OOE+00 O.OOE+00 O.OOE+00 6.80E+02 Y-91M 2.22E-03 O.OOE+00 8.08E-05 O.OOE+00 O.OOE+00 O.OOE+00 4.35E+00 Y-91 3.50E+00 O.OOE+/-00 9.36E-02 O.OOE+00 O.OOE+00 O.OOE+00 4.66E+02 Y-92 2.09E-02 0.00E+00 5.99E-04 O.OOE+00 O.OOE+00 O.OOE+00 6.05E+02 Y-93 6.63E-02 O.OOE+00 1.82E-03 O.OOE+00 O.OOE+00 O.OOE+00 9.88E+02 Zr-95 6.74E-01 1.48E-01 1.32E-01 O.OOE+00 2.12E-01 O.OOE+00 1.55E+02 Zr-97 4.06E-02 5.87E-03 3.47E-03 O.OOE+00 8.43E-03 O.OOE+00 8.90E+02 Nb-95 1.31E-01 5.09E-02 3.64E-02 O.OOE+00 4.78E-02 O.OOE+00 9.42E+01 Mo-99 O.OOE+00 7.73E+01 1.91E+01 O.OOE+00 1.65E+02 O.OOE+00 6.40E+01 Tc- 99M 5.37E-03 1.05E-02 1.74E-01 O.OOE+00 1.53E-01 5.34E-03 5.99E+00 Tc-101 6.22E-03 6.51E-03 8.26E-02 O.OOE+00 1.I1E-01 3.44E-03 2.07E-02 Ru-103 4.25E+00 O.OOE+00 1.63E+00 O.OOE+00 1.07E+01 O.OOE+00 1.1OE+02 Ru-105 3.75E-01 O.OOE+00 1.36E-01 O.OOE+00 3.30E+00 O.OOE+00 2.45E+02 Ru-106 6.80E+01 O.OOE+00 8.49E+00 O.OOE+00 9.19E+01 O.OOE+00 1.06E+03 Ag-ll0M 3.13E+00 2.12E+00 1.69E+00 O.OOE+00 3.94E+00 O.OOE+00 2.52E+02 Te-125M 6.63E+01 1.80E+01 8.84E+00 1.86E+01 O.OOE+00 O.OOE+00 6.40E+01 Page 11.3-13

CY-BY-1 70-301 Revision 5 Table 3-3 (continued) I Site Specific Potable Water Dose Factors for Child Age Group Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Te-127M 1.68E+02 4.52E+01 1.99E+01 4.02E+01 4.79E+02 O.OOE+00 1.36E+02 Te-127 2.74E+00 7.38E-01 5.87E-01 1.90E+00 7.79E+00 0.OOE+00 1.07E+02 Te-129M 2.83E+02 7.91E+01 4.40E+01 9.13E+01 8.31E+02 0.OOE+00 3.45E+02 Te-129 7.79E-01 2.17E-01 1.85E-01 5.56E-01 2.28E+00 0.OOE+00 4.85E+01 Te-131M 4.19E+01 1.45E+01 1.54E+01 2.98E+01 1.40E+02 0.OOE+00 5.87E+02 Te-131 4.83E-01 1.47E-01 1.44E-01 3.69E-01 1.46E+00 0.OOE+00 2.53E+00 Te-132 5.87E+01 2.60E+01 3.14E+01 3.78E+01 2.41E+02 0.OOE+00 2.62E+02 1-130 1.70E+01 3.43E+01 1.77E+01 3.78E+03 5.13E+01 0.OOE+00 1.60E+01 1-131 1.OOE+02 1.01E+02 5.72E+01 3.33E+04 1.65E+02 0.OOE+00 8.95E+00 1-132 4.65E+00 8.55E+00 3.93E+00 3.97E+02 1.31E+01 0.OOE+00 1.O1E+01 1-133 3.44E+01 4.26E+01 1.61E+01 7.91E+03 7.09E+01 0.OOE+00 1.72E+01 1-134 2.44E+00 4.52E+00 2.08E+00 1.04E+02 6.92E+00 O.OOE+00 3.OOE+00 1-135 1.02E+01 1.83E+01 8.66E+00 1.62E+03 2.81E+01 O.OOE+00 1.40E+01 Cs-134 1.36E+03 2.23E+03 4.71E+02 0.OOE+00 6.92E+02 2.48E+02 1.20E+01 Cs-136 1.37E+02 3.76E+02 2.43E+02 O.OOE+00 2.OOE+02 2.98E+01 1.32E+01 Cs-137 1.90E+03 1.82E+03 2.69E+02 0.00E+00 5.93E+02 2.13E+02 1.14E+01 Cs-138 1.33E+00 1.84E+00 1.17E+00 O.OOE+00 1.30E+00 1.40E-01 8.49E-01 Ba-139 2.41E+00 1.28E-03 6.98E-02 O.OOE+00 1.12E-03 7.56E-04 1.39E+02 Ba-140 4.83E+02 4.23E-01 2.82E+01 O.OOE+00 1.38E-01 2.52E-01 2.45E+02 Ba-141 1.16E+00 6.51E-04 3.78E-02 0.OOE+00 5.63E-04 3.83E-03 6.63E-01 Ba-142 5.08E-01 3.66E-04 2.84E-02 0.OOE+00 2.96E-04 2.15E-04 6.63E-03 La-140 5.87E-02 2.05E-02 6.92E-03 0.OOE+00 O.OOE+00 0.OOE+00 5.72E+02 La-142 3.05E-03 9.71E-04 3.04E-04 0.OOE+00 0.OOE+00 O.OOE+00 1.92E+02 Ce-141 2.31E-01 1.15E-01 1.71E-02 0.OOE+00 5.05E-02 O.OOE+00 1.44E+02 Ce-143 4.06E-02 2.20E+01 3.19E-03 0.OOE+00 9.24E-03 0.OOE+0O 3.23E+02 Ce-144 1.21E+01 3.79E+00 6.45E-01 0.OOE+00 2.1OE+00 0.OOE+0O 9.88E+02 Pr-143 2.28E-01 6.86E-02 1.13E-02 O.OOE+00 3.72E-02 0.OOE+00 2.47E+02 Pr-144 7.50E-04 2.32E-04 3.77E-05 O.OOE+00 1.23E-04 0.00E+00 4.99E-01 Nd-147 1.62E-01 1.31E-01 1.02E-02 O.OOE+00 7.21E-02 O.OOE+00 2.08E+02 W-187 2.49E+00 1.48E+00 6.63E-01 0.OOE+00 0.OOE+00 0.OOE+00 2.08E+02 Np-239 3.05E-02 2.19E-03 1.54E-03 0.OOE+00 6.34E-03 0.OOE+0O 1.62E+02 Notes:

1) Units are mrem/hr per giCi/ml.

Page 11.3-14

CY-BY-1 70-301 Revision 5 Table 3-4 Site Specific Potable Water Dose Factors for Infant Age Group Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 0.OOE+00 6.62E-01 6.62E-01 6.62E-01 6.62E-01 6.62E-01 6.62E-01 Na-24 3.80E+01 3.80E+01 3.80E+01 3.80E+01 3.80E+01 3.80E+01 3.80E+01 Cr-51 0.OOE+00 0.OOE+00 5.30E-02 3.46E-02 7.56E-03 6.73E-02 1.55E+00 Mn-54 O.OOE+00 7.49E+01 1.70E+01 O.OOE+00 1.66E+01 0.OOE+00 2.75E+01 Mn-56 0.OOE+00 3.08E+00 5.30E-01 O.OOE+00 2.64E+00 0.OOE+00 2.80E+02 Fe-55 5.23E+01 3.38E+01 9.03E+00 0.OOE+00 0.OOE+00 1.65E+01 4.29E+00 Fe-59 1.16E+02 2.02E+02 7.98E+01 0.OOE+00 0.OOE+00 5.98E+01 9.67E+01 Co-58 O.OOE+00 1.35E+01 3.38E+01 0.OOE+00 O.OOE+00 O.OOE+00 3.37E+01 Co-60 O.OOE+00 4.06E+01 9.59E+01 0.OOE+00 O.OOE+00 0.OOE+00 9.67E+01 Ni-63 2.39E+03 1.47E+02 8.28E+01 0.OOE+/-00 O.OOE+00 O.OOE+00 7.34E+00 Ni-65 1.77E+01 2.OOE+00 9.1OE-01 O.OOE+00 0.OOE+00 0.OOE+00 1.52E+02 Cu-64 O.OOE+00 2.29E+00 1.06E+00 O.OOE+00 3.87E+00 0.OOE+00 4.70E+01 Zn-65 6.92E+01 2.37E+02 1.09E+02 O.OOE+00 1.15E+02 O.OOE+00 2.01E+02 Zn-69 3.51E-01 6.32E-01 4.70E-02 O.OOE+00 2.63E-01 O.OOE+00 5.15E+01 Br-83 O.OOE+00 0.00E+00 1.37E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Br-84 O.OOE+00 0.OOE+00 1.44E+00 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 Br-85 O.OOE+00 0.OOE+00 7.30E-02 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 Rb-86 0.OOE+00 6.40E+02 3.16E+02 0.OOE+00 0.OOE+00 0.OOE+00 1.64E+01 Rb-88 O.OOE+00 1.87E+00 1.03E+00 O.OOE+00 0.OOE+00 0.OOE+00 1.82E+00 Rb-89 O.OOE+00 1.08E+00 7.41E-01 O.OOE+00 0.OOE+00 0.OOE+00 3.66E-01 Sr-89 9.44E+03 0.OOE+00 2.71E+02 O.OOE+00 0.OOE+00 0.OOE+00 1.94E+02 Sr-90 1.06E+05 0.OOE+00 2.16E+03 O.OOE+÷0 0.OOE+00 O.OOE+00 8.69E+02 Sr-91 1.88E+02 O.OOE+00 6.81E+00 O.OOE+00 O.OOE+00 O.OOE+00 2.23E+02 Sr-92 7.22E+01 0.OOE+00 2.68E+00 O.OOE+00 O.OOE+00 O.OOE+00 7.79E+02 Y-90 3.27E-01 O.OOE+00 8.77E-03 0.OOE+00 O.OOE+00 0.OOE+00 4.51E+02 Y-91M 3.05E-03 0.OOE+00 1.04E-04 O.OOE+0O 0.OOE+00 O.OOE+00 1.02E+01 Y-91 4.25E+00 0.OOE+00 1.13E-01 0.OOE+00 O.OOE+00 0.OOE+00 3.05E+02 Y-92 2.88E-02 0.OOE+00 8.09E-04 O.OOE+00 O.OOE+00 0.OOE+00 5.49E+02 Y-93 9.14E-02 0.OOE+00 2.49E-03 O.OOE+00 O.OOE+00 O.OOE+00 7.22E+02 Zr-95 7.75E-01 1.89E-01 1.34E-01 O.OOE+00 2.04E-01 0.OOE+00 9.41E+01 Zr-97 5.57E-02 9.56E-03 4.36E-03 O.OOE+00 9.63E-03 O.OOE+00 6.09E+02 Nb-95 1.58E-01 6.51E-02 3.76E-02 O.OOE+00 4.66E-02 O.OOE+00 5.49E+01 Mo-99 0.OOE+00 1.28E+02 2.49E+01 O.OOE+00 1.91E+02 0.OOE+00 4.21E+O1 Tc- 99M 7.22E-03 1.49E-02 1.92E-01 O.OOE+00 1.60E-01 7.79E-03 4.33E+00 Tc-101 8.54E-03 1.08E-02 1.06E-01 O.OOE+00 1.28E-01 5.87E-03 1.83E+00 Ru-103 5.57E+00 0.00E+00 1.86E+00 O.OOE+00 1.16E+O1 O.OOE+00 6.77E+01 Ru-105 5.12E-01 0.OOE+00 1.72E-01 0.OOE+00 3.76E+00 0.OOE+00 2.04E+02 Ru-106 9.07E+01 O.OOE+00 1.13E+01 O.OOE+00 1.07E+02 0.OOE+00 6.88E+02 Ag-ll0M 3.75E+00 2.73E+00 1.81E+00 0.OOE+00 3.91E+00 0.OOE+00 1.42E+02 Te-125M 8.77E+01 2.93E+01 1.19E+01 2.95E+01 0.OOE+00 0.OOE+00 4.18E+01 Page 11.3-15

CY-BY-1 70-301 Revision 5 Table 3-4 (continued) I Site Specific Potable Water Dose Factors for Infant Age Group Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Te-127M 2.20E+02 7.30E+01 2.66E+01 6.36E+01 5.42E+02 0.OOE+00 8.88E+01 Te-127 3.76E+00 1.26E+00 8.09E-01 3.06E+00 9.18E+00 0.OOE+00 7.90E+01 Te-129M 3.76E+02 1.29E+02 5.79E+01 1.44E+02 9.41E+02 O.OOE+00 2.25E+02 Te-129 1.07E+00 3.68E-01 2.49E-01 8.95E-01 2.66E+00 O.OOE+00 8.54E+01 Te-131M 5.72E+01 2.30E+01 1.90E+01 4.66E+01 1.58E+02 O.OOE+00 3.87E+02 Te-131 6.62E-01 2.45E-01 1.86E-01 5.91E-01 1.69E+00 0.OOE+00 2.67E+01 Te-132 7.82E+01 3.87E+01 3.62E+01 5.72E+01 2.42E+02 0.OOE+00 1.43E+02 1-130 2.26E+01 4.97E+01 1.99E+01 5.57E+03 5.45E+01 0.OOE+00 1.06E+01 I-131 1.35E+02 1.59E+02 7.OOE+01 5.23E+04 1.86E+02 0.OOE+00 5.68E+00 1-132 6.24E+00 1.27E+01 4.51E+00 5.94E+02 1.41E+01 0.OOE+00 1.03E+01 1-133 4.70E+01 6.85E+01 2.01E+01 1.25E+04 8.05E+01 O.OOE+00 1.16E+01 1-134 3.27E+00 6.70E+00 2.38EtOO 1.56E+02 7.49E+00 0.OOE+00 6.92E+00 1-135 1.37E+01 2.72E+01 9.93E+00 2.44E+03 3.04E+01 0.OOE+00 9.86E+00 Cs-134 1.42E+03 2.64E+03 2.67E+02 0.OOE+00 6.81E+02 2.79E+02 7.19E+00 Cs-136 1.73E+02 5.08E+02 1.90E+02 0.OOE+00 2.02E+02 4.14E+01 7.71E+00 Cs-137 1.96E+03 2.30E+03 1.63E+02 0.OOE+00 6.17E+02 2.50E+02 7.19E+00 Cs-138 1.81E+00 2.94E+00 1.43E+00 0.OOE+00 1.47E+00 2.29E-01 4.70E+00 Ba-139 3.31E+00 2.20E-03 9.59E-02 0.OOE+00 1.32E-03 1.33E-03 2.1OE+02 Ba-140 6.43E+02 6.43E-01 3a31E+01 0.OOE+00 1.53E-01 3.95E-01 1.58E+02 Ba-141 1.60E+00 1.09E-03 5.04E-02 0.OOE+00 6.58E-04 6.66E-04 1.95E+01 Ba-142 6.92E-01 5.76E-04 3.41E-02 0.OOE+00 3.31E-04 3.48E-04 2.86E+00 La-140 7.94E-02 3.13E-02 8.05E-03 0.OOE+00 0.OOE+00 0.OOE+00 3.68E+02 La-142 4.14E-03 1.52E-03 3.64E-04 0.OOE+00 0.OOE+00 0.OOE+00 2.58E+02 Ce-141 2.96E-01 1.81E-01 2.13E-02 0.OOE+00 5.57E-02 0.OOE+00 9.33E+01 Ce-143 5.57E-02 3.69E+01 4.21E-03 0.OOE+00 1.08E-02 0.OOE+00 2.16E+02 Ce-144 1.12E+01 4.59E+00 6.28E-01 0.OOE+00 1.85E+00 0.OOE+00 6.43E+02 Pr-143 3.06E-01 1.14E-01 1.52E-02 0.OOE+00 4.25E-02 0.OOE+00 1.61E+02 Pr-144 1.03E-03 3.99E-04 5.19E-05 0.OOE+00 1.44E-04 0.OOE+00 1.85E+01 Nd-147 2.08E-01 2.14E-01 1.31E-02 0.00E+00 8.24E-02 0.OOE+00 1.35E+02 W-187 3.40E+00 2.36E+00 8.16E-01 O.OOE+00 0.OOE+00 0.00E+00 1.39E+02 Np-239 4.18E-02 3.74E-03 2.11E-03 0.OOE+00 7.45E-03 0.OOE+00 1.08E+02 Notes:

1) Units are mrem/hr per gCi/ml.

Page 11.3-16

CY-BY-1 70-301 Revision 5 Table 3-5 Site Specific Fish Ingestion Dose Factors for Adult Age Group Nuclide Bone Liver T Body Thyroid Kidney Lune GI-LLI H-3 O.OOE+00 1.29E-01 1.29E-01 1.29E-01 1.29E-01 1.29E-01 1.29E-01 Na-24 4.07E+02 4.07E+02 4.07E+02 4.07E+02 4.07E+02 4.07E+02 4.07E+02 Cr-51 O.OOE+00 O.OOE+0 1.27E+00 7.61E-01 2.81E-01 1.69E+00 3.20E+02 Mn-54 O.OOE+00 4.38E+03 8.35E+02 O.OOE+00 1.30E+03 0.001E+00 1.34E+04 Mn-56 O.OOE+00 1.1OE+02 1.95E+01 O.OOE+00 1.40E+02 O.OOE+00 3.51E+03 Fe-55 6.58E+02 4.55E+02 1.06E+02 O.OOE+00 O.OOE+00 2.54E+02 2.61E+02 Fe-59 1.04E+03 2.44E+03 9.36E+02 O.OOE+00 O.OOE+00 6.82E+02 8.14E+03 Co-58 O.OOE+00 8.92E+01 2.OOE+02 O.OOE+00 O.OOE+00 O.OOE+00 1.81E+03 Co-60 O.OOE+00 2.56E+02 5.65E+02 O.OOE+00 O.OOE+00 O.OOE+00 4.8 1E+03 Ni-63 3.11E+04 2.16E+03 1.04E+03 O.OOE+00 O.OOE+00 O.OOE+00 4.50E+02 Ni-65 1.26E+02 1.64E+O1 7.49E+0 0.003E+00 O.OOE+00 0.00E+00 4.17E+02 Cu-64 O.OOE+00 9.97E+00 4.68E+00 O.OOE+00 2.5 1E+O1 O.OOE+00 8.50E+02 Zn-65 2.32E+04 7.37E+04 3.33E+04 O.OOE+00 4.93E+04 O.OOE+00 4.64E+04 Zn-69 4.93E+O1 9.43E+01 6.56E+00 O.OOE+00 6.13E+01 O.OOE+00 1.42E+01 Br-83 O.OOE+00 0.00E+00 4.04E+01 O.OOE+00 O.OOE+00 O.OOE+00 5.82E+01 Br-84 O.OOE+00 O.OOE+00 5.24E+01 O.OOE+00 O.OOE+00 O.OOE+00 4.11 E-04 Br-85 O.OOE+00 0.00E+00 2.15E+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Rb-86 O.OOE+00 1.01E+05 4.71E+04 0.00E+00 O.OOE+00 0.00E+00 1.99E+04 Rb-88 O.OOE+00 2.90E+02 1.54E+02 O.OOE+00 O.OOE+00 O.OOE+00 4.OOE-09 Rb-89 O.OOE+00 1.92E+02 1.35E+02 O.OOE+00 0.00E+00 0.00E+00 1.12E-11 Sr-89 2.21E+04 O.OOE+00 6.35E+02 0.00E+00 O.OOE+00 O.OOE+00 3.55E+03 Sr-90 6.26E+05 O.OOE+0O 1.26E+04 O.OOE+0O O.OOE+00 O.OOE+00 1.57E+04 Sr-91 4.07E+02 O.OOE+00 1.64E+01 O.OOE+0 O.OOE+00 O.OOE+00 1.94E+03 Sr-92 1.54E+02 O.OOE+00 6.68E+00 O.OOE+00 O.OOE+00 O.OOE+00 3.06E+03 Y-90 5.76E-01 O.OOE+00 1.54E-02 O.OOE+00 O.OOE+00 O.OOE+00 6.1OE+03 Y-91M 5.44E-03 O.OOE+00 2.11E-04 O.OOE+00 O.OOE+00 O.OOE+00 1.60E-02 Y-91 8.44E+00 O.OOE+00 2.26E-01 O.OOE+00 O.OOE+00 O.OOE+00 4.64E+03 Y-92 5.06E-02 O.OOE+00 1.48E-03 0.00E+00 O.OOE+00 0.00E+00 8.86E+02 Y-93 1.60E-01 0.00E+00 4.43E-03 O.OOE+00 O.OOE+00 0.00E+00 5.09E+03 Zr-95 2.40E-01 7.70E-02 5.21E-02 O.OOE+00 1.21E-01 0.OOE+00 2.44E+02 Zr-97 1.33E-02 2.68E-03 1.22E-03 0.00E+00 4.04E-03 O.OOE+00 8.30E+02 Nb-95 4.47E+02 2.48E+02 1.34E+02 O.OOE+00 2.46E+02 O.OOE+00 1.51E+06 Mo-99 O.OOE+00 1.03E+02 1.96E+O1 O.OOE+00 2.34E+02 O.OOE+00 2.39E+02 Tc- 99M 8.87E-03 2.5 1E-02 3.19E-01 O.OOE+00 3.8 1E-01 1.23E-02 1.48E+01 Tc-101 9.12E-03 1.31E-02 1.29E-01 0.00E+00 2.37E-01 6.72E-03 3.95E-14 Ru-103 4.43E+00 O.OOE+00 1.91E+00 O.OOE+00 1.69E+01 O.OOE+00 5.17E+02 Ru-105 3.69E-01 O.OOE+0 1.46E-01 O.OOE+00 4.76E+00 O.OOE+00 2.26E+02 Ru-106 6.58E+O1 O.OOE+0 8.33E+00 0.00E+00 1.27E+02 O.OOE+00 4.26E+03 Ag-ll0M 8.81E-01 8.15E-01 4.84E-01 0.00E+00 1.60E+00 O.OOE+00 3.33E+02 Te-125M 2.57E+03 9.30E+02 3.44E+02 7.72E+02 1.04E+04 0.000E+0 1.02E+04 Page 11.3-17

CY-BY-1 70-301 Revision 5 Table 3-5 (continued)

Site Specific Fish Ingestion Dose Factors for Adult Age Group Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Te-127M 6.48E+03 2.32E+03 7.90E+02 1.66E+03 2.63E+04 0.OOE+00 2.17E+04 Te-127 1.05E+02 3.78E+01 2.28E+01 7.80E+01 4.29E+02 O.OOE+00 8.31E+03 Te-129M 1.1OE+04 4.11E+03 1.74E+03 3.78E+03 4.60E+04 0.OOE+00 5.54E+04 Te-129 3.01E+01 1.13E+O1 7.33E+00 2.31E+01 1.26E+02 O.OOE+00 2.27E+01 Te-131M 1.66E+03 8.1OE+02 6.75E+02 1.28E+03 8.21E+03 O.OOE+00 8.04E+04 Te-131 1.89E+01 7.88E+00 5.96E+00 1.55E+01 8.26E+01 0.OOE+00 2.67E+00 Te-132 2.41E+03 1.56E+03 1.47E+03 1.72E+03 1.50E+04 0.OOE+00 7.38E+04 1-130 2.71E+01 8.01E+01 3.16E+01 6.79E+03 1.25E+02 0.OOE+00 6.89E+01 1-131 1.49E+02 2.14E+02 1.22E+02 7.OOE+04 3.66E+02 O.OOE+00 5.64E+01 1-132 7.29E+00 1.95E+01 6.82E+00 6.82E+02 3.11E+01 0.OOE+00 3.66E+00 1-133 5.10E+01 8.87E+01 2.70E+01 1.30E+04 1.55E+02 O.OOE+00 7.97E+01 1-134 3.81E+00 1.03E+01 3.70E+00 1.79E+02 1.64E+01 0.OOE+00 9.01E-03 1-135 1.59E+01 4.17E+01 1.54E+01 2.75E+03 6.68E+01 O.OOE+00 4.70E+01 Cs-134 2.98E+05 7.09E+05 5.79E+05 0.00E+00 2.29E+05 7.61E+04 1.24E+04 Cs-136 3.12E+04 1.23E+05 8.86E+04 0.OOE+00 6.85E+04 9.38E+03 1.40E+04 Cs-137 3.82E+05 5.22E+05 3.42E+05 0.OOE+00 1.77E+05 5.89E+04 1.01E+04 Cs-138 2.64E+02 5.22E+02 2.59E+02 0.OOE+00 3.84E+02 3.79E+01 2.23E-03 Ba-139 '9.29E-01 6.62E-04 2.72E-02 0.OOE+00 6.19E-04 3.75E-04 1.65E+00 Ba-140 1.94E+02 2.44E-01 1.27E+01 0.00E+00 8.30E-02 1.40E-01 4.OOE+02 Ba-141 4.51E-01 3.41E-04 1.52E-02 0.00E+00 3.17E-04 1.93E-04 2.13E-10 Ba-142 2.04E-01 2.1OE-04 1.28E-02 0.OOE+00 1.77E-04 1.19E-04 2.87E-19 La-140 1.50E-01 7.54E-02 1.99E-02 0.OOE+00 0.OOE+00 O.OOE+00 5.54E+03 La-142 7.66E-03 3.48E-03 8.68E-04 0.OOE+00 0.OOE+00 O.OOE+00 2.54E+01 Ce-141 2.24E-02 1.52E-02 1.72E-03 0.OOE+00 7.04E-03 0.OOE+00 5.79E+01 Ce-143 3.95E-03 2.92E+00 3.23E-04 O.OOE+00 1.29E-03 O.OOE+00 1.09E+02 Ce-144 1.17E+00 4.88E-01 6.27E-02 0.OOE+00 2.90E-01 O.OOE+00 3.95E+02 Pr-143 5.51E-01 2.21E-01 2.73E-02 0.OOE+00 1.27E-01 O.OOE+00 2.41E+03 Pr-144 1.80E-03 7.48E-04 9.16E-05 0.OOE+00 4.22E-04 O.OOE+00 2.59E-10 Nd-147 3.76E-01 4.35E-01 2.60E-02 0.OOE+00 2.54E-01 0.OOE+00 2.09E+03 W-187 2.96E+02 2.47E+02 8.65E+O1 0.OOE+00 0.OOE+00 0.OOE+00 8.10E+04 JNp-239 2.85E-02 2.80E-03 1.54E-03 0.OOE+00 8.74E-03 0.OOE+00 5.75E+02 Notes:

1) Units are mrem/hr per jtCi/ml.

Page 11.3-18

CY-BY-1 70-301 Revision 5 Table 3-6 Site Specific Fish Ingestion Dose Factors for Teen Age Group Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 O.OOE+00 9.92E-02 9.92E-02 9.92E-02 9.92E-02 9.92E-02 9.92E-02 Na-24 4.20E+02 4.20E+02 4.20E+02 4.20E+02 4.20E+02 4.20E+02 4.20E+02 Cr-51 O.OOE+00 O.OOE+00 1.31E+00 7.30E-01 2.88E-01 1.88E+00 2.21E+02 Mn-54 O.OOE+00 4.30E+03 8.54E+02 O.OOE+00 1.28E+03 O.OOE+00 8.83E+03 Mn-56 O.OOE+00 1.15E+02 2.05E+O1 O.OOE+00 1.46E+02 O.OOE+00 7.59E+03 Fe-55 6.89E+02 4.89E+02 1.14E+02 O.OOE+00 O.OOE+00 3.1OE+02 2.12E+02 Fe-59 1.07E+03 2.50E+03 9.65E+02 O.OOE+00 O.OOE+00 7.88E+02 5.91E+03 Co-58 0.OOE+00 8.86E+01 2.04E+02 O.OOE+00 O.OOE+00 0.OOE+00 1.22E+03 Co-60 0.OOE+00 2.56E+02 5.77E+02 O.OOE+00 O.OOE+00 O.OOE+00 3.34E+03 Ni-63 3.23E+04 2.28E+03 1.09E+03 0.OOE+00 O.OOE+00 O.OOE+00 3.63E+02 Ni-65 1.37E+02 1.75E+01 7.95E+00 O.OOE+00 O.OOE+00 O.OOE+00 9.47E+02 Cu-64 O.OOE+00 1.05E+01 4.93E+00 O.OOE+00 2.65E+01 0.OOE+00 8.14E+02 Zn-65 2.1OE+04 7.30E+04 3.40E+04 O.OOE+00 4.67E+04 O.OOE+00 3.09E+04 Zn-69 5.36E+01 1.02E+02 7.15E+00 O.OOE+O0 6.68E+01 O.OOE+00 1.88E+02 Br-83 0.OOE+00 O.OOE+00 4.40E+01 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 Br-84 0.OOE+00 O.OOE+00 5.53E+01 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 Br-85 0.OOE+00 O.OOE+00 2.34E+00 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 Rb-86 0.OOE+00 1.09E+05 5.11E+04 0.OOE+00 O.OOE+00 0.OOE+00 1.61E+04 Rb-88 0.OOE+00 3.11E+02 1.66E+02 O.OOE+00 O.OOE+00 O.OOE+00 2.66E-05 Rb-89 O.OOE+00 2.01E+02 1.42E+02 0.OOE+00 O.OOE+00 O.OOE+00 3.08E-07 Sr-89 2.41E+04 O.OOE+00 6.89E+02 O.OOE+0O 0.OOE+00 0.00E+00 2.87E+03 Sr-90 5.58E+05 O.OOE+00 1.12E+04 O.OOE+00 O.OOE+00 O.OOE+00 1.27E+04 Sr-91 4.42E+02 O.OOE+00 1.76E+01 O.OOE+00 O.OOE+00 0.OOE+00 2.OOE+03 Sr-92 1.67E+02 O.OOE+00 7.11 E+00 O.OOE+00 O.OOE+00 O.OOE+00 4.25E+03 Y-90 6.25E-01 O.OOE+00 1.68E-02 O.OOE+00 O.OOE+00 O.OOE+00 5.15E+03 Y-91M 5.88E-03 O.OOE+00 2.25E-04 O.OOE+00 O.OOE+00 O.OOE+00 2.78E-01 Y-91 9.17E+00 O.OOE+00 2.46E-01 O.OOE+0O 0I UWE+00 O.OOE+00 3.76E+03 Y-92 5.52E-02 O.OOE+00 1.60E-03 O.OOE+0O 0.OOE+00 O.OOE+00 1.51E+03 Y-93 1.75E-01 O.OOE+00 4.79E-03 0.OOE+00 O.OOE+00 O.OOE+00 5.34E+03 Zr-95 2.48E-01 7.82E-02 5.38E-02 0.OOE+00 1.15E-01 O.OOE+00 1.81E+02 Zr-97 1.43E-02 2.82E-03 1.30E-03 0.OOE+00 4.28E-03 O.OOE+00 7.64E+02 Nb-95 4.50E+02 2.50E+02 1.37E+02 O.OOE+00 2.42E+02 O.OOE+00 1.07E+06 Mo-99 O.OOE+00 1.1OE+02 2.1OE+01 0.OOE+00 2.52E+02 O.OOE+00 1.97E+02 Tc- 99M 9.08E-03 2.53E-02 3.28E-01 0.OOE+00 3.78E-01 1.41E-02 1.66E+01 Tc-101 9.85E-03 1.40E-02 1.38E-01 0.OOE+00 2.53E-01 8.54E-03 2.39E-09 Ru-103 4.65E+00 O.OOE+00 1.99E+00 0.OOE+00 1.64E+01 O.OOE+00 3.89E+02 Ru-105 3.98E-01 O.OOE+00 1.54E-01 0.OOE+00 5.02E+00 O.OOE+00 3.21E+02 Ru-106 7.15E+01 O.OOE+00 9.01E+00 0.OOE+00 1.38E+02 0.00E+O0 3.43E+03 Ag- lOM 8.60E-01 8.14E-01 4.95E-01 O.OOE+00 1.55E+00 O.OOE+00 2.29E+02 Te-125M 2.79E+03 1.01E+03 3.74E+02 7.81E+02 O.OOE+0 O.OOE+00 8.24E+03 Page 11.3-19

CY-BY-1 70-301 Revision 5 Table 3-6 (continued) I Site Specific Fish Ingestion Dose Factors for Teen Age Group Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Te-127M 7.06E+03 2.50E+03 8.39E+02 1.68E+03 2.86E+04 O.OOE+00 1.76E+04 Te-127 1.15E+02 4.09E+01 2.48E+01 7.95E+01 4.67E+02 O.OOE+00 8.90E+03 Te-129M 1.19E+04 4.41E+03 1.88E+03 3.84E+03 4.98E+04 0.OOE+00 4.47E+04 Te-129 3.27E+01 1.22E+01 7.95E+00 2.33E+01 1.37E+02 0.OOE+00 1.79E+02 Te-131M 1.78E+03 8.54E+02 7.12E+02 1.28E+03 8.90E+03 0.OOE+00 6.85E+04 Te-131 2.04E+01 8.39E+00 6.36E+00 1.57E+01 8.90E+01 O.OOE+00 1.67E+00 Te-132 2.55E+03 1.61E+03 1.52E+03 1.70E+03 1.55E+04 0.OOE+00 5.11E+04 1-130 2.82E+01 8.15E+01 3.26E+01 6.65E+03 1.26E+02 O.OOE+00 6.27E+01 1-131 1.60E+02 2.24E+02 1.20E+02 6.54E+04 3.86E+02 O.OOE+00 4.43E+01 1-132 7.63E+00 2.OOE+01 7.17E+00 6.73E+02 3.15E+01 0.00E+00 8.70E+00 1-133 5.50E+01 9.33E+01 2.85E+01 1.30E+04 1.64E+02 0.OOE+00 7.06E+01 1-134 3.99E+00 1.06E+01 3.80E+00 1.76E+02 1.67E+01 O.OOE+00 1.40E-01 1-135 1.67E+01 4.30E+01 1.59E+01 2.76E+03 6.79E+01 0.OOE+00 4.76E+01 Cs-134 3.05E+05 7.19E+05 3.33E+05 O.OOE+00 2.28E+05 8.72E+04 8.94E+03 Cs-136 3.13E+04 1.23E+05 8.28E+04 0.OOE+00 6.71E+04 1.06E+04 9.92E+03 Cs-137 4.09E+05 5.44E+05 1.89E+05 0.OOE+00 1.85E+05 7.19E+04 7.73E+03 Cs-138 2.83E+02 5.44E+02 2.72E+02 0.OOE+00 4.01E+02 4.67E+01 2.47E-01 Ba-139 1.01E+00 7.14E-04 2.95E-02 0.OOE+00 6.73E-04 4.92E-04 9.05E+00 Ba-140 2.07E+02 2.54E-01 1.34E+01 0.OOE+00 8.61E-02 1.71E-01 3.20E+02 Ba-141 4.90E-01 3.66E-04 1.63E-02 0.OOE+00 3.39E-04 2.50E-04 1.04E-06 Ba-142 2.18E-01 2.18E-04 1.34E-02 0.OOE+00 1.85E-04 1.45E-04 6.70E-13 La-140 1.59E-01 7.80E-02 2.07E-02 0.OOE+00 0.OOE+00 0.OOE+00 4.48E+03 La-142 8.16E-03 3.63E-03 9.03E-04 0.OOE+00 0.OOE+00 0.OOE+00 1.10E+02 Ce-141 2.43E-02 1.62E-02 1.86E-03 O.OOE+00 7.62E-03 0.OOE+00 4.63E+01 Ce-143 4.29E-03 3.12E+00 3.48E-04 O.OOE+00 1.40E-03 O.OOE+00 9.38E+01 Ce-144 1.27E+00 5.25E-01 6.82E-02 0.OOE+00 3.14E-01 0.OOE+00 3.19E+02 Pr-143 5.97E-01 2.38E-01 2.97E-02 0.OOE+00 1.39E-01 0.OOE+00 1.97E+03 Pr-144 1.96E-03 8.03E-04 9.94E-05 0.OOE+00 4.61E-04 0.OOE+00 2.16E-06 Nd-147 4.28E-01 4.65E-01 2.79E-02 0.OOE+00 2.73E-01 0.00E+00 1.68E+03 W-187 3.20E+02 2.60E+02 9.13E+01 0.OOE+00 0.OOE+00 O.OOE+00 7.05E+04 Np-239 3.21E-02 3.03E-03 1.68E-03 0.OOE+00 9.50E-03 0.OOE+00 4.87E+02 Notes:

1) Units are mrem/hr per 4iCi/ml.

Page 11.3-20

CY-BY-1 70-301 Revision 5 Table 3-7 Site Specific Fish Ingestion Dose Factors for Child Age Group Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 0.OOE+00 8.21E-02 8.21E-02 8.21E-02 8.21E-02 8.21E-02 8.21E-02 Na-24 4.56E+02 4.56E+02 4.56E+02 4.56E+02 4.56E+02 4.56E+02 4.56E+02 Cr-51 O.OOE+00 0.OOE+00 1.40E+00 7.77E-01 2.12E-01 1.42E+00 7.43E+01 Mn-54 0.OOE+00 3.37E+03 8.97E+02 0.OOE+00 9.44E+02 O.OOE+O0 2.83E+03 Mn-56 0.OOE+00 1.05E+02 2.37E+01 O.OOE+00 1.27E+02 0.OOE+00 1.52E+04 Fe-55 9.05E+02 4.80E+02 1.49E+02 O.OOE+00 0.OOE+00 2.71E+02 8.89E+01 Fe-59 1.30E+03 2.1OE+03 1.05E+03 0.OOE+00 0.OOE+00 6.09E+02 2.19E+03 Co-58 0.OOE+00 7.08E+01 2.17E+02 0.OOE+00 O.OOE+00 O.OOE+00 4.13E-02 Co-60 0.OOE+00 2.08E+02 6.14E+02 O.OOE+00 0.OOE+00 O.OOE+00 1.15E+03 Ni-63 4.23E+04 2.27E+03 1.44E+03 0.OOE+00 0.OOE+00 O.OOE+00 1.53E+02 Ni-65 1.75E+02 1.64E+01 9.60E+00 O.OOE+00 O.OOE+00 O.OOE+00 2.01E+03 Cu-64 O.OOE+00 9.64E+00 5.82E+00 0.OOE+00 2.33E+01 0.OOE+00 4.52E+02 Zn-65 2.16E+04 5.74E+04 3.57E+04 O.OOE+00 3.62E+04 0.OOE+00 1.01E+04 Zn-69 6.89E+01 9.96E+01 9.20E+00 0.OOE+00 6.04E+01 0.OOE+00 6.28E+03 Br-83 O.OOE+00 0.OOE+00 5.65E+01 0.OOE+00 0.OOE+00 0.OOE+0O 0.OOE+00 Br-84 O.OOE+00 0.OOE+00 6.54E+01 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 Br-85 O.OOE+00 0.OOE+00 3.01E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Rb-86 0.OOE+00 1.05E+05 6.48E+04 O.OOE+00 0.OOE+00 0.OOE+00 6.78E+03 Rb-88 O.OOE+00 2.99E+02 2.08E+02 0.OOE+00 O.OOE+00 0.OOE+00 1.47E+01 Rb-89 0.OOE+00 1.84E+02 1.64E+02 0.OOE+00 0.OOE+0O 0.OOE+00 1.60E+00 Sr-89 3.11E+04 O.OOE+00 8.90E+02 0.OOE+00 0.OOE+00 0.OOE+00 1.21E+03 Sr-90 6.04E+05 0.OOE+00 1.22E+04 O.OOE+00 0.OOE+00 0.OOE+00 5.40E+03 Sr-91 5.66E+02 O.OOE+00 2.14E+01 0.OOE+00 O.OOE+00 0.OOE+00 1.25E+03 Sr-92 2.13E+02 O.OOE+00 8.54E+00 0.OOE+00 0.OOE+00 O.OOE+00 4.04E+03 Y-90 8.08E-01 O.OOE+00 2.16E-02 0.OOE+00 O.OOE+00 0.OOE+00 2.30E+03 Y-91M 7.51E-03 O.OOE+00 2.73E-04 0.OOE+00 O.OOE+00 O.OOE+00 1.47E+01 Y-91 1.18E+01 O.OOE+00 3.17E-01 O.OOE+00 0.OOE+00 0.OOE+00 1.58E+03 Y-92 7.08E-02 O.OOE+00 2.03E-03 0.OOE+00 O.OOE+00 0.OOE+00 2.05E+03 Y-93 2.24E-01 0.OOE+00 6.16E-03 O.OOE+00 0.OOE+00 0.OOE+00 3.34E+03 Zr-95 3.01E-01 6.62E-02 5.89E-02 0.OOE+00 9.47E-02 O.OOE+00 6.90E+01 Zr-97 1.81E-02 2.62E-03 1.55E-03 0.OOE+00 3.76E-03 O.OOE+00 3.97E+02 Nb-95 5.31E+02 2.07E+02 1.48E+02 0.OOE+00 1.94E+02 0.OOE+00 3.82E+05 Mo-99 O.OOE+00 1.05E+02 2.59E+01 0.OOE+00 2.23E+02 0.OOE+00 8.65E+01 Tc- 99M 1.09E-02 2.14E-02 3.54E-01 0.OOE+00 3.10E-01 1.08E-02 1.22E+01 Tc-101 1.26E-02 1.32E-02 1.68E-01 0.OOE+00 2.25E-01 6.99E-03 4.20E-02 Ru-103 5.75E+00 0.OOE+00 2.21E+00 O.OOE+00 1.45E+01 0.OOE+00 1.49E+02 Ru-105 5.07E-01 0.OOE+00 1.84E-01 0.OOE+00 4.46E+00 O.OOE+00 3.31E+02 Ru-106 9.20E+01 0.OOE+00 1.15E+01 0.OOE+00 1.24E+02 O.OOE+00 1.43E+03 Ag- l10M 9.75E-01 6.59E-01 5.26E-01 0.OOE+00 1.23E+00 0.OOE+00 7.83E+01 Te-125M 3.59E+03 9.72E+02 4.78E+02 1.01E+03 0.OOE+00 0.OOE+00 3.46E+03 Page 11.3-21

CY-BY-1 70-301 Revision 5 Table 3-7 (continued)

Site Specific Fish Ingestion Dose Factors for Child Age Group Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Te-127M 9.09E+03 2.45E+03 1.08E+03 2.17E+03 2.59E+04 O.OOE+00 7.36E+03 Te-127 1.48E+02 4.OOE+01 3.18E+01 1.03E+02 4.22E+02 0.OOE+00 5.79E+03 Te-129M 1.53E+04 4.28E+03 2.38E+03 4.94E+03 4.50E+04 0.OOE+00 1.87E+04 Te-129 4.22E+01 1.18E+01 1.OOE+01 3.01E+01 1.23E+02 0.OOE+00 2.62E+03 Te-131M 2.27E+03 7.83E+02 8.34E+02 1.61E+03 7.58E+03 0.OOE+00 3.18E+04 Te-131 2.61E+01 7.96E+00 7.77E+00 2.OOE+01 7.90E+01 0.OOE+00 1.37E+02 Te-132 3.18E+03 1.41E+03 1.70E+03 2.05E+03 1.31E+04 0.OOE+00 1.42E+04 1-130 3.45E+01 6.96E+01 3.59E+01 7.67E+03 1.04E+02 0.OOE+00 3.26E+01 1-131 2.03E+02 2.04E+02 1.16E+02 6.75E+04 3.35E+02 0.OOE+00 1.82E+01 1-132 9.44E+00 1.73E+01 7.98E+00 8.05E+02 2.65E+01 0.OOE+00 2.04E+01 1-133 6.99E+O1 8.64E+01 3.27E+01 1.60E+04 1.44E+02 0.OOE+00 3.48E+01 1-134 4.94E+00 9.18E+00 4.22E+00 2.11E+02 1.40E+01 0.OOE+00 6.09E+00 1-135 2.06E+01 3.72E+01 1.76E+01 3.29E+03 5.70E+01 O.OOE+00 2.83E+01 Cs-134 3.68E+05 6.04E+05 1.27E+05 0.OOE+00 1.87E+05 6.72E+04 3.26E+03 Cs-136 3.70E+04 1.02E+05 6.58E+04 0.OOE+00 5.41E+04 8.07E+03 3.57E+03 Cs-137 5.14E+05 4.92E+05 7.27E+04 O.OOE+00 1.60E+05 5.77E+04 3.08E+03 Cs-138 3.59E+02 4.99E+02 3.16E+02 0.OOE+00 3.51E+02 3.78E+01 2.30E+02 Ba-139 1.30E+00 6.95E-04 3.78E-02 0.OOE+00 6.07E-04 4.09E-04 7.52E+01 Ba-140 2.61E+02 2.29E-01 1.53E+01 O.OOE+00 7.46E-02 1.37E-01 1.32E+02 Ba-141 6.29E-01 3.52E-04 2.05E-02 0.OOE+00 3.05E-04 2.07E-03 3.59E-01 Ba-142 2.75E-01 1.98E-04 1.54E-02 0.OOE+00 1.60E-04 1.16E-04 3.59E-03 La-140 1.99E-01 6.94E-02 2.34E-02 O.OOE+00 0.OOE+00 0.00E+00 1.94E+03 La-142 1.03E-02 3.28E-03 1.03E-03 0.OOE+00 0.OOE+00 0.OOE+00 6.51E+02 Ce-141 3.12E-02 1.56E-02 2.31E-03 0.OOE+00 6.83E-03 O.OOE+00 1.94E+01 Ce-143 5.50E-03 2.98E+00 4.32E-04 O.OOE+00 1.25E-03 O.OOE+00 4.37E+01 Ce-144 1.64E+00 5.13E-01 8.73E-02 0.OOE+00 2.84E-01 0.OOE+00 1.34E+02 Pr-143 7.73E-01 2.32E-01 3.83E-02 0.OOE+00 1.26E-01 0.OOE+00 8.34E+02 Pr-144 2.54E-03 7.85E-04 1.28E-04 0.OOE+00 4.15E-04 O.OOE+00 1.69E+00 Nd-147 5.49E-01 4.44E-01 3.44E-02 O.OOE+00 2.44E-01 O.OOE+00 7.04E+02 W-187 4.05E+02 2.40E+02 1.08E+02 O.OOE+00 O.OOE+00 O.OOE+00 3.37E+04 Np-239 4.13E-02 2.97E-03 2.08E-03 0.OOE+00 8.57E-03 0.OOE+00 2.19E+02 Notes:

1) Units are mrem/hr per jiCi/ml.

2) The infant age group is assumed to receive no dose through the fish ingestion pathway; therefore, no dose factors are supplied.

Page 11.3-22

CY-BY-1 70-301 Revision 5 Table 3-8 Bioaccumulation Factors (BFI) to be Used in the Absence of Site-Specific Data Element BFj for Freshwater Fish Reference (pCi/kg per pCi/L)

H 9.OE-01 6 Be 2.8E+01 Footnote 2 C 4.6E+03 6 F 2.2E+02 Footnote 16 Na 1.OE+02 6 Mg 2.8E+01 Footnote 2 Al 2.2E+03 Footnote 13 P 1.OE+05 6 Cl 2.2E+02 Footnote 16 Ar NA NA K 1.OE+03 Footnote 1 Ca 2.8E+01 Footnote 2 Sc 2.5E+01 Footnote 3 Ti 3.3E+00 Footnote 4 V 3.OE+04 Footnote 5 Cr 2.OE+02 6 Mn 4.OE+02 6 Fe 1.OE+02 6 Co 5.OE+01 6 Ni 1.OE+02 6 Cu 5.OE+01 6 Zn 2.OE+03 6 Ga 2.2E+03 Footnote 13 Ge 2.4E+03 Footnote 12 As 3.3E+04 Footnote 14 Se 4.0E+02 Footnote 15 Br 4.2E+02 6 Kr NA NA Rb 2.OE+03 6 Sr 3.OE+01 6 Y 2.5E+01 6 Zr 3.3E+00 6 Nb 3.OE+04 6 Mo 1.OE+01 6 Tc 1.5E+01 6 Ru 1.OE+01 6 Rh 1.OE+01 6 Pd 1.OE+02 Footnote 9 Page 11.3-23

CY-BY-1 70-301 Revision 5 Table 3-8 (cont.) I Bloaccumulation Factors (BFI) to be Used in the Absence of Site-Specific Data Cd 2.0E+03 Footnote 11 In 2.2E+03 Footnote 13 Sn 2.4E+03 Footnote 12 Sb 1.OE+00 98 Ag 2.3E+00 56 Te 4.OE+02 6 1 1.5E+01 6 Xe NA NA Cs 2.OE+03 6 Ba 4.OE+00 6 La 2.5E+01 6 Ce 1.OE+00 6 Pr 2.5E+01 6 Nd 2.5E+01 6 Pm 3.OE+01 98 Sm 3.OE+01 Footnote 3 Eu 1.OE+02 Footnote 3 Gd 2.6E+01 Footnote 3 Dy 2.2E+03 Footnote 3 Er 3.3E+04 Footnote 3 Tm 4.0E+02 Footnote 3 Yb 2.2E+02 Footnote 3 Lu 2.5E+01 Footnote 3 Hf 3.3E+00 Footnote 4 Ta 3.OE+04 Footnote 5 W 1.2E+03 6 Re 2.1 E+02 Footnote 6 Os 5.5E+01 Footnote 7 Ir 3.OE+01 Footnote 8 Pt 1.OE+02 Footnote 9 Au 2.6E+01 Footnote 10 Hg 2.OE+03 Footnote 11 TI 2.2E+03 Footnote 13 Pb 3.OE+02 98 Bi 2.OE+01 98 Ra 5.OE+01 98 Th 3.OE+01 98 U 1.OE+01 98 Np 1.OE+01 6 Am 3.OE+01 98 Page 11.3-24

CY-BY-1 70-301 Revision 5 Footnotes:

NA = It is assumed that noble gases are not accumulated.

In Reference 6, see Table A-1 in the ODCM Training and Reference Material.

A number of bioaccumulation factors could not be found in literature. In this case, the periodic table was used in conjunction with published element values. This method was used for periodic table columns except where there were no values for column 3A so the average of columns 2B and 4A was assigned.

1. Value is the average of Reference 6 values in literature for H, Na, Rb and Cs.

2. Value is the average of Ref. 6 values in literature for Sr, Ba and Ref. 98 values for Ra.

3. Value is the same as the Reference 6 value used for Y.

4. Value is the same as the Reference 6 value used for Zr.

5. Value is the same as the Reference 6 value used for Nb.

6. Value is the average of Reference 6 values in literature for Mn and Tc.

7. Value is the average of Reference 6 values in literature for Fe and Ru.

8. Value is the average of Reference 6 values in literature for Co and Rh.

9. Value is the same as the Reference 6 value used for Ni.

10. Value is the average of Reference 6 values in literature for Cu and Reference 56 value for Ag.

11. Value used is the same as the Reference 6 value used for Zn.

12. Value is the average of Reference 6 value in literature for C and Reference 98 value for Pb.

13. Value is the average of columns 2B and 4A, where column 2B is the "Reference 6 value for Zn" and column 4A is the average of "Reference 6 value for C and Reference 98 value for Pb".

14. Value is the average of Ref. 6 value found in literature for P and the Ref. 98 values for Bi and Sb.

15. Value is the same as the Reference 6 value used for Te.

16. Value is the average of Reference 6 values found in literature for Br and I.

Page 11.3-25

CY-BY-1 70-301 Revision 5 4.0 GASEOUS EFFLUENTS 4.1 Gaseous Effluents - General Information This section reviews the offsite radiological limits applicable to the nuclear power stations and presents in detail the equations and procedures used to assess compliance with these limits. This calculational approach uses the methodology of NUREG-0133 (Reference 14), and incorporates certain simplifications such as the use of average meteorology.

4.1.1 Pre-calculated atmospheric transport parameters are based on historical average atmospheric conditions. These historical meteorological conditions have resulted in the dispersion parameters shown in Table 4-1, Table 4-2 and Table 4-8.

4.1.2 The equations and parameters of this section are for use in calculating offsite radiation doses during routine operating conditions. They are not for use in calculating doses due to non-routine releases (e.g., accident releases).

4.1.3 An overview of the required compliance is given in Table 1-1. The dose components are itemized and referenced, and an indication of their regulatory application is noted. Additionally, the locations of dose receivers for each dose component are given in Table 1-2.

4.1.4 Airborne Release Point Classifications The pattem of dispersion of airborne releases is dependent on the height of the release point relative to adjacent structures. Each release point is classified as one of the following three height-dependent types:

" Stack (or Elevated) Release Point (denoted by the letter S or subscript s)

Ground Level Release Point (denoted by the letter G or subscript g)

" Vent (or Mixed Mode) Release Point (denoted by the letter V or subscript v) 4.1.5 Operability and Use of Gaseous Effluent Treatment Systems IOCFR50 Appendix I and ODCM Part I require that the ventilation exhaust treatment system and the waste gas holdup system be used when projected offsite doses in 31 days, due to gaseous effluent releases, from each reactor unit, exceed any of the following limits:

0.2 mrad to air from gamma radiation.

0.4 mrad to air from beta radiation.

0.3 mrem to any organ of a member of the public.

Page 11.4-1

CY-BY-1 70-301 Revision 5 The station must project doses due to gaseous releases from the site at least once per 31 days. The calculational methods shown in sections 4.2.2 and 4.2.3 are used for this dose projection.

4.1.6 For a release attributable to a processing or effluent system shared by more than one reactor unit, the dose due to an individual unit is obtained by proportioning the effluents among the units sharing the system.

4.2 Gaseous Effluents - Dose and Dose Rate Calculation Requirements 4.2.1 Instantaneous Dose Rates 4.2.1.1 Noble Gas: Total Body Dose Rate ODCM Part I limits the total body dose rate due to noble gases in gaseous effluents released from a site to areas at and beyond the site boundary to less than or equal to 500 mrem/yr at all times.

The total body dose rate due to noble gases released in gaseous effluents is calculated by the following expression:

D)T. =K, {(X/Q)TQ. *1+(X/Qy. Q"+*(X/Q)gyQ,9} (4-1)

The summation is over noble gas radionuclides i.

Since Byron does not have an elevated release point, the Qis term is not used.

DTB Total Body Dose Rate [mrem/yr]

Dose rate to the total body due to gamma radiation from noble gas radionuclides released in gaseous effluents.

Qis, Qiv, Qig Release Rate [gCi/sec]

Measured release rate of radionuclide i from a stack, vent or ground level release point, respectively.

Ki Gamma Total Body Dose Conversion Factor [(mrem/yr)/(pCi/m 3 )]

Gamma total body dose factor due to gamma emissions for noble gas radionuclide i. K values are taken from Table 4-27 Page 11.4-2

CY-BY-1 70-301 Revision 5 Relative Concentration Factor [sec/m 3 ]

(X/0)8 (x/Q)V Radioactivity concentration based on semi-infinite cloud methodology at a (Z/Q)g specified location per unit of radioactivity release rate for a stack, vent, or ground level release, respectively. See Table 4-1.

To comply with this specification, the effluent radiation monitor has a setpoint corresponding to an offsite total body dose rate at or below the limit (see Part II Section 2.6). In addition, compliance is assessed by calculating offsite total body dose rate based on periodic samples obtained per station procedures.

4.2.1.2 Noble Gas: Skin Dose Rate ODCM Part I limits the skin dose rate due to noble gases in gaseous effluents released from a site to areas at and beyond the site boundary to less than or equal to a dose rate of 3000 mrem/yr at all times. (See TRM 3.11 .f)

The skin dose rate due to noble gases released in gaseous effluents is calculated by the following expression:

DSK= ({L,[(x/Q).Q,.

, + (X/Q).Q , +W(XQ).Q0,1 (4-2)

+ (1.11) M, [ (Z/Q):Q,' +(X/Q) Q,v +(x/Q)-Q1 g] (

The summation is over noble gas radionuclides I.

DSK Skin Dose Rate [mrem/yr]

Dose rate to skin due to beta and gamma radiation from noble gas radionuclides released in gaseous effluents.

Li Skin Dose Conversion Factor [(mrem/yr)/(pCi/m 3)]

Skin dose factor due to gamma emissions for noble gas radionuclide i. L values are taken from Table 4-27 M1 Gamma Air Dose Conversion Factor [(mrad/yr)/(lCi/m 3 )]

Gamma air dose rate factor per unit of radioactivity release rate for radionuclide i.

See Table 4-27 for Gamma Air Dose conversion factors (From Table B-1 of Regulatory Guide 1.109).

Since Byron does not have an elevated release point, the Q1s term is not used.

Page 11.4-3

CY-BY-1 70-301 Revision 5 To comply with this specification, gaseous effluent radiation monitors have setpoints corresponding to an offsite skin dose rate at or below the limit (see Part II Section 2.6). In addition, compliance is assessed by calculating offsite skin dose rate based on periodic samples obtained per station procedures.

4.2.1.3 Non-Noble Gas Radionuclides: Organ Dose Rate ODCM Part I limits the dose rate to any organ, due to radioactive materials in gaseous effluents released from a site to areas at and beyond the site boundary, to less than or equal to a dose rate of 1500 mrem/yr (See TRM 3.11.f)

Typically the child is considered to be the limiting receptor in calculating dose rate to organs due to inhalation of non-noble gas radionuclides in gaseous effluents.

The dose rate to any child organ due to inhalation is calculated by the following expression:

. NNG D(ch*ld)1Qnhal)j = ".R(ch,,d),(,nha,)j{(Z/Q). Q,. + (X/QLQ1 . +(X/Q)gQ,g} (4-3)

The summation is over non-noble gas radionuclides i.

. NNG D(Ch,,d)I(Inha,)J Inhalation Dose Rate [mrem/yr]

Dose rate to the child age group from radionuclide i, via the inhalation pathway to organ j due to non-noble gas radionuclides.

R(Child)i(inhal)j Inhalation Dose Factor [(mrem/yr)/(p Ci/m 3)]

Inhalation dose factor for child age group for radionuclide i, and organ j.

Inhalation dose factors for non-noble gas radionuclides (child) are shown in Table 4-11 Since Byron does not have an elevated release point, the Q1s term is not used.

ODCM Part I requires the dose rate due to non-noble gas radioactive materials in airborne effluents be determined to be within the above limit in accordance with a sampling and analysis program specified in TRM Table T3.1 1.f-1.

The child organ dose rate due to inhalation is calculated in each sector at the location of the highest offsite X/Q (see Table 4-1). The result for the sector with the highest organ inhalation dose rate is compared to the limit.

Page 11.4-4

CY-BY-1 70-301 Revision 5 4.2.2 Time Averaged Dose from Noble Gas 4.2.2.1 Gamma Air Dose ODCM and TRM limits the gamma air dose due to noble gas effluents released from each reactor unit to areas at and beyond the unrestricted area boundary to the following:

" Less than or equal to 5 mrad per calendar quarter.

Less than or equal to 10 mrad per calendar year.

The gamma air dose due to noble gases released in gaseous effluents is calculated by the following expression:

D, = (3.17E-8)M,{ (X/Q)rA, +.(X/Q)yA, +(X/Q)A' A,} (4-4)

The summation is over noble gas radionuclides i.

Drf Gamma Air Dose [mrad]

Dose to air due to gamma radiation from noble gas radionuclides released in gaseous effluents.

3.17E-8 Conversion Constant (seconds to years) [yr/sec]

MI Gamma Air Dose Conversion Factor [(mrad/yr)/(gCi/m 3)]

Gamma air dose rate factor per unit of radioactivity release rate for radionuclide i.

See Table 4-27 for Gamma Air Dose conversion factors (From Table B-1 of Regulatory Guide 1.109).

(X/Q)r, (X/Q)r, (X/Q)r Gamma-X/Q Factor [sec/m 3 ]

Radioactivity concentration based on finite cloud methodology at a specific location per unit of radioactivity release rate from a stack, vent or ground level release, respectively. See Table 4-3 for Gamma-V/Q Factors.

Ais, A-v, Aig Cumulative Radionuclide Release [pCi]

Measured cumulative release of radionuclide i over the time period of interest from a stack, vent, or ground level release point, respectively.

Since Byron does not have an elevated release point, the Ais term is not used.

Page 11.4-5

CY-BY-1 70-301 Revision 5 TRM 3.11 .g requires determination of cumulative and projected gamma air dose contributions due to noble gases for the current calendar quarter and the current calendar year at least once per 31 days.

Gamma air dose is calculated for the sector with the highest offsite (X/Q)t and is compared with the Part I limits on gamma air dose.

For a release attributable to a processing or effluent system shared by more than one reactor unit, the dose due to an individual unit is obtained by proportioning the effluents among the units sharing the system.

4.2.2.2 Beta Air Dose TRM Chapter 3.11 limits beta air dose due to noble gases in gaseous effluents released from each reactor unit to areas at and beyond the unrestricted area boundary to the following:

, Less than or equal to 10 mrad per calendar quarter.

" Less than or equal to 20 mrad per calendar year.

The beta air dose due to noble gases released in gaseous effluents is calculated by the following expression:

D, = (3.17E - 8)E{f[(X6/Q).A4. + (X/Q)0Aw + (X/Q A91 1

} (4-5)

The summation is over noble gas radionuclides i.

Dp Beta Dose [mrad]

Dose to air due to beta radiation from noble gas radionuclides released in gaseous effluents.

3.17E-8 Conversion Constant (seconds to years) [yr/sec]

N, Beta Air Dose Conversion Factor [(mrad/yr)/(gCi/m 3 )]

Beta air dose rate per unit of radioactivity concentration for radionuclide i. See Table 4-27 for Beta Air Dose conversion factors (From Table B-1 of Regulatory Guide 1.109).

Page 11.4-6

CY-BY-1 70-301 Revision 5 (x/Q)s Relative Concentration Factor [sec/m 3]

(XIQ)v (XIQ)g Radioactivity concentration based on semi-infinite cloud methodology at a specified location per unit of radioactivity release rate for a stack, vent, or ground level release, respectively. See Table 4-1.

A-s, A1v, Aig Cumulative Radionuclide Release [Ci]

Measured cumulative release of radionuclide i over the time period of interest from a stack, vent, or ground level release point, respectively.

Since Byron does not have an elevated release point, the Ais term is not used.

TRM 3.11 .g requires determination of cumulative and projected beta air dose contributions due to noble gases for the current calendar quarter and the current calendar year at least once per 31 days.

Beta air dose is calculated for the sector with the highest offsite (XIQ) and is compared with the ODCM Part I limit on beta air dose.

For a release attributable to a processing or effluent system shared by more than one reactor unit, the dose due to an individual unit is obtained by proportioning the effluents among the units sharing the system.

4.2.2.3 Whole Body Dose The total body dose, to any receiver is due, in part, to gamma radiation emitted from radioactivity in airborne effluents. This component is added to others to demonstrate compliance to the requirements of 40CFRI 90 and 10CFR20.

The total body dose component due to gamma radiation from noble gases released in gaseous effluents is calculated by the following expression:

DTO =(3.17E-8)XK,{(X/Q)'

I A,. +(X/Q) A,, +(X/Q)'YA. } (4-6)

The summation is over noble gas radionuclides i.

DTB Total Body Dose [mrem]

Dose to the total body due to gamma radiation from noble gas radionuclides released in gaseous effluents.

3.17E-8 Conversion Constant (seconds to years) [yr/sec]

Page 11.4-7

CY-BY-1 70-301 Revision 5 K, Gamma Total Body Dose Conversion Factor [(mremlyr)l(pCilm 3 )]

Gamma total body dose factor due to gamma emissions for noble gas radionuclide i released from a stack, vent or ground level release point, respectively. See Table 4-27 for Gamma total body dose conversion factors. (From Table B-1 of Regulatory Guide 1.109)

Ais, Av, Ag Cumulative Radionuclide Release [gjCi]

Measured cumulative -release of radionuclide i over the time period of interest from a stack, vent, or ground level release point, respectively.

The total body dose is also calculated for the 40CFR1 90 and 10CFR20 compliance assessments. In some cases, the total body dose may be required in IOCFR50 Appendix I assessments (See Part II Table 1-1).

4.2.2.4 Skin Dose There is no regulatory requirement to evaluate skin dose. However, this component is evaluated for reference as there is skin dose design objective contained in 10CFR50 Appendix I. Note that in the unlikely event that beta air dose guideline is exceeded, then the skin dose will require evaluation.

The part of skin dose due to noble gases released in gaseous effluents is calculated by the following expression:

sK (3.17E -8){L[ I (X/Q). A,. + (Z/Q), A, + (X/Q)gAig (

+ (1.11)M, [ (Z/Q)7A, + (X/Q)yA1 , +(z/Q)A 19,] }

The summation is over noble gas radionuclides i.

DSK Skin Dose (mrem]

Dose to the skin due to beta and gamma radiation from noble gas radionuclides released in gaseous effluents.

Li Beta Skin Dose Conversion Factor [(mrem/yr)/(jiCilm 3 )]

Beta skin dose rate per unit of radioactivity concentration for radionuclide

i. Taken from Table 4-27.

1.11 Conversion Constant (rads in air to rem in tissue) [mrem/mrad]

All other terms have been previously defined.

Page 11.4-8

CY-BY-1 70-301 Revision 5 The skin dose is calculated for reference only.

4.2.3 Time Averaged Dose from Non-Noble Gas Radionuclides TRM 3.11 provides the following limits, based on 10CFR50 Appendix I, on the dose to a member of the public from specified non-noble gas radionuclides in gaseous effluents released from each reactor unit to areas at and beyond the unrestricted area boundary:

" Less than or equal to 7.5 mrem to any organ during any calendar quarter

" Less than or equal to 15 mrem to any organ during any calendar year The individual dose components are also required as part of the 40CFR1 90 assessments and combined as part of the 10CFR20 assessment (Part II Table 1-1).

The dose due to radionuclides deposited on the ground is considered to be a component of the deep dose equivalent for 10CFR20 compliance and an organ (and total body) dose component for 10CFR50 Appendix I and 40CFR1 90 compliance.

The dose is calculated for releases in the time period under consideration.

Specifically, the dose is calculated as follows:

DNNG = (3.17E-8)XX:[WRaipjA,. +WvR.,pjAi, +W9 R ,lA 19 ] (4-8) p I The summation is over pathways p and non-noble gas radionuclides i.

DaG Dose Due to Non-Noble Gas Radionuclides [mrem]

Dose due to non-noble gases (radioiodines, tritium and particulates) to age group a, and to organ j.

3.17E-8 Conversion Constant (seconds to years) [yr/sec]

Ws, Wv, Wg Relative Concentration Factor Radioactive concentration at a specific location per unit of radioactivity release rate or concentration for stack, vent or ground level release, respectively.

Ws, Wv, or Wg = (x/Q)s, (x/Q)v or (X/Q)g for immersion, inhalation and all tritium pathways.

Ws, Wv, or Wg = (D/Q)s, (D/Q)v or (D/Q)g for ground plain and all ingestion pathways.

Page 11.4-9

CY-BY-1 70-301 Revision 5 (X/Q)s, (Z/Q)V, (x/Q)g Relative Concentration Factor [sec/m 3]

Radioactivity concentration based on semi-infinite cloud model at a specified location per unit of radioactivity release rate for a stack, vent, or ground level release, respectively. See Table 4-1 through Table 4-6.

(D/Q)s, (D/Q)v, (D/Q)g Relative Deposition Factor [1/M 2]

Radioactivity concentration at a specified location per unit of radioactivity release concentration for a stack, vent, or ground level release, respectively. See Table 4-1 through Table 4-6.

Ralpj Site-Specific Dose Factor [(M2 mrem/yr)/(gCi/sec)]

or [(mrem/yr)/(gCi/m 3 )]

Site-specific dose factor for age group a, nuclide i, pathway p and organ j.

Pathways included are ground plane exposure, inhalation, vegetation ingestion, milk ingestion and meat ingestion. Values of Raipj are provided in Table 4-7 and Table 4-9 through Table 4-26.

Ais, Aiv, Aig Cumulative Radionuclide Release [gCi]

Measured cumulative release of radionuclide i over the time period of interest from a stack, vent, or ground level release point, respectively.

Since Byron does not have an elevated release point, the stack terms for A1s, Ws, (/,Q)s, and (D/Q)s are not used.

TRM 3.11 .h requires cumulative and projected dose contributions for the current calendar quarter and the current calendar year for the specified non-noble gas radionuclides in airborne effluents to be determined at least once per 31 days.

To comply with this specification, Byron Station obtains and analyzes samples in accordance with the radioactive gaseous waste or gaseous effluent sampling and analysis program (TRM 3.11 .f-1). In accordance with NUREG 0133 (Reference 14),

dose due to non-noble gases is assessed at the location in the unrestricted area where the combination of existing pathways and receptor age groups indicates the maximum potential exposure. The inhalation and ground plane exposure pathways are considered to exist at all locations. The food ingestion pathways at a specific location are considered based on their existence as determined by land use census. The values used for (X/Q) and (D/Q) are shown in Table 4-1 through Table 4-6 and correspond to the applicable pathway location.

Page 11.4-10

CY-BY-1 70-301 Revision 5 For a release attributable to a processing or effluent system shared by more than one reactor, the dose due to an individual unit is obtained by proportioning the effluents among the units sharing the system.

The dose evaluated is also included as part of the 10CFR20 and 40CFRI90 assessment (See Part II Section 5).

4.2.3.1 Ground Plane The site-specific dose factor for ground deposition of radioactivity is considered to be a total body dose component and is calculated by the following expression:

[1- tb Rl,(GP)j [D/Q] = K'K "(0.7)DFG, RI(Gp)j[D/Q] Ground Plane Deposition Dose Factor [(M2 mrem/yr)/(l.Ci/sec)]

Site-specific ground plane dose factor for age group a, nuclide i and organ

j. The ground plane dose is calculated using (D/Q).

K' Conversion Constant (1 E6 pCi per giCi) [pCi/4Ci]

K" Conversion Constant (8760 hr/yr) [hr/yr]

0.7 Shielding Factor; a factor that accounts for dimensionless shielding due to occupancy of structures.

DFGI Ground Plane Dose Conversion Factor [(mrem/hr)/(pCi/m 2 )]

Dose rate to the total body per unit of surface radioactivity concentration due to standing on ground uniformly contaminated with radionuclide i. Ground Plane Dose Conversion Factors are shown in Table 4-8.

Note that ground plane dose conversion factors are only given for the total body and no age group. Doses to other organs are assumed to be equal to the total body dose. All age groups are assumed to receive the same dose.

).I Radiological Decay Constant [hr']

Radiological decay constant for radionuclide i.

tb Time Period of Ground Deposition [hr]

Time period during which the radioactivity on the ground is assumed to have been deposited (see Part II Table 1-3).

Page 11.4-11

CY-BY-1 70-301 Revision 5 The ground plane exposure pathway is considered to exist at all locations.

4.2.3.2 Inhalation The site-specific dose factor for inhalation is calculated by the following expression:

R al(Inhal)j [/Q] = K'BR.DFA., (4-10)

Ra,(Inh,)j[X/Q] Inhalation Pathway Dose Factor [(mrem/yr)/(l.Ci/m 3)]

Site-specific inhalation dose factor for age group a, nuclide i and organ j. The inhalation dose is calculated using (X/Q).

K' Conversion Constant (1 E6 pCi per laCi) [pCi/pCi]

BRa Individual Air Inhalation Rate [m3/yr]

The air intake rate for individuals in age group a. See Table E-5 of Regulatory Guide 1.109.

DFAk1j Inhalation Dose Conversion Factor [mrem/pCi]

Dose commitment to an individual in age group a to organ j per unit of activity of radionuclide i inhaled. Taken from Tables E-7 through E-10 of Regulatory Guide 1.109. The value for H-3 is taken from NUREG 4013 (Reference 107).

The inhalation exposure pathway is considered to exist at all locations.

4.2.3.3 Ingestion: Vegetation Food ingestion pathway doses are calculated at locations indicated by the land use census survey. If no real pathway exists within 5 miles of the station, the cow-milk pathway is assumed to be located at 5 miles. Food pathway calculations are not made for sectors in which the offsite regions near the station are over bodies of water.

The dose factor for consumption of vegetables is calculated by the following expression:

RaI(Veg)J [D/QJ = K'[Y (;rr+*, ) (DFLaij) [U'f'e-'t' + Ufoe--'th] (4-11)

Page 11.4-12

CY-BY-1 70-301 Revision 5 R=I(vg)j[D/Q] Vegetation Ingestion Pathway Dose Factor

[(M2 mrem/yr)/(gCi/sec)]

Site-specific vegetation ingestion dose factor for age group a, nuclide i and organ j. With the exception of H-3, the vegetation dose is calculated using (D/Q).

K' Conversion Constant (1E6 pCi per jiCi) [pCi/gCi]

r Vegetation Retention Factor [dimensionless]

Yv Agricultural Productivity Yield [kg/ M 2 ]

Radiological Decay Constant [l/sec]

Radiological decay constant for radionuclide i AW, Weathering Decay Constant [l/sec]

Removal constant for physical loss of activity by weathering. See ODCM Part II Table 1-3.

DFLaij Ingestion Dose Conversion Factor [mrem/pCi]

Ingestion dose conversion factor for age group a, nuclide i and organ.j.

Converts pCi ingested to mrem. Taken from Tables E-1 1 though E-14 of Regulatory Guide 1.109. The value for H-3 is taken from NUREG 4013 (Reference 107).

UaL Consumption Rate for Fresh Leafy Vegetation [kg/yr]

Consumption rate for fresh leafy vegetation for age group a.

Uas Consumption Rate for Stored Vegetation [kg/yr]

Consumption rate for stored vegetation for age group a.

fL Local Leafy Vegetation Fraction [dimensionless]

Fraction of the annual intake of fresh leafy vegetation that is grown locally.

fg Local Stored Vegetation Fraction [dimensionless]

Fraction of the annual intake of stored vegetation that is grown locally.

Page 11.4-13

CY-BY-1 70-301 Revision 5 tL Environmental Transport Time - Fresh Vegetation [sec]

Average time between harvest of leafy vegetation and its consumption.

th Environmental Transport Time - Stored Vegetation [sec]

Average time between harvest of stored vegetation and its consumption.

The tritium dose from the vegetation pathway must be considered separately as the transport mechanism is based on airborne concentration rather than ground deposition. The dose factor for the tritium vegetation pathway is:

R+a(H-3XVG)j X/Q]= K'K-(U~fL +Us fg)DFLa(H-3j0.75(0.5/H)) (4-12)

Ra(H-3XVeg)j [x/Q] Tritium Vegetation Ingestion Pathway Dose Factor

[(mrem/yr)/(lgCi/m3]

Site-specific tritium vegetation ingestion dose factor for age group a and organ j. The tritium vegetation dose is calculated using X/Q.

K"' Conversion Constant (1E3 gm per Kg) [gm/Kg]

H Absolute Atmospheric Humidity [gm/m 3]

0.75 Water Fraction [dimensionless]

The fraction of total vegetation that is water.

0.5 Specific Activity Ratio [dimensionless]

4.2.3.4 Ingestion: Milk The dose factor for consumption of milk is calculated by the following expressions:

X,+X Fm(r)(OFLai)f-L-RI(Mik)j[D/Q]= K'QF(Uam) , + A:--fPfy. 4-3 (41]3)

Ra,(.ik)j[D/Q] Milk Ingestion Pathway Dose Factor

[(M 2 mrem/yr)/(ltCi/sec)]

Site-specific milk ingestion dose factor for age group a, nuclide i and organ j. With the exception of H-3, the milk dose factor is calculated using (D/Q).

K' Conversion Constant (1E6 pCi per giCi) [pCi/gCi]

Page 11.4-14

CY-BY-1 70-301 Revision 5 QF Feed Consumption [Kg/da]

Amount of feed consumed by milk animal each day. See ODCM Part II Table 1-3.

Uam Milk Consumption Rate [l/yr]

Milk consumption rate for age group a.

Fm Stable Element Transfer Coefficient for Milk [da/i]

Fraction of animal's daily intake of a particular chemical element that appears in each liter of milk (pCi/I in milk per pCi/da ingested by animal). See ODCM Part II Table 1-4.

fp Pasture Time Fraction [dimensionless]

Fraction of year that animal is on pasture.

fs Pasture Grass Fraction [dimensionless]

Fraction of animal feed that is pasture grass while animal is on pasture.

Yp Agricultural Productivity Yield - Pasture Grass [kg/m2]

The agricultural productivity by unit area of pasture feed grass.

Ys Agricultural Productivity Yield - Stored Feed [kg/m2]

The agricultural productivity by unit area of stored feed.

th Environmental Transport Time - Stored Feed [sec]

Average time between harvest to consumption of stored feed by milk animal.

tf Environmental Transport Time - Pasture to Consumption [sec]

Average time from pasture, to milk animal, to milk, to consumption.

All other terms have been previously defined.

The tritium dose from the milk pathway must be considered separately as the transport mechanism is based on airborne concentration rather than ground deposition. The dose factor for the tritium milk pathway is:

Page 11.4-15

CY-BY-1 70-301 Revision 5 Ra(H-3XM,,k)j [x/Q] = K'K-Fm QFUamDFLa(H.4 )j[0.75(0.5/H)] (4-14)

-- r ,..1 Ra(H_3XMIIk)j IX/QJ Tritium Milk Ingestion Pathway Dose Factor

[(mrem/yr)/(pCi/m 3 )]

Site-specific tritium milk ingestion dose factor for age group a and organ j.

The tritium milk dose is calculated using X/Q.

K1' Conversion Constant (1E3 gm per Kg) [gm/Kg]

H Absolute Atmospheric Humidity [gm/m 3]

0.75 Water Fraction [dimensionless]

The fraction of total feed that is water.

0.5 Specific Activity Ratio [dimensionless]

4.2.3.5 Ingestion: Meat The dose factor for consumption of meat is calculated by the following expression:

R18(Mea8)j[D/Q] = K' QF(Ujf) F,(r[(DFLYj)[fPf° + (1-- fPfs)e-24th Xf+%w [Ys YD Ral(Mo=)j D/Q] Meat Ingestion Pathway Dose Factor

[(M 2 mrem/yr)/(pCi/sec)]

Site-specific meat ingestion dose factor for age group a, nuclide I and organ j. With the exception of H-3, the meat dose factor is calculated using (D/Q).

Uaf Meat Consumption Rate [kg/yr]

Meat consumption rate for age group a.

Stable Element Transfer Coefficient for Meat [da/Kg]

Fraction of animal's daily intake of a particular chemical element that appears in each Kg of meat (pCi/Kg in meat per pCi/da ingested by animal). See ODCM Part II Table 1-4.

th Environmental Transport Time - Stored Feed [sec]

Page 11.4-16

CY-BY-1 70-301 Revision 5 Average time between harvest to consumption of stored feed by meat animal.

tf Environmental Transport Time - Pasture to Consumption [sec]

Average time from pasture, to meat animal, to meat, to consumption.

All other terms have been previously defined.

The tritium dose from the meat pathway must be considered separately as the transport mechanism is based on airborne concentration rather than ground deposition. The dose factor for the tritium meat pathway is:

Ra(H_3XMeat)j [X/Q] = K'K"Ff QFUDFLa(H_3)j [0.75(0.5/H)] (4-16)

Ra(H-3XMoat)j [X/Q] Tritium Meat Ingestion Pathway Dose Factor [(mrem/yr)/(g Ci/m 3 )]

Site-specific tritium meat ingestion dose factor for age group a and organ j. The tritium meat dose is calculated using X/Q.

K'" Conversion Constant (1 E3 gm per Kg) [gm/Kg]

H Absolute Atmospheric Humidity [gm/m 3 ]

0.75 Water Fraction [dimensionless]

The fraction of total feed that is water.

0.5 Specific Activity Ratio [dimensionless]

All other terms have been previously defined.

Page 11.4-17

CY-BY-1 70-301 Revision 5 Table 4-1 X/Q and D/Q Maxima at or Beyond the Unrestricted Area Boundary DoeWmund Nixed Nods(Vent) tteease Ground Level Re3em Direction Radius X/S Radius D/O Radius X/O 0/S (veters) O(u011**) ("eton) C(I/WM)Z ("two) (OW/W~s) Cllm0"n N 1875. 1.9111-0 1575. 1.9831-09 1875. 8.676E-O 4.671E-09 WllE 1829. 1.6M71-07 1029. 1.921E-09 1329. 7.53114-? 4.2711-09 ME I56. 1.5309-07 158. 1.RIE-09 155. 7.876E-O 4.3111E-09 En 1234. 1.351-0? 1234. 1.764E-09 1234. 8.01*6W 5.036E-09 E 122Y. 1.61E-07 122?. 2.33511-09 1227. .11431-066.26-09 ESE 991. Z.5191-07 991. 3.H40-09 991. 1.6921-06 9.896-09 BE 1006. 3.02fE-0T 1006. 3.SS6-09 1006. 2.480f-06 1.11SE-U 6O 800. 4.4971-07 800. 3.7611-09 100. 4.1521-06 1.421-S 94S. 2.249W-0T 945. 2.11E-09 945. 1.941E06 9.3646-09 SW 97!. 1.4761-0T 97!. 1.9701-09 9?1. 1.305E-06 6.6721-09 811 106T. 1.1481-0T 106?. 1.76t1-09 1067. 9.2751-07 5.3161-09 WSW 1212. 1.1991-0? 1212. 1.9031-09 1212. 7.644-0 5.0021-09 u 1189. 1.7M-07 1189. 1.8701-09 1189. 9.34SE-0? 5.3301-09 M 122?. 1.205-07 1227. 1.22-09 1227. 6.54M-O 3.745E-09 11 1126. 1.68611-07 1128. 1.7151-09 1112. 8.6071-07 4.9641-09 10110 1044. 3.043-07T 1044. 3.2231-09 1044. 1.432=-06 8.711E-09 lyrm site Ketecrolglcalt onto 1/76 - 2157M Note: Based on "Irrigation from the Rock River" letter from G.P. Lahti (Sargent and Lundy) to J.C. Golden (NSEP), June 4, 1990 and the formulas in Reg. Guide 1.109.

X/Q is used for beta skin, and inhalation dose pathways. See Sections 4.2.1, 4.2.2 and 4.2.3.2.

D/Q is used for produce and leafy vegetable pathways. See Section 4.2.3.

The ground level release data are provided for reference purposes only. Routine dose calculations are performed using mixed mode data.

Radius is the approximate distance from the midpoint between gaseous effluent release points to the location of the highest X/Q or D/Q at or beyond the unrestricted area boundary (UAB).

Page 11.4-18

CY-BY-1 70-301 Revision 5 Table 4-2 X/Q and D/Q Maxima at or Beyond the Restricted Area Boundary Damind Nixed Node(Vnt) RIli Oruellmi Lee Itetine Direction Radius XAI adlus 0/0 Radius Xe 0/B (usteri) (0s04%") Cmitere) (lt/2) (enters) (um/cr31)* 1/(iAq)

M7. 6.3571-07 M. 7.00ft-09 M. 3.ZO0-06 1;.03619-08 536. 8.Y73-07 53m. 1.0461-01 536. 5.0161-06 !.1931-05

52. 6.11=-07 5H2. 1.79n-09 528. 4.3711-06 ;.6461-0 EM 474. 5.3411-07 474. 5.9471-09 474. 4.0141-06 1.34H6-01

46. 6.6m9-07 466. 7.93K-w 4611 5.359E-06 i..9301-0S 480. 7.3771-07 480. 8.9U11-09 480. 5.4-06 11.1441-08 427. 1.126-06 42T. 1.009-U 427. 1.024-05 1-.3521-06 410. 1.3491-06 410. 3.7441-19 410. 1.3051-05 6*.044E-0

'U' M9. 1.4411-06 295. t.I7i1-U 295. 1.3911-05 !i.70E-08 299. 9.321-,r 299. 6.293-09 299. 9.376E-06 I. 1911-0S am 451. 3.94W-0T 451. 5.046-09 451. 3.6611-06 n.0951-08 W3u 386. 6.0961-0 386. T.451-09 386. 4.6991-06 3.0-W-0 V 379. 1.0411-06 379. 6.1161-09 379. 6.009-06 3-.3I5-06 WNu 365. 7.4541-07 365. 6A.IR-09 365. 4.3121-06 I-.S3O-08 Wu 445. 7.3941-07 "4S. 6.1171-09 445. 4.0681-06 2.1961-06 NOW 656. 6.1t1-0T d46. 6.17,3-09 43. 2."01-06 I.671-06 Byron Sits Neteor"Ot9caI Date 1176 - TW/67 Note: Based on "irrigation from the Rock River" letter from G.P. Lahti (Sargent and Lundy) to J.C. Golden (NSEP), June 4, 1990 and the formulas in Reg. Guide 1.109.

The ground level release data are provided for reference purposes only. Routine dose calculations are performed using mixed mode data.

Radius is the approximate distance from the midpoint between gaseous effluent release points to the location of the highest X/Q or D/Q at or beyond the restricted area boundary (RAB).

Page 11.4-19

CY-BY-1 70-301 Revision 5 Table 4-3 Maximum Offsite Gamma-X/Q Downwind Ground. Vent Direction Radius Gamma-X/Q Gamma-X/Q (meters) (sec/m**3) (sec/m**3)

N 1875 4.80E-07 1.46E-07 NNE 1829 4.16E-07 1.36E-07 NE 1585 4.34E-07 1.31E-07 ENE 1234 4.83E-07 1.27E-07 E 1227 6.10E-07 1.50E-07 ESE 991 8.73E-07 2.13E-07 SE 1006 1.24E-06 2.45E-07 SSE 800 1.83E-06 3.02E-07 S 945 9.68E-07 1.85E-07 SSW 975 6.69E-07 1.34E-07 SW 1067 4.84E-07 1.08E-07 WSW 1212 4.19E-07 1.11 E-07 W 1189 5.07E.-07 1.39E-07 WNW 1227 3.54E-07 9.70E-08 NW 1128 4.61E-07 1.29E-07 NNW 1044 7.43E-07 2.15E-07 Page 11.4-20

CY-BY-1 70-301 Revision 5 Table 4-4 X/Q and D/Q at the Nearest Resident Locations within 5 miles Mixed Mode (Vent)

Location Description Direction Distance Ground Level Release Release X/Q3 D/Q s/Qe D/Q Miles meters sec/m3 nl2 sec/m° m-2 NEAREST RESIDENCE N 2.67 4300 3.70E-07 9.80E-10 6.30E-08 3.80E-10 NEAREST RESIDENCE NNE 0.99 1600 1.50E-06 5.30E-09 8.30E-08 1.70E-09 NEAREST RESIDENCE NE 1.18 1900 1.OOE-06 3.40E-09 6.60E-08 1.10E-09 NEAREST RESIDENCE ENE 1.30 2100 8.20E-07 2.20E-09 4.60E-08 7.30E-10 NEAREST RESIDENCE E 1.30 2100 1.20E-06 2.80E-09 5.90E-08 9.40E-10 NEAREST RESIDENCE ESE 1.43 2300 9.1OE-07 2.10E-09 5.10E-08 7.10E-10 NEAREST RESIDENCE SE 0.75 1200 3.60E-06 7.40E-09 6.90E-08 2.OOE-09 NEAREST RESIDENCE SSE 0.62 1000 3.80E-06 8.1OE-09 5.40E-08 1.60E-09 NEAREST RESIDENCE S 0.50 800 3.40E-06 1.20E-08 8.40E-08 2.40E-09 NEAREST RESIDENCE SSW 0.62 1000 1.70E-06 6.80E-09 6.40E-08 1.90E-09 NEAREST RESIDENCE SW 0.75 1200 7.80E-07 3.10E-09 3.50E-08 8.80E-10 NEAREST RESIDENCE WSW 1.68 2700 3.30E-07 1.40E-09 5.40E-08 6.50E-10 NEAREST RESIDENCE W 1.68 2700 5.50E-07 1.40E-09 5.20E-08 4.10E-10 NEAREST RESIDENCE WNW 0.75 1200 1.70E-06 5.20E-09 4.60E-08 1.OOE-09 NEAREST RESIDENCE NW 0.99 1600 1.1OE-06 3.30E-09 4.30E-08 7.30E-10 NEAREST RESIDENCE NNW 1.30 2100 8.50E-07 2.90E-09 6.20E-08 7.90E-10 Page 11.4-21

CY-BY-1 70-301 Revision 5 Table 4-5 z/Q and D/Q at the Nearest Cow Milk Locations within 5 miles Mixed Mode (Vent)

Location Description Direction Distance Ground Level Release Release X/Q D/Q x/Q D/Q miles meters sec/m 3 m-2 sec/m3 m"2 COW MILK N 4.97 8000 1.50E-07 3.20E-10 4.20E-08 1.40E-10 COW MILK NNE 4.97 8000 1.30E-07 3.10E-10 3.90E-08 1.60E-10 COW MILK NE 1.86 3000 5.OOE-07 1.50E-09 6.70E-08 6.20E-10 COW MILK ENE 4.97 8000 1.10E-07 2.00E-10 2.90E-08 1.10E-10 COW MILK E 4.97 8000 1.60E-07 2.70E-10 3.90E-08 1.40E-10 COW MILK ESE 4.97 8000 1.40E-07 2.30E-10 3.50E-08 1.20E-10 COW MILK SE 4.97 8000 2.OOE-07 2.70E-10 3.80E-08 1.40E-10 COW MILK SSE 4.97 8000 1.50E-07 2.20E-10 3.10E-08 1.20E-10 COW MILK S 4.78 7700 9.10E-08 2.40E-10 2.90E-08 1.50E-10 COW MILK SSW 4.97 8000 6.1OE-08 1.80E-10 2.20E-08 1.20E-10 COW MILK SW 4.97 8000 3.90E-08 1.10E-10 1.50E-08 7.10E-11 COW MILK WSW 4.97 8000 6.30E-08 2.10E-10 2.50E-08 1.30E-10 COW MILK W 2.49 4000 3.OOE-07 7.20E-10 4.90E-08 2.60E-10 COW MILK WNW 3.29 5300 1.70E-07 4.OOE-10 3.40E-08 1.50E-10 COW MILK NW 2.98 4800 2.1OE-07 4.90E-10 3.70E-08 1.80E-10 COW MILK NNW 4.97 8000 1.10E-07 2.70E-10 3.50E-08 1.20E-10 Page 11.4-22

CY-BY-1 70-301 Revision 5 Table 4-6 X/Q and D/Q at the Nearest Cow Meat Locations within 5 miles Mixed Mode (Vent)

Location Description Direction Distance Ground Level Release Release X/Q D/Q X/Q D/Q2 miles meters sec/mr3 m2 sec/m 3 m" COW MEAT N 2.98 4800 3.1OE-07 8.1OE-10 6.OOE-08 3.20E-10 COW MEAT NNE 1.49 2400 7.70E-07 2.60E-09 7.60E-08 9.90E-10 COW MEAT NE 3.42 5500 2.OOE-07 5.30E-10 5.20E-08 2.70E-10 COW MEAT ENE 2.30 3700 3.40E-07 8.10E-10 4.30E-08 3.50E-10 COW MEAT E 2.24 3600 5.00E-07 1.10E-09 5.80E-08 4.70E-10 COW MEAT ESE 1.49 2400 8.50E-07 2.OOE-09 5.10E-08 6.80E-10 COW MEAT SE 1.68 2700 9.80E-07 1.80E-09 5.90E-08 6.90E-10 COW MEAT SSE 3.17 5100 2.90E-07 4.90E-10 4.1OE-08 2.40E-10 COW MEAT S 0.56 900 2.80E-06 9.90E-09 7.70E-08 2.10E-09 COW MEAT SSW 2.17 3500 2.1OE-07 8.OOE-10 4.OOE-08 4.30E-10 COW MEAT SW 3.17 5100 7.60E-08 2.50E-10 2.10E-08 1.50E-10 COW MEAT WSW 1.68 2700 3.30E-07 1.40E-09 5.40E-08 6.50E-10 COW MEAT W 1.68 2700 5.50E-07 1.40E-09 5.20E-08 4.10E-10 COW MEAT WNW 3.29 5300 1.70E-07 4.OOE-10 3.40E-08 1.50E-10 COW MEAT NW 3.79 6100 1.50E-07 3.20E-10 3.30E-08 1.30E-10 COW MEAT NNW 1.37 2200 7.90E-07 2.70E-09 6.20E-08 7.50E-10 Page 11.4-23

CY-BY-1 70-301 Revision 5 Table 4-7 Ground Plane Dose Factors Nuclide Bone Liver T Bodv Thyroid Kidney Lunz GI-LLI H-3 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 Na-24 1.20E+07 1.20E+07 1.20E+07 1.20E+07 1.20E+07 1.20E+07 1.20E+07 Cr-51 4.65E+06 4.65E+06 4.65E+06 4.65E+06 4.65E+06 4.65E+06 4.65E+06 Mn-54 .1.38E+09 1.38E+09 1.38E+09 1.38E+09 1.38E+09 1.38E+09 1.38E+09 Mn-56 9.03E+05 9.03E+05 9.03E+05 9.03E+05 9.03E+05 9.03E+05 9.03E+05 Fe-55 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+0 0.OOE+00 O.OOE+00 Fe-59 2.73E+08 2.73E+08 2.73E+08 2.73E+08 2.73E+08 2.73E+08 2.73E+08 Co-58 3.80E+08 3.80E+08 3.80E+08 3.80E+08 3.80E+08 3.80E+08 3.80E+08 Co-60 2.45E+10 2.45E+10 2.45E+10 2.45E+10 2.45E+10 2.45E+10 2.45E+10 Ni-63 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+0 O.OOE+00 O.OOE+00 Ni-65 2.97E+05 2.97E+05 2.97E+05 2.97E+05 2.97E+05 2.97E+05 2.97E+05 Cu-64 6.05E+05 6.05E+05 6.05E+05 6.05E+05 6.05E+05 6.05E+05 6.05E+05 Zn-65 7.46E+08 7.46E+08 7.46E+08 7.46E+08 7.46E+08 7.46E+08 7.46E+08 Zn-69 O.OOE+00 O.OOE+00 O.OOE+0O O.OOE+00 O.OOE+0+/- O.OOE+00 O.OOE+00 Br-83 4.87E+03 4.87E+03 4.87E+03 4.87E+03 4.87E+03 4.87E+03 4.87E+03 Br-84 2.03E+05 2.03E+05 2.03E+05 2.03E+05 2.03E+05 2.03E+05 2.03E+05 Br-85 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+0 O.OOE+00 0.OOE+00 O.OOE+0 Rb-86 9.01E+06 9.01E+06 9.01E+06 9.01E+06 9.01E+06 9.01E+06 9.01E+06 Rb-88 .3.31E+04 3.31E+04 3.31E+04 3.31E+04 3.31E+04 3.31E+04 3.31E+04 Rb-89 1.23E+05 1.23E+05 1.23E+05 1.23E+05 1.23E+05 1.23E+05 1.23E+05 Sr-89 2.16E+04 2.16E+04 2.16E+04 2.16E+04 2.16E+04 2.16E+04 2.16E+04 Sr-90 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+0O Sr-91 2.14E+06 2.14E+06 2.14E+06 2.14E+06 2.14E+06 2.14E+06 2.14E+06 Sr-92 7.76E+05 7.76E+05 7.76E+05 7.76E+05 7.76E+05 7.76E+05 7.76E+05 Y-90 4.50E+03 4.50E+03 4.50E+03 4.50E+03 4.50E+03 4.50E+03 4.50E+03 Y-91M 1.OOE+05 1.OOE+05 1.OOE+05 1.OOE+05 1.OOE+05 1.OOE+05 1.OOE+05 Y-91 1.07E+06 1.07E+06 1.07E+06 1.07E+06 1.07E+06 1.07E+06 1.07E+06 Y-92 1.80E+05 1.80E+05 1.80E+05 1.80E+05 1.80E+05 1.80E+05 1.80E+05 Y-93 1.83E+05 1.83E+05 1.83E+05 1.83E+05 1.83E+05 1.83E+05 1.83E+05 Zr-95 2.45E+08 2.45E+08 2.45E+08 2.45E+08 2.45E+08 2.45E+08 2.45E+08 Zr-97 2.96E+06 2.96E+06 2.96E+06 2.96E+06 2.96E+06 2.96E+06 2.96E+06 Nb-95 1.37E+08 1.37E+08 1.37E+08 1.37E+08 1.37E+08 1.37E+08 1.37E+08 Mo-99 3.99E+06 3.99E+06 3.99E+06 3.99E+06 3.99E+06 3.99E+06 3.99E+06 Tc- 99M 1.84E+05 1.84E+05 1.84E+05 1.84E+05 1.84E+05 1.84E+05 1.84E+05 Tc-101 2.03E+04 2.03E+04 2.03E+04 2.03E+04 2.03E+04 2.03E+04 2.03E+04 Ru-103 1.08E+08 1.08E+08 1.08E+08 1.08E+08 1.08E+08 1.08E+08 1.08E+08 Ru-105 6.36E+05 6.36E+05 6.36E+05 6.36E+05 6.36E+05 6.36E+05 6.36E+05 Ru-106 4.22E+08 4.22E+08 4.22E+08 4.22E+08 4.22E+08 4.22E+08 4.22E+08 Ag-ill0M 3.45E+09 3.45E+09 3.45E+09 3.45E+09 3.45E+09 3.45E+09 3.45E+09 Page 11.4-24

CY-BY-1 70-301 Revision 5 Table 4-7 (Continued)

Ground Plane Dose Factors (same for all age groups)

Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Te-125M 1.56E+06 1.56E+06 1.56E+06 1.56E+06 1.56E+06 1.56E+06 1.56E+06 Te-127M 9.16E+04 9.16E+04 9.16E+04 9.16E+04 9.16E+04 9.16E+04 9.16E+04 Te-127 2.99E+03 2.99E+03 2.99E+03 2.99E+03 2.99E+03 2.99E+03 2.99E+03 Te-129M 1.98E+07 1.98E+07 1.98E+07 1.98E+07 1.98E+07 1.98E+07 1.98E+07 Te-129 2.62E+04 2.62E+04 2.62E+04 2.62E+04 2.62E+04 2.62E+04 2.62E+04 Te-131M 8.02E+06 8.02E+06 8.02E+06 8.02E+06 8.02E+06 8.02E+06 8.02E+06 Te-131 2.92E+04 2.92E+04 2.92E+04 2.92E+04 2.92E+04 2.92E+04 2.92E+04 Te-132 4.22E+06 4.22E+06 4.22E+06 4.22E+06 4.22E+06 4.22E+06 4.22E+06 1-130 5.50E+06 5.50E+06 5.50E+06 5.50E+06 5.50E+06 5.50E+06 5.50E+06 1-131 1.72E+07 1.72E+07 1.72E+07 1.72E+07 1.72E+07 1.72E+07 1.72E+07 1-132 1.25E+06 1.25E+06 1.25E+06 1.25E+06 1.25E+06 1.25E+06 1.25E+06 1-133 2.45E+06 2.45E+06 2.45E+06 2.45E+06 2.45E+06 2.45E+06 2.45E+06 1-134 4.46E+05 4.46E+05 4.46E+05 4.46E+05 4.46E+05 4.46E+05 4.46E+05 1-135 2.53E+06 2.53E+06 2.53E+06 2.53E+06 2.53E+06 2.53E+06 2.53E+06 Cs-134 6.94E+09 6.94E+09 6.94E+09 6.94E+09 6.94E+09 6.94E+09 6.94E+09 Cs-136 1.50E+08 1.50E+08 1.50E+08 1.50E+08 1.50E+08 1.50E+08 1.50E+08 Cs-137 1.76E+10 1.76E+10 1.76E+10 1.76E+10 1.76E+10 1.76E+10 1.76E+10 Cs-138 3.59E+05 3.59E+05 3.59E+05 3.59E+05 3.59E+05 3.59E+05 3.59E+05 Ba-139 1.06E+05 1.06E+05 1.06E+05 1.06E+05 1.06E+05 1.06E+05 1.06E+05 Ba-140 2.05E+07 2.05E+07 2.05E+07 2.05E+07 2.05E+07 2.05E+07 2.05E+07 Ba-141 4.17E+04 4.17E+04 4.17E+04 4.17E+04 4.17E+04 4.17E+04 4.17E+04 Ba-142 4.44E+04 4.44E+04 4.44E+04 4.44E+04 4.44E+04 4.44E+04 4.44E+04 La-140 1.92E+07 1.92E+07 1.92E+07 1.92E+07 1.92E+07 1.92E+07 1.92E+07 La-142 7.60E+05 7.60E+05 7.60E+05 7.60E+05 7.60E+05 7.60E+05 7.60E+05 Ce-141 1.37E+07 1.37E+07 1.37E+07 1.37E+07 1.37E+07 1.37E+07 1.37E+07 Ce-143 2.31E+06 2.31E+06 2.31E+06 2.31E+06 2.31E+06 2.31E+06 2.31E+06 Ce-144 6.96E+07 6.96E+07 6.96E+07 6.96E+07 6.96E+07 6.96E+07 6.96E+07 Pr-143 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 Pr-144 1.84E+03 1.84E+03 1.84E+03 1.84E+03 1.84E+03 1.84E+03 1.84E+03 Nd-147 8.48E+06 8.48E+06 8.48E+06 8.48E+06 8.48E+06 8.48E+06 8.48E+06 W-187 2.35E+06 2.35E+06 2.35E+06 2.35E+06 2.35E+06 2.35E+06 2.35E+06 Np-239 1.71E+06 1.71E+06 1.71E+06 1.71E+06 1.71E+06 1.71E+06 1.71E+06 Notes:

1) Units are M2 mrem/yr per tCi/sec.

2) All age groups are assumed to receive the same dose.

Page 11.4-25

CY-BY-1 70-301 Revision 5 Table 4-8 External Dose Factors for Standing on Contaminated Ground DFGa (mrem/hr Der DCi/ m 2)

Whole Body Whole Body Element Dose Factor Reference Element Dose Factor Reference H-3 0.00E+00 6 Be-7 5.95E-10 99 C-14 0.OOE+00 6 F-18 1.19E-08 99 Na-22 2.42E-08 99 Na-24 2.50E-08 6 Mg-27 1.14E-08 99 Mg-28 1.48E-08 99 AI-26 2.95E-08 99 AI-28 2.OOE-08 99 P-32 0.00E+00 6 CI-38 1.70E-08 99 Ar-41 1.39E-08 99 K-40 2.22E-09 99 K-42 4.64E-09 99 K-43 1.19E-08 99 Ca-47 1.14E-08 99 Sc-44 2.50E-08 99 Sc-46m 1.21 E-09 99 Sc-46 2.24E-08 99 Sc-47 1.46E-09 99 71-44 1.95E-09 99 V-48 3.21E-08 99 Cr-51 2.20E-10 6 Mn-52m 2.79E-08 99 Mn-52 3.80E-08 99 Mn-54 5.80E-09 6 Mn-56 1.10E-08 6 Fe-52 9.12E-09 99 Fe-55 0.OOE+00 6 Fe-59 8.00E-09 6 Co-57 1.65E-09 99 Co-58 7.00E-09 6 Co-60 1.70E-08 6 Ni-63 0.00E+00 6 Ni-65 3.70E-09 6 Cu-64 1.50E-09 6 Cu-67 1.52E-09 99 Cu-68 8.60E-091 Zn-65 4.00E-09 6 Zn-69m 5.06E-09 99 Zn-69 0.00E+00 6 Ga-66 2.70E-08 99 Ga-67 1.89E-09 99 Ga-68 1.24E-08 99 Ga-72 3.00E-08 99 Ge-77 1.34E-08 99 As-72 2.23E-08 99 As-73 1.16E-10 99 As-74 9.41E-09 99 As-76 6.46E-09 99 As-77 1.79E-10 99 Se-73 1.38E-08 99 Se-75 4.98E-09 99 Br-77 3.84E-09 99 Br-80 2.01E-09 99 Br-82 3.00E-08 99 Br-83 6.40E-1I 6 Br-84 1.20E-08 6 Br-85 0.00E+00 6 Kr-79 3.07E-09 99 Kr-81 1.59E-10 99 Kr-83m 1.42E-11 99 Kr-85m 2.24E-09 99 Kr-85 1.35E-10 99 Kr-87 1.03E-08 99 Kr-88 2.07E-08 99 Kr-90 1.56E-08 99 Rb-84 1.07E-08 99 Rb-86 6.30E-10 6 Rb-87 0.00E+00 99 Rb-88 3.50E-09 6 Rb-89 1.50E-08 6 Sr-85 6.16E-09 99 Sr-87m 3.92E-09 99 Sr-89 5.60E-13 6 Sr-90 1.84E-11 99 Sr-91 7.1OE-09 6 Sr-92 9.00E-09 6 Y-86 4.00E-08 99 Y-87 5.53E-09 99 Y-88 2.88E-08 99 Y-90 2.20E-12 6 Y-91m 3.80E-09 6 Y-91 2.40E-1i1 6 Y-92 1.60E-09 6 Y-93 5.70E-10 6 Zr-95 5.00E-09 6 Zr-97 5.50E-09 6 Nb-94 1.84E-08 99 Nb-95 5.10E-09 6 Nb-97m 8.57E-09 99 Nb-97 8.48E-09 99 Mo-99 1.90E-09 6 Tc-99m 9.60E-10 6 Tc-101 2.70E-09 6 Tc-104 1.83E-081 Ru-97 2.99E-09 99 Ru-1 03 3.60E-09 6 Ru-105 4.50E-09 6 Ru/Rh-1 06 5.76E-093 6,99 Pc-109 3.80E-10 99 Cc-109 1.12E-10 99 In-ill 5.11E-09 99 In-115m 2.01E-09 99 In-116 0.00E+002 Sn-1 13 1.15E-09 99 Sn-1 17m 1.96E-08 99 Sn-119m 7.05E-11 99 Sb-117 0.0OE+002 Sb-122 2.71 E-091 Sb-124 1.16E-081 Sb-125 4.56E-09 99 Sb-126 7.13E-10 99 Ag-108m 1.92E-08 99 Ag-108 1.14E-09 99 Ag-110m 1.80E-08 6 Ag-1 11 6.75E-10 99 Te-121m 2.65E-09 99 Te-121 6.75E-09 99 Te-123m 1.88E-09 99 Te-125m 3.50E-11 6 Page 11.4-26

CY-BY-1 70-301 Revision 5 Table 4-8 (cont.)

External Dose Factors for Standing on Contaminated Ground DFGi, (mrem/hr Der oCi/m M2 )

Whole Body Whole Body Element Dose Factor Reference Element- Dose Factor Reference Te-125 0.OOE+002 Te-127m 1.10E-12 6 Te-127 1.OOE-1I 6 Te-129m 7.70E-10 6 Te-129 7.10E-10 6 Te-131m 8.40E-09 6 Te-131 2.20E-09 6 Te-l-132 3.40E-096 6 Te-134 1.05E-08 99 1-123 2.12E-09 99 1-124 1.23E-08 99 1-125 2.89E-1 0 99 1-130 1.40E-08 6 1-131 2.80E-09 6 1-133 3.70E-09 6 1-134 1.60E-08 6 1-135 1.20E-08 6 Xe-127 3.44E-09 99 Xe-129m 5.57E-10 99 Xe-131 m 2.13E-10 99 Xe-133m 4.81E-10 99 Xe-133 5.91E-10 99 Xe-135m 5.23E-09 99 Xe-135 3.36E-09 99 Xe-137 4.26E-09 99 Xe- 138 1.30E-08 99 Cs-129 3.39E-09 99 Cs- 132 8.40E-09 99 Cs- 134 1.20E-08 4 6 Cs-136 1.50E-08 6 Cs-137/Ba-137m 1.14E-08 6,99 Cs- 138 2.1OE-08 6 Cs-1i39 5.15E-09 99 Ba-131 5.74E-09 99 Ba-133m 8.10E-10 99 Ba-133 4.85E-09 99 Ba-135m 7.26E-10 99 Ba-137m 7.17E-09 99 Ba-137 O.OOE+0O( Ba-139 2.40E-09 6 Ba-La-140 1.71 E-088 6 Ba-141 4.30E-09 6 Ba-142 7.90E-09 6 La-142 1.50E-08 6 Ce-1 39 2.04E-09 99 Ce-141 5.50E-10 6 Ce-143 2.20E-09 6 Ce-Pr-144 5.20E-10 7 6 Pr-142 1.84E-09 99 Pr-143 O.OOE+00 6 Nc-147 1.OOE-09 6 Nc-149 5.32E-09 99 Pm-145 3.38E-10 99 Pm-148m 2.35E-08 99 Pm-148 7.22E-09 99 Pm-149 5.32E-10 99 Sm-153 8.95E-10 99 Eu-152 1.30E-08 99 Eu-154 1.41 E-08 99 Eu-155 8.27E-10 99 Gc-1i53 1.46E-09 99 Dy-157 4.39E-09 99 Er-169 6.12E-14 99 Er-171 5.11E-09 99 Tm-170 3.41E-10 99 Yb-169 4.12E-09 99 Yb-175 4.94E-10 99 Lu-177 4.60E-1 0 99 Hf-1181 6.67E-091 99 Ta-182 1.42E-08 99 Ta- 183 2.93E-09 W-187 3.1OE-09 6 Re-188 1.89E-09 99 Os-191 9.83E-10 99 Ir-194 2.31 E-09 99 Pt-1i95m 9.79E-10 99 Pt-197 3.57E-10 99 Au-195m 2.54E-09 99 Au-195 1.14E-09 99 Au-198 5.19E-09 99 Au-199 1.18E-09 99 Hg-197 9.33E-10 99 Hg-203 2.89E-09 2 99 TI-201 1.24E-09 99 TI-206 0.OOE+00 TI-208 3.58E-08 99 Pb-203 3.88E-09 99 Pb-210 3.57E-11 99 Pb-212 1.91E-09 99 Pb-214 3.18E-09 99 BI-206 3.74E-08 99 Bi-207 1.77E-08 99 Bi-214 1.71E-08 99 Ra-226 8.78E- 1I 99 Th-232 8.14E-12 99 U-238 7.98E-12 99 Np-239 9.50E-10 6 Am-241 3.48E-10 99 1 Value derived by comparing the percentage and MeV of the nuclide's gammas and then comparing to Cesium- 137, as a value was not available in the literature.

2 0.0 due to low yield and short half-life. A value was not available in the literature.

3 Value is the sum of Ru-1 06 (1.50E-9) and Rh-1 06 (4.26E-9). The Rh-1 06 value Is from Reference 99 and the Ru-106 value Is from Reference 6.

4 Value is the sum of Cs-137 (4.20E-9) and Ba-137m (7.17E-9). The values are from references 6 and 99, respectively.

Page 11.4-27

CY-BY-1 70-301 Revision 5 Table 4-8 (cont.)

External Dose Factors for Standing on Contaminated Ground DFGIj (mrem/hr per pCi/ 2 )

5 Value is the sum of Te-132 (1.70E-9) and 1-132 (1.70E-9).

6 Value is the sum of Ba-140 (2.1OE-9) and La-140 (1.50E-8) from reference 6. In Reference 6, see Table E-6.

7 Value is the sum of Ce-144 (3.20E-10) and Pr-144 (2.OOE-10) from reference 6.

Note: Dose assessments for 10CFR20 and 40CFR190 compliance are made for an adult only.

Dose assessments for 10CFR50 Appendix are made using dose factors of Regulatory Guide 1.109 (Reference

6) for all age groups.

Page 11.4-28

CY-BY-1 70-301 Revision 5 Table 4-9 Adult Inhalation Dose Factors Nucide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 O.OOE+00 7.18E+02 7.18E+02 7.18E+02 7.18E+02 7.18E+02 7.18E+02 Na-24 1.02E+04 1.02E+04 1.02E+04 1.02E+04 1.02E+04 1.02E+04 1.02E+04 Cr-51 O.OOE+00 O.OOE+00 1.00E+02 5.95E+01 2.28E+01 1.44E+04 3.32E+03 Mn-54 0.OOE+00 3.96E+04 6.30E+03 O.OOE+0O 9.84E+03 1.40E+06 7.74E+04 Mn-56 0.OOE+00 1.24E+00 1.83E-01 O.OOE+0O 1.30E+0O 9.44E+03 2.02E+04 Fe-55 2.46E+04 1.70E+04 3.94E+03 O.OOE+0O O.OOE+0O 7.21E+04 6.03E+03 Fe-59 1.18E+04 2.78E+04 1.06E+04 O.OOE+00 O.OOE+0O 1.02E+06 1.88E+05 Co-58 O.OOE+00 1.58E+03 2.07E+03 O.OOE+0O O.OOE+0O 9.28E+05 1.06E+05 Co-60 0.OOE+00 1.15E+04 1.48E+04 O.OOE+00 O.OOE+00 5.97E+06 2.85E+05 Ni-63 4.32E+05 3.14E+04 1.45E+04 O.OOE+0O O.OOE+00 1.78E+05 1.34E+04 Ni-65 1.54E+00 2.10E-01 9.12E-02 O.OOE+0O O.OOE+00 5.60E+03 1.23E+04 Cu-64 O.OOE+00 1.46E+00 6.15E-01 O.OOE+0O 4.62E+00 6.78E+03 4.90E+04 Zn-65 3.24E+04 1.03E+05 4.66E+04 O.OOE+0O 6.90E+04 8.64E+05 5.34E+04 Zn-69 3.38E-02 6.51E-02 4.52E-03 O.OOE+00 4.22E-02 9.20E+02 1.63E+01 Br-83 O.OOE+00 O.OOE+00 2.41E+02 O.OOE+00 0.OOE+00 0.OOE+00 2.32E+02 Br-84 O.OOE+00 O.OOE+00 3.13E+02 O.OOE+00 O.OOE+00 0.OOE+00 1.64E-03 Br-85 0.OOE+00 O.OOE+00 1.28E+01 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 Rb-86 O.OOE+00 1.35E+05 5.90E+04 O.OOE+00 O.OOE+00 0.OOE+00 1.66E+04 Rb-88 O.OOE+00 3.87E+02 1.93E+02 O.OOE+00 O.OOE+00 0.OOE+00 3.34E-09 Rb-89 O.OOE+00 2.56E+02 1.70E+02 O.OOE+00 O.OOE+00 O.OOE+00 9.28E- 12 Sr-89 3.04E+05 0.OOE+00 8.72E+03 0.00E+00 O.OOE+00 1.40E+06 3.50E+05 Sr-90 2.87E+07 O.OOE+00 5.77E+05 O.OOE+00 O.OOE+00 9.60E+06 7.22E+05 Sr-91 6.19E+01 0.OOE+00 2.50E+00 O.OOE+00 O.OOE+00 3.65E+04 1.91E+05 Sr-92 6.74E+00 0.OOE+00 2.91E-01 O.OOE+00 O.OOE+00 1.65E+04 4.30E+04 Y-90 2.09E+03 O.OOE+00 5.61E+01 O.OOE+00 O.OOE+00 1.70E+05 5.06E+05 Y-91M 2.61E-01 O.OOE+00 1.02E-02 O.OOE+00 O.OOE+00 1.92E+03 1.33E+00 Y-91 4.62E+05 O.OOE+00 1.24E+04 0.OOE+00 0.OOE+00 1.70E+06 3.85E+05 Y-92 1.03E+01 O.OOE+00 3.02E-01 0.OOE+00 O.OOE+00 1.57E+04 7.35E+04 Y-93 9.44E+01 O.OOE+00 2.61E+00 0.OOE+00 O.OOE+00 4.85E+04 4.22E+05 Zr-95 1.07E+05 3.44E+04 2.33E+04 O.OOE+00 5.42E+04 1.77E+06 1.50E+05 Zr-97 9.68E+01 1.96E+01 9.04E+00 O.OOE+00 2.97E+01 7.87E+04 5.23E+05 Nb-95 1.41E+04 7.82E+03 4.21E+03 O.OOE+00 7.74E+03 5.05E+05 1.04E+05 Mo-99 O.OOE+00 1.21E+02 2.30E+01 O.OOE+00 2.91E+02 9.12E+04 2.48E+05 Tc- 99M 1.03E-03 2.91E-03 3.70E-02 O.OOE+00 4.42E-02 7.64E+02 4.16E+03 Tc-101 4.18E-05 6.02E-05 5.90E-04 O.OOE+00 1.08E-03 3.99E+02 1.09E-1 1 Ru-103 1.53E+03 O.OOE+00 6.58E+02 O.OOE+00 5.83E+03 5.05E+05 1.10E+05 Ru-105 7.90E-01 0.OOE+00 3.11 E-01 0.OOE+00 1.02E+00 1.1OE+04 4.82E+04 Ru-106 6.91E+04 O.OOE+00 8.72E+03 O.OOE+00 1.34E+05 9.36E+06 9.12E+05 Ag- I1OM 1.08E+04 1.00E+04 5.94E+03 O.OOE+00 1.97E+04 4.63E+06 3.02E+05 Page 11.4-29

CY-BY-1 70-301 Revision 5 Table 4-9 (Continued) 1 Adult Inhalation Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Luna GI-LLI Te-125M 3.42E+03 1.58E+03 4.67E+02 1.05E+03 1.24E+04 3.14E+05 7.06E+04 Te-127M 1.26E+04 5.77E+03 1.57E+03 3.29E+03 4.58E+04 9.60E+05 1.50E+05 Te-127 1.40E+00 6.42E-01 3.10E-01 1.06E+00 5.10E+00 6.51E+03 5.74E+04 Te-129M 9.76E+03 4.67E+03 1.58E+03 3.44E+03 3.66E+04 1.16E+06 3.83E+05 Te-129 4.98E-02 2.39E-02 1.24E-02 3.90E-02 1.87E-01 1.94E+03 1.57E+02 Te-131M 6.99E+01 4.36E+01 2.90E+01 5.50E+01 3.09E+02 1.46E+05 5.56E+05 Te-131 1.11E-02 5.95E-03 3.59E-03 9.36E-03 4.37E-02 1.39E+03 1.84E+01 Te-132 2.60E+02 2.15E+02 1.62E+02 1.90E+02 1.46E+03 2.88E+05 5.1OE+05 1-130 4.58E+03 1.34E+04 5.28E+03 1.14E+06 2.09E+04 0.OOE+00 7.69E+03 1-131 2.52E+04 3.58E+04 2.05E+04 1.19E+07 6.13E+04 O.OOE+00 6.28E+03 1-132 1.16E+03 3.26E+03 1.16E+03 1.14E+05 5.18E+03 0.OOE+00 4.06E+02 1-133 8.64E+03 1.48E+04 4.52E+03 2.15E+06 2.58E+04 O.OOE+00 8.88E+03 1-134 6.44E+02 1.73E+03 6.15E+02 2.98E+04 2.75E+03 0.OOE+00 1.01E+00 1-135 2.68E+03 6.98E+03 2.57E+03 4.48E+05 1.11E+04 0.OOE+00 5.25E+03 Cs-134 3.73E+05 8.48E+05 7.28E+05 O.OOE+00 2.87E+05 9.76E+04 1.04E+04 Cs-136 3.90E+04 1.46E+05 1.10E+05 O.OOE+00 8.56E+04 1.20E+04 1.17E+04 Cs-137 4.78E+05 6.21E+05 4.28E+05 O.OOE+00 2.22E+05 7.52E+04 8.40E+03 Cs-138 3.31E+02 6.21E+02 3.24E+02 0.OOE+00 4.80E+02 4.86E+01 1.86E-03 Ba-139 9.36E-01 6.66E-04 2.74E-02 0.OOE+00 6.22E-04 3.76E+03 8.96E+02 Ba-140 3.90E+04 4.90E+01 2.57E+03 0.OOE+00 1.67E+01 1.27E+06 2.18E+05 Ba-141 1.OOE-01 7.53E-05 3.36E-03 0.OOE+00 7.OOE-05 1.94E+03 1.16E-07 Ba-142 2.63E-02 2.70E-05 1.66E-03 O.OOE+00 2.29E-05 1.19E+03 1.57E-16 La-140 3.44E+02 1.74E+02 4.58E+01 0.OOE+00 0.OOE+00 1.36E+05 4.58E+05 La-142 6.83E-01 3.10E-01 7.72E-02 0.OOE+00 0.OOE+00 6.33E+03 2.11E+03 Ce-141 1.99E+04 1.35E+04 1.53E+03 O.OOE+00 6.26E+03 3.62E+05 1.20E+05 Ce-143 1.86E+02 1.38E+02 1.53E+01 0.OOE+00 6.08E+01 7.98E+04 2.26E+05 Ce-144 3.43E+06 1.43E+06 1.84E+05 O.OOE+00 8.48E+05 7.78E+06 8.16E+05 Pr-143 9.36E+03 3.75E+03 4.64E+02 0.OOE+00 2.16E+03 2.81E+05 2.OOE+05 Pr-144 3.01E-02 1.25E-02 1.53E-03 O.OOE+00 7.05E-03 1.02E+03 2.15E-08 Nd-147 5.27E+03 6.10E+03 3.65E+02 O.OOE+00 3.56E+03 2.21E+05 1.73E+05 W-187 8.48E+00 7.08E+00 2.48E-00 0.00E+00 0.OOE+00 2.90E+04 1.55E+05 Np-239 2.30E+02 2.03E+02 1.24E+01 0.OOE+00 7.OOE+01 3.76E+04 1.19E+05 Notes:

1) Units are mrem/yr per IRCi/m 3.

Page 11.4-30

CY-BY-1 70-301 Revision 5 Table 4-10 Teen Inhalation Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 0.OOE+00 7.25E+02 7.25E+02 7.25E+02 7.25E+02 7.25E+02 7.25E+02 Na-24 1.38E+04 1.38E+04 1.38E+04 1.38E+04 1.38E+04 1.38E+04 1.38E+04 Cr-51 0.OOE+0O 0.OOE+00 1.35E+02 7.50E+01 3.07E+01 2.10E+04 3.OOE+03 Mn-54 O.OOE+00 5.11 E+04 8.40E+03 0.OOE+00 1.27E+04 1.98E+06 6.68E+04 Mn-56 0.00E+00 1.70E+00 2.52E-01 0.OOE+00 1.79E+00 1.52E+04 5.74E+04 Fe-55 3.34E+04 2.38E+04 5.54E+/-03 0.OOE+00 O.OOE+00 1.24E+05 6.39E+03 Fe-59 1.59E+04 3.70E+04 1.43E+04 0.OOE+00 O.OOE+00 1.53E+06 1.78E+05 Co-58 O.OOE+00 2.07E+03 2.78E+03 O.OOE+00 O.OOE+00 1.34E+06 9.52E+04 Co-60 O.OOE+00 1.51E+04 1.98E+04 0.OOE+00 0.OOE+00 8.72E+06 2.59E+05 Ni-63 5.80E+05 4.34E+04 1.98E+04 O.OOE+00 0.OOE+00 3.07E+05 1.42E+04 Ni-65 2.18E+00 2.93E-01 1.27E-01 O.OOE+00 O.OOE+00 9.36E+03 3.67E+04 Cu-64 0.OOE+00 2.03E+00 8.48E-01 0.OOE+00 6.41E+00 1.I1E+04 6.14E+04 Zn-65, 3.86E+04 1.34E+05 6.24E+04 0.00E+00 8.64E+04 1.24E+06 4.66E+04 Zn-69 4.83E-02 9.20E-02 6.46E-03 0.OOE+00 6.02E-02 1.58E+03 2.85E+02 Br-83 0.OOE+00 0.OOE+00 3.44E+02 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Br-84 0.OOE+00 O.OOE+00 4.33E+02 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Br-85 0.OOE+00 O.OOE+00 1.83E+01 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Rb-86 O.OOE+00 1.90E+05 8.40E+04 0.OOE+00 0.OOE+00 0.OOE+00 1.77E+04 Rb-88 0.OOE+00 5.46E+02 2.72E+02 0.OOE+00 0.OOE+00 O.OOE+00 2.92E-05 Rb-89 O.OOE+00 3.52E+02 2.33E+02 0.OOE+00 0.OOE+00 O.OOE+00 3.38E-07 Sr-89 4.34E+05 0.OOE+00 1.25E+04 O.OOE+00 O.OOE+00 2.42E+06 3.71E+05 Sr-90 3.31 E+07 O.OOE+00 6.66E+05 0.OOE+00 O.OOE+00 1.65E+07 7.65E+05 Sr-91 8.80E+01 0.OOE+00 3.51E+00 0.OOE+00 O.OOE+00 6.07E+04 2.59E+05 Sr-92 9.52E+00 0.OOE+00 4.06E-01 0.OOE+00 O.OOE+00 2.74E+04 1.19E+05 Y-90 2.98E+03 O.OOE+00 8.OOE+01 0.OOE+00 O.OOE+00 2.93E+05 5.59E+05 Y-91M 3.70E-01 0.OOE+00 1.42E-02 0.OOE+00 O.OOE+00 3.20E+03 3.02E,01 Y-91 6.61E+05 0.OOE+00 1.77E+04 0.OOE+00 0.OOE+00 2.94E+06 4.09E+05 Y-92 1.47E+01 0.OOE+00 4.29E-01 O.OOE+00 O.OOE+00 2.68E+04 1.65E+05 Y-93 1.35E+02 O.OOE+00 3.72E+00 0.OOE+00 0.OOE+00 8.32E+04 5.79E+05 Zr-95 1.46E+05 4.58E+04 3.15E+-04 O.OOE+00 6.74E+04 2.69E+06 1.49E+05 Zr-97 1.38E+02 2.72E+01 1.26E+01 O.OOE+00 4.12E+01 1.30E+05 6.30E+05 Nb-95 1.86E+04 1.03E+04 5.66E+03 O.OOE+0O 1.00E+04 7.51E+05 9.68E+04 Mo-99 0.OOE+00 1.69E+02 3.22E+O1 O.OOE+00 4.11E+02 1.54E+05 2.69E+05 Tc- 99M 1.38E-03 3.86E-03 4.99E-02 O.OOE+00 5.76E-02 1.15E+03 6.13E+03 Tc-101 5.92E-05 8.40E-05 8.24E-04 0.OOE+00 1.52E-03 6.67E+02 8.72E-07 Ru-103 2.10E+03 O.OOE+00 8.96E+02 0.OOE+00 7.43E+03 7.83E+05 1.09E+05 Ru-105 1.12E+00 0.OOE+00 4.34E-01 O.OOE+00 1.41E+00 1.82E+04 9.04E+04 Ru-106 9.84E+04 0.OOE+00 1.24E+04 O.OOE+00 1.90E+05 1.61E+07 9.60E+05 jAg-10M 1.38E+04 1.3 1E+04 7.99E+03 0.OOE+00 2.50E+04 6.75E+06 2.73E+05 Page 11.4-31

CY-BY-1 70-301 Revision 5 Table 4-10 (Continued) I Teen Inhalation Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Te-125M 4.88E+03 2.24E+03 6.67E+02 1.40E+03 O.OOE+00 5.36E+05 7.50E+04 Te-127M 1.80E+04 8.16E+03 2.18E+03 4.38E+03 6.54E+04 1.66E+06 1.59E+05 Te-127 2.01E+00 9.12E-01 4.42E-01 1.42E+00 7.28E+00 1.12E+04 8.08E+04 Te-129M 1.39E+04 6.58E+03 2.25E+03 4.58E+03 5.19E+04 1.98E+06 4.05E+05 Te-129 7.10E-02 3.38E-02 1.76E-02 5.18E-02 2.66E-01 3.30E+03 1.62E+03 Te-131M 9.84E+01 6.01E+01 4.02E+01 7.25E+01 4.39E+02 2.38E+05 6.21E+05 Te-131 1.58E-02 8.32E-03 5.04E-03 1.24E-02 6.18E-02 2.34E+03 1.51E+01 Te-132 3.60E+02 2.90E+02 2.19E+02 2.46E+02 1.95E+03 4.49E+05 4.63E+05 1-130 6.24E+03 1.79E+04 7.17E+03 1.49E+06 2.75E+04 0.OOE+00 9.12E+03 1-131 3.54E+04 4.91E+04 2.64E+04 1.46E+07 8.40E+04 O.OOE+00 6.49E+03 1-132 1.59E+03 4.38E+03 1.58E+03 1.51E+05 6.92E+03 O.OOE+00 1.27E+03 1-133 1.22E+04 2.05E+04 6.22E+03 2.92E+06 3.59E+04 O.OOE+00 1.03E+04 1-134 8.88E+02 2.32E+03 8.40E+02 3.95E+04 3.66E+03 0.OOE+00 2.04E+01 1-135 3.70E+03 9.44E+03 3.49E+03 6.21E+05 1.49E+04 O.OOE+00 6.95E+03 Cs-134 5.02E+05 1.13E+06 5.49E+05 O.OOE+00 3.75E+05 1.46E+05 9.76E+03 Cs-136 5.15E+04 1.94E+05 1.37E+05 0.OOE+00 1.10E+05 1.78E+04 1.09E+04 Cs-137 6.70E+05 8.48E+05 3.11E+05 0.OOE+00 3.04E+05 1.21E+05 8.48E+03 Cs-138 4.66E+02 8.56E+02 4.46E+02 O.OOE+00 6.62E+02 7.87E+01 2.70E-01 Ba-139 1.34E+00 9.44E-04 3.90E-02 0.OOE+00 8.88E-04 6.46E+03 6.45E+03 Ba-140 5.47E+04 6.70E+01 3.52E+03 0.OOE+00 2.28E+01 2.03E+06 2.29E+05 Ba-141 1.42E-01 1.06E-04 4.74E-03 O.OOE+0 9.84E-05 3.29E+03 7.46E-04 Ba-142 3.70E-02 3.70E-05 2.27E-03 O.OOE+0O 3.14E-05 1.91E+03 4.79E-10 La-140 4.79E+02 2.36E+02 6.26E+01 O.OOE+00 O.OOE+00 2.14E+05 4.87E+05 La-142 9.60E-01 4.25E-01 1.06E-01 0.OOE+00 0.OOE+00 1.02E+04 1.20E+04 Ce-141 2.84E+04 1.90E+04 2.17E+03 0.OOE+00 8.88E+03 6.14E+05 1.26E+05 Ce-143 2.66E+02 1.94E+02 2.16E+01 0.OOE+00 8.64E+01 1.30E+05 2.55E+05 Ce-144 4.89E+06 2.02E+06 2.62E+05 0.OOE+00 1.21E+06 1.34E+07 8.64E+05 Pr-143 1.34E+04 5.31E+03 6.62E+02 0.OOE+00 3.09E+03 4.83E+05 2.14E+05 Pr-144 4.30E-02 1.76E-02 2.18E-03 0.OOE+00 1.01E-02 1.75E+03 2.35E-04 Nd-147 7.86E+03 8.56E+03 5.13E+02 O.OOE+00 5.02E+03 3.72E+05 1.82E+05 W-187 1.20E+01 9.76E+00 3.43E+00 0.OOE+00 0.OOE+00 4.74E+04 1.77E+05 Np-239 3.38E+02 2.88E+02 1.77E+01 0.OOE+00 1.OOE+02 6.49E+04 1.32E+05 Notes:

1) Units are mrem/yr per g.Ci/m 3.

Page 11.4-32

CY-BY-170-301 Revision 5 Table 4-11 Child Inhalation Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lunp. GI-LLI H-3 O.OOE+00 6.40E+02 6.40E+02 6.40E+02 6.40E+02 6.40E+02 6.40E+02 Na-24 1.61E+04 1.61E+04 1.61E+04 1.61E+04 1.61E+04 1.61E+04 1.61E+04 Cr-51 O.OOE+00 O.OOE+00 1.54E+02 8.55E+01 2.43E+01 1.70E+04 1.08E+03 Mn-54 O.OOE+00 4.29E+04 9.51E+03 O.OOE+00 1.OOE+04 1.58E+06 2.29E+04 Mn-56 0.OOE+00 1.66E+00 3.12E-01 O.OOE+00 1.67E+00 1.31E+04 1.23E+05 Fe-55 4.74E+04 2.52E+04 7.77E+03 O.OOEO00 O.OOE+00 1.11 E+05 2.87E+03 Fe-59 2.07E+04 3.34E+04 1.67E+04 O.OOE+00 O.OOE+00 1.27E+06 7.07E+04 Co-58 O.OOE+00 1.77E+03 3.16E+03 O.OOE+00 O.OOE+00 1.11E+06 3.44E+04 Co-60 O.OOE+00 1.31E+04 2.26E+04 O.OOE+00 O.OOE+00 7.07E+06 9.62E+04 Ni-63 8.21E+05 4.63E+04 2.80E+04 O.OOE+00 O.OOE+00 2.75E+05 6.33E+03 Ni-65 2.99E+00 2.96E-01 1.64E-01 O.OOE+00 O.OOE+00 8.18E+03 8.40E+04 Cu-64 O.OOE+00 1.99E+00 1.07E+00 O.OOE+00 6.03E+00 9.58E+03 3.67E+04 Zn-65 4.26E+04 1.13E+05 7.03E+04 O.OOE+00 7.14E+04 9.95E+05 1.63E+04 Zn-69 6.70E-02 9.66E-02 8.92E-03 O.OOE+00 5.85E-02 1.42E+03 1.02E+04 Br-83 O.OOE+00 0.OOE+00 4.74E+02 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 Br-84 O.OOE+00 0.OOE+00 5.48E+02 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 Br-85 O.OOE+00 O.OOE+00 2.53E+01 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 Rb-86 O.OOE+00 1.98E+05 1.14E+05 O.OOE+00 O.OOE+00 O.OOE+00 7.99E+03 Rb-88 0.OOE+00 5.62E+02 3.66E+02 O.OOE+00 O.OOE+00 0.OOE+00 1.72E+01 Rb-89 0.OOE+00 3.45E+02 2.90E+02 O.OOE+00 O.OOE+00 0.OOE+0O 1.89E+00 Sr-89 5.99E+05 0.OOE+00 1.72E+04 O.OOE+00 O.OOE+00 2.16E+06 1.67E+05 Sr-90 3.85E+07 0.OOE+00 7.66E+05 O.OOE+00 O.OOE+00 1.48E+07 3.43E+05 Sr-91 11.21E+02 O.OOE+00 4.59E+00 O.OOE+00 O.OOE+00 5.33E+04 1.74E+05 Sr-92 1.31E+01 O.OOE+00 5.25E-01 O.OOE+0 O.OOE+00 2.40E+04 2.42E+05 Y-90 4.11E+03 0.OOE+00 1.11E+02 O.OOE+0 O.OOE+00 2.62E+05 2.68E+05 Y-91M 5.07E-01 0.OOE+00 1.84E-02 O.OOE+00 O.OOE+00 2.81E+03 1.72E+03 Y-91 9.14E+05 O.OOE+00 2.44E+04 O.OOE+00 O.OOE+00 2.63E+06 1.84E+05 Y-92 2.04E+01 0.OOE+00 5.81E-01 O.OOE+00 O.OOE+00 2.39E+04 2.39E+05 Y-93 1.86E+02 O.OOE+00 5.11E+00 O.OOE+0O 0.OOE+O0 7.44E+04 3.89E+05 Zr-95 1.90E+05 4.18E+04 3.70E+04 O.OOE+00 5.96E+04 2.23E+06 6.1 1E+04 Zr-97 1.88E+02 2.72E+01 1.60E+01 0.OOE+00 3.89E+01 1.13E+05 3.51E+05 Nb-95 2.35E+04 9.18E+03 6.55E+03 O.OOE+00 8.62E+03 6.14E+05 3.70E+04 Mo-99 O.OOE+00 1.72E+02 4.26E+01 O.OOE+00 3.92E+02 1.35E+05 1.27E+05 Tc- 99M 1.78E-03 3.48E-03 5.77E-02 O.OOE+00 5.07E-02 9.5 1E+02 4.81E+03 Tc-101 8.10E-05 8.51E-05 1.08E-03 O.OOE+00 1.45E-03 5.85E+02 1.63E+01 Ru-103 2.79E+03 O.OOE+00 1.07E+03 O.OOE+00 7.03E+03 6.62E+05 4.48E+04 Ru-105 1.53E+00 O.OOE+0 5.55E-01 O.OOE+00 1.34E+00 1.59E+04 9.95E+04 Ru-106 1.36E+05 0.OOE+0 1.69E+04 O.OOE+00 1.84E+O5 1.43E+07 4.29E+05 Ag;11MI 1.69E+04 1.14E+04 9.14E+03 O.OOE+00 2.12E+04 5.48E+06 1.OOE+05 Page 11.4-33

CY-BY-1 70-301 Revision 5 Table 4-11 (Continued) I Child Inhalation Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Te-125M 6.73E+03 2.33E+03 9.14E+02 1.92E+03 O.OOE+O0 4.77E+/-05 3.38E+04 Te-127M 2.49E+04 8.55E+03 3.02E+03 6.07E+03 6.36E+04 1.48E+06 7.14E+04 Te-127 2.77E+00 9.51E-01 6.11E-01 1.96E+00 7.07E+00 1.00E+04 5.62E+04 Te-129M 1.92E+04 6.85E+03 3.04E+03 6.33E+03 5.03E+04 1.76E+06 1.82E+05 Te-129 9.77E-02 3.50E-02 2.38E-02 7.14E-02 2.57E-01 2.93E+03 2.55E+04 Te-131M 1.34E+02 5.92E+01 5.07E+01 9.77E+01 4.OOE+02 2.06E+05 3.08E+05 Te-131 2.17E-02 8.44E-03 6.59E-03 1.70E-02 5.88E-02 2.05E+03 1.33E+03 Te-132 4.81E+02 2.72E+02 2.63E+02 3.17E+02 1.77E+03 3.77E+05 1.38E+05 1-130 8.18E+03 1.64E+04 8.44E+03 1.85E+06 2.45E+04 O.OOE+00 5.1 1E+03 1-131 4.81E+04 4.81E+04 2.73E+04 1.62E+07 7.88E+04 0.OOE+00 2.84E+03 1-132 2.12E+03 4.07E+03 1.88E+03 1.94E+05 6.25E+03 0.OOE+00 3.20E+03 1-133 1.66E+04 2.03E+04 7.70E+03 3.85E+06 3.38E+04 O.OOE+00 5.48E+03 1-134 1.17E+03 2.16E+03 9.95E+02 5.07E+04 3.30E+03 O.OOE+00 9.55E+02 1-135 4.92E+03 8.73E+03 4.14E+03 7.92E+05 1.34E+04 0.OOE+00 4.44E+03 Cs-134 6.51E+05 1.01E+06 2.25E+05 O.OOE+00 3.30E+05 1.21E+05 3.85E+03 Cs-136 6.51E+04 1.71E+05 1.16E+05 0.OOE+00 9.55E+04 1.45E+04 4.18E+03 Cs-137 9.07E+05 8.25E+05 1.28E+05 O.OOE+00 2.82E+05 1.04E+05 3.62E+03 Cs-138 6.33E+02 8.40E+02 5.55E+02 O.OOE+00 6.22E+02 6.81E+01 2.70E+02 Ba-139 1.84E+00 9.84E-04 5.37E-02 O.OOE+00 8.62E-04 5.77E+03 5.77E+04 Ba-140 7.40E+04 6.48E+01 4.33E+03 O.OOE+00 2.1 1E+01 1.74E+06 1.02E+05 Ba-141 1.96E-01 1.09E-04 6.36E-03 O.OOE+00 9.47E-05 2.92E+03 2.75E+02 Ba-142 5.OOE-02 3.60E-05 2.79E-03 O.OOE+00 2.91E-05 1.64E+03 2.74E+00 La-140 6.44E+02 2.25E+02 7.55E+01 O.OOE+00 O.OOE+00 1.83E+05 2.26E+05 La-142 1.30E+00 4.1 IE-01 1.29E-01 O.OOE+00 O.OOE+00 8.70E+03 7.59E+04 Ce-141 3.92E+04 1.95E+04 2.90E+03 O.OOE+00 8.55E+03 5.44E+05 5.66E+04 Ce-143 3.66E+02 1.99E+02 2.87E+01 0.OOE+00 8.36E+01 1.15E+05 1.27E+05 Ce-144 6.77E+06 2.12E+06 3.61E+05 0.OOE+00 1.17E+06 1.20E+07 3.89E+05 Pr-143 1.85E+04 5.55E+03 9.14E+02 O.OOE+00 3.OOE+03 4.33E+05 9.73E+04 Pr-144 5.96E-02 1.85E-02 3.OOE-03 O.OOE+0+/- 9.77E-03 1.57E+03 1.97E+02 Nd-147 1.08E+04 8.73E+03 6.81E+02 0.OOE+0 4.81E+03 3.28E+05 8.21E+04 W-187 1.63E+01 9.66E+00 4.33E+00 O.OOE+0 O.OOE+00 4.11E+04 9.1OE+04 Np-239 4.66E+02 3.01E+02 2.35E+01 O.OOE+00 9.73E+01 5.81E+04 6.40E+04 Notes:

1) Units are mrem/yr per gCi/m 3 .

Page 11.4-34

CY-BY-1 70-301 Revision 5 Table 4-12 Infant Inhalation Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 O.OOE+00 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 3.68E+02 Na-24 1.06E+04 1.06E+04 1.06E+04 1.06E+04 1.06E+04 1.06E+04 1.06E+04 Cr-51 O.OOE+00 0.OOE+00 8.95E+01 5.75E+01 1.32E+01 1.28E+04 3.57E+02 Mn-54 0.OOE+00 2.53E+04 4.98E+03 O.OOE+00 4.98E+03 1.00E+06 7.06E+03 Mn-56 O.OOE+00 1.54E+00 2.21E-01 0.OOE+00 1.10E+00 1.25E+04 7.17E+04 Fe-55 1.97E+04 1.17E+04 3.33E+03 0.OOE+00 O.OOE+00 8.69E+04 1.09E+03 Fe-59 1.36E+04 2.35E+04 9.48E+03 0.OOE+00 O.OOE+00 1.02E+06 2.48E+04 Co-58 O.OOE+00 1.22E+03 1.82E+03 0.OOE+00 O.OOE+00 7.77E+05 1.11E+04 Co-60 O.OOE+00 8.02E+03 1.18E+04 O.OOE+00 O.OOE+00 4.51E+06 3.19E+04 Ni-63 3.39E+05 2.04E+04 1.16E+04 O.OOE+00 O.OOE+00 2.09E+05 2.42E+03 Ni-65 2.39E+00 2.84E-01 1.23E-01 0.OOE+00 O.OOE+00 8.12E+03 5.01E+04 Cu-64 O.OOE+00 1.88E+00 7.74E-01 0.OOE+00 3.98E+00 9.30E+03 1.50E+04 Zn-65 1.93E+04 6.26E+04 3.11E+04 0.OOE+00 3.25E+04 6.47E+05 5.14E+04 Zn-69 5.39E-02 9.67E-02 7.18E-03 O.OOE+00 4.02E-02 1.47E+03 1.32E+04 Br-83 O.OOE+00 0.OOE+00 3.81E+02 0.OOE+00 O.OOE+00 O.OOE+0+/- 0.OOE+00 Br-84 O.OOE+00 0.OOE+00 4.OOE+02 O.OOE+00 O.OOE+00 O.OOE+0+/- 0.OOE+00 Br-85 O.OOE+00 0.OOE+00 2.04E+01 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 Rb-86 0.OOE+00 1.90E+05 8.82E+04 0.OOE+00 O.OOE+00 O.OOE+00 3.04E+03 Rb-88 O.OOE+00 5.57E+02 2.87E+02 0.OOE+00 O.OOE+00 0.OOE+0O 3.39E+02 Rb-89 O.OOE+00 3.21E+02 2.06E+02 O.OOE+00 0.OOE+00 O.OOE+0O 6.82E+01 Sr-89 3.98E+05 O.OOE+00 1.14E+04 O.OOE+00 O.OOE+00 2.03E+06 6.40E+04 Sr-90 1.55E+07 O.OOE+00 3.12E+05 O.OOE+00 O.OOE+00 1.12E+07 1.31E+05 Sr-91 9.56E+01 O.OOE+00 3.46E+0O 0.OOE+00 0.OOE+00 5.26E+04 7.34E+04 Sr-92 1.05E+01 0.OOE+00 3.91E-01 O.OOE+00 O.OOE+00 2.38E+04 1.40E+05 Y-90 3.29E+03 0.OOE+00 8.82E+01 O.OOE+00 O.OOE+00 2.69E+05 1.04E+05 Y-91M 4.07E-01 O.OOE+00 1.39E-02 O.OOE+00 O.OOE+00 2.79E+03 2.35E+03 Y-91 5.88E+05 O.OOE+00 1.57E+04 0.OOE+00 O.OOE+00 2.45E+06 7.03E+04 Y-92 1.64E+01 O.OOE+00 4.61E-01 O.OOE+00 O.OOE+00 2.45E+04 1.27E+05 Y-93 1.50E+02 O.OOE+00 4.07E+00 O.OOE+00 O.OOE+00 7.64E+04 1.67E+05 Zr-95 1.15E+05 2.79E+04 2.03E+04 O.OOE+00 3.11E+04 1.75E+06 2.17E+04 Zr-97 1.50E+02 2.56E+01 1.17E+01 O.OOE+00 2.59E+01 1.10E+05 1.40E+05 Nb-95 1.57E+04 6.43E+03 3.78E+03 O.OOE+00 4.72E+03 4.79E+05 1.27E+04 Mo-99 O.OOE+00 1.65E+02 3.23E+01 O.OOE+00 2.65E+02 1.35E+05 4.87E+04 Tc- 99M 1.40E-03 2.88E-03 3.72E-02 O.OOE+00 3.1 1E-02 8.1 1E+02 2.03E+03 Tc-101 6.51E-05 8.23E-05 8.12E-04 0.OOE+00 9.79E-04 5.84E+02 8.44E+02 Ru-103 2.02E+03 O.OOE+00 6.79E+02 O.OOE+00 4.24E+03 5.52E+05 1.61E+04 Ru-105 1.22E+00 0.OOE+00 4.10E-01 O.OOE+00 8.99E-01 1.57E+04 4.84E+04 Ru-106 8.68E+04 0.OOE+00 1.09E+04 O.OOE+00 1.07E+05 1.16E+07 1.64E+05 jAg-11MI 9.98E+03 7.22E+03 5.OOE+03 O.OOE+00 1.09E+04 3.67E+06 3.30E+04 Page 11.4-35

CY-BY-1 70-301 Revision 5 Table 4-12 (Continued) I Infant Inhalation Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Luniz GI-LLI Te-125M 4.76E+03 1.99E+03 6.58E+02 1.62E+03 0.OOE+00 4.47E+05 1.29E+04 Te-127M 1.67E+04 6.90E+03 2.07E+03 4.87E+03 3.75E+04 1.31E+06 2.73E+04 Te-127 2.23E+00 9.53E-01 4.89E-01 1.85E+00 4.86E+00 1.03E+04 2.44E+04 Te-129M 1.41E+04 6.09E+03 2.23E+03 5.47E+03 3.18E+04 1.68E+06 6.90E+04 Te-129 7.88E-02 3.47E-02 1.88E-02 6.75E-02 1.75E-01 3.OOE+03 2.63E+04 Te-131M 1.07E+02 5.50E+01 3.63E+01 8.93E+01 2.65E+02 1.99E+05 1.19E+05 Te-131 1.74E-02 8.22E-03 5.OOE-03 1.58E-02 3.99E-02 2.06E+03 8.22E+03 Te-132 3.72E+02 2.37E+02 1.76E+02 2.79E+02 1.03E+03 3.40E+05 4.41E+04 1-130 6.36E+03 1.39E+04 5.57E+03 1.60E+06 1.53E+04 0.OOE+00 1.99E+03 1-131 3.79E+04 4.44E+04 1.96E+04 1.48E+07 5.18E+04 0.OOE+00 1.06E+03 1-132 1.69E+03 3.54E+03 1.26E+03 1.69E+05 3.95E+03 O.OOE+00 1.90E+03 1-133 1.32E+04 1.92E+04 5.60E+03 3.56E+06 2.24E+04 0.OOE+00 2.16E+03 1-134 9.21E+02 1.88E+03 6.65E+02 4.45E+04 2.09E+03 O.OOE+00 1.29E+03 1-135 3.86E+03 7.60E+03 2.77E+03 6.96E+05 8.47E+03 O.OOE+00 1.83E+03 Cs-134 3.96E+05 7.03E+05 7.45E+04 0.OOE+00 1.90E+05 7.97E+04 1.33E+03 Cs-136 4.83E+04 1.35E+05 5.29E+04 0.OOE+00 5.64E+04 1.18E+04 1.43E+03 Cs-137 5.49E+05 6.12E+05 4.55E+04 0.OOE+00 1.72E+05 7.13E+04 1.33E+03 Cs-138 5.05E+02 7.81E+02 3.98E+02 0.OOE+00 4.1OE+0216.54E+01 8.76E+02 Ba-139 1.48E+00 9.84E-04 4.30E-02 0.OOE+00 5.92E-04 5.95E+03 5.10E+04 Ba-140 5.60E+04 5.60E+01 2.90E+03 0.OOE+00 1.34E+01 1.60E+06 3.84E+04 Ba-141 1.57E-01 1.08E-04 4.97E-03 0.OOE+00 6.50E-05 2.97E+03 4.75E+03 Ba-142 3.98E-02 3.30E-05 1.96E-03 0.OOE+00 1.90E-05 1.55E+03 6.93E+02 La-140 5.05E+02 2.OOE+02 5.15E+01 0.OOE+00 O.OOE+00 1.68E+05 8.48E+04 La-142 1.03E+00 3.77E-01 9.04E-02 0.OOE+00 O.OOE+00 8.22E+03 5.95E+04 Ce-141 2.77E+04 1.67E+04 1.99E+03 0.OOE+00 5.25E+03 5.17E+05 2.16E+04 Ce-143 2.93E+02 1.93E+02 2.21E+01 0.OOE+00 5.64E+01 1.16E+05 4.97E+04 Ce-144 3.19E+06 1.21E+06 1.76E+05 0.OOE+00 5.38E+05 9.84E+06 1.48E+05 Pr-143 1.40E+04 5.24E+03 6.99E+02 0.OOE+00 1.97E+03 4.33E+05 3.72E+04 Pr-144 4.79E-02 1.85E-02 2.41E-03 0.OOE+00 6.72E-03 1.61E+03 4.28E+03 Nd-147 7.94E+03 8.13E+03 5.OOE+02 O.OOE+00 3.15E+03 3.22E+05 3.12E+04 W-187 1.30E+01 9.02E+00 3.12E+00 0.OOE+00 O.OOE+00 3.96E+04 3.56E+04 NL1-239 3.71E+02 2.98E+02 1.88E+01 0.OOE+00 6.62E+01 5.95E+04 2.49E+04 Notes:

1) Units are mrem/yr per jiCi/m 3 .

Page 11.4-36

CY-BY-1 70-301 Revision 5 Table 4-13 Adult Vegetation Dose Factors Nuclide Bone Liver T Body Thyroid Kidney LunR GI-LLI H-3 O.OOE+00 1.29E+03 1.29E+03 1.29E+03 1.29E+03 1.29E+03 1.29E+03 Na-24 2.69E+05 2.69E+05 2.69E+05 2.69E+05 2.69E+05 2.69E+05 2.69E+05 Cr-51 O.OOE+00 O.OOE+00 4.64E+04 2.77E+04 1.02E+04 6.1-5E+04 1.17E+07 Mn-54 O.OOE+00 3.13E+08 5.97E+07 O.OOE+00 9.31E+07 0.OOE+00 9.58E+08 Mn-56 0.OOE+00 1.54E+01 2.73E+00 O.OOE+00 1.95E+01 O.OOE+00 4.91E+02 Fe-55 2.10E+08 1.45E+08 3.38E+07 O.OOE+00 O.OOE+00 8.08E+07 8.31E+07 Fe-59 1.26E+08 2.96E+08 1.13E+08 O.OOE+00 O.OOE+00 8.27E+07 9.87E+08 Co-58 O.OOE+00 3.08E+07 6.90E+07 O.OOE+00 0.OOE+00 O.OOE+00 6.24E+08 Co-60 O.OOE+00 1.67E+08 3.69E+08 O.OOE+00 O.OOE+00 O.OOE+00 3.14E+09 Ni-63 1.04E+10 7.21E+08 3.49E+08 O.OOE+00 O.OOE+00 O.OOE+00 1.50E+08 Ni-65 5.97E+01 7.75E+00 3.54E+00 O.OOE+00 O.OOE+00 O.OOE+00 1.97E+02 Cu-64 O.OOE+00 9.09E+03 4.27E+03 O.OOE+00 2.29E+04 O.OOE+00 7.75E+05 Zn-65 3.17E+08 1.01E+09 4.56E+08 O.OOE+00 6.75E+08 0.OOE+00 6.36E+08 Zn-69 4.95E-06 9.48E-06 6.59E-07 O.OOE+00 6.16E-06 O.OOE+00 1.42E-06 Br-83 0.OOE+00 0.OOE+00 3.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 4.32E+00 Br-84 O.OOE+00 0.OOE+00 2.20E-1 I O.OOE+00 O.OOE+00 O.OOE+00 1.72E-16 Br-85 O.OOE+OO 0.0OOE+00 O.OOE+00 O.OOE+0 0.OOE+00 O.OOE+00 O.OOE+00 Rb-86 O.OOE+00 2.20E+08 1.03E+08 O.OOE+00 0.OOE+00 0.OOE+00 4.34E+07 Rb-88 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 Rb-89 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 Sr-89 9.95E+09 O.OOE+00 2.86E+08 O.OOE+000.OOE+00 O.OOE+00 1.60E+09 Sr-90 6.95E+1 1 O.OOE+00 1.40E+10 O.OOE+00 0.OOE+00 O.OOE+00 1.75E+10 Sr-91 3.01E+05 O.OOE+00 1.22E+04 O.OOE+00 O.OOE+00 O.OOE+00 1.43E+06 Sr-92 4.12E+02 0.OOE+00 1.78E+01 O.OOE+00 O.OOE+00 O.OOE+00 8.17E+03 Y-90 1.33E+04 O.OOE+00 3.57E+-02 O.OOE+00 O.OOE+00 O.OOE+00 1.41E+08 Y-91M 4.93E-09 0.OOE+00 1.91E-10 O.OOE+000.OOE+00 O.OOE+00 1.45E-08 Y-91 5.12E+06 0.OOE+00 1.37E+05 O.OOE+00 0.OOE+00 O.OOE+00 2.82E+09 Y-92 8.95E-01 0.OOE+00 2.62E-02 O.OOE+00 0.OOE+00 O.OOE+00 1.57E+04 Y-93 1.67E+02 0.OOE+00 4.62E+00 O.OOE+00 O.OOE+00 O.OOE+00 5.31E+06 Zr-95 1.18E+06 3.77E+05 2.55E+05 O.OOE+00 5.92E+05 O.OOE+00 1.20E+09 Zr-97 3.35E+02 6.77E+01 3.09E+01 O.OOE+00 1.02E+02 O.OOE+00 2.10E+07 Nb-95 1.43E+05 7.95E+04 4.27E+04 O.OOE+00 7.86E+04 O.OOE+00 4.83E+08 Mo-99 0.OOE+00 6.14E+06 1.17E+06 O.OOE+00 1.39E+07 O.OOE+00 1.42E+07 Tc-99M 3.06E+00 8.64E+00 1.1OE+02 0.OOE+00 1.31E+02 4.23E+00 5.11E+03 Tc-101 0.OOE+00 O.OOE+00 O.OOE+0 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Ru-103 4.77E+06 0.OOE+00 2.05E+06 O.OOE+00 1.82E+07 O.OOE+00 5.57E+08 Ru-105 5.27E+01 0.OOE+00 2.08E+01 O.OOE+00 6.81E+02 O.OOE+00 3.23E+04 Ru-106 1.93E+08 O.OOE+00 2.44E+07 O.OOE+00 3.72E+08 O.OOE+00 1.25E+10 Ag- 11OM 1.05E+07 9.75E+06 5.79E+06 0.OOE+00 1.92E+07 O.OOE+00 3.98E+09 Page 11.4-37

CY-BY-1 70-301 Revision 5 Table 4-13 (Continued) I Adult Vegetation Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Te-125M 9.67E+07 3.50E+07 1.30E+07 2.91E+07 3.93E+08 0.OOE+00 3.86E+08 Te-127M 3.49E+08 1.25E+08 4.26E+07 8.92E+07 1.42E+09 0.OOE+00 1.17E+09 Te-127 5.68E+03 2.04E+03 1.23E+03 4.21E+03 2.31E+04 0.OOE+00 4.48E+05 Te-129M 2.51E+08 9.37E+07 3.97E+07 8.62E+07 1.05E+09 0.OOE+00 1.26E+09 Te-129 7.14E-04 2.68E-04 1.74E-04 5.48E-04 3.OOE-03 O.OOE+00 5.39E-04 Te-131M 9.09E+05 4.45E+05 3.71E+05 7.04E+05 4.50E+06 0.OOE+00 4.41E+07 Te-131 1.26E-15 5.26E-16 3.97E-16 1.03E-15 5.51E-15 0.OOE+00 1.78E-16 Te-132 4.28E+06 2.77E+06 2.60E+06 3.06E+06 2.67E+07 0.OOE+00 1.31E+08 1-130 3.89E+05 1.15E+06 4.52E+05 9.72E+07 1.79E+06 0.OOE+00 9.87E+05 1-131 8.07E+07 1.15E+08 6.62E+07 3.78E+10 1.98E+08 0.OOE+00 3.05E+07 1-132 5.58E+01 1.49E+02 5.22E+01 5.22E+03 2.38E+02 0.OOE+00 2.80E+01 1-133 2.08E+06 3.62E+06 1.1OE+06 5.32E+08 6.31E+06 0.OOE+00 3.25E+06 1-134 8.55E-05 2.32E-04 8.31E-05 4.02E-03 3.69E-04 0.OOE+00 2.02E-07 1-135 3.87E+04 1.O1E+05 3.74E+04 6.68E+06 1.62E+05 0.OOE+00 1.14E+05 Cs-134 4.67E+09 1.11E+10 9.08E+09 0.OOE+00 3.59E+09 1.19E+09 1.94E+08 Cs-136 4.25E+07 1.68E+08 1.21E+08 0.OOE+00 9.33E+07 1.28E+07 1.90E+07 Cs-137 6.36E+09 8.70E+09 5.70E+09 O.OOE+00 2.95E+09 9.81E+08 1.68E+08 Cs-138 3.32E-11 6.56E-11 3.25E-11 0.OOE+00 4.82E-11 4.76E-12 2.80E-16 Ba-139 2.71E-02 1.93E-05 7.92E-04 0.OOE+00 1.80E-05 1.09E-05 4.80E-02 Ba-140 1.29E+08 1.61E+05 8.42E+06 0.OOE+00 5.49E+04 9.24E+04 2.65E+08 Ba-141 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00O0.OOE+0O 0.OOE+00 Ba-142 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 La-140 11.98E+03 9.97E+02 2.63E+02 0.OOE+00 0.OOE+00 0.OOE+00 7.32E+07 La-142 1.94E-04 8.83E-05 2.20E-05 0.OOE+00 0.OOE+00 0.OOE+00 6.45E-01 Ce-141 1.97E+05 1.33E+05 1.51E+04 0.OOE+00 6.19E+04 O.OOE+00 5.09E+08 Ce-143 9.94E+02 7.35E+05 8.13E+01 O.OOE+00 3.24E+02 O.OOE+00 2.75E+07 Ce-144 3.29E+07 1.38E+07 1.77E+06 O.OOE+00 8.16E+06 O.OOE+00 1.11E+10 Pr-143 6.27E+04 2.51E+04 3.11E+03 O.OOE+00 1.45E+04 O.OOE+00 2.75E+08 Pr-144 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 Nd-147 3.37E+04 3.90E+04 2.33E+03 O.OOE+00 2.28E+04 0.OOE+00 1.87E+08 W-187 3.79E+04 3.17E+04 1.11E+04 0.OOE+00 O.OOE+00 0.OOE+00 1.04E+07 Np-239 1.42E+03 1.40E+02 7.72E+01 0.OOE+00 4.37E+02 O.OOE+00 2.87E+07 Notes:

1) Units are m2 mrem/yr per jiCi/sec with the exception of H-3.

2) For H-3, the units are mrem/yr per gCi/m 3.

Page 11.4-38

CY-BY-1 70-301 Revision 5 Table 4-14 Teen Vegetation Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Luna GI-LLI H-3 0.OOE+00 1.47E+03 1.47E+03 1.47E+03 1.47E+03 1.47E+03 1.47E+03 Na-24 2.39E+05 2.39E+05 2.39E+05 2.39E+05 2.39E+05 2.39E+05 2.39E+05 Cr-51 O.OOE+00 O.OOE+00 6.16E+04 3.42E+04 1.35E+04 8.79E+04 1.03E+07 Mn-54 0.OOE+00 4.54E+08 9.01E+07 0.OOE+00 1.36E+08 O.OOE+00 9.32E+08 Mn-56 0.OOE+00 1.39E+01 2.47E+00 0.OOE+00 1.76E+01 O.OOE+0O 9.13E+02 Fe-55 3.26E+08 2.31E+08 5.39E+07 0.OOE+00 O.OOE+00 1.47E+08 1.50E+08 Fe-59 1.79E+08 4.18E+08 1.61E+08 0.OOE+00 O.OOE+00 1.32E+08 9.89E+08 Co-58 O.OOE+00 4.37E+07 1.01E+08 O.OOE+00 O.OOE+00 O.OOE+00 6.02E+08 Co-60 0.OOE+00 2.49E+08 5.60E+08 O.OOE+00 O.OOE+00 O.OOE+0O 3.24E+09 Ni-63 1.61E+10 1.13E+09 5.45E+08 0.OOE+00 0.OOE+00 O.OOE+00 1.81E+08 Ni-65 5.55E+01 7.10E+00 3.23E+00 O.OOE+00 O.OOE+00 O.OOE+00 3.85E+02 Cu-64 O.OOE+00 8.24E+03 3.87E+03 O.OOE+00 2.08E+04 O.OOE+0O 6.39E+05 Zn-65 4.24E+08 1.47E+09 6.86E+08 0.OOE+00 9.41E+08 O.OOE+00 6.23E+08 Zn-69 4.64E-06 8.84E-06 6.19E-07 O.OOE+00 5.78E-06 O.OOE+00 1.63E-05 Br-83 0.OOE+00 O.OOE+00 2.81E+00 O.OOE+00 O.OOE+00 O.OOE+0O 0.OOE+00 Br-84 O.OOE+00 O.OOE+00 2.OOE-1 1 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 Br-85 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 Rb-86 O.OOE+00 2.75E+08 1.29E+08 O.OOE+00 0.OOE+00 O.OOE+00 4.06E+07 Rb-88 0.OOE+00 O.OOE+00 O.OOE+0+/- 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 Rb-89 0.OOE+00 O.OOE+00 0.OOE+ 0.0OOE+00 O.OOE+00 O.OOE+0O O.OOE+00 Sr-89 1.51E+10 O.OOE+00 4.33E+08 O.OOE+00 O.OOE+00 O.OOE+0 1.80E+09 Sr-90 9.22E+11 0.OOE+00 1.84E+10 O.OOE+0O O.OOE+00 O.OOE+00 2.11E+10 Sr-91 2.81E+05 0.OOE+00 1.12E+04 O.OOE+0+/- O.OOE+00 O.OOE+0+/- 1.27E+06 Sr-92 3.84E+02 0.OOE+00 1.64E+01 O.OOE+0O 0.OOE+00 O.OOE+0 9.78E+03 Y-90 1.24E+04 O.OOE+00 3.35E+02 O.OOE+0+/- O.OOE+00 O.OOE+0+/- 1.02E+08 Y-91M 4.59E-09 O.OOE+00 1.75E-10 0.OOE+0 O.OOE+00 O.OOE+0 2.17E-07 Y-91 7.84E+06 O.OOE+00 2.10E+05 0.OOE+0O O.OOE+00 O.OOE+0+/- 3.21E+09 Y-92 8.41E-01 O.OOE+00 2.43E-02 0.OOE+0 O.OOE+00 O.OOE+00 2.31E+04 Y-93 1.57E+02 0.OOE+00 4.30E+00 0.OOE+0 0.OOE+00 O.OOE+00 4.80E+06 Zr-95 1.72E+06 5.44E+05 3.74E+05 O.OOE+00 7.99E+05 O.OOE+00 1.26E+09 Zr-97 3.10E+02 6.14E+01 2.83E+01 0.OOE+00 9.31E+01 O.OOE+0+/- 1.66E+07 Nb-95 1.93E+05 1.07E+05 5.90E+04 0.OOE+00 1.04E+05 O.OOE+00 4.58E+08 Mo-99 O.OOE+0 5.63E+06 1.07E+06 O.OOE+00 1.29E+07 O.OOE+00 1.01E+07 Tc- 99M 2.70E+00 7.52E+00 9.75E+O1 O.OOE+00 1.12E+02 4.17E+00 4.94E+03 Tc-101 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+0O O.OOE+00 Ru-103 6.82E+06 0.OOE+00 2.91E+06 O.OOE+00 2.40E+07 O.OOE+00 5.69E+08 Ru-105 4.90E+01 0.OOE+00 1.90E+01 O.OOE+00 6.18E+02 O.OOE+00 3.95E+04 Ru-106 3.09E+08 O.OOE+00 3.90E+07 0.OOE+00 5.97E+08 O.OOE+00 1.48E+10 Ag-i 1OM 1.52E+07 1.44E+07 8.73E+06 0.OOE+00 2.74E+07 0.OOE+00 4.03E+09 Page 11.4-39

CY-BY-1 70-301 Revision 5 Table 4-14 (Continued) I Teen Vegetation Dose Factors Nuclide Bone Liver 'T Body Thyroid Kidney Luna GI-LLI Te-125M 1.49E+08 5.35E+07 1.99E+07 4.15E+07 O.OOE+00 O.OOE+00 4.38E+08 Te-127M 5.51E+08 1.96E+08 6.56E+07 1.31E+08 2.24E+09 O.OOE+00 1.37E+09 Te-127 5.36E+03 1.90E+03 1.15E+03 3.70E+03 2.17E+04 0.OOE+0O 4.14E+05 Te-129M 3.61E+08 1.34E+08 5.72E+07 1.17E+08 1.51E+09 0.OOE+00 1.36E+09 Te-129 6.68E-04 2.49E-04 1.63E-04 4.77E-04 2.80E-03 O.OOE+00 3.65E-03 Te-131M 8.42E+05 4.04E+05 3.37E+05 6.07E+05 4.21E+06 O.OOE+O0 3.24E+07 Te-131 1.17E-15 4.82E-16 3.66E-16 9.01E-16 5.11E-15 0.OOE+00 9.60E-17 Te-132 3.89E+06 2:46E+06 2.32E+06 2.60E+06 2.36E+07 0.OOE+00 7.81E+07 1-130 3.47E+05 1.O1E+06 4.01E+05 8.20E+07 1.55E+06 0.OOE+00 7.73E+05 1-131 7.68E+07 1.08E+08 5.78E+07 3.14E+10 1.85E+08 O.OOE+O0 2.13E+07 1-132 5.03E+01 1.32E+02 4.72E+01 4.43E+03 2.07E+02 O.OOE+O0 5.73E+01 1-133 1.93E+06 3.28E+06 1.OOE+06 4.58E+08 5.75E+06 O.OOE+00 2.48E+06 1-134 7.73E-05 2.05E-04 7.36E-05 3.41E-03 3.23E-04 O.OOE+O0 2.70E-06 1-135 3.49E+04 8.99E+04 3.33E+04 5.78E+06 1.42E+05 O.OOE+00 9.97E+04 Cs-134 7.10E+09 1.67E+10 7.75E+09 O.OOE+O0 5.31E+09 2.03E+09 2.08E+08 Cs-136 4.35E+07 1.71E+08 1.15E+08 O.OOE+OO 9.31E+07 1.47E+07 1.38E+07 Cs-137 1.01E+10 1.35E+10 4.69E+09 O.OOE+O0 4.59E+09 1.78E+09 1.92E+08 Cs-138 3.07E-11 5.89E-11 2.94E-11 0.OOE+00 4.35E-11 5.06E-12 2.67E-14 Ba-139 2.55E-02 1.79E-05 7.42E-04 O.OOE+00 1.69E-05 1.23E-05 2.27E-01 Ba-140 1.38E+08 1.69E+05 8.90E+06 O.OOE+O0 5.74E+04 1.14E+05 2.13E+08 Ba-141 O.OOE+O0 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+0O 0.OOE+00 O.OOE+00 Ba-142 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+0O O.OOE+O0 0.OOE+00 O.OOE+00 La-140 1.81E+03 8.88E+02 2.36E+02 O.OOE+00 O.OOE+O0 0.OOE+00 5.1OE+07 La-142 1.78E-04 7.92E-05 1.97E-05 O.OOE+00 0.OOE+0O 0.OOE+00 2.41E+00 Ce-141 2.83E+05 1.89E+05 2.17E+04 0.OOE+00 8.89E+04 0.OOE+00 5.40E+08 Ce-143 9.29E+02 6.76E+05 7.55E+01 O.OOE+00 3.03E+02 O.OOE+O0 2.03E+07 Ce-144 5.27E+07 2.18E+07 2.83E+06 O.OOE+00 1.30E+07 0.OOE+00 1.33E+10 Pr-143 7.01E+04 2.80E+04 3.49E+03 0.OOE+00 1.63E+04 0.OOE+00 2.31E+08 Pr-144 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+0O Nd-147 3.67E+04 4.OOE+04 2.39E+03 O.OOE+00 2.35E+04 O.OOE+O0 1.44E+08 W-187 3.53E+04 2.87E+04 1.O1E+04 O.OOE+00 0.OOE+0O 0.OOE+00 7.78E+06 Np-239 1.38E+03 1.30E+02 7.24E+01 O.OOE+00 4.09E+02 O.OOE+00 2.10E+07 Notes:

1) Units are m2 mrem/yr per tCi/sec with the exception of H-3.

2) For H-3, the units are mreml/yr per gCi/m 3.

Page 11.4-40

CY-BY-1 70-301 Revision 5 Table 4-15 Child Vegetation Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lunu GI-LLI H-3 0.OOE+00 2.29E+03 2.29E+03 2.29E+03 2.29E+03 2.29E+03 2.29E+03 Na-24 3.73E+05 3.73E+05 3.73E+05 3.73E+05 3.73E+05 3.73E+05 3.73E+05 Cr-51 O.OOE+00 O.OOE+O0 1.17E+05 6.49E+04 1.77E+04 1.18E+05 6.20E+06 Mn-54 0.OOE+00 6.65E+08 1.77E+08 0.OOE+00 1.86E+08 0.OOE+00 5.58E+08 Mn-56 0.OOE+0O 1.82E+01 4.10E+00 O.OOE+00 2.20E+01 0.OOE+00 2.63E+03 Fe-55 8.01E+08 4.25E+08 1.32E+08 0.00E+00 O.OOE+00 2.40E+08 7.87E+07 Fe-59 3.97E+08 6.42E+08 3.20E+08 0.00E+00 0.OOE+00 1.86E+08 6.69E+08 Co-58 0.OOE+0 6.45E+07 1.97E+08 0.OOE+00 O.OOE+0O 0.OOE+00 3.76E+08 Co-60 0.OOE+00 3.78E+08 1.12E+09 0.OOE+00 0.OOE+00 0.OOE+00 2.10E+09 Ni-63 3.95E+10 2.11E+09 1.34E+09 0.OOE+00 O.OOE+00 O.OOE+00 1.42E+08 Ni-65 1.02E+02 9.59E+00 5.60E+00 O.OOE+00 0.OOE+00 0.OOE+00 1.18E+03 Cu-64 0.OOE+00 1.09E+04 6.56E+03 0.OOE+00 2.62E+04 0.OOE+00 5.10E+05 Zn-65 8.12E+08 2.16E+09 1.35E+09 O.OOE+00 1.36E+09 0.OOE+00 3.80E+08 Zn-69 8.56E-06 1.24E-05 1.14E-06 0.OOE+00 7.50E-06 0.OOE+00 7.80E-04 Br-83 0.OOE+00 0.OOE+00 5.18E+00 O.OOE+00 0.OOE+0O 0.OOE+00 O.OOE+00 Br-84 O.OOE+00 0.OOE+00 3.39E-1 1 0.OOE+00 0.OOE+0O 0.OOE+00 O.OOE+00 Br-85 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 Rb-86 0.OOE+00 4.54E+08 2.79E+08 0.OOE+00 0.OOE+0 0.OOE+00 2.92E+07 Rb-88 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Rb-89 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 Sr-89 13.59E+10 0.OOE+00 1.03E+09 0.OOE+00 0.OOE+00 0.OOE+00 1.39E+09 Sr-90 1.87E+12 0.OOE+00 3.77E+10 O.OOE+00 0.OOE+00 0.OOE+00 1.67E+10 Sr-91 5.17E+05 0.OOE+00 1.95E+04 O.OOE+00 0.OOE+00 0.OOE+00 1.14E+06 Sr-92 7.04E+02 0.OOE+00 2.82E+01 0.OOE+00 O.OOE+0O 0.OOE+00 1.33E+04 Y-90 2.31E+04 0.OOE+00 6.18E+02 O.OOE+00 0.OOE+0+/- 0.OOE+00 6.57E+07 Y-91M 8.42E-09 0.OOE+00 3.06E-10 O.OOE+00 O.OOE+00 0.OOE+00 1.65E-05 Y-91 1.87E+07 0.OOE+00 4.99E+05 0.OOE+00 0.OOE+00 0.OOE+00 2.49E+09 Y-92 1.55E+00 O.OOE+00 4.43E-02 0.OOE+00 0.OOE+00 0.OOE+00 4.47E+04 Y-93 2.89E+02 0.OOE+00 7.94E+00 0.OOE+00 O.OOE+00 0.OOE+00 4.31E+06 Zr-95 3.86E+06 8.50E+05 7.56E+05 0.OOE+00 1.22E+06 0.OOE+00 8.86E+08 Zr-97 5.67E+02 8.19E+01 4.83E+01 0.OOE+00 1.18E+02 O.OOE+00 1.24E+07 Nb-95 4.12E+05 1.61E+05 1.15E+05 O.OOE+00 1.51E+05 0.OOE+00 2.97E+08 Mo-99 0.OOE+00 7.69E+06 1.90E+06 O.OOE+00 1.64E+07 0.OOE+00 6.36E+06 Tc- 99M 4.64E+00 9.10E+00 1.51E+02 0.OOE+00 1.32E+02 4.62E+00 5.18E+03 Tc-101 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Ru-103 1.53E+07 O.OOE+00 5.89E+06 0.OOE+00 3.86E+07 0.OOE+00 3.96E+08 Ru-105 8.97E+01 0.OOE+00 3.25E+01 0.OOE+00 7.89E+02 O.OOE+00 5.86E+04 Ru-106 7.45E+08 O.OOE+00 9.30E+07 O.OOE+00 1.O1E+09 0.OOE+00 1.16E+10 Ag- 110M 3.21E+07 2.17E+07 1.74E+07 0.OOE+00 4.04E+07 O.OOE+00 2.58E+09 Page 11.4-41

CY-BY-1 70-301 Revision 5 Table 4-15 (Continued) I Child Vegetation Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Te-125M 3.51E+08 9.52E+07 4.68E+07 9.86E+07 O.OOE+00 O.OOE+00 3.39E+08 Te-127M 1.32E+09 3.56E+08 1.57E+08 3.16E+08 3.77E+09 0.OOE+00 1.07E+09 Te-127 9.89E+03 2.67E+03 2.12E+03 6.84E+03 2.81E+04 O.OOE+00 3.86E+05 Te-129M 8.40E+08 2.35E+08 1.30E+08 2.71E+08 2.47E+09 0.OOE+00 1.02E+09 Te-129 1.24E-03 3.45E-04 2.94E-04 8.83E-04 3.62E-03 O.OOE+00 7.70E-02 Te-131M 1.54E+06 5.32E+05 5.66E+05 1.09E+06 5.15E+06 0.OOE+00 2.16E+07 Te-131 2.15E-15 6.57E-16 6.41E-16 1.65E-15 6.51E-15 O.OOE+00 1.13E-14 Te-132 6.97E+06 3.09E+06 3.73E+06 4.49E+06 2.86E+07 O.OOE+00 3.1 1E+07 1-130 6.10E+05 1.23E+06 6.35E+05 1.36E+08 1.84E+06 0.OOE+00 5.76E+05 1-131 1.43E+08 1.44E+08 8.17E+07 4.75E+10 2.36E+08 O.OOE+00 1.28E+07 1-132 8.93E+01 1.64E+02 7.54E+01 7.61E+03 2.51E+02 0.OOE+00 1.93E+02 1-133 3.52E+06 4.36E+06 1.65E+06 8.09E+08 7.26E+06 0.OOE+00 1.76E+06 1-134 1.37E-04 2.55E-04 1.17E-04 5.86E-03 3.90E-04 0.OOE+00 1.69E-04 1-135 6.20E+04 1.12E+05 5.28E+04 9.89E+06 1.71E+05 O.OOE+00 8.51E+04 Cs-134 1.60E+10 2.63E+10 5.55E+09 0.OOE+00 8.16E+09 2.93E+09 1.42E+08 Cs-136 8.18E+07 2.25E+08 1.46E+08 O.OOE+00 1.20E+08 1.79E+07 7.90E+06 Cs-137 2.39E+10 2.29E+10 3.38E+09 O.OOE+00 7.46E+09 2.68E+09 1.43E+08 Cs-138 5.58E-11 7.75E-11 4.92E-11 O.OOE+00 5.45E-11 5.87E-12 3.57E-11 Ba-139 4.69E-02 2.51E-05 1.36E-03 0.OOE+00 2.19E-05 1.47E-05 2.71E+00 Ba-140 2.77E+08 2.43E+05 1.62E+07 0.OOE+00 7.90E+04 1.45E+05 1.40E+08 Ba-141 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ba-142 O.OOE+0 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+OO La-140 3.25E+03 1.13E+03 3.82E+02 0.OOE+00 O.OOE+00 O.OOE+00 3.16E+07 La-142 3.23E-04 1.03E-04 3.22E-05 0.OOE+00 O.OOE+00 O.OOE+00 2.04E+01 Ce-141 6.55E+05 3.27E+05 4.85E+04 O.OOE+00 1.43E+05 O.OOE+00 4.08E+08 Ce-143 1.71E+03 9.28E+05 1.34E+02 0.OOE+00 3.89E+02 O.OOE+00 1.36E+07 Ce-144 1.27E+08 3.98E+07 6.78E+06 0.OOE+00 2.21E+07 O.OOE+00 1.04E+10 Pr-143 1.46E+05 4.38E+04 7.24E+03 0.OOE+00 2.37E+04 0.OOE+00 1.57E+08 Pr-144 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+0+/- O.OOE+00 O.OOE+0O Nd-147 7.27E+04 5.89E+04 4.56E+03 0.OOE+00 3.23E+04 O.OOE+00 9.33E+07 W-187 6.41E+04 3.80E+04 1.70E+04 0.OOE+00 0.OOE+00 O.OOE+00 5.34E+06 Np-239 2.55E+03 1.83E+02 1.29E+02 0.OOE+00 5.30E+02 O.OOE+00 1.36E+07 Notes:

1) Units are m 2 mrem/yr per gCi/sec with the exception of H-3.

2) For H-3, the units are mrem/yr per 9.tCi/m 3.

3) The infant age group is assumed to receive no dose through the vegetation ingestion pathway therefore no dose factors are supplied.

Page 11.4-42

CY-BY-170-301 Revision 5 Table 4-16 Adult Grass-Cow-Milk Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lune GI-LLI H-3 O.OOE+00 4.35E+02 4.35E+02 4.35E+02 4.35E+02 4.35E+02 4.35E+02 Na-24 2.46E+06 2.46E+06 2.46E+06 2.46E+06 2.46E+06 2.46E+06 2.46E+06 Cr-51 O.OOE+00 O.OOE+00 2.86E+04 1.71E+04 6.29E+03 3.79E+04 7.18E+06 Mn-54 O.OOE+00 8.41E+06 1.61E+06 O.OOE+00 2.50E+06 0.OOE+00 2.58E+07 Mn-56 0.OOE+00 4.13E-03 7.32E-04 O.OOE+00 5.24E-03 O.OOE+00 1.32E-01 Fe-55 2.51E+07 1.74E+07 4.05E+06 O.OOE+00 O.OOE+00 9.68E+06 9.95E+06 Fe-59 2.97E+07 6.98E+07 2.67E+07 O.OOE+00 O.OOE+00 1.95E+07 2.33E+08 Co-58 0.60E+00 4.72E+06 1.06E+07 O.OOE+00 O.OOE+00 O.OOE+00 9.56E+07 Co-60 O.OOE+00 1.64E+07 3.62E+07 O.OOE+00 0.OOE+00 0.OOE+00 3.08E+08 Ni-63 6.73E+09 4.66E+08 2.26E+08 O.OOE+00 O.OOE+00 0.OOE+00 9.73E+07 Ni-65 3.70E-01 4.81E-02 2.19E-02 O.OOE+00 O.OOE+00 O.OOE+00 1.22E+00 Cu-64 O.OOE+00 2.36E+04 1.11E+04 O.OOE+00 5.95E+04 O.OOE+00 2.01E+06 Zn-65 1.37E+09 4.36E+09 1.97E+09 O.OOE+00 2.92E+09 O.OOE+00 2.75E+09 Zn-69 2.01E-12 3.84E-12 2.67E-13 0.OOE+00 2.50E-12 0.OOE+00 5.78E-13 Br-83 O.OOE+0O 0.OOE+00 9.65E-02 0.OOE+00 0.OOE+00 0.OOE+00 1.39E-01 Br-84 0.OOE+0O 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Br-85 O.OOE+0 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Rb-86 0.OOE+00 2.60E+09 1.21E+09 O.OOE+00 O.OOE+00 O.OOE+00 5.12E+08 Rb-88 0.OOE+0 0.0OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Rb-89 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Sr-89 1.45E+09 O.OOE+00 4.16E+07 O.OOE+00 O.OOE+00 O.OOE+00 2.33E+08 Sr-90 5.38E+10 O.OOE+00 1.08E+09 O.OOE+00 O.OOE+00 O.OOE+00 1.35E+09 Sr-91 2.87E+04 O.OOE+00 1.16E+03 O.OOE+00 O.OOE+00 O.OOE+00 1.37E+05 Sr-92 4.84E-01 O.OOE+00 2.09E-02 O.OOE+0O O.OOE+00 O.OOE+00 9.58E+00 Y-90 7.10E+01 O.OOE+00 1.90E+00 O.OOE+0 O.OOE+00 O.OOE+00 7.52E+05 Y-91M 6.42E-20 O.OOE+00 O.OOE+00 O.OOE+0 O.OOE+00 O.OOE+00 1.89E-19 Y-91 8.59E+03 O.OOE+00 2.30E+02 O.OOE+0 O.OOE+00 O.OOE+00 4.73E+06 Y-92 5.57E-05 O.OOE+00 1.63E-06 O.OOE+0O O.OOE+00 O.OOE+00 9.75E-01 Y-93 2.22E-01 O.OOE+00 6.12E-03 O.OOE+0O O.OOE+00 O.OOE+00 7.03E+03 Zr-95 9.44E+02 3.03E+02 2.05E+02 O.OOE+0O 4.75E+02 O.OOE+00 9.59E+05 Zr-97 4.32E-01 8.72E-02 3.99E-02 O.OOE+0O 1.32E-01 O.OOE+00 2.70E+04 Nb-95 8.26E+04 4.60E+04 2.47E+04 0.OOE+0O 4.54E+04 O.OOE+00 2.79E+08 Mo-99 O.OOE+00 2.47E+07 4.70E+06 0.OOE+00 5.60E+07 O.OOE+00 5.73E+07 Tc- 99M 3.31E+00 9.35E+00 1.19E+02 O.OOE+00 1.42E+02 4.58E+00 5.53E+03 Tc-101 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+0 0.OOE+00 O.OOE+00 O.OOE+00 Ru-103 1.02E+03 O.OOE+00 4.39E+02 O.OOE+00 3.88E+03 O.OOE+00 1.19E+05 Ru-105 8.51E-04 0.OOE+00 3.36E-04 O.OOE+00 1.10E-02 0.00E+00 5.20E-01 Ru-106 2.04E+04 0.OOE+00 2.58E+03 O.OOE+00 3.94E+04 0.OOE+00 1.32E+06 Ag-i 10M 5.82E+07 5.39E+07 3.20E+07 0.OOE+00 1.06E+08 0.00E+00 2.20E+10 Page 11.4-43

CY-BY-1 70-301 Revision 5 Table 4-16 (Continued) I Adult Grass-Cow-Milk Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Te-125M 1.63E+07 5.91E+06 2.18E+06 4.90E+06 6.63E+07 0.OOE+00 6.51E+07 Te-127M 4.58E+07 1.64E+07 5.58E+06 1.17E+07 1.86E+08 0.OOE+00 1.54E+08 Te-127 6.66E+02 2.39E+02 1.44E+02 4.94E+02 2.71E+03 0.OOE+00 5.26E+04 Te-129M 6.02E+07 2.24E+07 9.52E+06 2.07E+07 2.51E+08 0.OOE+00 3.03E+08 Te-129 2.83E-10 1.06E-10 6.88E-11 2.17E-10 1.19E-090.OOE+00 2.13E-10 Te-131M 3.61E+05 1.76E+05 1.47E+05 2.79E+05 1.79E+06 O.OOE+00 1.75E+07 Te-131 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 Te-132 2.39E+06 1.55E+06 1.45E+06 1.71E+06 1.49E+07 0.OOE+00 7.32E+07 1-130 4.18E+05 1.23E+06 4.86E+05 1.04E+08 1.92E+06 0.OOE+00 1.06E+06 1-131 2.96E+08 4.23E+08 2.43E+08 1.39E+1 1 7.26E+08 0.OOE+00 1.12E+08 1-132 1.65E-01 4.40E-01 1.54E-01 1.54E+01 7.02E-01 0.OOE+00 8.27E-02 1-133 3.88E+06 6.74E+06 2.06E+06 9.91E+08 1.18E+07 O.OOE+00 6.06E+06 1-134 1.89E-12 5.13E-12 1.83E-12 8.89E-11 8.16E-12 0.OOE+00 4.47E-15 1-135 1.29E+04 3.38E+04 1.25E+04 2.23E+06 5.42E+04 O.OOE+00 3.82E+04 Cs-134 5.65E+09 1.35E+10 1.10E+10 0.OOE+00 4.35E+09 1.45E+09 2.35E+08 Cs-136 2.63E+08 1.04E+09 7.46E+08 O.OOE+00 5.77E+08 7.91E+07 1.18E+08 Cs-137 7.38E+09 1.O1E+10 6.61E+09 O.OOE+00 3.43E+09 1.14E+09 1.95E+08 Cs-138 O.OOE+00 O.OOE+00 O.OOE+00 0.60E+00 O.OOE+00 O.OOE+0 O.OOE+00 Ba-139 4.43E-08 3.16E-11 1.30E-09 0.OOE+00 2.95E-11 1.79E-11 7.86E-08 Ba-140 2.69E+07 3.38E+04 1.76E+06 0.OOE+00 1.15E+04 1.93E+04 5.54E+07 Ba-141 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ba-142 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 La-140 4.52E+00 2.28E+00 6.02E-01 O.OOE+00 0.OOE+00 O.OOE+00 1.67E+05 La-142 1.89E-11 8.59E-12 2.14E-12 0.OOE+00 0.OOE+00 O.OOE+00 6.28E-08 Ce-141 4.84E+03 3.28E+03 3.72E+02 O.OOE+00 1.52E+03 0.OOE+00 1.25E+07 Ce-143 4.15E+01 3.07E+04 3.39E+00 0.0OE+00 1.35E+01 0.OOE+00 1.15E+06 Ce-144 3.58E+05 1.50E+05 1.92E+04 0.00E+00 8.87E+04 O.OOE+00 1.21E+08 Pr-143 1.58E+02 6.34E+01 7.83E+00 O.OOE+00 3.66E+01 O.OOE+00 6.92E+05 Pr-144 0.OOE+00 O.OOE+00 0.OOE+0O 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 Nd-147 9.48E+01 1.1OE+02 6.56E+00 0.OOE+00 6.41E+01 O.OOE+00 5.26E+05 W-187 6.51E+03 5.44E+03 1.90E+03 0.OOE+00 O.OOE+00 0.OOE+00 1.78E+06 Np-239 3.67E+00 3.61E-01 1.99E-O1 O.OOE+00 1.12E+0 0.OOE+00 7.40E+04 Notes:

1) Units are m2 mrem/yr per jiCi/sec with the exception of H-3.

2) For H-3, the units are mrem/yr per tCi/m 3.

Page 11.4-44

CY-BY-1.70-301 Revision 5 Table 4-17 Teen Grass-Cow-Milk Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 O.OOE+00 5.66E+02 5.66E+02 5.66E+02 5.66E+02 5.66E-02 5.66E+02 Na-24 4.29E+06 4.29E+06 4.29E+06 4.29E+06 4.29E+06 4.29E+06 4.29E+06 Cr-51 O.OOE+00 O.OOE+00 4.99E+04 2.77E+04 1.09E+04 7.12E+04 8.38E+06 Mn-54 O.OOE+00 1.40E+07 2.78E+06 O.OOE+00 4.18E+06 0.OOE+00 2.87E+07 Mn-56 0.OOE+00 7.32E-03 1.30E-03 O.OOE+00 9.27E-03 O.OOE+00 4.82E-01 Fe-55 4.45E+07 3.16E+07 7.36E+06 O.OOE+00 O.OOE+00 2.OOE+07 1.37E+07 Fe-59 5.18E+07 1.21E+08 4.67E+07 O.OOE+00 O.OOE+00 3.81E+07 2.86E+08 Co-58 O.OOE+00 7.94E+06 1.83E+07 O.OOE+00 O.OOE+00 O.OOE+00 1.09E+08 Co-60 O.OOE+00 2.78E+07 6.26E+07 O.OOE+00 0.OOE+00 O.OOE+00 3.62E+08 Ni-63 1.18E+10 8.35E+08 4.01E+08 O.OOE+00 O.OOE+00 O.OOE+00 1.33E+08 Ni-65 6.78E-01 8.66E-02 3.94E-02 O.OOE+00 0.OOE+00 O.OOE+00 4.70E+00 Cu-64 O.OOE+00 4.21E+04 1.98E+04 O.OOE+00 1.06E+05 O.OOE+00 3.26E+06 Zn-65 2.11E+09 7.31E+09 3.41E+09 O.OOE+00 4.68E+09 O.OOE+00 3.10E+09 Zn-69 3.70E-12 7.05E-12 4.94E-13 0.OOE+00 4.61E-12 O.OOE+00 1.30E-1 1 Br-83 0.OOE+00 O.OOE+00 1.78E-01 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 Br-84 O.OOE+00 O.OOE+00 O.OOE+0+/- 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Br-85 O.OOE+00 O.OOE+00 O.OOE+0 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 Rb-86 O.OOE+00 4.73E+09 2.22E+09 0.OOE+00 O.OOE+00 O.OOE+00 7.01E+08 Rb-88 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Rb-89 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Sr-89 2.67E+09 0.00E+00 7.66E+07 0.OOE+00 O.OOE+00 O.OOE+00 3.18E+08 Sr-90 8.13E+10 O.OOE+00 1.63E+09 O.OOE+00 0.OOE+00 O.OOE+00 1.86E+09 Sr-91 5.27E+04 O.OOE+00 2.10E+03 O.OOE+00 O.OOE+00 O.OOE+00 2.39E+05 Sr-92 8.85E-01 O.OOE+00 3.77E-02 0.OOE+00 O.OOE+00 O.OOE+00 2.26E+01 Y-90 1.30E+02 O.OOE+00 3.51E+00 O.OOE+00 O.OOE+00 0.OOE+00 1.08E+06 Y-91M 1.18E-19i O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 5.55E-18 Y-91 11.58E+04 O.OOE+00 4.24E+02 O.OOE+00 O.OOE+00 O.OOE+00 6.48E+06 Y-92 1.03E-04 0.OOE+00 2.98E-06 O.OOE+00 0.OOE+00 O.OOE+00 2.82E+00 Y-93 4.09E-01 0.OOE+00 1.12E-02 O.OOE+00 0.OOE+00 O.OOE+00 1.25E+04 Zr-95 1.65E+03 5.21E+02 3.58E+02 0.OOE+00 7.65E+02 O.OOE+00 1.20E+06 Zr-97 7.87E-01 1.56E-01 7.17E-02 0.OOE+00 2.36E-01 O.OOE+00 4.22E+04 Nb-95 1.41E+05 7.82E+04 4.30E+04 O.OOE+00 7.58E+04 O.OOE+00 3.34E+08 Mo-99 O.OOE+00 4.46E+07 8.51E+06 0.OOE+00 1.02E+08 O.OOE+00 8.OOE+07 Tc- 99M 5.74E+00 1.60E+01 2.07E+02 0.OOE+00 2.39E+02 8.89E+00 1.05E+04 Tc-101 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+0 0.OOE+00 Ru-103 1.81E+03 O.OOE+00 7.74E+02 0.OOE+00 6.38E+03 0.OOE+00 1.51E+05 Ru-105 1.55E-03 0.OOE+00 6.03E-04 0.OOE+00 1.96E-02 O.OOE+00 1.25E+00 Ru-106 3.75E+04 0.OOE+00 4.73E+03 0.OOE+00 7.24E+04 O.OOE+00 1.80E+06 Ag-I1OM 9.63E+07 9.11E+07 5.54E+07 O.OOE+00 1.74E+08 O.OOE+00 2.56E+10 Page 11.4-45

CY-BY-1 70-301 Revision 5 Table 4-17 (Continued) I Teen Grass-Cow-Milk Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Te-125M 3.01E+07 1.08E+07 4.02E+06 8.40E+06 O.OOE+O0 O.OOE+00 8.87E+07 Te-127M 8.44E+07 2.99E+07 1.OOE+07 2.01E+07 3.42E+08 0.OOE+00 2.10E+08 Te-127 1.24E+03 4.38E+02 2.66E+02 8.52E+02 5.OOE+03 0.OOE+00 9.54E+04 Te-129M 1.1OE+08 4.09E+07 1.74E+07 3.55E+07 4.61E+08 O.OOE+00 4.13E+08 Te-129 5.20E-10 1.94E-10 1.27E-10 3.72E-10 2.18E-09 0.OOE+O0 2.84E-09 Te-131M 6.57E+05 3.15E+05 2.63E+05 4.74E+05 3.28E+06 0.OOE+00 2.53E+07 Te-131 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 Te-132 4.27E+06 2.71E+06 2.55E+06 2.85E+06 2.60E+07 0.OOE+00 8.57E+07 1-130 7.35E+05 2.13E+06 8.49E+05 1.73E+08 3.27E+06 0.OOE+00 1.63E+06 1-131 5.37E+08 7.52E+08 4.04E+08 2.19E+11 1.29E+09 O.OOE+00 1.49E+08 1-132 2.92E-01 7.64E-01 2.74E-01 2.57E+01 1.20E+00 0.OOE+00 3.33E-01 1-133 7.08E+06 1.20E+07 3.66E+06 1.68E+09 2.11E+07 0.OOE+00 9.09E+06 1-134 3.35E-12 8.89E-12 3.19E-12 1.48E-10 1.40E-11 O.OOE+00 1.17E-13 1-135 2.29E+04 5.91E+04 2.19E+04 3.80E+06 9.33E+04 0.OOE+00 6.54E+04 Cs-134 9.82E+09 2.31E+10 1.07E+10 0.OOE+00 7.34E+09 2.80E+09 2.87E+08 Cs-136 4.47E+08 1.76E+09 1.18E+09 O.OOE+00 9.58E+08 1.51E+08 1.42E+08 Cs-137 1.34E+10 1.78E+10 6.20E+09 0.OOE+00 6.06E+09 2.35E+09 2.53E+08 Cs-138 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 Ba-139 8.20E-08 5.77E-11 2.39E-090.OOE+00 5.44E-11 3.98E-11 7.31E-07 Ba-140 4.85E+07 5.95E+04 3.13E+06 0.OOE+00 2.02E+04 4.OOE+04 7.49E+07 Ba-141 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+0O 0.OOE+00 0.OOE+00 Ba-142 0.OOE+00 O.OOE+0O 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 La-140 8.12E+00 3.99E+00 1.06E+00 0.OOE+00 O.OOE+00 O.OOE+00 2.29E+05 La-142 3.41E-11 1.51E-11 3.77E-12 0.OOE+00 0.OOE+00 0.OOE+00 4.61E-07 Ce-141 8.88E+03 5.93E+03 6.81E+02 0.OOE+00 2.79E+03 0.OOE+00 1.70E+07 Ce-143 7.62E+01 5.55E+04 6.20E+00 0.OOE+00 2.49E+01 O.OOE+00 1.67E+06 Ce-144 6.58E+05 2.72E+05 3.54E+04 0.00E+00 1.63E+05 0.OOE+00 1.66E+08 Pr-143 2.90E+02 1.16E+02 1.44E+01 0.00E+00 6.74E+01 0.00E+00 9.55E+05 Pr-144 0.OOE+00 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Nd-147 1.82E+02 1.98E+02 1.19E+01 O.OOE+00 1.17E+02 0.OOE+00 7.16E+05 W-187 1.19E+04 9.71E+03 3.40E+03 0.00E+00 0.OOE+00 0.00E+00 2.63E+06 Np-239 7.00E+00 6.60E-01 3.67E-01 0.00E+00 2.07E+00 0.00E+00 1.06E+05 Notes:

1) Units are m2 mrem/yr per gCi/sec with the exception of H-3.

2) For H-3, the units are mrem/yr per tCi/m 3 .

Page 11.4-46

CY-BY-1 70-301 Revision 5 Table 4-18 Child Grass-Cow-Milk Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 0.OOE+00 8.97E+02 8.97E+02 8.97E+02 8.97E+02 8.97E+02 8.97E+02 Na-24 8.93E+06 8.93E+06 8.93E+06 8.93E+06 8.93E+06 8.93E+06 8.93E+06 Cr-51 O.OOE+00 0.OOE+00 1.02E+05 5.65E+04 1.54E+04 1.03E+05 5.39E+06 Mn-54 O.OOE+00 2.10E+07 5.59E+06 0.OOE+00 5.88E+06 0.OOE+0+/- 1.76E+07 Mn-56 0.OOE+00 1.28E-02 2.88E-03 0.OOE+00 1.54E-02 0.OOE+00 1.85E+00 Fe-55 1.12E+08 5.93E+07 1.84E+07 0.OOE+00 0.OOE+00 3.35E+07 1.10E+07 Fe-59 1.20E+08 1.94E+08 9.69E+07 0.OOE+00 0.OOE+00 5.64E+07 2.02E+08 Co-58 O.OOE+00 1.21E+07 3.71E+07 O.OOE+O0 0.OOE+00 0.OOE+00 7.08E+07 Co-60 O.OOE+00 4.32E+07 1.27E+08 O.OOE+00 0.OOE+00 0.OOE+00 2.39E+08 Ni-63 2.96E+10 1.59E+09 1.O1E+09 O.OOE+00 0.OOE+00 0.OOE+00 1.07E+08 Ni-65 1.66E+00 1.56E-01 9.1 1E-02 O.OOE+00 0.OOE+00 0.OOE+00 1.91E+01 Cu-64 O.OOE+00 7.39E+04 4.47E+04 O.OOE+00 1.79E+05 0.OOE+00 3.47E+06 Zn-65 4.13E+09 1.1OE+10 6.85E+09 O.OOE+O0 6.94E+09 0.OOE+00 1.93E+09 Zn-69 9.10E-12 1.32E-1 1 1.22E-12 0.OOE+00 7.98E-12 0.OOE+00 8.29E-10 Br-83 O.OOE+00 O.OOE+O0 4.37E-01 0.OOE+00 O.OOE+00 0.OOE+00O0.OOE+00 Br-84 O.OOE+00 0.OOE+0 0.OOE+00 O.OOE+O0O.OOE+0 0.OOE+00 O.OOE+00 Br-85 O.OOE+0 0.OOE+0 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Rb-86 0.OOE+00 8.78E+09 5.40E+09 0.OOE+00 0.OOE+00 0.OOE+00 5.65E+08 Rb-88 0.OOE+0 0.0OOE+0 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 Rb-89 O.OOE+00 0.OOE+0O O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 Sr-89 6.62E+09 0.OOE+0O 1.89E+08 0.OOE+00 O.OOE+0O 0.OOE+00 2.56E+08 Sr-90 1.68E+1 1 0.OOE+0O 3.38E+09 O.OOE+O0 O.OOE+00 O.OOE+O0 1.51E+09 Sr-91 1.29E+05 0.OOE+0 4.88E+03 O.OOE+00 0.OOE+00 0.OOE+00 2.86E+05 Sr-92 2.16E+00 0.OOE+00 8.67E-02 O.OOE+00 0.OOE+00 O.OOE+00 4.09E+01 Y-90 3.23E+02 0.OOE+00 8.64E+00 O.OOE+00 O.OOE+00 O.OOE+00 9.19E+05 Y-91M 2.87E-19 0.OOE+00 1.04E-20 0.OOE+00 0.OOE+00 O.OOE+00 5.62E-16 Y-91 3.90E+04 0.OOE+0O 1.04E+03 0.OOE+00 O.OOE+00 O.OOE+00 5.20E+06 Y-92 2.53E-04 0.OOE+00 7.23E-06 0.OOE+00 0.OOE+00 0.OOE+00 7.30E+00 Y-93 1.OOE+0O 0.OOE+00 2.75E-02 0.OOE+00 0.OOE+00 0.OOE+00 1.50E+04 Zr-95 3.83E+03 8.43E+02 7.50E+02 0.OOE+00 1.21E+03 0.OOE+00 8.79E+05 Zr-97 1.91E+00 2.77E-01 1.63E-01 O.OOE+00 3.97E-01 0.OOE+00 4.19E+04 Nb-95 3.18E+05 1.24E+05 8.85E+04 O.OOE+00 1.16E+05 0.OOE+00 2.29E+08 Mo-99 0.OOE+00 8.12E+07 2.01E+07 0.OOE+00 1.73E+08 0.OOE+00 6.72E+07 Tc- 99M 1.32E+01 2.58E+01 4.28E+02 0.OOE+00 3.75E+/-02 1.31E+01 1.47E+04 Tc-101 O.OOE+00 O.OOE+O0 0.OOE+00 0.OOE+00 0.OOE+0O 0.OOE+00 O.OOE+00 Ru-103 4.28E+03 O.OOE+00 1.65E+03 0.OOE+00 1.08E+04 0.OOE+00 1.11E+05 Ru-105 3.79E-03 0.OOE+00 1.38E-03 0.OOE+00 3.33E-02 0.OOE+00 2.48E+00 Ru-106 9.24E+04 0.OOE+00 1.15E+04 0.OOE+00 1.25E+05 0.OOE+00 1.44E+06 Ag-110M 2.09E+08 1.41E+08 1.13E+08 0.00E+O0 2.63E+08 0.OOE+0O 1.68E+10 Page 11.4-47

CY-BY-1 70-301 Revision 5 Table 4-18 (Continued) I Child Grass-Cow-Milk Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lune GI-LLI Te-125M 7.38E+07 2.OOE+07 9.84E+06 2.07E+07 0.OOE+0 0.OOE+00 7.12E+07 Te-127M 2.08E+08 5.60E+07 2.47E+07 4.97E+07 5.93E+08 0.OOE+00 1.68E+08 Te-127 3.04E+03 8.19E+02 6.51E+02 2.10E+03 8.64E+03 O.OOE+00 1.19E+05 Te-129M 2.71E+08 7.58E+07 4.21E+07 8.75E+07 7.97E+08 0.OOE+00 3.31E+08 Te-129 1.28E-09 3.58E-10 3.05E-10 9.16E-10 3.75E-09 O.OOE+00 7.99E-08 Te-131M 1.60E+06 5.53E+05 5.88E+05 1.14E+06 5.35E+06 0.OOE+00 2.24E+07 Te-131 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+0 0.OOE+00 0.OOE+00 Te-132 1.02E+07 4.52E+06 5.46E+06 6.58E+06 4.19E+07 0.OOE+00 4.55E+07 1-130 1.72E+06 3.47E+06 1.79E+06 3.82E+08 5.19E+06 0.OOE+00 1.62E+06 1-131 1.30E+09 1.31E+09 7.45E+08 4.33E+l1 2.15E+09 O.OOE+00 1.17E+08 1-132 6.91E-01 1.27E+00 5.84E-01 5.89E+01 1.94E+00 0.OOE+00 1.49E+00 1-133 1.72E+07 2.13E+07 8.05E+06 3.95E+09 3.55E+07 0.OOE+00 8.57E+06 1-134 7.94E-12 1.47E-11 6.79E-12 3.39E-10 2.26E-11 0.OOE+00 9.78E-12 1-135 5.43E+04 9.78E+04 4.62E+04 8.66E+06 1.50E+05 O.OOE+00 7.45E+04 Cs-134 2.26E+10 3.72E+10 7.84E+09 0.OOE+00 1.15E+10 4.13E+09 2.OOE+08 Cs-136 1.O1E+09 2.77E+09 1.80E+09 0.OOE+00 1.48E+09 2.20E+08 9.75E+07 Cs-137 3.22E+10 3.09E+10 4.55E+09 0.OOE+00 1.01E+10 3.62E+09 1.93E+08 Cs-138 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Ba-139 2.01E-07 1.08E-10 5.84E-09 0.OOE+00 9.39E-11 6.33E-11 1.16E-05 Ba-140 1.17E+08 1.03E+05 6.84E+06 O.OOE+00 3.34E+04 6.12E+04 5.94E+07 Ba-141 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 Ba-142 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 La-140 1.95E+01 6.80E+00 2.29E+00 O.OOE+00 O.OOE+00 0.OOE+00 1.90E+05 La-142 8.24E-1 1 2.63E-1 1 8.22E-12 0.OOE+00 0.OOE+00 0.OOE+00 5.20E-06 Ce-141 2.19E+04 1.09E+04 1.62E+03 0.OOE+00 4.78E+03 O.OOE+00 1.36E+07 Ce-143 1.87E+02 1.O1E+05 1.47E+01 0.OOE+00 4.26E+01 0.OOE+00 1.49E+06 Ce-144 1.62E+06 5.09E+05 8.66E+04 0.OOE+00 2.82E+05 0.OOE+00 1.33E+08 Pr-143 7.18E+02 2.16E+02 3.57E+01 0.OOE+00 1.17E+02 0.OOE+00 7.75E+05 Pr-144 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+0 0.OOE+00 Nd-147 4.48E+02 3.63E+02 2.81E+01 0.OOE+00 1.99E+02 0.OOE+00 5.75E+05 W-187 2.89E+04 1.71E+04 7.67E+03 0.OOE+00 O.OOE+00O0.OOE+00 2.40E+06 Np-239 1.72E+01 1.24E+00 8.69E-01 0.OOE+00 3.58E+00 0.00E+0O 9.15E+04 Notes:

1) Units are m 2 nmrem/yr per gCi/sec with the exception of H-3.

2) For H-3, the units are mrem/yr per gCi/m3.

Page 11.4-48

CY-BY-1 70-301 Revision 5 Table 4-19 Infant Grass-Cow-Milk Dose Factors Nucide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 0.OOE+00 1.36E+03 1.36E+03 1.36E+03 1.36E+03 1.36E+03 1.36E+03 Na-24 1.56E+07 1.56E+07 1.56E+07 1.56E+07 1.56E+07 1.56E+07 1.56E+07 Cr-51 0.OOE+00 O.OOE+00 1.61E+05 1.05E+05 2.30E+04 2.05E+05 4.70E+06 Mn-54 O.OOE+00 3.90E+07 8.84E+06 O.OOE+00 8.64E+06 O.OOE+00 1.43E+07 Mn-56 0.OOE+00 3.13E-02 5.39E-03 0.OOE+00 2.69E-02 O.OOE+00 2.84E+00 Fe-55 1.35E+08 8.73E+07 2.33E+07 0.OOE+00 O.OOE+00 4.27E+07 1.11E+07 Fe-59 2.24E+08 3.92E+08 1.54E+08 O.OOE+00 0.OOE+00 1.16E+08 1.87E+08 Co-58 O.OOE+00 2.43E+07 6.05E+07 O.OOE+00 0.OOE+00 O.OOE+00 6.04E+07 Co-60 0.OOE+00 8.82E+07 2.08E+08 0.OOE+00 0.OOE+00 0.OOE+00 2.10E+08 Ni-63 3.49E+10 2.16E+09 1.21E+09 O.OOE+00 0.OOE+00 O.OOE+00 1.07E+08 Ni-65 3.51E+00 3.97E-01 1.81E-01 O.OOE+00 0.OOE+00 O.OOE+00 3.02E+01 Cu-64 0.OOE+00 1.84E+05 8.5 1E+04 O.OOE+00 3.11E+05 O.OOE+00 3.77E+06 Zn-65 5.55E+09 1.90E+10 8.78E+09 0.OOE+00 9.23E+09 O.OOE+00 1.61E+10 Zn-69 1.94E-11 3.49E-11 2.60E-12 0.OOE+00 1.45E-11 O.OOE+00 2.85E-09 Br-83 O.OOE+00 O.OOE+00 9.27E-01 0.OOE+0 0.0OOE+00 O.OOE+00 0.OOE+00 Br-84 O.OOE+00 O.OOE+0O 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 Br-85 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 Rb-86 O.OOE+00 2.23E+10 1.10E+10 0.00E+00 0.OOE+00 O.OOE+00 5.70E+08 Rb-88 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Rb-89 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Sr-89 1.26E+10 O.OOE+00 3.61E+08 O.OOE+00 0.OOE+00 O.OOE+00 2.59E+08 Sr-90 1.86E+1 1 O.OOE+00 3.77E+09 0.OOE+00 0.OOE+00 O.OOE+00 1.52E+09 Sr-91 2.70E+05 O.OOE+00 9.76E+03 0.OOE+00 0.OOE+00 O.OOE+00 3.19E+05 Sr-92 4.60E+00 0.OOE+00 1.71E-01 O.OOE+00 O.0OE+00 O.OOE+00 4.96E+01 Y-90 6.82E+02 0.OOE+00 1.83E+01 0.OOE+00 0.OOE+00 O.OOE+00 9.42E+05 Y-91M 6.09E-19 0.OOE+00 2.07E-20 0.OOE+00 0.OOE+00 0.OOE+00 2.03E-15 Y-91 7.33E+04 O.OOE+00 1.95E+03 0.OOE+00 O.OOE+00 O.OOE+00 5.25E+06 Y-92 5.37E-04 O.OOE+00 1.51E-05 0.OOE+00 O.OOE+00 0.OOE+00 1.02E+01 Y-93 2.14E+00 O.OOE+00 5.83E-02 0.OOE+00 O.OOE+00 O.OOE+00 1.69E+04 Zr-95 6.81E+03 1.66E+03 1.18E+03 0.OOE+00 1.79E+03 O.OOE+00 8.26E+05 Zr-97 4.05E+00 6.96E-01 3.18E-01 O.OOE+00 7.01E-01 O.OOE+00 4.44E+04 Nb-95 5.94E+05 2.45E+05 1.41E+05 O.OOE+00 1.75E+05 0.OOE+00 2.07E+08 Mo-99 O.OOE+00 2.08E+08 4.05E+07 0.OOE+00 3.10E+08 0.OOE+00 6.84E+07 Tc- 99M 2.74E+01 5.65E+01 7.27E+02 0.OOE+00 6.08E+02 2.95E+01 1.64E+04 Tc-101 O.OOE+00 O.OOE+00 0.OOE+0O 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 Ru-103 8.67E+03 O.OOE+00 2.90E+03 O.OOE+00 1.80E+04 0.OOE+00 1.05E+05 Ru-105 8.OOE-03 0.OOE+00 2.69E-03 0.OOE+00 5.88E-02 0.OOE+00 3.18E+00 Ru-106 1.90E+05 0.OOE+00 2.38E+04 0.OOE+00 2.25E+05 0.OOE+00 1.44E+06 Ag- 10M 3.86E+08 2.82E+0811.86E+08 0.OOE+00 4.03E+08 0.00E+00 1.46E+10 Page 11.4-49

CY-BY-1 70-301 Revision 5 Table 4-19 (Continued)

Infant Grass-Cow-Milk Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Te-125M 1.51E+08 5.04E+07 2.04E+07 5.08E+07 0.OOE++/-0 0.OOE+00 7.19E+07 Te-127M 4.21E+08 1.40E+08 5.10E+07 1.22E+08 1.04E+09 0.OOE+00 1.70E+08 Te-127 6.45E+03 2.16E+03 1.39E+03 5.25E+03 1.57E+04 0.OOE+00 1.35E+05 Te-129M 5.57E+08 1.91E+08 8.58E+07 2.14E+08 1.39E+09 0.OOE+00 3.33E+08 Te-129 2.72E-09 9.38E-10 6.35E-10 2.28E-09 6.77E-09 0.OOE+00 2.17E-07 Te-131M 3.37E+06 1.36E+06 1.12E+06 2.75E+06 9.35E+06 0.OOE+00 2.29E+07 Te-131 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+0O 0.OOE+00 0.OOE+00 Te-132 2.10E+07 1.04E+07 9.71E+06 1.54E+07 6.51E+07 0.OOE+00 3.85E+07 1-130 3.53E+06 7.77E+06 3.12E+06 8.71E+08 8.53E+06 0.OOE+00 1.67E+06 1-131 2.72E+09 3.20E+09 1.41E+09 1.05E+12 3.74E+09 O.OOE+00 1.14E+08 1-132 1.43E+00 2.91E+00 1.04E+00 1.36E+02 3.25E+00 0.OOE+00 2.36E+00 1-133 3.63E+07 5.29E+07 1.55E+07 9.62E+09 6.22E+07 0.OOE+00 8.95E+06 1-134 1.65E-11 3.37E-11 1.20E-11 7.87E-10 3.77E-11 0.OOE+00 3.49E-11 1-135 1.13E+05 2.25E+05 8.19E+04 2.01E+07 2.50E+05 O.OOE+00 8.13E+04 Cs-134 3.65E+10 6.80E+10 6.87E+09 O.OOE+00 1.75E+10 7.18E+09 1.85E+08 Cs-136 1.97E+09 5.80E+09 2.16E+09 O.OOE+00 2.3 1E+09 4.72E+08 8.80E+07 Cs-137 5.15E+10 6.02E+10 4.27E+09 0.OOE+00 1.62E+10 6.55E+09 1.88E+08 Cs-138 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 Ba-139 4.29E-07 2.84E-10 1.24E-08 O.OOE+00 1.71E-10 1.72E-10 2.72E-05 Ba-140 2.41E+08 2.41E+05 1.24E+07 O.OOE+00 5.72E+04 1.48E+05 5.92E+07 Ba-141 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+0 O.OOE+00 0.OOE+0O 0.OOE+00 Ba-142 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+0O 0.OOE+00 La-140 4.06E+01 1.60E+01 4.12E+00 O.OOE+00 O.OOE+00 0.OOE+00 1.88E+05 La-142 1.73E-10 6.35E-11 1.52E-11 O.OOE+00 O.OOE+00 0.OOE+00 1.08E-05 Ce-141 4.34E+04 2.64E+04 3.11E+03 O.OOE+00 8.15E+03 O.OOE+00 1.37E+07 Ce-143 3.96E+02 2.63E+05 3.OOE+01 0.00E+00 7.65E+01 O.OOE+00 1.53E+06 Ce-144 2.33E+06 9.52E+05 1.30E+05 0.OOE+00 3.85E+05 O.OOE+00 1.33E+08 Pr-143 1.49E+03 5.56E+02 7.37E+01 O.OOE+00 2.07E+02 0.OOE+00 7.84E+05 Pr-144 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 Nd-147 8.88E+02 9.12E+02 5.59E+01 O.OOE+0 '.OOE+00 +02 5.78E+05 W-187 6.08E+04 4.23E+04 1.46E+04 O.OOE+00 O.OOE+00 0.OOE+00 2.48E+06 Np-239 3.64E+01 3.26E+00 1.84E+00 O.OOE+00 6.50E+00 O.OOE+00 9.42E+04 Notes:

1) Units are M2 mrem/yr per tCi/sec with the exception of H-3.

2) For H-3, the units are mrem/yr per g.tCi/m 3.

Page 11.4-50

CY-BY-1 70-301 Revision 5 Table 4-20 Adult Grass-Goat-Milk Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lune GI-LLI 1H-3 0.OOE+00 8.88E+02 8.88E+02 8.88E+02 8.88E+02 8.88E+02 8.88E+02 Na-24 2.95E+05 2.95E+05 2.95E+05 2.95E+05 2.95E+05 2.95E+05 2.95E+05 Cr-51 O.OOE+00 O.OOE+00 3.43E+03 2.05E+03 7.55E+02 4.55E+03 8.62E+05 Mn-54 0.OOE+00 1.01E+06 1.93E+05 0.OOE+00 3.OOE+05 O.OOE+00 3.09E+06 Mn-56 10.OOE+00 4.95E-04 8.79E-05 0.OOE+00 6.29E-04 O.OOE+00 1.58E-02 Fe-55 3.26E+05 2.26E+05 5.26E+04 0.OOE+00 0.OOE+00 1.26E+05 1.29E+05 Fe-59 3.86E+05 9.07E+05 3.48E+05 0.OOE+00 O.OOE+00 2.53E+05 3.02E+06 Co-58 O.OOE+00 5.66E+05 1.27E+06 0.OOE+00 0.OOE+00 0.OOE+00 1.15E+07 Co-60 O.OOE+00 1.97E+06 4.34E+06 O.OOE+00O0.OOE+00 0.OOE+00 3.70E+07 Ni-63 8.07E+08 5.60E+07 2.71E+07 O.OOE+00 0.OOE+00 0.OOE+00 1.17E+07 Ni-65 4.44E-02 5.77E-03 2.63E-03 O.OOE+00 O.OOE+0O 0.OOE+00 1.46E-01 Cu-64 0.OOE+00 2.63E+03 1.23E+03 0.OOE+00 6.63E+03 0.OOE+00 2.24E+05 Zn-65 11.65E+08 5.24E+08 2.37E+08 0.OOE+00 3.50E+08 0.OOE+00 3.30E+08 Zn-69 2.41E-13 4.61E-13 3.21E-14 O.OOE+00 3.OOE-13 O.OOE+00 6.93E-14 Br-83 0.OOE+00 0.OOE+00 1.16E-02 0.OOE+00 O.OOE+00 O.OOE+00 1.67E-02 Br-84 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 Br-85 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 Rb-86 0.OOE+00 3.12E+08 1.45E+08 O.OOE+00 O.OOE+00 0.OOE+00 6.15E+07 Rb-88 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 Rb-89 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Sr-89 3.05E+09 O.OOE+00 8.74E+07 O.OOE+00 O.OOE+00 0.OOE+00 4.88E+08 Sr-90 1.13E+1 1 O.OOE+00 2.27E+09 0.OOE+00 O.OOE+00 0.OOE+00 2.84E+09 Sr-91 6.03E+04 0.OOE+00 2.44E+03 0.OOE+00 0.OOE+00 0.OOE+00 2.87E+05 Sr-92 1.02E+00 0.OOE+00 4.39E-02 O.OOE+00 O.OOE+00 O.OOE+00 2.01E+01 Y-90 8.52E+00 0.OOE+00 2.28E-01 0.OOE+00 O.OOE+00 O.OOE+00 9.03E+04 Y-91M O.OOE+00 0.OOE+00 0.OOE+0 0.OOE+00 0.OOE+00 0.OOE+00 2.26E-20 Y-91 11.03E+03 0.OOE+00 2.76E+01 0.OOE+00 0.OOE+00 0.OOE+00 5.67E+05 Y-92 6.68E-06 0.OOE+00 1.95E-07 O.OOE+00 0.OOE+00 O.OOE+00 1.17E-01 Y-93 2.66E-02 O.OOE+00 7.34E-04 O.OOE+00 O.OOE+00 0.OOE+00 8.43E+02 Zr-95 1.13E+02 3.63E+01 2.46E+01 0.OOE+00 5.70E+01 0.OOE+00 1.15E+05 Zr-97 5.19E-02 1.05E-02 4.79E-03 O.OOE+00 1.58E-02 0.OOE+00 3.24E+03 Nb-95 9.92E+03 5.52E+03 2.97E+03 0.OOE+00 5.45E+03 0.OOE+00 3.35E+07 Mo-99 0.OOE+00 2.97E+06 5.65E+05 0.OOE+00 6.72E+06 0.OOE+00 6.88E+06 Tc- 99M 3.97E-01 1.12E+00 1.43E+01 0.OOE+00 1.70E+01 5.50E-01 6.64E+02 Tc-101 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 Ru-103 1.22E+02 0.OOE+00 5.26E+01 0.OOE+00 4.66E+02 0.OOE+00 1.43E+04 Ru-105 1.02E-04 O.OOE+00 4.03E-05 O.OOE+00 1.32E-03 0.OOE+00 6.25E-02 Ru-106 2.45E+03 O.OOE+00 3.10E+02 0.OOE+00 4.73E+03 O.OOE+00 1.58E+05 Ag-11 OM 6.99E+06 6.46E+06 3.84E+06 0.OOE+00 1.27E+0710.OOE+00 2.64E+09 Page 11.4-51

CY-BY-170-301 Revision 5 Table 4-20 (Continued)

Adult Grass-Goat-Milk Dose Factors Nuclide Bone Liver ,T Body Thyroid Kidney Lune GI-LLI Te-125M 1.96E+06 7.09E+05 2.62E+05 5.88E+05 7.95E+06 O.OOE+00 7.81E+06 Te-127M 5.49E+06 1.96E+06 6.69E+05 1.40E+06 2.23E+07 0.OOE+00 1.84E+07 Te-127 8.OOE+01 2.87E+01 1.73E+01 5.92E+01 3.26E+02 O.OOE+00 6.31E+03 Te-129M 7.22E+06 2.69E+06 1.14E+06 2.48E+06 3.01E+07 O.OOE+00 3.64E+07 Te-129 3.39E-11 1.27E-11 8.26E-12 2.60E-11 1.43E-10 0.OOE+00 2.56E-11 Te-131M 4.33E+04 2.12E+04 1.76E+04 3.35E+04 2.14E+05 O.OOE+00 2.10E+06 Te-131 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 Te-132 2.87E+05 1.86E+05 1.74E+05 2.05E+05 1.79E+06 0.OOE+00 8.78E+06 1-130 5.01E+05 1.48E+06 5.84E+05 1.25E+08 2.31E+06 O.OOE+00 1.27E+06 1-131 3.55E+08 5.08E+08 2.91E+08 1.67E+11 8.71E+08 0.OOE+00 1.34E+08 1-132 1.98E-01 5.29E-01 1.85E-01 1.85E+01 8.42E-01 O.OOE+00 9.93E-02 1-133 4.65E+06 8.09E+06 2.47E+06 1.19E+09 1.41E+07 O.OOE+00 7.27E+06 1-134 2.27E-12 6.15E-12 2.20E-12 1.07E-10 9.79E-12 0.OOE+00 5.36E-15 1-135 1.55E+04 4.06E+04 1.50E+04 2.68E+06 6.51E+04 O.OOE+00 4.58E+04 Cs-134 1.70E+10 4.04E+10 3.30E+10 0.00E+00 1.31E+10 4.34E+09 7.06E+08 Cs-136 7.88E+08 3.11E+09 2.24E+09 0.OOE+00 1.73E+09 2.37E+08 3.53E+08 Cs-137 2.21E+10 3.03E+10 1.98E+10 0.OOE+00 1.03E+10 3.42E+09 5.86E+08 Cs-138 O.OOE+0O 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 Ba-139 5.32E-09 3.79E-12 1.56E-10 O.OOE+00 3.54E-12 2.15E-12 9.44E-09 Ba-140 3.23E+06 4.05E+03 2.11E+05 O.OOE+00 1.38E+03 2.32E+03 6.64E+06 Ba-141 0.OOE+0 0.OO0E+00 0.00E+00 0.00 0.OOE+00 0.OOE+00 0.OOE+00 Ba-142 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 La-140 5.43E-01 2.74E-01 7.23E-02 0.OOE+00 O.OOE+00 O.OOE+00 2.01E+04 La-142 2.27E-12 1.03E-12 2.57E-13 0.OOE+00 0.OOE+00 O.OOE+00 7.53E-09 Ce-141 5.81E+02 3.93E+02 4.46E+01 0.OOE+00 1.83E+02 O.OOE+00 1.50E+06 Ce-143 4.98E+00 3.68E+03 4.07E-01 0.OOE+00 1.62E+00 0.OOE+00 1.38E+05 Ce-144 4.29E+04 1.79E+04 2.30E+03 0.OOE+00 1.06E+04 0.OOE+00 1.45E+07 Pr-143 1.90E+01 7.60E+00 9.40E-01 0.OOE+00 4.39E+00 0.OOE+00 8.31E+04 Pr-144 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 Nd-147 1.14E+01 1.32E+01 7.87E-01 O.OOE+00 7.69E+00 0.OOE+00 6.31E+04 W-187 7.82E+02 6.53E+02 2.28E+02 0.OOE+00 0.OOE+00 0.OOE+00 2.14E+05 Np-239 4.40E-01 4.33E-02 2.39E-02 0.OOE+00 1.35E-01 0.OOE+00 8.88E+03 Notes:

1) Units are m2 mrem/yr per tCi/sec with the exception of H-3.

2) For H-3, the units are mrem/yr per pCi/m 3 .

Page 11.4-52

CY-BY-1 70-301 Revision 5 Table 4-21 Teen Grass-Goat-Milk Dose Factors Nucide Bone Liver T Bodv Thyroid Kidney Lunm GI-LLI H-3 0.OOE+00 1.16E+03 1.16E+03 1.16E+03 1.16E+03 1.16E+03 1.16E+03 Na-24 5.15E+05 5.15E+05 5.15E+05 5.15E+05 5.15E+05 5.15E+05 5.15E+05 Cr-51 0.OOE+00 0.OOE+00 5.99E+03 3.33E+03 1.31E+03 8.55E+03 1.O1E+06 Mn-54 O.OOE+00 1.68E+06 3.34E+05 0.OOE+00 5.02E+05 0.OOE+00 3.45E+06 Mn-56 0.OOE+00 8.78E-04 1.56E-04 0.OOE+00 1.11E-03 0.OOE+00 5.78E-02 Fe-55 5.79E+05 4.11E+05 9.57E+04 0.OOE+00 0.OOE+00 2.60E+05 1.78E+05 Fe-59 6.74E+05 1.57E+06 6.07E+05 O.OOE+00 O.OOE+00 4.96E+05 3.72E+06 Co-58 O.OOE+00 9.53E+05 2.20E+06 O.OOE+00 0.OOE+00 0.OOE+00 1.31E+07 Co-60 0.OOE+00 3.34E+06 7.52E+06 O.OOE+00 0.OOE+00 0.OOE+00 4.35E+07 Ni-63 1.42E+09 1.OOE+08 4.81E+07 O.OOE+00 0.OOE+00 0.OOE+00 1.59E+07 Ni-65 8.13E-02 1.04E-02 4.73E-03 0.OOE+00 O.OOE+0 0.OOE+00 5.63E-01 Cu-64 O.OOE+00 4.69E+03 2.20E+03 0.OOE+00 1.19E+04 0.OOE+00 3.64E+05 Zn-65 2.53E+08 8.78E+08 4.09E+08 O.OOE+00 5.62E+08 0.OOE+00 3.72E+08 Zn-69 4.44E-13 8.46E-13 5.92E-14 0.OOE+00 5.53E-13 0.OOE+00 1.56E-12 Br-83 0.OOE+0 0.0OOE+00 2.13E-02 0.OOE+00 O.OOE+00 0:00E+00 0.OOE+00 Br-84 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Br-85 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 Rb-86 0.OOE+00 5.68E+08 2.67E+08 0.OOE+00 0.OOE+00 0.OOE+00 8.41E+07 Rb-88 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+0O O.OOE+00 0.OOE+00 Rb-89 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Sr-89 5.61E+09 0.OOE+00 1.61E+08 0.OOE+00 0.OOE+00 0.OOE+00 6.69E+08 Sr-90 1.71E+1 1 0.OOE+00 3.41E+09 0.OOE+00 0.OOE+00 0.OOE+00 3.90E+09 Sr-91 1.11E+05 0.OOE+00 4.41E+03 0.OOE+00 0.OOE+00 0.OOE+00 5.02E+05 Sr-92 1.86E+00 O.OOE+00 7.92E-02 0.OOE+00 0.OOE+00 0.OOE+00 4.74E+01 Y-90 1.56E+01 0.OOE+00 4.21E-01 O.OOE+00 0.OOE+00 0.OOE+00 1.29E+05 Y-91M 1.41E-20 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 6.66E-19 Y-91 1.90E+03 O.OOE+00 5.08E+01 0.OOE+00 0.OOE+00 O.OOE+00 7.77E+05 Y-92 1.23E-05 O.OOE+00 3.57E-07 0.OOE+00 0.OOE+00 0.OOE+00 3.39E-01 Y-93 4.90E-02 0.OOE+0 1.34E-03 O.OOE+00 0.OOE+00 0.OOE+00 1.50E+03 Zr-95 1.98E+02 6.25E+01 4.30E+01 O.OOE+00 9.18E+01 0.OOE+00 1.44E+05 Zr-97 9.44E-02 1.87E-02 8.61E-03 0.OOE+00 2.83E-02 O.OOE+00 5.06E+03 Nb-95 1.69E+04 9.38E+03 5.16E+03 O.OOE+00 9.09E+03 O.OOE+00 4.01E+07 Mo-99 0.OOE+00 5.36E+06 1.02E+06 O.OOE+00 1.23E+07 0.OOE+00 9.59E+06 Tc- 99M 6.89E-01 1.92E+00 2.49E+01 0.OOE+00 2.86E+01 1.07E+00 1.26E+03 Tc-101 0.OOE+00 0.OOE+0 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 Ru-103 2.17E+02 0.OOE+00 9.29E+01 0.OOE+00 7.66E+02 0.OOE+00 1.81E+04 Ru-105 1.86E-04 0.OOE+00 7.24E-05 0.OOE+00 2.35E-03 0.OOE+00 1.51E-01 Ru-106 4.50E+03 0.OOE+00 5.67E+02 O.OOE+00 8.68E+03 0.OOE+00 2.16E+05 Ag-i IOM 1.16E+07 1.09E+07 6.65E+06 0.OOE+00 2.09E+07 0.OOE+00 3.07E+09 Page 11.4-53

CY-BY-1 70-301 Revision 5 Table 4-21 (Continued) I Teen Grass-Goat-Milk Dose Factors Nuclide 'Bone Liver TBody Thyroid Kidney Lune GI-LLI Te-125M 3.61E+06 1.30E+06 4.82E+05 1.01E+06 O.OOE+00 O.OOE+00 1.06E+07 Te-127M 1.01E+07 3.59E+06 1.20E+06 2.41E+06 4.10E+07 O.OOE+00 2.52E+07 Te-127 1.48E+02 5.25E+01 3.19E+01 1.02E+02 6.OOE+02 O.OOE+00 1.14E+04 Te-129M 1.32E+07 4.90E+06 2.09E+06 4.26E+06 5.53E+07 O.OOE+00 4.96E+07 Te-129 6.24E-11 2.33E-11 1.52E-11 4.46E-11 2.62E-100.OOE+00 3.41E-10 Te-131M 7.88E+04 3.78E+04 3.15E+04 5.68E+04 3.94E+05 O.OOE+00 3.03E+06 Te-131 O.OOE+00 O.OOE+0 0.0OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 Te-132 5.13E+05 3.25E+05 3.06E+05 3.42E+05 3.12E+06 O.OOE+00 1.03E+07 1-130 8.82E+05 2.55E+06 1.02E+06 2.08E+08 3.93E+06 O.OOE+00 1.96E+06 1-131 6.45E+08 9.02E+08 4.85E+08 2.63E+11 1.55E+09 O.OOE+00 1.78E+08 1-132 3.50E-01 9.17E-01 3.29E-01 3.09E+01 1.44E+00 0.OOE+00 3.99E-01 1-133 8.50E+06 1.44E+07 4.40E+06 2.01E+09 2.53E+07 O.OOE+00 1.09E+07 1-134 4.03E-12 1.07E-11 3.83E-12 1.78E-10 1.68E-11 O.OOE+00 1.41E-13 1-135 2.75E+04 7.09E+04 2.63E+04 4.56E+06 1.12E+05 O.OOE+00 7.85E+04 Cs-134 2.94E+10 6.93E+10 3.22E+10 O.OOE+00 2.20E+10 8.41E+09 8.62E+08 Cs-136 1.34E+09 5.28E+09 3.54E+09 O.OOE+00 2.87E+09 4.53E+08 4.25E+08 Cs-137 4.02E+10 5.34E+10 1.86E+10 O.OOE+00 1.82E+10 7.06E+09 7.60E+08 Cs-138 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ba-139 9.84E-09 6.92E-12 2.87E-10 O.OOE+00 6.53E-12 4.77E-12 8.78E-08 Ba-140 5.82E+06 7.14E+03 3.75E+05 O.OOE+00 2.42E+03 4.80E+03 8.98E+06 Ba-141 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 Ba-142 O.OOE+00 O.OOE+00 0.OOE+0 0.0OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 La-140 9.75E-01 4.79E-01 1.27E-01 0.OOE+00 O.OOE+00 O.OOE+00 2.75E+04 La-142 4.09E-12 1.82E-12 4.53E-13 0.OOE+00 O.OOE+00 O.OOE+00 5.53E-08 Ce-141 1.07E+03 7.12E+02 8.17E+01 0.OOE+00 3.35E+02 O.OOE+0O 2.04E+06 Ce-143 9.15E+00 6.66E+03 7.44E-01 O.OOE+00 2.99E+00 O.OOE+00 2.OOE+05 Ce-144 7.90E+04 3.27E+04 4.24E+03 0.OOE+00 1.95E+04 O.OOE+00 1.99E+07 Pr-143 3.48E+01 1.39E+01 1.73E+00 0.OOE+00 8.08E+00 O.OOE+0O 1.15E+05 Pr-144 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+0 0.OOE+00 Nd-147 2.19E+01 2.38E+01 1.43E+00 O.OOE+00 1.40E+01 O.OOE+0 8.59E+04 W-187 1.43E+03 1.17E+03 4.08E+02 O.OOE+00 O.OOE+00 O.OOE+0O 3.15E+05 Np-239 8.40E-01 '7.92E-02 4.40E-02 O.OOE+00 2.49E-01 0.OOE+00 1.27E+04 Notes:

1) Units are m2 mrem/yr per jiCi/sec with the exception of H-3.

2) For H-3, the units are mrem/yr per gCi/m 3.

Page 11.4-54

CY-BY-1 70-301 Revision 5 Table 4-22 Child Grass-Goat-Milk Dose Factors Nucide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 O.OOE+00 1.83E+03 1.83E+03 1.83E+03 1.83E+03 1.83E+03 1.83E+03 Na-24 1.07E+06 1.07E+06 1.07E+06 1.07E+06 1.07E+06 1.07E+06 1.07E+06 Cr-51 0.OOE+00 O.OOE+00 1.22E+04 6.78E+03 1.85E+03 1.24E+04 6.47E+05 Mn-54 0.OOE+00 2.52E+06 6.70E+05 O.OOE+00 7.06E+05 0.OOE+00 2.11 E+06 Mn-56 0.OOE+00 1.53E-03 3.46E-04 O.OOE+00 1.85E-03 0.OOE+00 2.22E-01 Fe-55 1.45E+06 7.71E+05 2.39E+05 O.OOE+00 O.OOE+00 4.36E+05 1.43E+05 Fe-59 1.56E+06 2.53E+06 1.26E+06 O.OOE+00 O.OOE+00 7.33E+05 2.63E+06 Co-58 O.OOE+00 1.46E+06 4.46E+06 O.OOE+00 O.OOE+00 O.OOE+00 8.49E+06 Co-60 O.OOE+00 5.18E+06 1.53E+07 O.OOE+00 O.OOE+00 0.OOE+00 2.87E+07 Ni-63 3.56E+09 1.90E+08 1.21E+08 O.OOE+00 O.OOE+00 O.OOE+00 1.28E+07 Ni-65 1.99E-01 1.87E-02 1.09E-02 O.OOE+00 O.OOE+00 O.OOE+00 2.29E+00 Cu-64 O.OOE+00 8.24E+03 4.98E+03 O.OOE+00 1.99E+04 O.OOE+00 3.87E+05 Zn-65 4.96E+08 1.32E+09 8.22E+08 O.OOE+00 8.33E+08 O.OOE+00 2.32E+08 Zn-69 1.09E-12 1.58E-12 1.46E-13 O.OOE+00 9.57E-13 O.OOE+00 9.95E-11 Br-83 0.OOE+00 O.OOE+00 5.24E-02 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 Br-84 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Br-85 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Rb-86 0.OOE+00 1.05E+09 6.48E+08 O.OOE+00 O.OOE+00 O.OOE+00 6.78E+07 Rb-88 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+0O 0.OOE+00 Rb-89 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+0 0.OOE+00 Sr-89 1.39E+10 O.OOE+00 3.97E+08 O.OOE+00 O.OOE+00 0.OOE+0 5.38E+08 Sr-90 3.53E+1 1 O.OOE+00 7.11E+09 O.OOE+00 O.OOE+00 0.OOE÷0 3.16E+09 Sr-91 2.72E+05 O.OOE+00 1.03E+04 O.OOE+00 O.OOE+00 0.OOE+0+/- 6.OOE+05 Sr-92 4.54E+00 O0OOE+00 1.82E-01 O.OOE+00 O.OOE+00 O.OOE+00 8.60E+01 Y-90 3.87E+01 O.OOE+00 1.04E+00 O.OOE+00 O.OOE+00 O.OOE+00 1.10E+05 Y-91M 3.45E-20 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 6.75E-17 Y-91 4.68E+03 O.OOE+00 1.25E+02 O.OOE+00 O.OOE+00 O.OOE+00 6.24E+05 Y-92 3.03E-05 O.OOE+00 8.67E-07 O.OOE+00 O.OOE+00 O.OOE+00 8.75E-01 Y-93 1.20E-01 O.OOE+00 3.31E-03 O.OOE+00 O.OOE+00 O.OOE+00 1.80E+03 Zr-95 4.60E+02 1.01E+02 9.OOE+01 O.OOE+00 1.45E+02 O.OOE+00 1.05E+05 Zr-97 2.30E-01 3.32E-02 1.96E-02 0.OOE+00 4.77E-02 O.OOE+00 5.03E+03 Nb-95 3.82E+04 1.49E+04 1.06E+04 0.OOE+00 1.40E+04 0.OOE+00 2.75E+07 Mo-99 0.OOE+00 9.75E+06 2.41E+06 O.OOE+00 2.08E+07 O.OOE+00 8.06E+06 Tc- 99M 1.58E+00 3.10E+00 5.14E+01 O.OOE+00 4.50E+01 1.57E+00 1.76E+03 Tc-101 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 Ru-103 5.14E+02 0.OOE+00 1.97E+02 O.OOE+00 1.29E+03 0.OOE+00 1.33E+04 Ru-105 4.55E-04 O.OOE+00 1.65E-04 0.OOE+00 4.OOE-03 0.OOE+00 2.97E-01 Ru-106 1.1 1E+04 0.OOE+00 1.38E+03 O.OOE+00 1.50E+04 0.OOE+00 1.72E+05 Ag-110M 2.51E+07 1.69E+07 1.35E+07 0.OOE++/-O 3.15E+07 0.00E+00 2.01E+09 Page 11.4-55

CY-BY-1 70-301 Revision 5 Table 4-22 (Continued)

Child Grass-Goat-Milk Dose Factors Nuclide Bone Liver 'T Body Thyroid Kidney Lung GI-LLI Te-125M 8.86E+06 2.40E+06 1.18E+06 2.49E+06 O.OOE+0* O.OOE+00 8.55E+06 Te-127M 2.50E+07 6.72E+06 2.96E+06 5.97E+06 7.12E+07 O.OOE+00 2.02E+07 Te-127 3.64E+02 9.83E+01 7.82E+01 2.52E+02 1.04E+03 0.OOE+00 1.42E+04 Te-129M 3.26E+07 9.09E+06 5.05E+06 1.05E+07 9.56E+07 0.OOE+00 3.97E+07 Te-129 1.54E-10 4.30E-11 3.66E-11 1.10E-10 4.51E-100.OOE+00 9.59E-09 Te- 131M 1.92E+05 6.63E+04 7.06E+04 1.36E+05 6.42E+05 0.OOE+00 2.69E+06 Te-131 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 Te-132 1.22E+06 5.42E+05 6.55E+05 7.89E+05 5.03E+06 O.OOE+00 5.46E+06 1-130 2.06E+06 4.17E+06 2.15E+06 4.59E+08 6.23E+06 O.OOE+00 1.95E+06 1-131 1.56E+09 1.57E+09 8.94E+08 5.20E+11 2.58E+09 0.OOE+00 1.40E+08 1-132 8.29E-01 1.52E+00 7.OOE-01 7.07E+01 2.33E+00 0.OOE+00 1.79E+00 1-133 2.06E+07 2.55E+07 9.66E+06 4.74E+09 4.25E+07 0.OOE+00 1.03E+07 1-134 9.53E-12 1.77E-11 8.14E-12 4.07E-10 2.71E-11 O.OOE+00 1.17E-11 1-135 6.52E+04 1.17E+05 5.55E+04 1.04E+07 1.80E+05 O.OOE+00 8.94E+04 Cs-134 6.79E+10 1.11E+I1 2.35E+10 O.OOE+00 3.45E+101 1.24E+10 6.01E+08 Cs-136 3.03E+09 8.32E+09 5.39E+09 O.OOE+00 4.43E+09 6.61E+08 2.92E+08 Cs-137 9.67E+10 9.26E+10 1.37E+10 0.OOE+00 3.02E+10 1.09E+10 5.80E+08 Cs-138 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 Ba-139 2.42E-08 1.29E-11 7.01E-100.OOE+00 1.13E-11 7.59E-12 1.40E-06 Ba-140 1.41E+07 1.23E+04 8.21E+05 0.OOE+00 4.01E+03 7.34E+03 7.12E+06 Ba-141 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 Ba-142 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+0O La-140 2.33E+00 8.16E-01 2.75E-01 0.OOE+/-00 0.OOE+00 O.OOE+00 2.27E+04 La-142 9.88E-12 3.15E-12 9.87E-13 O.OOE+00 0.OOE+00 0.OOE+00 6.24E-07 Ce-141 2.62E+03 1.31E+03 1.94E+02 0.OOE+00 5.74E+02 0.OOE+00 1.63E+06 Ce-143 2.25E+01 1.22E+04 1.76E+00 0.OOE+00 5.11E+00 0.OOE+00 1.78E+05 Ce-144 1.95E+05 6.11E+04 1.04E+04 0.OOE+00 3.38E+04 0.OOE+00 1.59E+07 Pr-143 8.62E+01 2.59E+01 4.28E+00 O.OOE+00 1.40E+01 0.OOE+00 9.30E+04 Pr-144 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+0O Nd-147 5.37E+01 4.35E+01 3.37E+00 0.OOE+00 2.39E+01 0.OOE+00 6.89E+04 W-187 3.47E+03 2.05E+03 9.21E+02 0.OOE+00 0.OOE+00 0.OOE+00 2.88E+05 Np-239 2.07E+00 1.48E-01 1.04E-01 0.OOE+00 4.29E-01 O.OOE+00 1.10E+04 Notes:

1) Units are m2 mrem/yr per jtCi/sec with the exception of H-3.

2) For H-3, the units are mrem/yr per j+/-Ci/m 3.

Page 11.4-56

CY-BY-1 70-301 Revision 5 Table 4-23 Infant Grass-Goat-Milk Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 O.OOE+00 2.78E+03 2.78E+03 2.78E+03 2.78E+03 2.78E+03 2.78E+03 Na-24 1.87E+06 1.87E+06 1.87E+06 1.87E+06 1.87E+06 1.87E+06 1.87E+06 Cr-51 0.OOE+00 0.OOE+00 1.93E+04 1.26E+04 2.76E+03 2.46E+04 5.64E+05 Mn-54 O.OOE+00 4.68E+06 1.06E+06 0.OOE+00 1.04E+06 O.OOE+00 1.72E+06 Mn-56 0.OOE+00 3.75E-03 6.47E-04 0.OOE+00 3.22E-03 O.OOE+00 3.41E-01 Fe-55 1.76E+06 1.13E+06 3.03E+05 0.OOE+00 O.OOE+00 5.55E+05 1.44E+05 Fe-59 2.92E+06 5.09E+06 2.01E+06 O.OOE+00 O.OOE+00 1.51E+06 2.43E+06 Co-58 O.OOE+00 2.91E+06 7.26E+06 0.OOE+00 O.OOE+00 O.OOE+00 7.25E+06 Co-60 0.OOE+00 1.06E+07 2.50E+07 0.OOE+00 0.OOE+00 O.OOE+00 2.52E+07 Ni-63 4.19E+09 2.59E+08 1.45E+08 O.OOE+00 0.OOE+00 0.OOE+00 1.29E+07 Ni-65 4.21E-01 4.77E-02 2.17E-02 0.OOE+00 O.OOE+00 O.OOE+00 3.63E+00 Cu-64 O.OOE+00 2.05E+04 9.48E+03 0.OOE+00 3.46E+04 O.OOE+00 4.20E+05 Zn-65 6.66E+08 2.28E+09 1.05E+09 0.OOE+00 1.11 E+09 O.OOE+00 1.93E+09 Zn-69 2.33E-12 4.19E-12 3.12E-13 0.OOE+00 1.74E-12 O.OOE+00 3.42E-10 Br-83 O.OOE+00 O.OOE+00 1.11 E-0 1 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Br-84 O.OOE+0O O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Br-85 0.OOE+0O O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Rb-86 O.OOE+0O 2.67E+09 1.32E+09 0.OOE+00 O.OOE+00 O.OOE+00 6.84E+07 Rb-88 O.OOE+0O 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Rb-89 O.OOE+0 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Sr-89 2.64E+10 0.OOE+00 7.58E+08 0.OOE+00 O.OOE+00 O.OOE+00 5.43E+08 Sr-90 3.91E+I 1 O.OOE+00 7.92E+09 0.OOE+00 O.OOE+00 O.OOE+00 3.19E+09 Sr-91 5.66E+05 O.OOE+00 2.05E+04 0.OOE+00 O.OOE+00 O.OOE+00 6.70E+05 Sr-92 9.65E+0O 0.OOE+00 3.59E-01 0.OOE+00 O.OOE+00 O.OOE+00 1.04E+02 Y-90 18.19E+01 O.OOE+00 2.20E+00 O.OOE+00 O.OOE+00 O.OOE+00 1.13E+05 Y-91M 7.31E-20 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 2.44E-16 Y-91 8.79E+03 O.OOE+00 2.34E+02 O.OOE+00 O.OOE+00 O.OOE+00 6.30E+05 Y-92 6.44E-05 O.OOE+00 1.81E-06 O.OOE+00 O.OOE+00 O.OOE+00 1.23E+00 Y-93 2.57E-01 O.OOE+00 6.99E-03 O.OOE+00 O.OOE+00 O.OOE+00 2.03E+03 Zr-95 8.17E+02 1.99E+02 1.41E+02 O.OOE+00 2.15E+02 O.OOE+00 9.91E+04 Zr-97 4.87E-01 8.35E-02 3.81E-02 O.OOE+00 8.42E-02 O.OOE+00 5.33E+03 Nb-95 7.13E+04 2.94E+04 1.70E+04 O.OOE+00 2.1OE+04 0.OOE+00 2.48E+07 Mo-99 0.OOE+00 2.49E+07 4.86E+06 O.OOE+00 3.72E+07 O.OOE+00 8.21E+06 Tc- 99M 3.29E+00 6.78E+00 8.73E+01 0.OOE+00 7.29E+01 3.54E+00 1.97E+03 Tc-101 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ru-103 1.04E+03 O.OOE+00 3.48E+02 O.OOE+00 2.16E+03 0.OOE+00 1.27E+04 Ru-105 9.60E-04 O.OOE+0( 3.23E-04 0.OOE+00 7.06E-03 0.OOE+00 3.82E-01 Ru-106 2.28E+04 0.OOE+0 2.85E+03 0.OOE+00 2.70E+04 0.OOE+00 1.73E+05 Ag- I1OM 4.63E+07 3.38E+07 2.24E+07 0.OOE+00 4.84E+07 0.OOE+00 1.75E+09 Page 11.4-57

CY-BY-1 70-301 Revision 5.

Error! Reference source not found. (Continued)

Infant Grass-Goat-Milk Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lun2 GI-LLI Te-125M 1.81E+07 6.05E+06 2.45E+06 6.09E+06 0.OOE+00 0.OOE+00 8.62E+06 Te-127M 5.05E+07 1.68E+07 6.12E+06 1.46E+07 1.24E+08 0.OOE+00 2.04E+07 Te-127 7.74E+02 2.59E+02 1.66E+02 6.30E+02 1.89E+03 0.OOE+00 1.63E+04 Te-129M 6.68E+07 2.29E+07 1.03E+07 2.57E+07 1.67E+0810.OOE+00 3.99E+07 Te-129 3.26E-10 1.13E-1O 7.62E-11 2.74E-10 8.13E-100.OOE+00 2.61E-08 Te-131M 4.05E+05 1.63E+05 1.35E+05 3.30E+05 1.12E+06 O.OOE+00 2.74E+06 Te-131 O.OOE+00 O.OOE+00 0.OOE+0 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 Te-132 2.52E+06 1.25E+06 1.17E+06 1.84E+06 7.81E+06 0.OOE+00 4.62E+06 1-130 4.24E+06 9.32E+06 3.74E+06 1.04E+09 1.02E+07 0.OOE+00 2.OOE+06 1-131 3.26E+09 3.85E+09 1.69E+09 1.26E+12 4.49E+09 0.OOE+00 1.37E+08 1-132 1.72E+00 3.49E+00 1.24E+00 1.64E+02 3.90E+00 0.OOE+00 2.83E+00 1-133 4.36E+07 6.35E+07 1.86E+07 1.15E+10 7.46E+07 0.OOE+00 1.07E+07 1-134 1.98E-11 4.05E-11 1.44E-11 9.44E-10 4.53E-11 0.OOE+00 4.19E-11 1-135 1.36E+05 2.70E+05 9.83E+04 2.42E+07 3.01E+05 0.OOE+00 9.76E+04 Cs-134 1.09E+l 1 2.04E+11 2.06E+10 O.OOE+00 5.25E+10 2.15E+10 5.54E+08 Cs-136 5.91E+09 1.74E+10 6.49E+09 O.OOE+00 6.93E+09 1.42E+09 2.64E+08 Cs-137 1.54E+11 1.81E+ll 1.28E+10 O.OOE+00 4.85E+10 1.96E+10 5.65E+08 Cs-138 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+0O Ba-139 5.14E-08 3.41E-11 1.49E-09 0.OOE+00 2.05E-11 2.07E-11 3.26E-06 Ba-140 2.89E+07 2.89E+04 1.49E+06 O.OOE+00 6.87E+03 1.78E+04 7.11E+06 Ba-141 O.OOE+00 O.OOE+0O 0.OOE+00 O.OOE+00 0.OOE+0O O.OOE+00 0.OOE+00 Ba-142 O.OOE+00 0.OOE+0O 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+0C La-140 4.88E+00 1.92E+00 4.95E-01 0.OOE+00 0.OOE+00 O.OOE+00 2.26E+04 La-142 2.08E-11 7.62E-12 1.82E-12 0.OOE+00 0.OOE+00 0.OOE+00 1.29E-06 Ce-141 5.20E+03 3.17E+03 3.73E+02 0.OOE+00 9.78E+02 O.OOE+00 1.64E+06 Ce-143 4.75E+01 3.15E+04 3.60E+00 0.OOE+00 9.19E+00 0.OOE+00 1.84E+05 Ce-144 2.79E+05 1.14E+05 1.56E+04 0.OOE+00 4.62E+04 0.OOE+00 1.60E+07 Pr-143 1.78E+02 6.67E+01 8.84E+00 0.OOE+00 2.48E+01 0.OOE+00 9.41E+04 Pr-144 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+0C Nd-147 1.07E+02 1.09E+02 6.70E+00 0.OOE+00 4.22E+01 0.OOE+00 6.93E+04 W-187 7.29E+03 5.07E+03 1.75E+03 O.OOE+00 O.OOE+00 0.OOE+00 2.98E+05 Np-239 4.37E+00 3.91E-01 2.21E-01 O.OOE+00 7.80E-01 0.OOE+00 1.13E+04 Notes:

1) Units are M2 mrem/yr per giCi/sec with the exception of H-3.

2) For H-3, the units are mrem/yr per .Ci/m 3.

Page 11.4-58

CY-BY-1 70-301 Revision 5 Table 4-23 Adult Grass-Cow-Meat Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 0.OOE+00 1.85E+02 1.85E+02 1.85E+02 1.85E+02 1.85E+02 1.85E+02 Na-24 1.45E-03 1.45E-03 1.45E-03 1.45E-03 1.45E-03 1.45E-03 1.45E-03 Cr-51 O.OOE+00 0.OOE+00 7.04E+03 4.21E+03 1.55E+03 9.34E+03 1.77E+06 Mn-54 O.OOE+00 9.18E+06 1.75E+06 O.OOE+00 2.73E+06 0.OOE+00 2.81E+07 Mn-56 0.OOE+00 0.00E+00 O.OOE+0 0.001E+00 O.OOE+00 0.OOE+0O 0.OOE+00 Fe-55 2.93E+08 2.03E+08 4.72E+07 O.OOE+00 O.OOE+00 1.13E+08 1.16E+08 Fe-59 2.65E+08 6.24E+08 2.39E+08 O.OOE+00 O.OOE+00 1.74E+08 2.08E+09 Co-58 O.OOE+00 1.82E+07 4.09E+07 O.OOE+00 O.OOE+00 O.OOE+00 3.70E+08 Co-60 0.OOE+00 7.52E+07 1.66E+08 O.OOE+00 O.OOE+00 O.OOE+0O 1.41E+09 Ni-63 1.89E+10 1.31E+09 6.33E+08 O.OOE+00 O.OOE+00 0.003E+0 2.73E+08 Ni-65 O.OOE+00 O.OOE+00 O.OOE+0 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 Cu-64 O.OOE+00 2.52E-07 1.18E-07 O.OOE+00 6.36E-07 O.OOE+00 2.15E-05 Zn-65 3.56E+08 1.13E+09 5.12E+08 O.OOE+00 7.57E+08 O.OOE+00 7.13E+08 Zn-69 0.00E+/-OO 0.00E+00 O.00E+OO 0.00E+00 0.OOE+00 O.OOE+00 0.OOE+00 Br-83 O.OOE+00 0800E+00 O.OOE+0 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 Br-84 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+0 0.0OOE+00 Br-85 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Rb-86 O.OOE+00 4.88E+08 2.28E+08 O.OOE+00 O.OOE+00 0.OOE+00 9.63E+07 Rb-88 0.OOE+00 O.OOE+00 O.OOE+0O O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Rb-89 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+0 0.0OOE+00 Sr-89 3.01E+08 O.OOE+00 8.65E+06 O.OOE+00 O.OOE+00 0.OOE+00 4.83E+07 Sr-90 1.43E+10 O.OOE+00 2.87E+08 O.OOE+00 O.OOE+00 0.OOE+00 3.59E+08 Sr-91 1.43E-10 O.OOE+00 5.79E-12 O.OOE+00 O.OOE+00 0.OOE+00 6.83E-10 Sr-92 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 Y-90 1.08E+02 O.OOE+00 2.91E+0 0.OOE+00 O.OOE+00 0.OOE+00 1.15E+06 Y-91M 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 Y-91 1.13E+06 O.OOE+00 3.03E+04 0.OOE+00 O.OOE+00 O.OOE+00 6.23E+08 Y-92 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 Y-93 4.39E-12 O.OOE+00 1.21E-13 O.OOE+00 0.OOE+00 O.OOE+00 1.39E-07 Zr-95 1.87E+06 6.01E+05 4.07E+05 O.OOE+00 9.43E+05 O.OOE+00 1.91E+09 Zr-97 2.04E-05 4.12E-06 1.88E-06 O.OOE+00 6.22E-06 O.OOE+00 1.28E+00 Nb-95 2.30E+06 1.28E+06 6.89E+05 0.OOE+00 1.27E+06 0.OOE+00 7.78E+09 Mo-99 0.OOE+00 9.93E+04 1.89E+04 0.OOE+00 2.25E+05 0.OOE+00 2.30E+05 Tc- 99M 0.OOE+00 1.22E-20 1.56E-19 0.OOE+00 1.85E-19 0.OOE+00 7.23E-18 Tc-101 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 Ru-103 1.05E+08 O.OOE+00 4.53E+07 O.OOE+00 4.01E+08 O.OOE+00 1.23E+10 Ru-105 0.OOE+0+/- O.OOE+00 O.OOE+00 O.OOE+00 0.001+00 0.OOE+00 0.OOE+00 Ru-106 2.80E+09 0.00E+00 3.54E+08 0.OOE+00 5.40E+09 0.OOE+00 1.81E+/-+ 1 Ag- 11OM 6.68E+06 6.18E+06 3.67E+06 0.OOE+001 1.22E+07 O.OOE+00 2.52E+09 Page 11.4-59

CY-BY-1 70-301 Revision 5 Table 4-23 (Continued) I Adult Grass-Cow-Meat Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lunm GI-LLI Te-125M 3.59E+08 1.30E+08 4.81E+07 1.08E+08 1.46E+09 O.OOE-00 1.43E+09 Te-127M 1.12E+09 3.99E+08 1.36E+08 2.85E+08 4.53E+09 O.OOE+00 3.74E+09 Te-127 2.50E-10 8.98E-11 5.41E-11 1.85E-10 1.02E-090.OOE+00 1.97E-08 Te-129M 1.13E+09 4.23E+08 1.79E+08 3.89E+08 4.73E+09 0.OOE+00 5.71E+09 Te-129 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Te-131M 4.49E+02 2.20E+02 1.83E+02 3.48E+02 2.23E+03 0.OOE+00 2.18E+04 Te-131 O.OOE+0O 0.OOE+00 0.OOE+0 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Te-132 1.40E+06 9.03E+05 8.48E+05 9.98E+05 8.70E+06 O.OOE+00 4.27E+07 1-130 2.03E-06 5.98E-06 2.36E-06 5.07E-04 9.33E-06 O.OOE+00 5.15E-06 1-131 1.07E+07 1.54E+07 8.80E+06 5.03E+09 2.63E+07 0.OOE+00 4.05E+06 1-132 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 1-133 3.70E-01 6.43E-01 1.96E-01 9.45E+01 1.12E+00 0.OOE+00 5.78E-01 1-134 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 1-135 4.66E-17 1.22E-16 4.50E-17 8.04E-15 1.95E-16 0.OOE+00 1.38E-16 Cs-134 6.58E+08 1.57E+09 1.28E+09 O.OOE+00 5.07E+08 1.68E+08 2.74E+07 Cs-136 1.20E+07 4.73E+07 3.40E+07 0.OOE+00 2.63E+07 3.61E+06 5.37E+06 Cs-137 8.72E+08 1.19E+09 7.81E+08 0.OOE+00 4.05E+08 1.35E+08 2.31E+07 Cs-138 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+0O 0.OOE+00 0.OOE+00 Ba-139 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+0O Ba-140 2.88E+07 3-61E+04 1.88E+06 0.OOE+00 1.23E+04 2.07E+04 5.92E+07 Ba-141 0.OOE+0O O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 Ba-142 O.OOE+0O O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+0C La-140 3.76E-02 1.90E-02 5.01E-03 0.OOE+00 O.OOE+00 O.OOE+00 1.39E+03 La-142 0.OOE+0+/- 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 Ce-141 11.40E+04 9.49E+03 1.08E+03 0.OOE+00 4.41E+03 0.OOE+00 3.63E+07 Ce-143 1.99E-02 1.47E+01 1.63E-03 0.OOE+00 6.47E-03 0.OOE+00 5.49E+02 Ce-144 1.46E+06 6.09E+05 7.83E+04 0.OOE+00 3.61E+05 O.OOE+00 4.93E+08 Pr-143 2.10E+04 8.42E+03 1.04E+03 0.OOE+00 4.86E+03 O.OOE+00 9.20E+07 Pr-144 0.OOE+0O 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+0O 0.OOE+00 Nd-147 7.21E+03 8.33E+03 4.98E+02 O.OOE+00 4.87E+03 0.OOE+00 4.OOE+07 W-187 2.07E-02 1.73E-02 6.04E-03 O.OOE+00 0.OOE+00 0.OOE+00 5.66E+00 Np-239 2.57E-01 2.53E-02 1.40E-02 0.OOE+0O 7.90E-02 0.OOE+00 5.19E+03 Notes:

1) Units are m2 mrem/yr per jtCi/sec with the exception of H-3.

2) For H-3, the units are mrem/yr per gCi/m 3.

Page 11.4-60

CY-BY-1 70-301 Revision 5 Table 4-24 Teen Grass-Cow-Meat Dose Factors Nuclide Bone Liver T Bodv Thyroid Kidney Lunp- GI-LLI H-3 O.OOE+00 1.1OE+02 1.1OE+02 1.1OE+02 1.10E+02 1.10E+02 1.1OE+02 Na-24 1.16E-03 1.16E-03 1.16E-03 1.16E-03 1.16E-03 1.16E-03 1.16E-03 Cr-51 0.OOE+00 0.OOE+00 5.63E+03 3.13E+03 1.23E+03 8.04E+03 9.46E+05 Mn-54 0.OOE+00 7.OOE+06 1.39E+06 0.OOE+00 2.09E+06 0.OOE+00 1.44E+07 Mn-56 0.00E+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 Fe-55 2.38E+08 1.69E+08 3.94E+07 0.OOE+00 O.OOE+00 1.07E+08 7.31E+07 Fe-59 2.12E+08 4.95E+08 1.91E+08 0.OOE+00 O.OOE+00 1.56E+08 1.17E+09 Co-58 O.OOE+00 1.41E+07 3.24E+07 0.OOE+00 O.OOE+00 0.OOE+00 1.94E+08 Co-60 0.OOE+0O 5.83E+07 1.31E+08 0.OOE+00 0.OOE+00 O.OOE+00 7.60E+08 Ni-63 1.52E+10 1.07E+09 5.15E+08 0.OOE+00 0.OOE+00 0.OOE+00 1.71E+08 Ni-65 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 Cu-64 0.OOE+00 2.06E-07 9.68E-08 0.OOE+00 5.21E-07 0.OOE+00 1.60E-05 Zn-65 2.50E+08 8.69E+08 4.05E+08 0.OOE+00 5.56E+08 0.OOE+00 3.68E+08 Zn-69 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 Br-83 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Br-84 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 Br-85 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Rb-86 0.OOE+00 4.08E+08 1.91E+08 0.OOE+00 O.OOE+00 O.OOE+00 6.03E+07 Rb-88 0.OOE+00 0.OOE+00 0.OOE+0 0.0OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 Rb-89 O.OOE+00 0.OOE+0O 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 Sr-89 2.54E+08 0.OOE+0 7.28E+06 0.OOE+00 0.OOE+00 0.OOE+00 3.03E+07 Sr-90 9.89E+09 0.OOE+00 1.98E+08 0.OOE+00 0.OOE+00 O.OOE+00 2.26E+08 Sr-91 1.21E-10 0.OOE+00 4.80E-12 0.OOE+00 0.OOE+00 O.OOE+00 5.47E-10 Sr-92 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+0 0.OOE+00 0.OOE+00 O.OOE+00 Y-90 9.13E+01 0.OOE+00 2.46E+00 O.OOE+00 O.OOE+00 0.OOE+00 7.53E+05 Y-91M 0.OOE+00 0.OOE+0 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+0 Y-91 9.54E+05 0.OOE+00 2.56E+04 0.OOE+00 0.OOE+00 0.OOE+00 3.91E+08 Y-92 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Y-93 3.71E-12 0.OOE+00 1.02E-13 O.OOE+00 O.OOE+0O 0.OOE+00 1.13E-07 Zr-95 11.50E+06 4.74E+05 3.26E+05 0.OOE+00 6.96E+05 0.OOE+00 1.09E+09 Zr-97 1.70E-05 3.37E-06 1.55E-06 O.OOE+00 5.10E-06 0.OOE+00 9.11E-01 Nb-95 1.80E+06 9.98E+05 5.49E+05 O.OOE+00 9.67E+05 0.OOE+00 4.27E+09 Mo-99 0.OOE+00 8.21E+04 1.57E+04 0.OOE+00 1.88E+05 O.OOE+00 1.47E+05 Tc- 99M 0.OOE+00 0.OOE+00 1.24E-19 0.OOE+00 1.43E-19 O.OOE+00 6.29E-18 Tc-101 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Ru-103 8.56E+07 0.OOE+00 3.66E+07 0.OOE+00 3.02E+08 0.OOE+00 7.15E+09 Ru-105 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Ru-106 2.36E+09 O.OOE+00 2.97E+08 0.OOE+00 4.55E+09 0.OOE+00 1.13E+11 Ag-I10M 5.06E+06 4.79E+06 2.91E+06 0.OOE+00 9.13E+06 0.OOE+00 1.35E+09 Page 11.4-61

CY-BY-1 70-301 Revision 5 Table 4-24 (Continued)

Teen Grass-Cow-Meat Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Te-125M 3.03E+08 1.09E+08 4.06E+07 8.47E+07 0.OOE+00 O.OOE+00 8.95E+08 Te-127M 9.41E+08 3.34E+08 1.12E+08 2.24E+08 3.82E+09 0.OOE+00 2.35E+09 Te-127 2.12E-10 7.53E-11 4.57E-11 1.46E-10 8.60E-10 O.OOE+00 1.64E-08 Te-129M 9.49E+08 3.52E+08 1.50E+08 3.06E+08 3.97E+09 O.OOE+00 3.56E+09 Te-129 0.OOE+00 0.OOE+0O 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 Te-131M 3.75E+02 1.80E+02 1.50E+02 2.70E+02 1.87E+03 O.OOE+00 1.44E+04 Te-131 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+0O 0.OOE+00 Te-132 1.14E+06 7.24E+05 6.81E+05 7.63E+05 6.94E+06 0.OOE+00 2.29E+07 1-130 1.63E-06 4.72E-06 1.88E-06 3.85E-04 7.27E-06 O.OOE+00 3.63E-06 1-131 8.92E+06 1.25E+07 6.71E+06 3.64E+09 2.15E+07 0.OOE+00 2.47E+06 1-132 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 1-133 3.09E-01 5.25E-01 1.60E-01 7.32E+01 9.20E-01 O.OOE+00 3.97E-01 1-134 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 1-135 3.79E-17 9.75E-17 3.61E-17 6.27E-15 1.54E-16 0.OOE+00 1.08E-16 Cs-134 5.23E+08 1.23E+09 5.71E+08 O.OOE+00 3.91E+08 1.49E+08 1.53E+07 Cs-136 9.34E+06 3.68E+07 2.47E+07 O.OOE+00 2.OOE+07 3.15E+06 2.96E+06 Cs-137 7.24E+08 9.63E+08 3.36E+08 0.OOE+00 3.28E+08 1.27E+08 1.37E+07 Cs-138 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 Ba-139 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ba-140 2.38E+07 2.91E+04 1.53E+06 0.OOE+00 9.88E+03 1.96E+04 3.67E+07 Ba-141 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 Ba-142 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 La-140 3.09E-02 1.52E-02 4.04E-03 0.OOE+00 0.OOE+00 O.OOE+00 8.73E+02 La-142 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 Ce-141 1.18E+04 7.87E+03 9.04E+02 0.OOE+00 3.70E+03 O.OOE+00 2.25E+07 Ce-143 1.67E-02 1.22E+01 1.36E-03 0.OOE+00 5.46E-03 0.OOE+00 3.66E+02 Ce-144 1.23E+06 5.08E+05 6.60E+04 O.OOE+00 3.04E+05 O.OOE+00 3.09E+08 Pr-143 1.77E+04 7.05E+03 8.79E+02 0.OOE+00 4.1OE+03 O.OOE+00 5.81E+07 Pr-144 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+0O Nd-147 6.35E+03 6.90E+03 4.14E+02 0.OOE+00 4.05E+03 0.OOE+00 2.49E+07 W-187 1.73E-02 1.41E-02 4.94E-03 O.OOE+00 O.OOE+00 O.OOE+00 3.82E+00 INp-239 2.25E-01 2.12E-02 1.18E-02 0.OOE+00 6.66E-02 0.OOE+00 3.41E+03 Notes:

1) Units are m 2 mrem/yr per jtCi/sec with the3 exception of H-3.

2) For H-3, the units are mrem/yr per jiCi/m .

Page 11.4-62

CY-BY-1 70-301 Revision 5 Table 4-25 Child Grass-Cow-Meat Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI H-3 O.OOE+00 1.34E+02 1.34E+02 1.34E+02 1.34E+02 1.34E+02 1.34E+02 Na-24 1.84E-03 1.84E-03 1.84E-03 1.84E-03 1.84E-03 1.84E-03 1.84E-03 Cr-51 0.OOE+00 0.OOE+00 8.78E+03 4.87E+03 1.33E+03 8.90E+03 4.66E+05 Mn-54 0.OOE+00 8.01E+06 2.13E+06 0.OOE+00 2.25E+06 0.OOE+00 6.72E+06 Mn-56 O.OOE+00 O.OOE+00 0.OOE+00 0.OOE+0O 0.OOE+00 0.OOE+00 0.OOE+00 Fe-55 4.57E+08 2.42E+08 7.51E+07 O.OOE+0O 0.OOE+00 1.37E+08 4.49E+07 Fe-59 3.76E+08 6.08E+08 3.03E+08 0.OOE+0O 0.OOE+00 1.76E+08 6.34E+08 Co-58 0.OOE+00 1.64E+07 5.03E+07 O.OOE+00 0.OOE+00 O.OOE+00 9.59E+07 Co-60 O.OOE+00 6.93E+07 2.04E+08 O.OOE+00 0.OOE+00 O.OOE+00 3.84E+08 Ni-63 2.91E+10 1.56E+09 9.91E+08 O.OOE+00 O.OOE+00 0.OOE+00 1.05E+08 Ni-65 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+0 0.OOE+00 O.OOE+00 Cu-64 O.OOE+00 2.77E-07 1.67E-07 O.OOE+00 6.68E-07 0.OOE+00 1.30E-05 Zn-65 3.75E+08 1.OOE+09 6.22E+08 O.OOE+00 6.30E+08 O.OOE+00 1.76E+08 Zn-69 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+0O 0.OOE-+00 0.OOE+00 O.OOE+00 Br-83 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Br-84 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+0 0.OOE+00 0.OOE+00 0.OOE+00 Br-85 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 Rb-86 0.OOE+00 5.78E+08 3.55E+08 0.OOE+0O 0.OOE+00 0.OOE+00 3.72E+07 Rb-88 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Rb-89 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 Sr-89 4.81E+08 0.OOE+00 1.37E+07 0.OOE+00 0.OOE+00 0.OOE+00 1.86E+07 Sr-90 1.57E+10 0.OOE+00 3.15E+08 0.OOE+00 0.OOE+00 0.OOE+00 1.40E+08 Sr-91 2.26E-10 0.OOE+00 8.54E-12 O.OOE+0O 0.OOE+00 0.OOE+00 5.OOE-10 Sr-92 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 Y-90 1.73E+02 0.OOE+00 4.62E+00 0.OOE+0O 0.OOE+00 O.OOE+00 4.92E+05 Y-91M 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+0O 0.OOE+00 0.OOE+00 O.OOE+00 Y-91 1.80E+06 0.OOE+00 4.82E+04 0.OOE+00 0.OOE+00 0.OOE+00 2.40E+08 Y-92 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+0O 0.OOE+00 0:OOE+00 0.OOE+00 Y-93 6.97E-12 0.OOE+00 1.91E-13 O.OOE+00 0.OOE+00 0.OOE+00 1.04E-07 Zr-95 2.67E+06 5.86E+05 5.22E+05 0.OOE+00 8.39E+05 0.OOE+00 6.11E+08 Zr-97 3.16E-05 4.57E-06 2.70E-06 O.OOE+00 6.56E-06 O.OOE+00 6.93E-01 Nb-95 3.11E+06 1.21E+06 8.64E+05 O.OOE+00 1.14E+06 O.OOE+00 2.24E+09 Mo-99 0.OOE+00 1.14E+05 2.82E+04 O.OOE+00 2.44E+05 O.OOE+00 9.44E+04 Tc- 99M 0.OOE+00 1.18E-20 1.96E-19 O.OOE+00 1.72E-19 0.OOE+00 6.72E-18 Tc-101 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 Ru-103 1.55E+08 O.OOE+0 5.95E+07 0.OOE+00 3.90E+08 0.OOE+00 4.OOE+09 Ru-105 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 Ru-106 4.44E+09 0.OOE+0 5.54E+08 0.OOE+00 5.99E+09 O.OOE+00 6.90E+10 Ag-i 10M 8.39E+06 5.67E+06 4.53E+06 0.OOE+00 1.06E+07 O.OOE+00 6.74E+08 Page 11.4-63

CY-BY-1 70-301 Revision 5 Table 4-25 (Continued)

Child Grass-Cow-Meat Dose Factors Nuclide Bone Liver T Body Thyroid Kidney Lung GI-LLI Te-125M 5.70E+08 1.54E+08 7.59E+07 1.60E+08 0.OOE+00 0.OOE+00 5.50E+08 Te-127M 1.77E+09 4.78E+08 2.1 1E+08 4.24E+08 5.06E+09 O.OOE+00 1.44E+09 Te-127 3.99E-10 1.08E-10 8.56E-11 2.76E-10 1.14E-090.OOE+00 1.56E-08 Te-129M 1.79E+09 5.OOE+08 2.78E+08 5.77E+08 5.25E+09 O.OOE+00 2.18E+09 Te-129 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 Te-131M 6.97E+02 2.41E+02 2.57E+02 4.96E+02 2.33E+03 O.OOE+00 9.78E+03 Te-131 O.OOE+0O O.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 Te-132 2.09E+06 9.23E+05 1.12E+06 1.34E+06 8.57E+06 0.OOE+00 9.30E+06 1-130 2.92E-06 5.89E-06 3.04E-06 6.49E-04 8.81E-06 0.OOE+00 2.76E-06 1-131 1.65E+07 1.66E+07 9.45E+06 5.50E+09 2.73E+07 O.OOE+00 1.48E+06 1-132 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 1-133 5.75E-01 7.10E-01 2.69E-01 1.32E+02 1.18E+00 O.OOE+00 2.86E-01 1-134 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 1-135 6.86E-17 1.23E-16 5.84E-17 1.09E-14 1.89E-16 0.OOE+00 9.40E-17 Cs-134 9.22E+08 1.51E+09 3.19E+08 0.OOE+00 4.69E+08 1.68E+08 8.16E+06 Cs-136 1.61E+07 4.43E+07 2.87E+07 O.OOE+00 2.36E+07 3.52E+06 1.56E+06 Cs-137 1.33E+09 1.28E+09 1.88E+08 O.OOE+00 4.16E+08 1.50E+08 7.99E+06 Cs-138 O.OOE+00 .OOE+0O .OOE+00.OOE+00 O.OOE+00 O.OOE+0O.OOE+00 Ba-139 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+0 0.0OOE+00 Ba-140 4.39E+07 3.84E+04 2.56E+06 0.OOE+00 1.25E+04 2.29E+04 2.22E+07 Ba-141 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 Ba-142 0.OOE+0 0.EOOE+ 0.0OOE+0 0.OOE+00 0.OOE+00 0.OOE+00 0.OOE+00 La-140 5.66E-02 1.98E-02 6.67E-03 O.OOE+00 0.OOE+00 0.OOE+00 5.52E+02 La-142 0.OOE+0O 0.OOE+00 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 Ce-141 2.22E+04 1.11E+04 1.64E+03 0.OOE+00 4.85E+03 0.OOE+00 1.38E+07 Ce-143 3.14E-02 1.70E+01 2.46E-03 O.OOE+00 7.14E-03 O.OOE+00 2.49E+02 Ce-144 2.32E+06 7.26E+05 1.24E+05 0.OOE+00 4.02E+05 O.OOE+00 1.89E+08 Pr-143 3.34E+04 1.OOE+04 1.66E+03 O.OOE+00 5.44E+03 O.OOE+00 3.61E+07 Pr-144 0.OOE+0 0.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 Nd-147 1.19E+04 9.65E+03 7.47E+02 0.OOE+0O 5.29E+03 0.OOE+00 1.53E+07 W-187 3.21E-02 1.90E-02 8.52E-03 0.OOE+0O O.OOE+00 O.OOE+00 2.67E+00 Np-239 4.23E-01 3.04E-02 2.14E-02 0.OOE+00 8.79E-02 O.OOE+00 2.25E+03 Notes:

1) Units are m 2 mrem/yr per I.Ci/sec with the exception of H-3.

2) For H-3, the units are mrem/yr per gtCi/m 3.

3) The infant age group is assumed to receive no dose through the meat ingestion pathway therefore no dose factors are supplied.

Page 11.4-64

CY-BY-1 70-301 Revision 5 Table 4-26 Byron Station Characteristics LOCATION: 3.7 miles SSW of Byron, Illinois Characteristics of Elevated Release Point: Not applicable (NA)

1) Release Height = m 2) Diameter= m

3) Exit Speed = ms"1 4) Heat Content Kcal s-1 Characteristics of Vent Stack Release Point

1) Release Height = 60.66 ma 2) Diameter = 2.80 m

3) Exit Speed = 13.00 ms-1a Characteristics of Ground Level Point

1) Release Height = 0 m

2) Building Factor (D) = 60.6 ma Meteorological Data A 250 ft Tower is Located 1036 m SW of vent stack release point Tower Data Used in Calculations Wind Speed Differential Release Point and Direction Temperature Elevated (NA) (NA)

Vent 250 ft 250-30 ft Ground 30 ft 250-30 ft a Used in calculating the meteorological and dose factors in Table 4-1 and Table 4-4.

Page 11.4-65

CY-BY-1 70-301 Revision 5 Table 4-27 Dose Factors for Noble Gases Beta Air Beta Skin Gamma Air Gamma Total Dose Factor Dose Factor Dose Factor Body Dose Factor Li Mi Ni Nuclide (mrad/yr per (mrem/yr per (mrad/rpe

mrem/yr per uCi/m3) uCi/m3) uCi/m3) uCi/m3)

Kr-83m 2.88E+02 1.93E+01 7.56E-02 Kr-85m 1.97E+03 1.46E+03 1.23E+03 1.17E+03 Kr-85 1.95E+03 1.34E+03 1.72E+01 1.61E+01 Kr-87 1.03E+04 9.73E+03 6.17E+03 5.92E+03 Kr-88 2.93E+03 2.37E+03 1.52E+04 1.47E+04 Kr-89 1.06E+04 1.01E+04 1.73E+04 1.66E+04 Kr-90 7.83E+03 7.29E+03 1.63E+04 1.56E+04 Xe-1 31m 1.11E+03 4.76E+02 1.56E+02 9.15E+01 Xe-133m 1.48E+03 9.94E+02 3.27E+02 2.51 E+02 Xe-1 33 1.05E+03 3.06E+02 3.53E+02 2.94E+02 Xe-1 35m 7.39E+02 7.11 E+02 3.36E+03 3.12E+03 Xe-1 35 2.46E+03 1.86E+03 1.92E+03 1.81 E+03 Xe-I 37 1.27E+04 1.22E+04 1.51 E+03 1.42E+03 Xe-138 4.75E+03 4.13E+03 9.21E+03 8.83E+03 Ar-41 3.28E+03 2.69E+03 9.30E+03 8.84E+03 Source: Table B-1 of US NRC Regulatory Guide 1.109 Page 11.4-66

CY-BY-1 70-301 Revision 5 5.0 TOTAL DOSE 5.1 Total Dose Calculation Requirements 5.1.1 Total Effective Dose Equivalent Limits; 10CFR20 and 40CFR190 The Byron Station is required to determine the total dose to a member of the public due to all uranium fuel cycle sources in order to assess compliance with 40CFR1 90 as part of demonstrating compliance with 10CFR20.

The total dose for the uranium fuel cycle is the sum of doses due to radioactivity in airborne and liquid effluents and the doses due to direct radiation from contained sources at the nuclear power station. When evaluation of total dose is required for a station, the following contributions are summed:

Doses due to airborne and liquid effluents from the station.

Doses due to liquid effluents from nuclear power stations upstream.

Doses due to any onsite radioactive waste storage facilities, if applicable.

10CFR20 requires compliance to dose limits expressed as "Total Effective Dose Equivalent" (TEDE). Although annual dose limits in 10CFR20 are now expressed in terms of TEDEs, 40CFR1 90 limits remain stated as organ dose. The NRC continues to require 10CFR50 Appendix I and 40CFR190 doses to be reported in terms of organ dose and not TEDE. Due to the fact that organ dose limits set forth in 40CFR1 90 are substantially lower than those of 10CFR20 (25 mrem/yr vs. 100 mrem/yr), the NRC has stated that demonstration of compliance with the dose limits in 40CFR1 90 will be deemed as demonstration of compliance with the dose limits of 10CFR20 for most facilities (Reference 104). In addition to compliance with 40CFR1 90, it may be necessary for a nuclear power plant to address dose from on-site activity by members of the public.

5.1.2 Total Dose Calculation Methodology In addition to the total body, skin and single organ dose assessments previously described, an additional assessment is required. The additional assessment addresses radiation dose due Page 11.5-1

CY-BY-1 70-301 Revision 5 to radioactivity contained within the nuclear power station and its structures.

Pressurized water reactors have the potential to affect off-site doses from contained sources of radioactivity, primarily due to gamma rays associated with radioactive material contained in onsite radwaste and radioactive material storage facilities.

5.2 Onsite Radwaste and Rad Material Storage Facilities A 10CFR50.59 analysis is required for radwaste storage facilities.

5.2.1 Process Waste Storage Facilities

Interim Radwaste Storage Facility (IRSF) structure

Concrete vaults containing radwaste liners 5.2.2 DAW Storage Facilities

Dry Active Waste (DAW) facilities (may include Butler buildings/warehouses)

Seavans or other temporary warehouses 5.2.3 Replaced Steam Generator Storage Facilities 5.2.4 ISFSI Facilities e Independent spent fuel storage installation facilities.

5.3 Methodology The external total body dose is comprised of the following parts:

1) Total body dose due to noble gas radionuclides in gaseous effluents (Section 4.2.2.3),

2) Dose due to other contained sources and

3) Total body dose due to radioactivity deposited on the ground (Section 4.2.3.1).

The external total body dose due to radioactivity deposited on the ground is accounted for in the determination of the non-noble gas dose and is considered in section 5.4.

Page 11.5-2

CY-BY-1 70-301 Revision 5 The total external total body dose, DEx, is given by:

Dx= DT + DOsF (5-1)

D Total External Total Body Dose [mrem]

Total external total body dose due to irradiation by external sources at the location of interest.

DT8 Noble Gas Total Body Dose [mrem]

External total body dose due to gamma radiation from noble gas radionuclides released in gaseous effluents at the location of interest. See Section 4.2.2.3.

DOSF Dose From On-Site Storage Facilities [mrem]

External total body dose due to gamma radiation from on-site, storage facilities at the location of interest. See Section 5.2.

5.4 Total Dose The total dose, DTt, in the unrestricted area to a member of the public due to plant operations is given by:

DTot = + nLIq + D.NNG (5-2) 4j aj where:

DTot Total Dose To Member of Public [mrem]

Total off-site dose to a member of public due to plant operations.

DEx Total External Total Body Dose [mrem]

Total body dose due to external exposure to noble gases, N-16 skyshine and on-site storage facilities.

DUq Liquid Effluent Dose [mrem]

Dose due to liquid effluents to age group a and organ J. The age group and organ with the highest dose from liquid effluents is used.

aNG Non-Noble Gaseous Effluent Dose [mrem]

Dose due to non-noble gaseous effluents to age group a and organ j. The age group and organ with the highest dose from non-noble gas effluents is used.

Page 11.5-3

CY-BY-1 70-301 Revision 5 5.5 COMPLIANCE TO TOTAL DOSE LIMITS 5.5.1 Total Effective Dose Equivalent Limit - 10CFR20 Compliance Each station's RECS limits the Total Effective Dose Equivalent (TEDE) to an annual limit of 100 mrem, as required by 10CFR20.1301 (a)(1). Demonstration of compliance with the limits of 40CFR1 90 (per Section 4.2.2) will be considered to demonstrate compliance with the 100 mrem/year limit.

5.5.2 Dose to a Member of the Public in the Unrestricted Area The NRC has stated that demonstration of compliance with the limits of 40CFR1 90 or with the design objectives of Appendix I to 10CFR50 will be deemed to demonstrate compliance with the limits of IOCFR20.1301(a)(1). Power reactors that comply with Appendix I may also have to demonstrate that they are within the 25 mrem limit of 40CFR1 90 (See Reference 104).

5.5.3 Dose to a Member of the Public in the Restricted Area In August of 1995, a revision to 10CFR20 was implemented that changed the definition of a member of the public. As a result, for each nuclear station, estimated doses were calculated for a member of the public who enters the site boundary, but is not authorized for unescorted access to the protected area of the site and does not enter any radiologically posted areas on the site.

Realistic assumptions were made for occupancy times and locations visited while within the site boundary.

These evaluations indicate that the doses estimated for these members of the public are well within the 10CFR20 limits. These dose evaluations will be performed annually and if necessary, a model will be developed and included in the ODCM.

Evaluation of the 40CFR190 dose is used to demonstrate compliance to 10CFR20 and satisfy station TRM and Technical Specifications (see ODCM Part I).

Page 11.5-4

CY-BY-1 70-301 Revision 5 5.5.4 Total Dose due to the Uranium Fuel Cycle (40CFR1 90)

RECS and 40CFR190 limit the annual (calendar year) dose or dose commitment to any member of the public due to releases of radioactivity and to radiation from uranium fuel cycle sources to the following:

Less than or equal to 25 mrem to the total body.

Less than or equal to 25 mrem to any organ except the thyroid.

Less than or equal to 75 mrem to the thyroid.

Total Dose Components This requirement includes the total dose from operations at the nuclear power station. This includes doses due to radioactive effluents (airborne and liquid) and dose due to direct radiation from non-effluent sources (e.g., sources contained in systems on site). It also includes dose due to plants under consideration, neighboring plants and dose due to other facilities in the uranium fuel cycle.

The operations comprising the uranium fuel cycle are specified in 40CFR190.02(b). The following are included to the extent that they directly support the production of electrical power for public use utilizing nuclear energy:

Milling of uranium ore.

Chemical conversion of uranium.

Isotopic enrichment of uranium.

Fabrication of uranium fuel.

" Generation of electricity by a light-watered-cooled nuclear power plant using uranium fuel.

" Reprocessing of spent uranium fuel.

Excluded are:

Mining operations.

Operations at waste disposal sites.

Transportation of any radioactive material in support of these operations.

The re-use of recovered non-uranium special nuclear and by-product materials from the cycle.

Page 11.5-5

CY-BY-1 70-301 Revision 5 5.6 When Compliance Assessment is Required Compliance with the 40CFR190 regulations is now required as part of demonstration of compliance to 10CFR20 regulations per 10CFR20.1301(d).

The dose due to the uranium fuel cycle is determined by equation 5-2 Page 11.5-6

CY-BY-1 70-301 Revision 5 6.0 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM The radiological environmental monitoring program for the environs around Byron Station is given in Table 6-1.

Figures 6-1 through 6-4 show sampling and monitoring locations.

Page II 6-1

CY-BY-1 70-301 Revision 5 Table 6-1 Radiological Environmental Monitoring Program Exposure Pathway Sampling or Type or Frequency and/or Sam Die Sampling or Monitoring Locations Collection Frequency of Analysis

1. Airborne Radioiodine and a. Indicators-Near Field Continuous sampler operation Radioiodine Canister:

Particulates with particulate sample 1-131 analysis weekly BY-21, Byron Nearsite N, collection weekly, or more on near field and control 0.3 mi N (0.5 km A) frequently if required by dust samples.1 BY-22, Byron Nearsite ESE, loading, and radioiodine canister 0.4 mi ESE (0.6 km F) collection weekly. Particulate Sampler:

BY-23, Byron Nearsite S, 0.6 mi S (1.0 km J) Gross beta analysis BY-24, Byron Nearsite SW, following weekly filter 0.6 mi SW (1.0 km L) change and gamma 3 isotopic analysis quarterly on composite filters by location on near field and control samples.

b. Indicators-Far Field BY-I, Byron, 3.0 mi N (4.8 km A)

BY-4, Paynes Pt., 5.0 mi SE (8.0 km G)

BY-6, Oregon, 4.7 mi SSW (7.5 km K)

c. Controls BY-8, Leaf River, 6.8.mi WNW (10.9 Km P)

Page II 6-2

CY-BY-1 70-301 Revision 5 Table 6-1 (Cont.)

Radiological Environmental Monitoring Program Exposure Pathway Sampling or Type or Frequency and/or Sam ple Samplinq or Monitoring Locations Collection Frequency of Analysis

2. Direct Radiation a. Indicators-Inner Ring Quarterly Gamma Dose Quarterly BY-101 -1, 0.3 mi N (0.5 km A)

BY-101-2, 0.3 mi N (0.5 km A)

BY-102-1, 0.9 mi NNE (1.5 km B)

BY-102-2, 1.0 mi NNE (1.5 km B)

BY-103-1, 1.7 mi NE (2.8 km C)

BY-103-2, 1.7 mi NE (2.7 km C)

BY-104-1, 1.5 mi ENE (2.4 km D)

BY-104-2, 1.5 mi ENE (2.4 km D)

BY-105-1, 1.3 mi E (2.1 km E)

BY-105-2, 1.3 mi E (2.1 km E)

BY-1 06-1, 1.4 mi ESE (2.3 km F)

BY-106-2, 1.4 mi ESE (2.3 km F)

BY-107-1, 1.4 mi SE (2.2 km G)

BY-107-2, 1.4 mi SE (2.2 km G)

BY-108-1, 0.7 mi SSE (1.1 km H)

BY-108-2, 0.6 mi SSE (1.0 km H)

BY-109-1, 0.6 mi S (1.0 km J)

BY-109-2, 0.6 mi S (1.0 km J)

BY-110-1, 0.6 mi SSW (1.0 km K)

BY-110-2, 0.6 mi SSW (1.0 km K)

BY-111-3, 0.7miSW (1.1 km L)

BY-111-4,0.8miSW (1.3kmL)

BY-112-3, 0.8 mi WSW (1.2 km M)

BY-112-4, 0.8 mi WSW (1.2 km M)

Page II 6-3

CY-BY-1 70-301 Revision 5 Table 6-1 (Cont.)

Radiological Environmental Monitoring Program Exposure Pathway Sampling or Type or Frequency and/or Sample Samplincq or Monitoring Locations Collection Frequency of Analysis

2. Direct Radiation Indicators-Inner Ring (cont'd)

(cont'd) BY-113-1, 0.7 miW (1.1 km N)

BY-113-2, 0.7miW (1.1 kmN)

BY-1 14-1, 0.8 mi WNW (1.2 km P)

BY-114-2, 0.8 mi WNW (1.3 km P)

BY-115-1, 1.0 mi NW (1.6 km Q)

BY-115-2, 1.0 mi NW (1.7 km Q)

BY-116-1, 1.4 mi NNW (2.3 km R)

BY-116-2, 1.4 mi NNW (2.3 km R)

b. Indicators-Outer Ring Quarterly Gamma Dose Quarterly BY-201-3, 4.5 mi N (7.1 km A)

BY-201-4, 4.4 mi N (7.1 km A)

BY-202-1, 4.3 mi NNE (6.9 km B)

BY-202-2, 4.8 mi NNE (7.6 km B)

BY-203-1, 4.8 mi NE (7.7 km C)

BY-203-2, 4.7 mi NE (7.5 km C)

BY-204-1, 4.2 mi ENE (6.6 km D)

BY-204-2, 4.1 mi ENE (6.5 km D)

BY-205-1, 3.8 mi E (6.2 km E)

BY-205-2, 3.8 mi E (6.2 km E)

BY-206-1, 4.1 mi ESE (6.5 km F)

BY-206-2, 4.4 mi ESE (7.0 km F)

BY-207-1, 4.2 mi SE (6.7 km G)

BY-207-2, 3.6 mi SE (5.8 km G)

Page II 6-4

CY-BY-1 70-301 Revision 5 Table 6-1 (Cont.)

Radiological Environmental Monitoring Program Exposure Pathway Sampling or Type of Frequency and/or Sample Samplinoq or Monitorinq Locations Collection Freauency of Analysis

2. Direct Radiation Indicators-Outer Ring (cont'd)

(cont'd) BY-208-1, 4.0 mi SSE (6.4 km H)

BY-208-2, 3.7 mi SSE (5.9 km H)

BY-209-1, 3.7 mi S (5.9 km J)

BY-209-4, 3.7 mi S (5.9 km J)

BY-210-3, 3.9 mi SSW (6.2 km K)

BY-210-4, 3.9 mi SSW (6.2 km K)

BY-211-1, 4.9 mi SW (7.9 km L)

BY-211-4, 4.9 mi SW (7.8 km L)

BY-212-1, 4.7 mi WSW (7.4 km M)

BY-212-4, 4.7 mi WSW (7.4 km M)

BY-213-1, 4.7 mi W (7.5 km N)

BY-213-4, 4.6 mi W (7.4 km N)

BY-214-1, 4.6 mi WNW (7.4 km P)

BY-214-4, 4.9 mi WNW (7.8 km P)

BY-215-1, 5.3 mi NW (8.4 km Q)

BY-215-4, 5.2 mi NW (8.3 km Q)

BY-216-1, 4.6 mi NNW (7.3 km R)

BY-216-2, 4.8 mi NNW (7.6 km R)

c. Indicators-Other Quarterly Gamma Dose Quarterly BY-01-1, 3.Omi N (4.76 km A)

BY-01 -2, 3.Omi N (4.76 km A)

BY-04-1, 5.Omi SE (7.98 km G)

BY-04-2, 5.Omi SE (7.98 km G)

BY-24-1, 0.6mi SW (1.03 km L)

BY-24-2, 0.6mi SW (1.03 km L)

BY-06-1, 4.7mi SSW (7.54km K)

BY-06-2, 4.7mi SSW (7.54 km K)

BY-21-1, 0.3mi N (0.48 km A)

Page II 6-5

CY-BY-1 70-301 Revision 5 Table 6-1 (Cont.)

Radiological Environmental Monitoring Program Exposure Pathway Sampling or Type of Frequency and/or Sample Sampling or Monitorinq Locations Collection Frequency of Analysis

2. Direct Radiation Indicators-Other (cont'd)

(cont'd)

BY-21-2, 0.3mi N (0.48 km A)

BY-22-1, 0.4mi ESE (0.60 km F)

BY-22-2, 0.4mi ESE (0.60 km F)

BY-23-1, 0.6mi S (0.95 km J)

BY-23-2, 0.6mi S (0.95 km J)

d. Control BY-08-1, 6.8mi WNW (10.9 km P)

BY-08-2, 6.8mi WNW (10.9 km P) I Page II 6-6

CY-BY-1 70-301 Revision 5 Table 6-1 (Cont.)

Radiological Environmental Monitoring Program Exposure Pathway Sampling or Type or Frequency and/or Sample Sampling or Monitoring Locations Collection Frequency of Analysis

3. Waterborne Ground/Well a. Indicators Quarterly Gamma isotopic3 and tritium analysis BY-14-1, 3200 German Church Rd quarterly.

1.0 mi SSE (1.6 km H)

BY-18, McCoy Farmstead 0.7 mi SW (1.2 km L)

BY-32, Wolford Well 1.8 mi W (2.9 km N)

BY-35, Vancko Well 2.0 mi WNW (3.22km P)

BY-36, Blanchard Well 1.0 mi NW (1.61 km Q)

BY-37, Alexander Well 1.80 mi WNW (2.90 km P)

Drinking There is no drinking water pathway within 6.2 mi downstream of the station.

Surface a. Indicators BY-12, Oregon Pool of Rock River, Weekly grab samples. Gross beta and gamma Downstream of Discharge, isotopic analysis on 4.5 mi SSW (7.3 km K) monthly composite; tritium analysis on quarterly composite.

b. Control BY-29, Byron, Upstream of Intake 3.0 mi N (4.8 km A)

Sediment a. Indicators 3 BY-12, Oregon Pool of Rock River, Semiannually Gamma isotopic Downstream of Discharge, analysis semiannually.

4.5 mi SSW (7.3 km K)

BY-34, Rock River Downstream of discharge 0.6 mi (0.96 km N)

Page II 6-7

CY-BY-1 70-301 Revision 5 Table 6-1 (Cont.) I Radiological Environmental Monitoring Program Exposure Pathway Sampling or Type or Frequency and/or Sam ple Samplinq or Monitoring Locations Collection Frequency of Analysis

4. In-gestion Milk a. Indicators Biweekly: May through Gamma isotopic 3 and October; monthly: 1-131 analysis 4 on each November through April. sample.

BY-20-1 R. Snodgrass,Dairy Farm 4.7 mi WSW (7.52km M)

BY-30, Don Roos Dairy, 5.3 mi SE (8.4 km G)

BY-38, D. Larson Goat Farm 5.0 miles ENE (8.05 km D)

b. Controls BY-26-1, Dennis Herbert's Dairy 12.8 mi N (20.6 km A) I Fish a. Indicator 3

BY-31, Rock River in vicinity of Discharge, Two times annually Gamma isotopic 2.2 mi WNW (3.5 km P) analysis on edible portions.

b. Control BY-29, Byron, Upstream of Intake 3.0 mi N (4.8 km A) 3 Food Products a. Indicators Annually Gamma isotopic analysis on each Two samples from each of the four sample.

major quadrants within 6.2 miles of the station.

Page II 6-8

CY-BY-1 70-301 Revision 5 Table 6-1 (Cont.) I Radiological Environmental Monitoring Program Exposure Pathway Sampling or Type of Frequency and/or Sam pie Sampling or Monitoring Locations Collection Frequency of Analysis Food Products b. Control Annually Gamma Isotopic 3 (cont'd) analysis on each sample.

Two samples within 9.3 to 18.6 miles of the station.

Sample locations for food products may vary based on availability and therefore are not required to be identified here but shall be taken.

Page II 6-9

CY-BY-1 70-301 Revision 5 Table 6-1 (Cont'd)

Radiological Environmental Monitoring Program

'Far field samples are not required to be analyzed, unless the respective near field sample results are inconsistent with previous measurements and radioactivity is confirmed as having its origin in airborne effluents from the station, or at the discretion of the Chemistry Manager.

2Airborne particulate sample filters shall be analyzed for gross beta radioactivity 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months or more after sampling to allow for radon and thoron daughter decay. If gross beta activity in air particulate samples is greater than ten times the yearly mean of control samples, gamma isotopic analysis shall be performed on the individual samples.

3 Gamma isotopic analysis means the identification and quantification of gamma-emitting radionuclides that may be attributable to the effluents from the station.

4 1-131 analysis means the analytical separation and counting procedure are specific for this radionuclide.

Page II 6-10

CY-BY-1 70-301 Revision 5 Page II 6-11

CY-BY-1 70-301 Revision 5 OFFSITE DOSE CALCULATION MANUAL 0 AIR SAMPLING LOCATION BYRON STATION E BYRON STATION FIGURE 6-2 OFFSITE AIR SAMPLING LOCATIONS Page II 6-12

CY-BY-170-301 Revision 5 OFFSITE DOSE STATION MANUAL CALCULATION BYRON FIGURE 6-3 0 TLD LOCATON INNER RING AND OUTER RING "LD LOCATIONS Page If6-13

CY-BY-1 70-301 Revision 5 OFF81TE DOSE CALCU.LATION MANUAL BYRON STATION RH MLK 0 SEDOMg FIGURE 6-4

÷ WA'M INGESTION AND WATERBORNE EXPOSURE WA IMATN T PATHWAY SAMPLE LOCATIONS Page II 6-14

CY-BY-1 70-301 Revision 5 Latitude/Longitude Positions of REMP Samples Table 6-2 Sampling Latitude Longitude Distance (km) Dlrectlon(degrees) Sector Location _ From Stack Vent Stack 4204506 08917023 Air Sampling Stations BY-01 4207057 08916796 4.76 5 A BY-04 4201 132 08913335 7.98 142 G BY-06 4200946 08919806 7.54 211 K BY-08 4207598 08923951 10.90 302 P BY-21 42 04745 089 16928 0.48 2 A BY-22 4204303 089 16 620 0.60 120 F BY-23 4203951 08916938 0.95 174 J BY-24 4204074 08917567 1.03 228 L Surface WaterlFish/Sediment Sam pling Locations BY-12 4201030 08919567 7.26 209 K BY-29 4207069 08916789 4.76 5 A BY-31 4205628 08919560 3.50 288 P BY-34 4202623 08920487 5.15 225 M Milk Sampling Locations BY-20-1 42 03 535 089 22 473 7.24 236 M BY-26-1 42 15665 89 16552 19.31 5 A I BY-30 4201869 8911999 8.21 124 G BY-38 4205434 08911414 8.05 67 D Well Water Sam ling Locations BY-14-1 4203665 08916657 1.6 160 H BY-18 4203965 08917438 1.2 217 L BY-32 4204516 08919139 2.9 260 N BY-35 4204858 089 19081 3.22 300 P BY-36 4204900 08917760 1.61 324 Q BY-37 4204946 08919148 2.90 ý304 P Vegetation Sam ling Location BY-Control BY-Quad 1 BY-Quad 2 BY-Quad 3 BY-Quad 4 Page II 6-15

CY-BY-1 70-301 Revision 5 Latitude/Longitude Positions of REMP Samples Table 6-2 TLD Locations Sampling Latitude Longitude Distance (km) Direction Sector Location (degrees) From Stack BY-101-1 4204749 08916950 0.52 2 A BY-101-2 4204776 08916937 0.50 6 A BY-102-1 4205254 08916513 1.49 26 B BY-102-2 42 05 251 089 16463 1.53 28 B BY-1 03-1 4205 441 089 15493 2.79 50 C BY-1 03-2 4205412 089 15497 2.73 50 C BY-104-1 4205010 08915479 2.37 66 D BY-104-2 4204982 089 15478 2.35 67 D BY-105-1 4204580 08915466 2.13 86 E BY-105-2 4204555 08915463 2.12 87 E BY-106-1 4204093 08915462 2.27 109 F BY-106-2 4204062 08915461 2.28 111 F BY-107-1 4203520 08915965 2.20 143 G BY-107-2 4203524 08915948 2.24 141 G BY-108-1 4203953 08916674 1.08 152 H BY-1 08-2 42 03 953 089 16 752 1.01 160 H BY-109-1 4203948 08917014 0.95 178 J BY-109-2 4203950 08917056 0.95 183 J BY-110-1 4203947 08917243 0.99 199 K BY-110-2 4203946 08917276 1.01 203 K BY-111-3 4203944 08917509 1.10 214 L BY-111-4 4203939 08917618 1.25 221 L BY-112'3 4204174 08917796 1.20 243 M BY-112-4 4204211 08917799 1.22 246 M BY-113-1 4204431 08917799 1.10 267 N BY-113-2 4204466 08917802 1.08 271 N BY-114-1 4204777 08917804 1.24 297 P BY-114-2 4204800 08917804 1.27 300 P BY-115-1 4205060 08917823 1.58 316 Q BY-115-2 4205084 08917821 1.65 316 Q BY-116-1 4205511 08917818 2.26 329 R BY-116-2 4205536 08917823 2.31 330 R BY-201-3 4208284 08917024 1,7.14 1 A BY-201-4 4208283 08916988 7.11 1 A Page II 6-16

CY-BY-1 70-301 Revision 5 Latitude/Longitude Positions of REMP Samples Table 6-2 TLD Locations Continued Sampling Latitude Longitude Distance (km) Direction Sector Location (degrees) From Stack BY-202-1 4208136 08916856 6.85 14 B BY-202-2 4208494 089 15490 7.62 14 B BY-203-1 42 07 704 08913 443 7.66 40 C BY-203-2 4207355 08913113 7.53 47 C BY-204-1 42 06244 089 12 828 6.64 61 D BY-204-2 42 05687 089 12 589 6.53 71 D BY-205-1 4204817 08912554 6.15 86 E BY-205-2 42 04 552 089 12 544 6.15 90 E BY-206-1 4203424 08912517 6.51 109 F BY-206-2 4202773 08912522 6.96 118 F BY-207-1 4201 676 089 13920 6.74 142 G BY-207-2 4202146 08914248 5.75 140 G BY-208-1 4201 455 089 14 739 6.41 152 H BY-208-2 42 01 353 089 16 039 5.94 168 H BY-209-1 42 01 295 089 16 971 5.86 181 J BY-209-4 4201 298 089 17087 5.85 183 J BY-210-3 4201 308 08918607 6.16 202 K BY-210-4 42 01 308 089 18 650 6.20 202 K BY-211-1 42 01 595 08921 203 7.85 228 L BY-211-4 42 01 587 089 21 167 7.84 228 L BY-212-1 42 02 908 089 21 986 7.44 248 M BY-212-4 42 02 941 089 22009 7.44 248 M BY-213-1 42 04 358 089 22 464 7.49 269 N BY-213-4 4204310 08922464 7.43 269 N BY-214-1 42 05632 089 22 167 7.43 288 P BY-214-4 4205635 08922126 7.83 288 P BY-215-1 42 07 708 08921 345 8.41 316 Q BY-215-4 4207677 08921 342 8.34 315 Q BY-216-1 42 07 835 089 19 749 7.33 330 R BY-216-2 42 08 308 089 19021 7.64 346 R BY-302-1 4204 574 089 16899 0.30 10 B Note: Wide Area Augmentation System (WAAS) is used for point identification.

Page 116-17

TRM Radioactive Liquid Effluent Monitoring Instrumentation 3.11.a 3.11 RADIOLOGICAL EFFLUENTS (RE) 3.1l.a Radioactive Liquid Effluent Monitoring Instrumentation TLCO 3.1l.a All radioactive liquid effluent monitoring instrumentation channels shown in Table T3.1l.a-I shall be OPERABLE.

APPLICABILITY: At all times.

ACTIONS

NOTES--------------------------------

1. 'Separate Condition entry is allowed for each channel.

2. All samples are to be analyzed for radioactivity at a lower limit of detection as specified in Table T3.11.c-1.

3. TLCO 3.0.c is not applicable.

4. TLCO 3.0.d is not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. One or more A.1 Suspend the release Immediately radioactive liquid of radioactive effluent monitoring liquid effluent instrumentation monitored by the channel Alarm/Trip affected channel.

Setpoint less OR conservative than Immediately required. A.2 Declare the channel inoperable.

B. Less than the B.1 Enter the Condition Immediately required radioactive referenced in liquid effluent Table T3.1l.a-l for monitoring the affected instrumentation channel(s).

channels OPERABLE.

(continued)

BYRON - UNITS 1 &2 3.11.a-1 Revision 1 Technical Requirements Manual

TRM ACTIONS (continued) Radioactive Liquid Effluent Monitoring Instrumentation 3.11.a CONDITION REQUIRED ACTION COMPLETION TIME C. As required by C.1 Verify at least two Prior to Required Action B.l independent samples initiating a and referenced by are analyzed. release Table T3.11.a-1.

~LM C.2 Verify at least two Prior to technically initiating a qualified members release of the facility staff independently verify the release rate calculations.

C. 3 Verify at least two Prior to technically initiating a qualified members release of the facility staff independently verify the discharge line valving.

C.4.1 Restore the 14 days required number of channels to OPERABLE.

OQR C.4.2 Supplement the In accordance Radioactive with Technical Effluent Release Specification Report pursuant to 5.6.3 Technical Specification 5.6.3 with the cause for failure to correct inoDerabilitv.

(continued)

BYRON - UNITS 1 &2 3.11.a-2 Revision 46 Technical Requirements Manual

TRM ACTIONS (continued) Radioactive Liquid Effluent Monitoring Instrumentation 3.11 .a CONDITION REQUIRED ACTION COMPLETION TIME D. As required by D.1 Verify grab samples Every 12 hours1.388889e-4 days 0.00333 hours 1.984127e-5 weeks 4.566e-6 months Required Action B.1 are collected and and referenced by analyzed.

Table T3.1l.a-l.

D.2.1 Restore the 30 days required number of channels to OPERABLE.

D.2.2 Supplement the In accordance Radioactive with Technical Effluent Release Specification Report pursuant to 5.6.3 Technical Specification 5.6.3 with the cause for failure to correct inoperability._

(continued)

BYRON - UNITS 1 &2 3.11.a-3 Revision 46 Technical Requirements Manual

TRM ACTIONS (continued) Radioactive Liquid Effluent Monitoring Instrumentation 3.11.a CONDITION REQUIRED ACTION COMPLETION TIME E. As required by E.l -------- NOTES------

Required Action B.1 1. Pump performance and referenced by curves generated Table T3.11.a-l. in place may be used to estimate flow.

2. Only required to be performed during actual releases.

Estimate flow rate. Every 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months AUD E.2.1 Restore the 30 days required number of channels to OPERABLE.

E.2.2 Supplement the In accordance Radioactive with Technical Effluent Release Specification Report pursuant to 5.6.3 Technical Specification 5.6.3 with the cause for failure to correct inoperability.

(continued)

BYRON-UNITS 1 &2 3.11.a-4 Revision 46 Technical Requirements Manual

TRM ACTIONS (continued) Radioactive Liquid Effluent Monitoring Instrumentation 3.11.a CONDITION REQUIRED ACTION COMPLETION TIME F. As required by F.1. 1-------- NOTE-------

Required Action B.1 Only required to be and referenced by performed when the Table T3.11.a-1. specific activity of the secondary coolant is

> 0.01 pCi/gm DOSE EQUIVALENT 1-131.

Verify grab samples Every 12 hours1.388889e-4 days 0.00333 hours 1.984127e-5 weeks 4.566e-6 months are collected and analyzed.

F.1.2 --------- NOTE-------

Only required to be performed when the specific activity of the secondary coolant is

< 0.01 pCi/gm DOSE EQUIVALENT 1-131.

Verify grab samples Every 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months are collected and analyzed.

ANL (continued)

BYRON - UNITS 1 &2 3.11.a-5 Revision 1 Technical Requirements Manual

TRM ACTIONS (continued) Radioactive Liquid Effluent Monitoring Instrumentation 3.11.a CONDITION REQUIRED ACTION COMPLETION TIME F.(continued) F.2.1 Restore the 30 days required number of channels to OPERABLE.

F.2.2 Supplement the In accordance Radioactive with Technical Effluent Release Specification Report pursuant to 5.6.3 Technical Specification 5.6.3 with the cause for failure to correct inoperability.

G. As required by G.1 Verify liquid grab Every 12 hours1.388889e-4 days 0.00333 hours 1.984127e-5 weeks 4.566e-6 months Required Action B.- samples are and referenced by collected and Table T3.1l.a-l. analyzed.

AND G.2.1 Restore the 30 days required number of channels to OPERABLE.

G.2.2 Supplement the In accordance Radioactive with Technical Effluent Release Specification Report pursuant to 5.6.3 Technical Specification 5.6.3 with the cause for failure to correct I_ inoperability.

(continued)

BYRON- UNITS 1 &2 3.11.a-6 Revision 46 Technical Requirements Manual

TRM ACTIONS Radioactive Liquid Effluent Monitoring Instrumentation 03 44 -

(continued)

CONDITION REQUIRED ACTION COMPLETION TIME H. Required Action and H.1 Suspend the release Immediately associated of radioactive Completion Time for liquid effluent Conditions C, D, E, monitored by the F, or G not met. affected channel.

SURVEILLANCE REQUIREMENTS

NOTES-------------------------- -

1. Refer to Table T3.1l.a-1 to determine which TSRs apply to each instrument.

2. Alarm/Trip Setpoints shall be set to ensure that the limits of Technical Requirement 3.1l.c are not exceeded. The Alarm/Trip Setpoints of these channels shall be determined and adjusted in accordance with the methodology and parameters in the OFFSITE DOSE CALCULATION MANUAL (ODCM).

SURVEILLANCE FREQUENCY TSR 3.11.a.1 Perform a CHANNEL CHECK. 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months TSR 3.1l.a.2 Perform a SOURCE CHECK. 31 days TSR 3.11.a.3 Perform a CHANNEL OPERATIONAL TEST. 92 days TSR 3.11.a.4 Perform a CHANNEL OPERATIONAL TEST. 184 days I

(continued)

BYRON - UNITS 1 & 2 3.11.a-7 Revision 46 Technical Requirements Manual

TRM SURVEILLANCE REQUIREMENTS (continued) Radioactive Liquid Effluent Monitoring Instrumentation 13 44 -

SURVEILLANCE FREQUENCY 18 months TSR 3.11.a.5 Perform a CHANNEL CALIBRATION.

TSR 3.11.a.6 Perform a SOURCE CHECK. Prior to each release BYRON - UNITS 1 &2 3.11.a-8 Revision 46 Technical Requirements Manual

TRM Radioactive Liquid Effluent Monitoring Instrumentation 3.11.a Table T3.1l.a-i (page 1 of 3)

Radioactive Liquid Effluent Monitoring Instrumentation REQUIRED SURVEILLANCE INSTRUMENT CHANNELS CONDITION REQUIREMENTS

1. Radioactivity Monitors Providing Alarm and Automatic Termination of Release

a. Liquid Radwaste Effluent Line (ORE-PRO01) 1 C TSR 3.1l.a.l TSR 3.11.a.4 (a)

TSR 3.1l.a.5 (c)

TSR 3.11.a.6

b. Fire and Oil Sump (ORE-PR005) 1 F TSR 3.11.a.l TSR 3.1l.a.2 TSR 3.11.a.4 (a)

TSR 3.1l.a.5 (c)

c. Condensate Polisher Sump Discharge 1 F TSR 3.11.a.1 TSR 3.1l.a.2 (ORE-PRO41) TSR 3.11.a.4 (a)

TSR 3.1l.a.5 (c)

(continued)

I (a) The CHANNEL OPERATIONAL TEST shall also demonstrate that automatic isolation of this pathway and control room alarm annunciation occur if any of the following conditions exists:

l.Instrument indicates measured levels above the Alarm/Trip Setpoint, or 2.Circuit failure (monitor loss of communications - alarm only, detector loss of counts, or monitor loss of power), or 3.Detector check source test failure, or 4.Detector channel out-of-service, or 5.Monitor loss of sample flow.

(c) The initial CHANNEL CALIBRATION shall be performed using one or more of the reference standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST. These standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATION, sources that have been related to the initial calibration shall be used.

BYRON - UNITS 1 &2 3.11.a-9 Revision 46 Technical Requirements Manual

TRM Radioactive Liquid Effluent Monitoring Instrumentation 3.11.a Table T3.11.a-1 (page 2 of 3)

Radioactive Liquid Effluent Monitoring Instrumentation REQUIRED SURVEILLANCE INSTRUMENT CHANNELS CONDITION REQUIREMENTS

2. Radioactivity Monitors Providing Alarm But Not Providing Automatic Termination of Release a.Essential Service Water i)Unit 1 1 D TSR 3.1l.a.l a)RCFC 1A and IC Outlet (lRE-PRO02) TSR 3.1l.a.2 TSR 3.1l.a.4 (b)

TSR 3.1l.a.5 (c) 1 0 TSR 3.1l.a.l b)RCFC IB and 1D Outlet (lRE-PR003) TSR 3.1l.a.2 TSR 3.11.a.4 (b)

TSR 3.1l.a.5 (c) 2)Unit 2 a)RCFC 2A and 2C Outlet (2RE-PR002) 1 D TSR 3.1l.a.l TSR 3.1l.a.2 TSR 3.1l.a.4 (b)

TSR 3.1l.a.5 (c) b)RCFC 2B and 2D Outlet (2RE-PR003) I 0 TSR 3.1l.a.1 TSR 3.1l.a.2 TSR 3.11.a.4 (b)

TSR 3.1l.a.5 (c) b.Station Blowdown Line (ORE-PRO10) 1 D TSR 3.1l.a.1 TSR 3.1l.a.2 TSR 3.1l.a.4 (b)

TSR 3.1l.a.5 (c).

(continued)

(b) The CHANNEL OPERATIONAL TEST shall also demonstrate that control room alarm annunciation occurs if any of the following conditions exists:

l.Instrument indicates measured levels above the Alarm Setpoint, or 2.Circuit failure (monitor loss of communications - alarm only, detector loss of counts, or monitor loss of power), or 3.Detector check source test failure, or 4.Detector channel out-of-service, or 5.Monitor loss of sample flow.

(c) The initial CHANNEL CALIBRATION shall be performed using 'one or more of the reference standards certified by the National Institute of Standards and Technology (NIST) or using I standards that have been obtained from suppliers that participate in measurement assurance I activities with NIST. These standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATION, sources that have been related to the initial calibration shall be used.

BYRON - UNITS 1 &2 3.11.a-10 Revision 46 Technical Requirements Manual

TRM Radioactive Liquid Effluent Monitoring Instrumentation 3.11.a Table T3.1l.a-i (page 3 of 3)

Radioactive Liquid Effluent Monitoring Instrumentation REQUIRED SURVEILLANCE INSTRUMENT CHANNELS CONDITION REQUIREMENTS

3. Flow Rate Measurement Devices a.Liquid Radwaste Effluent Line (Loop-WX001) I E TSR 3.1l.a.l(dl TSR 3.1l.a.3 TSR 3.1l.a.5 b.Liquid Radwaste Effluent Line (Loop-WX630) 1 E TSR 3.1l.a.l(d)

TSR 3.1l.a.3 c.Station Blowdown Line (Loop-CW032) 1 E TSR 3.1l.a.5 TSR 3.11.a.l(d)

I TSR 3.1l.a.3 TSR 3.1l.a.5

4. Radioactivity Monitors Providing Alarm and Automatic Closure of Surge Tank Vent Component Cooling Water Line a.(ORE-PRO09 and I/2RE-PRO09) 2 G TSR 3.1l.a.l TSR 3.1l.a.2 TSR 3.1l.a.4 (a)

TSR 3.1l.a.5 (c)

(a) The CHANNEL OPERATIONAL TEST shall also demonstrate that automatic isolation of this pathway and control room alarm annunciation occur if any of the following conditions exist:

l.Instrument indicates measured levels above the Alarm/Trip Setpoint, or 2.Circuit failure (monitor loss of communications - alarm only, detector loss of counts, or monitor loss of power), or 3.Detector check source test failure, or 4.Detector channel out-of-service, or 5.Monitor loss of sample flow.

(c) The initial CHANNEL CALIBRATION shall be performed using one or more of the reference standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST. These standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATION, sources that have been related to the initial calibration shall be used.

(d) CHANNEL CHECK shall consist of verifying indication of flow during periods of release.

CHANNEL CHECK shall be made at least once per 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months on days on which continuous, periodic, or batch releases are made.

BYRON- UNITS 1 &2 3.11.a-1l Revision 46 Technical Requirements Manual

TRM Radioactive Gaseous Effluent Monitoring Instrumentation 3.11.b 3.11 RADIOLOGICAL EFFLUENTS (RE) 3.ll.b Radioactive Gaseous Effluent Monitoring Instrumentation TLCO 3.11.b All radioactive gaseous effluent monitoring instrumentation channels shown in Table T3.1l.b-1 shall be OPERABLE.

APPLICABILITY: At all times.

ACTIONS

NOTES---------------------------------

1. Separate Condition entry is allowed for each channel.

2. TLCO 3.0.c is not applicable.

3. TLCO 3.o.d is not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. One or more gaseous A.1 Suspend the release Immediately effluent monitoring of radioactive instrumentation gaseous effluent channel Alarm/Trip monitored by the Setpoint(s) less affected channel.

conservative than required.

A.2 Declare the channel Immediately inoperable.

B. Less than the B.1 Enter the Condition Immediately required radioactive referenced in gaseous effluent Table T3.1l.b-I for monitoring the affected instrumentation channel(s).

channels OPERABLE.

(continued)

BYRON - UNITS 1 &2 3.11.b-1 Revision 1 Technical Requirements Manual

TRM ACTIONS (continued) Radioactive Gaseous Effluent Monitoring Instrumentation 3.11.b CONDITION REQUIRED ACTION COMPLETION TIME C. As required by C.1 Verify at least two Prior to Required Action B.1 independent samples initiating a and referenced by of the tank's release Table T3.1l.b-l. contents are analyzed.

AND C.2 Verify at least two Prior to technically initiating a qualified members release of the facility staff independently verify the release rate calculations.

C.3 Verify at least two Prior to technically initiating a qualified members release of the facility staff independently verify the discharge valve lineup.

AND C.4.1 Restore the 14 days required number of channels to OPERABLE.

OR C.4.2 Supplement the In accordance Radioactive with Technical Effluent Release Specification Report pursuant to 5.6.3 Technical Specification 5.6.3 with the cause for failure to correct the inoperability.

(continued)

BYRON - UNITS 1 &2 3.11.b-2 Revision 46 Technical Requirements Manual

ITRM ACTIONS (continued) Radioactive Gaseous Effluent Monitoring Instrumentation 3.11.b CONDITION REQUIRED ACTION COMPLETION TIME D. As required by D.1.1 Suspend PURGING via Immediately Required Action B.l this pathway.

and referenced by Table T3.1l.b-l.

D.1.2 Verify real time During release monitoring of radioactive effluents released via this pathway.

AND D.2.1 Restore the 7 days required number of channels to OPERABLE.

D.2.2 Supplement the In accordance Radioactive with Technical Effluent Release Specification Report pursuant to 5.6.3 Technical Specification 5.6.3 with the cause for failure to correct the inoperability.

.F. I (continued)

BYRON - UNITS 1 & 2 3.11.b-3 Revision 46 Technical Requirements Manual

TRM ACTIONS (continued) Radioactive Gaseous Effluent Monitoring Instrumentation 3.11.b CONDITION REQUIRED ACTION COMPLETION TIME E. As required by E.1 Estimate flow rate. Every 4 hours4.62963e-5 days 0.00111 hours 6.613757e-6 weeks 1.522e-6 months Required Action B.1 and referenced by ALN Table T3.1l.b-l.

E.2.1 Restore the 30 days required number of channels to OPERABLE.

E.2.2 Supplement the In accordance Radioactive with Technical Effluent Release Specification Report pursuant to 5.6.3 Technical Specification 5.6.3 with the cause for failure to correct the inoperability.

(continued)

BYRON - UNITS 1 &2 3.11.b-4 Revision 46 Technical Requirements Manual

TRM ACTIONS (continued) Radioactive Gaseous Effluent Monitoring Instrumentation 3.11.b CONDITION REQUIRED ACTION COMPLETION TIME F. As required by F.1 Verify samples are During release Required Action B.l continuously and referenced by collected with Table T3.1l.b-l. auxiliary sampling equipment as required by Table T3.1l.f-l.

ALM F.2.1 Restore the 30 days required number of channels to OPERABLE.

F.2.2 Supplement the In accordance Radioactive with Technical Effluent Release Specification Report pursuant to 5.6.3 Technical Specification 5.6.3 with the cause for failure to correct I__ the inoperability. 1 (continued)

BYRON - UNITS 1 &2 3.11.b-5 Revision 46 Technical Requirements Manual

TRM ACTIONS (continued) Radioactive Gaseous Effluent Monitoring Instrumentation 3.11.b CONDITION REQUIRED ACTION COMPLETION TIME G. As required by G.1 Verify gaseous grab Every 12 hours1.388889e-4 days 0.00333 hours 1.984127e-5 weeks 4.566e-6 months Required Action B.1 samples are and referenced by collected and Table T3.1l.b-l. analyzed for principle gamma emitters at a Lower Limit of Detection (LLD) as specified in TRM 3.11 Table T3.11.f-l. I ANu G.2.1 Restore the 30 days required number of channels to OPERABLE.

G.2.2 Supplement the In accordance Radioactive with Technical Effluent Release Specification Report pursuant to 5.6.3 Technical Specification 5.6.3 with the cause for failure to correct the inoperability.

H. Required Action and H.1 Suspend the release Immediately associated of radioactive Completion Time for gaseous effluent Conditions C, D, E, monitored by the F, or G not met. affected channel.

BYRON- UNITS 1 &2 3.11 .b-6 Revision 46 Technical Requirements Manual

TRM Radioactive Gaseous Effluent Monitoring Instrumentation 3.11.b SURVEILLANCE REQUIREMENTS

----------------------- NOTES---------------------------------

1. Refer to Table T3.11.b-1 to determine which TSRs apply to each instrument.

2. Alarm/Trip Setpoints shall be set to ensure that the limits of TLCO 3.11.f and Technical Specification 5.5.12 are not exceeded.

The Alarm/Trip Setpoints of these channels meeting TLCO 3.11.f shall be determined and adjusted in accordance with the methodology and parameters in the OFFSITE DOSE CALCULATION MANUAL (ODCM).

SURVEILLANCE FREQUENCY TSR 3.11.b.l Perform a CHANNEL CHECK. 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months TSR 3.11.b.2 Perform a SOURCE CHECK. 31 days TSR 3.1l.b.3 Perform a CHANNEL OPERATIONAL TEST. 92 days TSR 3.11.b.4 Perform a CHANNEL OPERATIONAL TEST. 184 days TSR 3.11.b.5 Perform a CHANNEL CALIBRATION. 18 months I TSR 3.11.b.6 Perform a CHANNEL CHECK. Prior to each release TSR 3.11.b.7 Perform a SOURCE CHECK. Prior to each I release BYRON - UNITS 1 &2 3.11.b-7 Revision 1 Technical Requirements Manual

TRM Radioactive Gaseous Effluent Monitoring Instrumentation 3.11 .b Table T3.1l.b-i (page 1 of 3)

Radioactive Gaseous Effluent Monitoring Instrumentation REQUIRED SURVEILLANCE INSTRUMENT CHANNELS CONDITION REQUIREMENTS U-i Plant Vent Monitoring System

1. Noble Gas Activity Monitor - Providing Alarm a.High Range (lRE-PR028D) 1 G TSR 3.11.b.i TSR 3.11.b.2 TSR 3 .11.b.4(b)

TSR 3.11.b.5(c)

SG TSR 3.1l.b.1 b.Low Range (IRE-PRO28S) TSR 3.1l.b.2 TSR 3.11.b.4(b)

TSR 3.1l.b.5(c) c.Iodine Sampler (IRE-PR028C) F TSR 3.11.b.1 TSR 3.11.b.2 TSR 3.11.b.4(b)

TSR 3.1l.b.5(c) d.Particulate Sampler (lRE-PR028A) 1F TSR 3.1l.b.1 TSR 3.11.b.2 TSR 3.11.b.4(b)

TSR 3.11.b.5(c) e.Effluent System Flow Rate Measuring Device E TSR 3.1l.b.l (LOOP-VA019) TSR 3.1l.b.3 TSR 3.ll.b.5 f.Sampler Flow Rate Measuring Device E TSR 3.11.b.1 (lFT-PR165) TSR 3.1l.b.4 TSR 3.11.b.5 (continued)

(b) The CHANNEL OPERATIONAL TEST shall also demonstrate that control room alarm annunciation occurs if any of the following conditions exists:

l.Instrument indicates measured levels above the Alarm Setpoint, or 2.Circuit failure (monitor loss of communications - alarm only, detector loss of counts, or monitor loss of power), or 3.Detector check source test failure, or 4.Detector channel out-of-service, or 5.Monitor loss of sample flow.

(c.) The initial CHANNEL CALIBRATION shall be performed using one or more of the reference standards certified by the National Institute of Standards and Technology (NIST) or using I standards that have been obtained from suppliers that participate in measurement assurance I activities with NIST. These standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATION, sources that have been related to the initial calibration shall be used.

BYRON - UNITS 1 &2 3.11. b-8 Revision 46 Technical Requirements Manual

TRM Radioactive Gaseous Effluent Monitoring Instrumentation 3.11 .b Table T3.1l.b-l (page 2 of 3)

Radioactive Gaseous Effluent Monitoring Instrumentation REQUIRED SURVEILLANCE INSTRUMENT CHANNELS CONDITION REQUIREMENTS U-2 Plant Vent Monitoring System

2. Noble Gas Activity Monitor - Providing Alarm a.High Range (2RE-PRO28D) 1 G TSR 3.11.b.1 TSR 3.1l.b.2 TSR 3.1l.b. 4 (b)

TSR 3.11.b.5(cl b.Low Range (2RE-PR028B) G TSR 3.11.b.2 TSR 3.1l.b.2 TSR 3.1l.b.4(b)

TSR 3.11.b.5(c)

TSR 3.11.b.1 c.Iodine Sampler (2RE-PR028C) TSR 3.1l.b.2 TSR 3.1l.b.4(b)

TSR 3.11.b.5(c)

d. Particulate Sampler (2RE-PRO28A) F TSR 3.11.b.l TSR 3.11.b.2 TSR 3.1l.b. 4 (b)

TSR 3.11.b.5(c) e.Effluent System Flow Rate Measuring Device E TSR 3.1l.b.1 (LOOP-VAO20) TSR 3.1l.b.3 TSR 3.11.b.5 I

f.Sampler Flow Rate Measuring Device 1 E TSR 3.11.b.1 (2FT-PRI65) TSR 3.11.b.4 TSR 3.11.b.5

3. Refer to Technical Requirements Manual 3.3.e for Gaseous Waste Management Explosive Gas Monitoring Instrumentation (continued)

(b) The CHANNEL OPERATIONAL TEST shall also demonstrate that control room alarm annunciation occurs if any of the following conditions exists:

l.Instrument indicates measured levels above the Alarm Setpoint, or 2.Circuit failure (monitor loss of communications - alarm only, detector loss of counts, or monitor loss of power), or 3.Detector check source test failure, or 4.Detector channel out-of-service, or 5.Monitor loss of sample flow.

(c) The initial CHANNEL CALIBRATION shall be performed using one or more of the reference standards certified by the National Institute of Standards and Technology (NIST) or using standards that have been obtained from suppliers that participate in measurement assurance activities with NIST. These standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATION, sources that have been related to the initial calibration shall be used.

BYRON - UNITS 1 &2 3.11.b-9 Revision 46 Technical Requirements Manual

TRM Radioactive Gaseous Effluent Monitorng Instrumentation 3.11.b Table T3.1l.b-l (page 3 of 3)

Radioactive Gaseous Effluent Monitoring Instrumentation REQUIRED SURVEILLANCE INSTRUMENT CHANNELS CONDITION REQUIREMENTS

4. Gas Decay Tank System Noble Gas Activity Monitor - Providing 2 C TSR 3.11.b. 4 (a)

Alarm and Automatic Termination of Release TSR 3.11.b.5(c)

TSR 3.1l.b.6 (ORE-PRO02A and 2B) TSR 3.1l.b.7

5. Containment Purge System a.Noble Gas Activity Monitor - Providing I D TSR 3.1l.b.1 TSR 3.1l.b.4(b)

Alarm (l/2RE-PRO01B)

TSR 3.11.b.5(c)

TSR 3.11.b.7 b.Iodine Sampler (1/2RE-PROO1C) 1 F TSR 3.11.b.5(c)

TSR 3.1l.b.6 TSR 3.11.b.7 c.Particulate Sampler (1/2RE-PROO1A) I F TSR 3.11.b.5(c)

TSR 3.11.b.6 TSR 3.11.b.7 (a) The CHANNEL OPERATIONAL TEST shall also demonstrate that automatic isolation of this pathway and control room alarm annunciation occur if any of the following conditions exists:

l.Instrument indicates measured levels above the Alarm/Trip Setpoint, or 2.Circuit failure (monitor loss of communications - alarm only, detector loss of counts, or monitor loss of power), or 3.Detector check source test failure, or 4.Detector channel out-of-service, or 5.Monitor loss of sample flow.

(b) The CHANNEL OPERATIONAL TEST shall also demonstrate that control room alarm annunciation occurs if any of the following conditions exists:

l.Instrument indicates measured levels above the Alarm Setpoint, or 2.Circuit failure (monitor loss of communications - alarm only, detector loss of counts, or monitor loss of power), or 3.Detector check source test failure, or 4.Detector channel out-of-service, or 5.Monitor loss of sample flow.

(c) The initial CHANNEL CALIBRATION shall be performed using one or more of the reference standards certified by the National Institute of Standards and Technology (NIST) or using I standards that have been obtained from suppliers that participate in measurement assurance I activities with NIST. These standards shall permit calibrating the system over its intended range of energy and measurement range. For subsequent CHANNEL CALIBRATION, sources that have been related to the initial calibration shall be used.

BYRON - UNITS 1 &2 3.11.b-10 Revision 46 Technical Requirements Manual

TRM Concentration Limits for Effluents 3.11.c 3.11 RADIOLOGICAL EFFLUENTS (RE) 3.11.c Concentration Limits for Effluents TLCO 3.11.c The concentration of radioactive material released in liquid effluents to UNRESTRICTED AREAS (see Byron Station OFFSITE DOSE CALCULATION MANUAL (ODCM) Annex, Appendix F, Figure F-i) shall be limited to 10 times the concentrations specified in 10 CFR Part 20, Appendix B, Table 2, Column 2, for radionuclides other than dissolved or entrained noble gases. For dissolved or entrained noble gases. the concentration shall be limited to 2 X 10" pCi/ml total activity.

APPLICABILITY: At all times.

ACTIONS

NOTES ----------------------------

1. Separate Condition entry is allowed for each release.

2. TLCO 3.0.c is not applicable.

3. TLCO 3.0.d is not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Concentration of A.1 Restore the Immediately radioactive material concentration within released exceeding the limit.

limit.

OR A.2 Terminate the Immediately release.

if BYRON - UNITS 1 & 2 3. 11.c -I Revision I Technical Requirements Manual

TRM Concentration Limits for Effluents 3.11.c SURVEILLANCE REQUIREMENTS

------------------- NOTES ------------------------------

1. All TSRs to be performed at frequency defined by Table T3.11.c-1.

2. The results of the radioactivity analysis shall be used in accordance with the methodology and parameters in the ODCM to assure that the concentrations at the point of release are maintained within the limits of TLCO 3.11.c.

SURVEILLANCE FREQUENCY TSR 3.11.c.1 Sample and analyze liquid wastes. Per Table T3.11.c-1 BYRON - UNITS 1 & 2 3.11.c - 2 Revision I Technical Requirements Manual

TRM Concentration Limits for Effluents 3.11.c Table T3.11.c-1 (Page I of 4)

Radioactive Liquid Waste Sampling and Analysis Program LOWER LIMIT OF

.MINIMUM DETECTION (LLD)

SAMPLING ANALYSIS TYPE OF ACTIVITY (pCi/ml) (Refer to LIQUID RELEASE TYPE FREQUENCY FREQUENCY ANALYSIS Note 1. Page 3.11.c-6)

1. Batch Release P P Principa b~amma 5 x 1i*

Tanks(aJ Each Batch Each Batch Emittersib9 1-131 1 x 10,6 P M Dissolved and Entrained I x 10-5 One Batch/M Gases (Gamma Emitters)

P M H-3 1 x 10" Each Batch Composite(c)

P QGross Alpha I x 10-1 Each Batch Composite(c)

Sr-89. Sr-90 5 x 106 Fe-55 1 x 10-6 (continued)

(a) A batch release is the discharge of liquid wastes of a discrete volume. Prior to sampling for analyses, each batch shall be isolated, and then thoroughly mixed.

(b) The principal gamma emitters for which the LLD specification applies include the following radionuclides:

Mn-54. Fe-59, Co-58. Co-60. Zn-65, Mo-99. Cs-134, Cs-137. and Ce-141. Ce-144 shall also be measured, but at the LLD of SE-06. This list does not mean that only these nuclides are to be considered. Other gamma peaks that are identifiable, together with those of the above nuclides. shall also be analyzed and reported in the Radioactive Effluent Release Report pursuant to Specification 5.6.3 in the format outlined in Regulatory Guide 1.21, Appendix B. Revision 1. June 1974.

(c) A composite sample is one in which the quantity of liquid sampled is proportional to the quantity of liquid waste discharged and in which the method of sampling employed results in a specimen that is representative of the liquids released, BYRON - UNITS I & 2 3.11.c - 3 Revision 24 Technical Requirements Manual

TRM Concentration Limits for Effluents 3.11.c Table T3.11.c-1 (Page 2 of 4)

Radioactive Liquid Waste Sampling and Analysis Program LOWER LIMIT OF MINIMUM DETECTION (LLD)

SAMPLING ANALYSIS TYPE OF ACTIVITY (pCi/ml) (Refer to LIQUID RELEASE TYPE FREQUENCY FREQUENCY ANALYSIS Note I. Page 3.11.c-6)

(continued)

(b) The principal gamma emitters for which the LLD specification applies include the following radionuclides:

Mn-54. Fe-59, Co-58. Co-60. Zn-65. Mo-99. Cs-134. Cs-137. and Ce-141. Ce-144 shall also be measured, but at the LLD of 5E-06. This list does not mean that only these nuclides are to be considered. Other gamma peaks that are identifiable, together with those of the above nuclides. shall also be analyzed and reported in the Radioactive Effluent Release Report pursuant to Specification 5.6.3 in the format outlined in Regulatory Guide 1.21. Appendix B. Revision 1. June 1974.

(d) A continuous release is the discharge of liquid wastes of a nondiscrete volume. e.g.. from a volume of a system that has an input flow during the continuous release.

(e) To be representative of the quantities and concentrations of radioactive materials in liquid effluents, samples shall be collected continuously in proportion to the rate of flow of the effluent stream. Prior to analyses.

all samples taken for the composite shall be thoroughly mixed in order for the composite sample to be representative of the effluent release.

BYRON - UNITS 1 & 2 3.11.c -4 Revision 24 Technical Requirements Manual

TRM Concentration Limits for Effluents 3.11.c Table T3.11.c-1 (Page 3 of 4)

Radioactive Liquid Waste Sampling and Analysis Program LOWER LIMIT OF MINIMUM DETECTION (LLD)

SAMPLING ANALYSIS TYPE OF ACTIVITY (pCi/ml) (Refer to LIQUID RELEASE TYPE FREQUENCY FREQUENCY ANALYSIS Note 1. Page 3.11,c-6)

3. Continu8. Principa M~amma 5 X 10 Release Grab Sample Emitters Essential Service Water Reactor Containment Fan 1-131 1 x 10.6 Cooler (RCFC)

Outlet Line Dissolved and Entrained 1 x 10-Gases (Gamma Emitters)

H-3 I x l0-1 (b) The principal gamma emitters for which the LLD specification applies include the following radionuclides:

Mn-54. Fe-59. Co-58. Co-60, Zn-65. Mo-99. Cs-134. Cs-137. and Ce-141. Ce-144 shall also be measured, but at the LLD of SE-06. This list does not mean that only these nuclides are to be considered. Other gamma peaks that are identifiable, together with those of the above nuclides, shall also be analyzed and reported in the Radioactive Effluent Release Report pursuant to Specification 5.6.3 in the format outlined in Regulatory Guide 1.21, Appendix B. Revision 1. June 1974.

(d) A continuous release is the discharge of liquid wastes of a nondiscrete volume. e.g.. from a volume of a system that has an input flow during the continuous release.

(f) Not required unless the Essential Service Water RCFC Outlet Radiation Monitors 1/2RE-PROO2 and 1/2RE-PRO03 indicates measured levels greater than I x 106 pCi/ml above background at any time during the week.

BYRON - UNITS 1 & 2 3.11.c - 5 Revision 24 Technical Requirements Manual

TRM Concentration Limits for Effluents 3.11.c Table T3.11.c-1 (Page 4 of 4)

Radioactive Liquid Waste Sampling and Analysis Program Note 1: Lower Limit of Detection (LLD)

The LLD is defined, for purposes of these Technical Requirements, as the smallest concentration of radioactive material in a sample that will yield a net count, above system background, that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal.

For a particular measurement system, which may include radiochemical separation:

LLD = 4.66 sb E

V

2.22 x 106

Y

exp (-AAT)

Where:

LLD = the lower limit of detection (microCuries per unit mass or volume),

sb= the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate (counts per minute).

E= the counting efficiency (counts per disintegration),

V= the sample size (units of mass or volume).

2.22 x 106 = the number of disintegrations per minute per microCurie, Y= the fractional radiochemical yield, when applicable, A= the radioactive decay constant for the particular radionuclide (sec 1 ), and AT = the elapsed time between the midpoint of sample collection and the time of counting (sec).

Typical values of E, V, Y. and AT should be used in the calculation.

It should be recognized that the LLD is defined as a before the fact limit representing the capability of a measurement system and not as an after the fact limit for a particular measurement.

BYRON - UNITS 1 & 2 3.11.c-6 Revision I Technical Requirements Manual

TRM Dose From Liquid Effluents 3.11.d 3.11 RADIOLOGICAL EFFLUENTS (RE) 3.11.d Dose From Liquid Effluents TLCO 3.11.d The dose or dose commitment to a MEMBER OF THE PUBLIC from radioactive materials in liquid effluents, from each unit, to UNRESTRICTED AREAS (see Byron Station OFFSITE DOSE CALCULATION MANUAL (ODCM) Annex, Appendix F, Figure F-i) shall be limited:

1. During any calendar quarter to ! 1.5 mrem to the whole body and to

5 mrem to any organ, and

2. During any calendar year to s 3 mrem to the whole body and to 5 10 mrem to any organ.

APPLICABILITY: At all times.

- 1. .i*

BYRON - UNITS 1 & 2 3. 11. d-1 Revision 1 Technical Requirements Manual

TRM Dose From Liquid Effluents 3.11.d ACTIONS

. NOTES ------------------------------

1. Separate Condition entry is allowed for each dose.

2. TLCO 3.0.c is not applicable.

3. TLCO 3.0.d is not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Calculated dose A.1 Submit Special Report 30 days exceeding above to the Commission limits, that identifies the cause(s) for exceeding the limit(s) and defines the corrective actions that have been taken to reduce the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the above limits.

SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY TSR 3.11.d.1 Determine cumulative dose contributions 31 days from liquid effluents for the current calendar quarter and the current calendar year.

BYRON - UNITS 1 & 2 3. 11. d-2 Revision 1 Technical Requirements Manual

TRM Liquid Radwaste Treatment System 3.11.e 3.11 RADIOLOGICAL EFFLUENTS (RE) 3.11.e Liquid Radwaste Treatment System TLCO 3.11.e The Liquid Radwaste Treatment System shall be OPERABLE and shall be used to reduce releases from each unit to UNRESTRICTED AREAS (see Byron Station OFFSITE DOSE CALCULATION MANUAL (ODCM) Annex, Appendix F, Figure F-i) when the projected dose would exceed 0.06 mrem to the whole body or 0.2 mrem to any organ in a 31 day period.

APPLICABILITY: At all times.

BYRON - UNITS 1 & 2 3. 11. e-1 Revision 1 Technical Requirements Manual

TRM Liquid Radwaste Treatment System 3.11.e ACTIONS

-- I

1. Separate Condition entry is a llowed for each release.

2. TLCO 3.0.c is not applicable.

3. TLCO 3.0.d is not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Radioactive liquid A.1 Submit Special Report 30 days waste being discharged to the Commission without treatment. that includes an explanation of why AND liquid radwaste was being discharged In excess of above without treatment, limits. identification of any inoperable equipment AND or subsystems, and the reason for the Any portion of the inoperability:

Liquid Radwaste action(s) taken to Treatment System not restore the in operation. inoperable equipment to OPERABLE status; and a summary description of actions(s) taken to prevent recurrence.

BYRON - UNITS 1 & 2 3. 11. e-2 Revision 1 Technical Requirements Manual

TRM Liquid Radwaste Treatment System 3.11.e SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY TSR 3.11.e.1 ----------------- NOTE---------------

Only required to be performed when the Liquid Radwaste Treatment System is not fully utilized.

Project doses due to liquid releases from 31 days each unit to UNRESTRICTED AREAS.

TSR 3.11.e.2 Verify the installed Liquid Radwaste Per the Treatment System is OPERABLE by meeting the applicable TSRs requirements of TLCO 3.11.c and TLCO 3.11.d.

BYRON - UNITS 1 & 2 3. 11 . e-3 Revision I Technical Requirements Manual

TRM Dose Rate for Gaseous Effluent 3.11.f 3.11 RADIOLOGICAL EFFLUENTS (RE) 3.11.f Dose Rate for Gaseous Effluent TLCO 3.11.f The dose rate in gaseous effluents from the site to areas at and beyond the SITE BOUNDARY (see Byron Station OFFSITE DOSE CALCULATION MANUAL (ODCM) Annex, Appendix F, Figure F-l) shall be limited to:

1. For noble gases: s 500 mrem/yr to the whole body and 5 3000 mrem/yr to the skin, and

2. For Iodine-131 and 133, for tritium, and for all radionuclides in particulate form with half-lives

> 8 days: : 1500 mrem/yr to any organ.

APPLICABILITY: At all times.

ACTIONS

NUIL-

1. Separate Condition entry is allowed for each dose rate.

2. TLCO 3.0.c is not applicable.

3. TLCO 3.0.d is not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Dose rate exceeding A.1 Restore the release Immediately above limits. rate to within limits.

9 Revision I BYRON - UNITS 1 & 2 3. 11. f-1 Technical Requirements Manual

TRM Dose Rate for Gaseous Effluent 3.11.f SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY TSR 3.11.f.1 Determine dose rate due to noble gases Per within limits. Table T3.11.f-1 TSR 3.11Jf.2 Determine dose rate due to 1-131, 1-133, Per tritium and all other radionuclides in Table T3.11.f-1 particulate form with half-lives > 8 days within limits.

.1 BYRON - UNITS 1 & 2 3. 11. f-2 Revision 1 Technical Requirements Manual

TRM Dose Rate for Gaseous Effluent 3.11.f Table T3.11.f-1 (Page I of 3)

Radioactive Gaseous Waste Sampling and Analysis Program LOWER LIMIT OF MINIMUM DETECTION (LLD)

SAMiPLING ANALYSIS TYPE OF ACTIVITY (CCi/ml) (Refer to GASEOUS RELEASE TYPE FREQUENCY FREQUENCY ANALYSIS Note 1. Page 3.11.f-5)

1. Waste Gas Decay P P Principal gamma 1 x 10" Tank Each Tank Each Tank Emittersa Grab Sample

2. Containment Purge P Each PURGE(b) Principal Gamma I x 10' Each PURGE(b) Grab Sample Emitters~a Grab Sample H-3 i x 10,1 (continued)

(a) The principal gamma.emitters for which the LLD specification applies include the following radionuclides:

Kr-87. Kr-88, Xe-133. Xe-133m. Xe-135. and Xe-138 in noble gas releases and Mn-54. Fe-59. Co-58. Co-60. Zn-65.

Mo-99, 1-131. Cs-134, Cs-137. Ce-141. and Ce-144 in iodine and particulate releases. This list does not mean that only these nuclides are to be considered. Other gamma peaks that are identifiable, together with those of the above nuclides. shall also be analyzed and reported in the Radioactive Effluent Release Report pursuant to Specification 5.6.3. in the format outlined in Regulatory Guide 1.21, Appendix B. Revision 1. June 1974.

(b) Sampling and analysis shall also be performed following shutdown, startup, or a THERMAL POWER change exceeding 15' of RATED THERMAL POWER within a 1-hour period.

BYRON - UNITS 1 & 2 3. 11. f-3 Revision 1 Technical Requirements Manual

TRM Dose Rate for Gaseous Effluent 3.11.f Table T3.11.f-1 (Page 2 of 3)

Radioactive Gaseous Waste Sampling and Analysis Program LOWER LIMIT OF MINIMUM DETECTION (LLD)

SAMPLING ANALYSIS TYPE OF ACTIVITY (pCi/ml) (Refer to GASEOUS RELEASE TYPE FREQUENCY FREQUENCY ANALYSIS Note 1. Page 3.11.f-5)

3. Auxiliary Building M(c)(d) M Principa agamma i x 10-Vent Stack Grab Sample Emitters (Units I and 2)

H-3 i x 10'1 Continuous(e) W(f) 1-131 1 x 1011 Charcoal Sample 1-133 1 x 10"-1 Continuous(e) W(f) Principaýa9amma i x i0u Charcoal Emitters Sample Continuous(e) Q Gross Alpha I x 10" Composite Particulate Sample Continuous(e) Q Sr-89. Sr-90 1 x 10-1 Composite Particulate Sample Continuous N.A. Noble Gases: I x 10.6 Noble Gas Gross Beta or Gamma Monitor (a) The principal gamma emitters for which the LLO specification applies include the following radionuclides:

Kr-87. Kr-88. Xe-133. Xe-133m. Xe-135. and Xe-138 in noble gas releases and Mn-54, Fe-59. Co-58. Co-60. Zn-65.

Mo-99. 1-131. Cs-134. Cs-137. Ce-141. and Ce-144 in iodine and particulate releases. This list does not mean that only these nuclides are to be considered. Other gamma peaks that are identifiable, together with those of the above nuclides, shall also be analyzed and reported in the Radioactive Effluent Release Report pursuant to Specification 5.6.3, in the format outlined in Regulatory Guide 1.21. Appendix B. Revision 1, June 1974.

(c) Tritium grab samples shall be taken at least once per 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months when the refueling canal is flooded.

(d) Tritium grab samples shall be taken at least once per 7 days from the spent fuel pool area, whenever spent fuel is in the spent fuel pool.

(e) The ratio of the sample flow rate to the sampled stream flow rate shall be known for the time period covered by each dose or dose rate calculation made in accordance with Technical Requirements 3.11.f. 3.11.g. and 3.11.h.

(f) Samples shall be changed at least once per 7 days and analyses shall be completed within 48 hours5.555556e-4 days 0.0133 hours 7.936508e-5 weeks 1.8264e-5 months after changing, or after removal from sampler. Sampling shall also be performed at least once per 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months for at least 7 days following each shutdown, startup or THERMAL POWER change exceeding 1S% of RATED THERMAL POWER within a 1-hour period and analyses shall be completed within 48 hours5.555556e-4 days 0.0133 hours 7.936508e-5 weeks 1.8264e-5 months of changing. When samples collected for 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months are analyzed, the corresponding LLDs may be increased by a factor of 10. This requirement does not apply if: (1) analysis shows that the DOSE EQUIVALENT 1-131 concentration in the reactor coolant has not increased more than a factor of 3. and (2) the noble gas monitor shows that effluent activity has not increased more than a factor of 3.

BYRON - UNITS 1 & 2 3. 11. f-4 Revision 1 Technical Requirements Manual

TRM Dose Rate for Gaseous Effluent 3.11.f Table T3.11.f-1 (Page 3 of 3)

Radioactive Gaseous Waste Sampling and Analysis Program Note 1: Lower Limit of Detection (LLD)

The LLD is defined, for purposes of these Technical Requirements, as the smallest concentration of radioactive material in a sample that will yield a net count, above system background, that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real" signal.

For a particular measurement system, which may include radiochemical separation:

LLD =4.66 sb E

V

2.22 x 106

Y

exp (-AAT)

Where:

LLD = the lower limit of detection (microCuries per unit mass or volume),

sb= the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate (counts per minute),

E = the counting efficiency (counts per disintegration),

V= the sample size (units of mass or volume),

2.22 x 106 = the number of disintegrations per minute per microCurie, Y= the fractional radiochemical yield, when applicable, A= the radioactive decay constant for the particular radionuclide (sec-i), and AT = the elapsed time between the midpoint of sample collection and the time of counting (sec).

Typical values of E. V, Y, and AT should be used in the calculation.

It should be recognized that the LLD is defined as a before the fact limit representing the capability of a measurement system and not as an after the fact limit for a particular measurement.

BYRON - UNITS 1 & 2 3.11.f-5 Revision I Technical Requirements Manual

I TRM Dose - Noble Gases 3.11.g 3.11 RADIOLOGICAL EFFLUENTS (RE) 3.11.g Dose - Noble Gases TLCO 3.11.g The air dose due to noble gases released in gaseous effluents, from each unit, to areas at and beyond the SITE

-BOUNDARY/UNRESTRICTED AREA boundary (see Byron Station OFFSITE DOSE CALCULATION MANUAL (ODCM) Annex, Appendix F, Figure F-i) shall be limited to:

1) During any calendar quarter: : 5 mrad for gamma radiation and s 10 mrad for beta radiation, and

2) During any calendar year: s 10 mrad for gamma radiation and 5 20 mrad for beta radiation.

APPLICABILITY: At all times.

BYRON - UNITS 1 & 2 3. 11. g-1 Revision 1 Technical Requirements Manual

TRM Dose - Noble Gases 3.11.g ACTIONS

------------------- NOTES------------

1. Separate Condition entry is allowed for each air dose.

2. TLCO 3.0.c is not applicable.

3. TLCO 3.0.d is not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Calculated air dose A.1 Submit a Special 30 days exceeding limit. Report to the Commission that identifies the cause(s) for exceeding the limits(s) and defines the corrective actions that have been taken to reduce the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the above limits.

SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY TSR 3.11.g.1 Determine cumulative dose contributions for 31 days noble gases for the current calendar quarter and current calendar year.

BYRON - UNITS I & 2 3. 11. g-2 Revision I Technical Requirements Manual

TRM Dose 131, 1-133, Tritium and Radioactive Material in Particulate Form 3.11.h 3.11 RADIOLOGICAL EFFLUENTS (RE) 3.11.h Dose 131, I-133,Tritium, and Radioactive Material in Particulate Form TLCO 3.11.h The dose to a MEMBER OF THE PUBLIC from 1-131, 1-133, tritium, and all radionuclides in particulate form with half-lives > 8 days in gaseous effluents released, from each unit, to areas at and beyond the SITE BOUNDARY/UNRESTRICTED AREA boundary(see BYRON Station OFFSITE DOSE CALCULATION MANUAL (ODCM) Figure 1-2 ) shall be limited to:

I

1) During any calendar quarter: < 7.5 mrem to any organ, and

2) During any calendar year:

15 mrem to any organ.

APPLICABILITY: At all times.

BYRON - UNITS 1 &2 3.11.h -1 Revision 46 Technical Requirements Manual

TRM Dose 131, 1-133, Tritium and Radioactive Material in Particulate Form 3.11.h ACTIONS -------------------------- NOTE---------------------------------

1. Separate Condition entry is allowed for each calculated dose.

2. TLCO 3.0.c is not applicable.

3. TLCO 3.0.d is not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Calculated dose A.1 Submit a Special 30 days exceeding limit. Report to the Commission that identifies the cause(s) for exceeding the limit and defines the corrective actions that have been taken to reduce the releases and the proposed corrective actions to be taken to assure that subsequent releases will be in compliance with the above limits.

SURVEILLANCE REQUIREMENTS BYRON - UNITS 1 & 2 3.11.h-2 Revision 1 Technical Requirements Manual

TRM SURVEILLANCE REQUIREMENT*bd§@ntji,,:) 1-133, Tritium and Radioactive Material in Particulate Form SURVEILLANCE FREQUENCY TSR 3.1l.h.l Determine cumulative dose contributions 31 days for Iodine-131 and 133, tritium, and radionuclides in particulate form with half-lives > 8 days for the current calendar quarter and current calendar year.

BYRON - UNITS 1 & 2 3.1 1.h -3 Revision 1 Technical Requirements Manual

TRM Gaseous Radwaste Treatment System 3.11.i 3.11 RADIOLOGICAL EFFLUENTS (RE) 3.11.i Gaseous Radwaste Treatment System TLCO 3.11.i The VENTILATION EXHAUST TREATMENT SYSTEM and the WASTE GAS HOLDUP SYSTEM shall be OPERABLE and shall be used to reduce activity in releases, from each unit, of gaseous effluents when the projected doses at and beyond the SITE BOUNDARY/UNRESTRICTED AREA boundary (see Byron Station OFFSITE DOSE CALCULATION MANUAL (ODCM) Figure 1-2 ) in 31 days would exceed:

1) 0.2 mrad to air from gamma radiation,

2) 0.4 mrad to air from beta radiation, or

3) 0.3 mrem to any organ of a MEMBER OF THE PUBLIC.

APPLICABILITY: At all times BYRON - UNITS 1 &2 3.11.i-1 Revision 46 Technical Requirements Manual

TRM Gaseous Radwaste Treatment System 3.11.i ACTIONS

NOTES---------------------------------

1. Separate Condition entry is allowed for each gaseous release.

2. TLCO 3.0.c is not applicable.

3. TLCO 3.0.d is not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. -------- NOTE ----------- A.1 Submit a Special 30 days Only applicable if Report to the radioactive gaseous Commission that waste being includes the discharged without following treatment. information:

a. Identification Gaseous releases in of any excess of limit. inoperable equipment or subsystems, and the reason for the inoperability,

b. Action(s) taken to restore the inoperable equipment to OPERABLE status, and

c. Summary description of action(s) taken to prevent recurrence.

BYRON - UNITS 1 &2 3.11.i-2 Revision 1 Technical Requirements Manual

TRM Gaseous Radwaste Treatment System 3.11.i SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY TSR 3.11..1- ---------------- NOTE-------------------

Only required to be performed when the Gaseous Radwaste Treatment Systems are not being fully utilized.

Project doses due to gaseous releases 31 days from each unit to areas at or beyond the SITE BOUNDARY/UNRESTRICTED AREA boundary.

TSR 3.11.i.2 Verify the installed VENTILATION Per the EXHAUST TREATMENT SYSTEM and WASTE GAS applicable HOLDUP SYSTEM are OPERABLE by meeting TSRs TSR 3.11.f, and TSR 3.11.g or TSR 3.11.h.

BYRON- UNITS 1 & 2 3.11 .i-3 Revision 1 Technical Requirements Manual

TRM Solid Radioactive Wastes 3.11.j

@ 3.11 RADIOLOGICAL EFFLUENTS (RE) 3.11.j Solid Radioactive Wastes TLCO 3.11.j Radioactive wastes shall be solidified or dewatered in accordance with the PROCESS CONTROL PROGRAM.

APPLICABILITY: At all times.

ACTIONS NOTES -------------------------------------

1. TLCO 3,0.c is not applicable.

2. TLCO 3,0.d is not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A.1 Solidification or A.1 Suspend shipment of Immediately dewatering not inadequately meeting either the processed wastes.

disposal site, shipping or AND transportation requirements. A.2 Determine root cause Prior to and correct to resuming preclude recurrence. shipments BYRON - UNITS 1 & 2 3.11.j -1 Revision I Technical Requirements Manual

TRM Solid Radioactive Wastes 3.11.j ACTIONS (continued)

CONDITION REQUIRED ACTION COMPLETION TIME B.I Solidification or B.1 Test the improperly Prior to dewatering not processed waste in resuming performed in each container to shipments accordance with ensure it meets the PROCESS burial ground and CONTROL PROGRAM. shipping requirements.

AND B.2 Take appropriate Prior to administrative action resuming to prevent shipments recurrence.

SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY TSR 3.11.j.1 The PROCESS CONTROL PROGRAM shall be used At least one to collect and test representative test representative specimens to verify the solidification of test specimen each type of wet radioactive waste. (Refer from at least to Note 1, Page 3.11.j-3) every tenth batch of each type of wet radioactive waste BYRON - UNITS 1 & 2 3.11.j -2 Revision 1 Technical Requirements Manual

TRM Solid Radioactive Wastes 3.11.j NOTE 1 Solidification of at least one representative test specimen from at least every tenth batch of each type of wet radioactive wastes (e.g., filter sludges, spent resins, evaporator bottoms, boric acid solutions and sodium sulfate solutions) shall be verified in accordance with the PROCESS CONTROL PROGRAM:

a. If any test specimen fails to verify solidification, the solidification of the batch under test shall be suspended until such time as additional test specimens can be obtained, alternative solidification parameters can be determined in accordance with the PROCESS CONTROL PROGRAM, and a subsequent test verifies solidification. Solidification of the batch may then be resumed using the alternative solidification parameters determined by the PROCESS CONTROL PROGRAM;

b. If the initial test specimen from a batch of waste fails to verify solidification, the PROCESS CONTROL PROGRAM shall provide for the collection and testing of representative test specimens from each consecutive batch of the same type of wet waste until at least 3 consecutive initial test specimens demonstrate solidification. The PROCESS CONTROL PROGRAM shall be modified as required, as provided in TLCO 5.2.5. to assure solidification of subsequent batches of waste: and

c. With the installed equipment incapable of meeting TLCO 3.11.j or declared out-of-service, restore the equipment to operable status or provide for contract capability to process wastes as necessary to satisfy all applicable transportation and disposal requirements.

BYRON - UNITS I & 2 3.11.j -3 Revision 1 Technical Requirements Manual

TRM Total Dose 3.11.k 3.11 RADIOLOGICAL EFFLUENTS (RE) 3.11.k Total Dose TLCO 3.11.k The annual(calendar year) dose or dose commitment to any MEMBER OF THE PUBLIC due to releases of radioactivity and to radiation from the uranium fuel cycle sources shall be limited to s 25 mrem to the whole body or any organ (except the thyroid) and 5 75 mrem to the thyroid.

APPLICABILITY: At all times.

ACTIONS

NOTES

1. Separate Condition entry is allowed for each calculated dose.

2. TLCO 3.0.c is not applicable.

3. TLCO 3.0.d is not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Calculated doses A.1 --------- NOTE------

exceeding twice the Calculations to TLCO limits for: include direct 3.11.d.1, radiation 3.11.d.2, contributions from 3.1l.g.I, the units and from 3.11.g.2, outside storage 3.11.h.1, or tanks.

3.11.h.2.

Determine if the 15 days TLCO 3.11.k limits have been exceeded.

(continued)

BYRON - UNITS I & 2 3. 11. k-I Revision 1 Technical Requirements Manual

TRM Total Dose 3.11.k ACTIONS (continued)

CONDITION REQUIRED ACTION COMPLETION TIME B. Required Action of B.1 Submit a Special 15 days Condition A determines Report to the the TLCO 3.11.k limits Commission (Refer to have been exceeded. Note 1.

Page 3.11.k-3).

SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY TSR 3.11.k.I ----------------- NOTE---------------

Only applicable if Condition A is entered.

Determine cumulative dose contributions In accordance from direct radiation from the units and with the from radwaste storage tanks. OFFSITE DOSE

'CALCULATION MANUAL (ODCM)

TSR 3.11.k.2 Determine cumulative dose contributions Per the from liquid and gaseous effluents in applicable TSRs accordance with TSR 3.11.d.1, TSR 3.11.g.1.

and TSR 3.11.h.1 and in accordance with the methodology and parameters in the OFFSITE DOSE CALCULATION MANUAL (ODCM).

TSR 3.11.k.3 Inspect the Old Steam Generator Storage 92 days Facility (OSGSF) sump for the presence of liquid and the appearance that seepage has occurred.

(continued)

BYRON - UNITS 1 & 2 3. 11. k-2 Revision I Technical Requirements Manual

TRM Total Dose 3.11.k SURVEILLANCE REQUIREMENTS (continued)

SURVEILLANCE FREQUENCY TSR 3.11.k.4 ----------------- NOTE---------------

Only required to be performed if TSR 3.11.k.3 identifies both the presence of liquid and indications of seepage.

Sample and analyze the liquid from the 92 days OSGSF sump.

BYRON - UNITS 1 & 2 3. 11. k-3 Revision 1 Technical Requirements Manual

TRM Total Dose 3.11.k NOTE 1 The Special Report shall define the corrective actions to be taken to reduce subsequent releases to prevent recurrence of exceeding the TLCO 3.11.k limits and includes the schedule for achieving conformance with the TLCO 3.11.k limits. The Special Report, as defined by 10 CFR 20.405c, shall include an analysis that estimates the radiation exposure to a MEMBER OF THE PUBLIC from the uranium cycle sources, including all effluent pathways and direct radiation, for the calendar year that includes the release(s) covered by this report. It shall also describe levels of radiation and concentration of radioactive material involved, and the cause of the exposure levels or concentrations. If the estimated dose(s) exceeds the TLCO 3.11.k limits, and if the release condition resulting in violation of 40 CFR Part 190 has not already been corrected, the Special Report shall include a request for a variance in accordance with the provisions of 40 CFR Part 190. Submittal of the report is considered a timely response and a variance is granted until staff action on the request is complete.

9 BYRON - UNITS 1 & 2 3. 11. k-4 Revision 1 Technical Requirements Manual

TRM Radiological Environmental Monitoring Program 3.12.a 3.12 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM 3.12.a Radiological Environmental Monitoring Program TLCO 3.12.a The Radiological Environmental Monitoring Program (REMP) shall be conducted as specified in Table T3.12.a-l.

APPLICABILITY: At all times.

ACTIONS

NOTES---------------------------------

1. TLCO 3.0.c is not applicable.

2. TLCO 3.0.d is not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. REMP not being conducted as specified in Table T3.12.a-l.

A.1 Submit in the Annual Radiological Environmental Operating Report, as required by Specification 5.6.2 In accordance with Technical Specification 5.6.2 I

, a description of the reasons for not conducting the program as required and the plans for preventing recurrence.

(continued)

BYRON - UNITS 1 &2 3.12.a-1 Revision 46 Technical Requirements Manual

TRM ACTIONS (continued) Radiological Environmental Monitoring Program 9 11 r-,

CONDITION REQUIRED ACTION COMPLETION TIME B. Level of B.1 -------- NOTE-------

radioactivity as a The methodology and result of plant parameters used to effluents in an estimate the environmental potential annual sampling medium at a dose to a MEMBER OF specified location THE PUBLIC shall be exceeding the indicated in this reporting limits of report.

Table T3.12.a-2 when averaged over any calendar quarter. Submit a Special 30 days Report to the Commission that identifies the cause(s) for exceeding the limit(s) and defines the corrective actions to be taken to reduce radioactive effluents so that the potential annual dose to a MEMBER OF THE PUBLIC is less than the calendar year limits of Technical Requirements 3.11.d I 3.1l.g and 3.11.h.

(continued)

BYRON- UNITS 1 &2 3.12.a-2 Revision 1 Technical Requirements Manual

TRM ACTIONS (continued) Radiological Environmental Monitoring Program n~ -40%

CONDITION REQUIRED ACTION COMPLETION TIME C. More than one of the C.I - --------NOTE ------

radionuclides in Table T3.12.a-2 are The methodology detected in the and parameters sampling medium. used to estimate the potential AND annual dose to a MEMBER OF THE C1 C2 PUBLIC shall be

-- + -+ ... >I1.0 indicated in this RL, RL 2 report.

30 days where; C = concentration RL = reporting Submit a Special level. Report to the Commission that identifies the cause(s) for exceeding the limit(s) and defines the corrective actions to be taken to reduce radioactive effluents so that the potential annual dose to a MEMBER OF THE PUBLIC is less than the calendar year limits of Technical Requirements 3.11.

d, 3.11.g and 3.11.h.

(continued)

BYRON - UNITS 1 & 2 3.12.a-3 Revision 1 Technical Requirements Manual

TRM ACTIONS (continued) Radiological Environmental Monitoring Program 03 -i -

CONDITION REQUIRED ACTION COMPLETION TIME D. Radionuclides other D.1-----------NOTE ---------

than those in The methodology and Table T3.12.a-2 are parameters used to detected. estimate the potential annual AND dose to a MEMBER OF THE PUBLIC shall be Are the result of indicated in this plant effluents. report.

AIM Submit a Special 30 days The potential annual Report to the dose to a MEMBER OF Commission that THE PUBLIC from all identifies the radionuclides is cause(s) for equal to or greater exceeding the than the calendar limit(s) and limits of Technical defines the Req-uirements 3.11.d, corrective actions 3.ll.g and 3.11.h. to be taken to reduce radioactive effluents so that the potential annual dose to a MEMBER OF THE PUBLIC is less than.

the calendar year limits of Technical Requirements 3.11 .d I 3.11.g and

_____ _________ ____ ____3 .1l.h._ _ _ _ _ _ _ _ _

E. Measured levels of E.1 Report and describe In accordance radioactivity not the condition in the with Technical the result of plant Annual Radiological Specification effluents. Environmental 5.6.2 Operating Report required by

Specification 5.6.2 (continued)

BYRON - UNITS 1 &2 3.12.a -4 Revision 46 Technical Requirements Manual

TRM Radiological Environmental Monitoring Program 3.12.a CONDITION REQUIRED ACTION COMPLETION TIME F. Milk or fresh leafy F.I Identify specific 30 days vegetablesamples locations for unavailable from one obtaining or more of the replacement samples sample locations and add them to the required by REMP given in the Table T3.12.a-l. OFFSITE DOSE CALCULATION MANUAL (ODCM).

AND F.2 Submit controlled 180 days version of the ODCM to the NRC including a revised figure(s) and table reflecting the new location(s) with supporting information identifying the cause of the unavailability of samples, deleting the specific locations from which samples were unavailable and justifying the selection of the new location(s) for obtaining samples.

BYRON - UNITS 1 & 2 3.12.a-5 Revision 1 Technical Requirements Manual

TRM Radiological Environmental Monitoring Program 3.12.a SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY TSR 3.12.a.1 The radiological environmental Per the monitoring samples shall be collected applicable pursuant to Table T3.12.a-i from the Table(s) specific locations given in the table and figure(s) in the ODCM and shall be analyzed pursuant to the requirements of Table T3.12.a-I and the detection capabilities required by Table T3.12.a-3.

BYRON- UNITS 1 &2 3.12.a-6 Revision 1 Technical Requirements Manual

TRM SURVEILLANCE REQUIREMENTS (continued) Radiological Environmental Monitoring Program 3.12.a Table T3.12.a-I (Page 1 Radiological Environmental Monitoring Program SAMPLING AND EXPOSURE PATHWAY NUMBER OF REPRESENTATIVE SAMPLES COLLECTION AND/OR SAMPLE AND SAMPLE LOCATIONS(a) FREQUENCY TYPE/FREQUENCY OF ANALYSIS

1. Airborne Samples from a total of eight Continuous Radioiodine Canister:

Radioiodine locations: sampler 1-131 analysis bi-weekly on and operation near field samples and Particulates a. Indicator - Near Field with sample control.(b) collection Four samples from locations weekly (or Particulate Sampler:

within 4 km (2.5 mi) in more Gross beta analysis different sectors, frequently if following weekly filter required due change(c) and gamma isotopic

b. Indicator - Far Field to dust analysis(d) quarterly on loading), composite filters by Three additional locations location on near field within 4 to 10 km (2.5 to samples and control. (b) 6.2 mi) in different sectors.

c. Control One sample from a control location within 10 to 30 k]n (6.2 to 18.6 mi).

(continued)

(a) Specific parameters of distance and direction from the centerline of the midpoint of the two units and additional description where pertinent, shall be provided for each and every sample location in Table 11-1 of the ODCM Station Annexes. Refer to NUREG-0133, "Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants,"

October 1978, and to Radiological Assessment Branch Technical Position, Revision 1, November 1979.

Deviations are permitted from the required sampling schedule if specimens are unobtainable due to hazardous conditions, seasonal unavailability, malfunction of sampling equipment, if a person/business who participates in the program goes out of business or no longer can provide samples, or due to a contractor omission which is corrected as soon as discovered.

If the equipment malfunctions, corrective actions shall be completed as soon as practical.

If a person/business supplying samples goes out of business, a replacement supplier should be found as soon as possible. Refer to Technical Requirements Manual section 3.12.a Required Action A.1 for guidance as to required actions to be taken whenever a sample is not obtained.

b) Far field samples are analyzed when the respective near field sample results are inconsistent with previous measurements and radioactivity is confirmed as having its origin in airborne effluents from the station, or at the discretion of the Health Physics Support Director.

(c) Airborne particulate sample filters shall be analyzed for gross beta radioactivity 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months or more after sampling to allow for radon and daughter decay. If gross beta activity in air particulate samples is greater than 10 times the yearly mean of control samples, gamma isotopic analysis shall be performed on the individual samples.

(d) Ganmma isotopic analysis means the identification and quantification of gamma emitting radionuclides that may be attributable to the effluents from the station.

BYRON- UNITS 1 &2 3.12.a-7 Revision 24 Technical Requirements Manual

TRM SURVEILLANCE REQUIREMENTS (continued) Radiological Environmental Monitoring Program 3.12.a Table T3.12.a-I (Page 2 of 5)

Radiological Environmental Monitoring Program SAMPLING AND EXPOSURE PATHWAY NUMBER OF REPRESENTATIVE SAMPLES COLLECTION AND/OR SAMPLE AND SAMPLE LOCATIONS(a) FREQUENCY TYPE/FREQUENCY OF ANALYSIS

2. Direct Forty routine monitoring Quarterly. Gamma dose on each TLD stations either with a Radiation(e) thermoluminescent dosimeter quarterly.

(TLD) or with one instrument for measuring dose rate continuously, placed as follows:

a. Indicator - Inner Ring (100 Series TLD) One in each meteorological sector, in the general area of the SITE BOUNDARY;

b. Indicator - Outer Ring (200 Series TLD) One in each meteorological sector, within 6 to 8 km (3.7 to 5.0 mi); and

c. Other One at each Airborne location given in part l.a.

and l.b.

The balance of the TLDs to be placed at special interest locations beyond the restricted locations beyond the Restricted Area where either a MEMBER OF THE PUBLIC or Exelon Nuclear employees have routine access (300 Series TLD).

d. Control One at each Airborne control location given in part l.c.

(continued)

(a) Specific parameters of distance and direction from the centerline of the midpoint of the two units and additional description where pertinent, shall be provided for each and every sample location in ODcM Part II Table 6-1 and Table 6-

2. Refer to NUREG-0133, "Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants, October 1978, and to Radiological Assessment Branch Technical Position, Revision 1, November 1979.

oeviations are permitted from the required sampling schedule if specimens are unobtainable due to hazardous conditions, seasonal unavailability, malfunction of sampling equipment, if a personibusiness who participates in the program goes out of business or no longer can provide samples, or due to a contractor omission which is corrected as soon as discovered. If the equipment malfunctions, corrective actions shall be completed as soon as practical. If a person/business supplying samples goes out of business, a replacement supplier should be found as soon as possible.

Refer to Technical Requirements Manual section 3.12.a Required Action A.1 for guidance as to required actions to be taken whenever a sample is not obtained.

(e) One or more instruments, such as a pressurized ion chamber, for measuring and recording dose rate continuously may be used in place of, or in addition to, integrating dosimeters. Film badges shall not be used as dosimeters for measuring direct radiation. The 40 locations is not an absolute number. The number of direct radiation monitoring stations may be reduced according to geographical limitations; e.g., if a station is adjacent to a lake, some sectors may be over water thereby reducing the number of dosimeters which could be placed at the indicated distances. The frequency of analysis or readout for TLD systems will depend upon the characteristics of the specific system used and should be selected to obtain optimum dose information with minimal fading.

BYRON - UNITS 1 &2 3.12.a-8 Revision 46 Technical Requirements Manual

TRM SURVEILLANCE REQUIREMENTS (continued) Radiological Environmental Monitoring Program 3,12.a Table T3.12.a-l (Page 3 of 5)

Radiological Environmental Monitoring Program SAMPLING AND EXPOSURE PATHWAY NUMBER OF REPRESENTATIVE SAMPLES COLLECTION AND/OR SAMPLE AND SAMPLE LOCATIONS(a) FREQUENCY TYPE/FREQUENCY OF ANALYSIS 3.Waterborne

a. Ground/ Well a. Indicator Quarterly. Gamma isotopic(d) and tritium analysis quarterly.

Samples from three sources only if likely to be affected.

b. Drinking(g)

a. Indicator Weekly grab Gross beta and gamma samples. isotopic analyses(d) on Some sample from each monthly composite; tritium community drinking water analysis on quarterly supply that could be composite.

affected by the station discharge within 10 km (6.2 mi) downstream of discharge. Weekly grab Gross beta and gamma

c. Surface If no community water supply isotopic analyses(d) on (Drinking Water) exists within samples. monthly composite; tritium 10 kln downstream of discharge analysis on quarterly then surface water sampling composite.

shall be performed.

a. Indicator One sample downstream.

a. Control Weekly grab Gross beta and gamma

d. Control Sample(g) samples. isotopic analyses(d) on One surface sample upstream monthly composite; tritium of discharge. analysis on quarterly composite.

a. Sediment a. Indicator Semiannually. Gamma isotopic analysis d)

At least one sample from semiannually.

downstream(g) area within 10 km (6.2 mi) distance.

(continued)

Specific parameters of distance and direction from the centerline of the midpoint of the two units and additional I

(a) description where pertinent, shall be provided for each and every sample location in ODCMPart II Table 6-1 and Table 6-

2. Refer to NUREG-0133, -Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants."

October 1978, and to Radiological Assessment Branch Technical Position, Revision 1, November 1979.

Deviations are permitted from the required sampling schedule if specimens are unobtainable due to hazardous conditions, seasonal unavailability, malfunction of sampling equipment, if a person/business who participates in the program goes out of business or no longer can provide samples, or due to a contractor omission which is corrected as soon as discovered. If the equipment malfunctions, corrective actions shall be completed as soon as practical. If a person/business supplying samples goes out of business, a replacement supplier should be found as soon as possible.

Refer to Technical Requirements Manual section 3.12.- Required Action A.1 for guidance as to required actions to be taken whenever a sample is not obtained.

(d) Gammaisotopic analysis means the identification and quantification of gamma emitting radionuclides that may be attributable to the effluents from the station.

(f) Groundwater samples shall be taken when this source is tapped for drinking or irrigation purposes in areas where the hydraulic gradient or recharge properties are suitable for contamination.

(g) The 'downstream' sample shall be taken in an area beyond but near the mixing zone. The 'upstream sample" shall be taken at a distance beyond significant influence of the discharge. Upstream samples in an estuary must be taken far enough up upstream to be beyond the station influence.

BYRON- UNITS 1 &2 3.12.a-9 Revision 46 Technical Requirements Manual

TRM SURVEILLANCE REQUIREMENTS (continued) Radiological Environmental Monitoring Program 3.12.a Table T3.12.a-l (Page 4 of 5)

Radiological Environmental Monitoring Program SAMPLING AND EXPOSURE PATHWAY NUMBER OF REPRESENTATIVE SAMPLES COLLECTION AND/OR SAMPLE AND SAMPLE LOCATIONS(a) FREQUENCY TYPE/FREQUENCY OF ANALYSIS

4. Ingestion a.Milk(h) a. Indicator Biweeklyfi) Gamma isotopic(d) and 1-131 Samples from milking animals when animals (J) analysis on each sample.

from a maximum of three are on locations within 10 km pasture (May (6.2 mi) distance, through October),

b. Control monthly at other times One sample from milking (November animals at a control through location within 15 to 30 km April).

(9.3 to 18.6 mi).

a. Indicator Two times Gamma isotopic analysis(d)

Representative samples of annually. on edible portions.

commercially and recreationally important b.Fish species in discharge area.

b. Control Representative samples of commercially and recreationally important species in control locations upstream of discharge. (continued)

(a) Specific parameters of distance and direction from the centerline. of the midpoint of the two units and additional description where pertinent, shall be provided for each and every sample location in ODCM Part II Table 6-l and Table 6-2. Refer to NUREG-0133, "Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants,"

October 1978, and to Radiological Assessment Branch Technical Position, Revision 1, I November 1979.

Deviations are permitted from the required sampling schedule if specimens are unobtainable due to hazardous conditions, seasonal unavailability, malfunction of sampling equipment, if a person/business who participates in the program goes out of business or no longer can provide samples, or due to a contractor omission which is corrected as soon as discovered.

If the equipment malfunctions, corrective actions shall be completed as soon as practical.

If a person/business supplying samples goes out of business, a replacement supplier should be found as soon as possible. Refer to Technical Requirements Manual section 3.12.a Required Action A.1 for guidance as to required actions to be taken whenever a sample is not obtained.

(d) Gamma isotopic analysis means the identification and quantification of gamma emitting radionuclides that may be attributable to the effluents from the station.

(h) If milking animals are not found in the designated indicator locations, or if the owners decline to participate in the REMP, all milk sampling shall be discontinued.

(i) Biweekly refers to every two weeks.

(j) 1-131 analysis means the analytical separation and counting procedure are specific for this radionuclide.

BYRON - UNITS 1 & 2 3.12.a -10 Revision 46 Technical Requirements Manual

TRM SURVEILLANCE REQUIREMENTS (continued) Radiological Environmental Monitoring Program 3.12.a Table T3.12.a-l (Page 5 of 5)

Radiological Environmental Monitoring Program SAMPLING AND EXPOSURE PATHWAY NUMBER OF REPRESENTATIVE SAMPLES COLLECTION AND/OR SAMPLE AND SAMPLE LOCATIONS(a) FREQUENCY TYPE/FREQUENCY OF ANALYSIS

4. Ingestion (continued) c.Food a. Indicator Annually. Gamma isotopic(d) analysis Products Two representative samples on each sample.

from the principal food pathways grown in each of four major quadrants within 10 km (6.2 mi):

At least one root vegetable samnple.(k)

At least one broad leaf vegetable (or vegetation).

(k)

b. Control Two representative samples similar to indicator samples grown within 15 to 30 km (9.3 to 18.6 mi).

(a) Specific parameters of distance and direction from the centerline of the midpoint of the two units and additional description where pertinent, shall be provided for each and every sample location in ODCM Part II Table 6-1 and Table 6-2. Refer to NUREG-0133, "Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants,*

October 1978, and to Radiological Assessment Branch Technical Position, Revision 1, November 1979.

I Deviations are permitted from the required sampling schedule if specimens are unobtainable due to hazardous conditions, seasonal unavailability, malfunction of sampling equipment, if a person/business who participates in the program goes out of business or no longer can provide samples, or due to a contractor omission which is corrected as soon as discovered.

If the equipment malfunctions, corrective actions shall be completed as soon as practical.

If a person/business supplying samples goes out of business, a replacement supplier should be found as soon as possible. Refer to Technical Requirements Manual section 3.12.a Required Action A.1 for guidance as to required actions to be taken whenever a sample is not obtained.

(d) Gamma isotopic analysis means the identification and quantification of gamma emitting radionuclides that may be attributable to the effluents from the station.

(k) One sample shall consist of a volume/weight of sample large enough to fill contractor specified container.

BYRON - UNITS 1 &2 3.12.a - 11 Revision 46 Technical Requirements Manual

TRM SURVEILLANCE REQUIREMENTS (continued) Radiological Environmental Monitoring Program 3.12.a Table T3.12.a-2 (Page 1 of 1)

Reporting Levels for Radioactivity Concentrations in Environmental Samples Reporting Levels AIRBORNE PARTICULATE FISH (pCi/kg, FOOD PRODUCTS ANALYSIS WATER (pCi/i) OR GASES wet) MILK (pCi/i) (pCi/kg, wet)

(pCi/Mr H-3 20,000(a)

Mn-54 1,000 30,000 Fe-59 400 10,000 Co-58 1,000 30,000 Co-60 300 10,000 Zn-65 300 20,000 Zr-95 400 Nb-95 400 1-131 2 (b) 0.9 3 100 Cs-134 30 10 1,000 60 1,000 Cs-137 50 20 2,000 70 2,000 Ba-140 200 300 La-140 200 300 (a) For drinking water samples. This is 40 CFR Part 141 value. If no drinking water pathway exists, a value of 30,000 pCi/l may be used.

(b) If no drinking water pathway exists, a value of 20 pCi/l may be used.

BYRON - UNITS 1 &2 3.12.a- 12 Revision 24 Technical Requirements Manual

TRM SURVEILLANCE REQUIREMENTS (continued) Radiological EEnvironmental Monitoring Program 3.12.a Table T3.12.a-3 (Page 1 of 2)

Detection Capabilities for Environmental Sample Analysis(a)

Lower Limit of Detection (LLD) (b) (Refer to Note 1, Page 3.12.a-14)

AIRBORNE PARTICULATE SEDIMENT OR GAS FISH FOOD (pCi/kg, ANALYSIS WATER (pCi/m 3 ) (pCi/kg, MILK PRODUCTS dry)

(pCi/l) wet) (pCi/i) (pCi/kg, wet)

Gross Beta 4 0.01 1000 I

H-3 2000 (c) (d)

Mn-54 15 130 Fe-59 30 260 Co-58,60 15 130 Zn-65 30 260 Zr-95 30 Nb-95 .15 1-131 0.07 1 60 I Cs-134 15 0.05 130 15 60 150 Cs-137 18 0.06 150 18 80 180 Ba-140 60 60 La-140 15 15 (a) This list does not mean that only these nuclides are to be considered. Other peaks at are identifiable, together with those of the above nuclides, shall also be analyzed and reported in the Annual Radiological Environmental Operating Report pursuant to Technical Specification 5.6.2.

(b) Required detection capabilities for thermoluminescent dosimeters used for environmental measurements shall be in accordance with the recommendations of Regulatory Guide 4.13.

(c) This LLD is the mimimum allowable, however, vendors performing environmental sample analysis offsite will be required to meet an LLD of 200 pCi/L (d)

(e)

If no drinking water pathways exists, a valve of 3000 pCi/L may be used.

If no drinking water pathway exists, a valve of 15 pCi/L may be used.

i BYRON - UNITS 1 &2 3.12.a- 13 Revision 46 Technical Requirements Manual

TRM SURVEILLANCE REQUIREMENTS (continued) Radiological Environmental Monitoring Program 3.12.a Table T3.12.a-3 (Page 2 of 2)

Detection Capabilities for Environmental Sample Analysis Lower Limit of Detection (LLD)

Note 1: Lower Limit of Detection (LLD)

The LLD is defined, for purposes of these Technical Requirements, as the smallest concentration of radioactive material in a sample that will yield a net count, .above system background, that will be detected with 95% probability with only 5% probability of falsely concluding that a blank observation represents a "real' signal.

For a particular measurement system, which may include radiochemical separation:

LLD =

E*V* 2.22* Y*exp(-AA r)

Where:

LLD =the "a priori" lower limit of detection (picoCuries per unit mass or volume),

sb =the standard deviation of the background counting rate or of the counting rate of a blank sample as appropriate (counts per minute),

E =the counting efficiency (counts per disintegration),

i V =the sample size (units of mass or volume),

2.22 = the number of disintegrations per minute per picoCurie, Y =the fractional radiochemical yield, when applicable, X =the radioactive decay constant for the particular radionuclide (sec-1), and at =the elapsed time between the midpoint of sample collection and the time of counting (sec).

Typical values of E, V, Y, and AT should be used in the calculation.

It should be recognized that the LLD is defined as a before the fact limit representing the capability of a measurement system and not as an after the fact limit for a particular measurement. Analyses shall be performed in such a manner that the stated LLDs will be achieved under routine conditions. Occasionally, background fluctuations, unavoidable small sample sizes, the presence of interfering nuclides, or other uncontrollable circumstances may render these LLDs unachievable. In such cases, the contributing factors shall be identified and described in the Annual Radiological Environmental Operating Report pursuant to Technical Specification 5.6.2.

BYRON - UNITS 1 &2 3.12.a-14 Revision 1 Technical Requirements Manual

TRM Land Use Census 3.12.b 3.12 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM 3.12.b Land UseCensus TLCO 3.12.b The Land Use Census shall be conducted and shall identify within a distance of 10 km (6.2 miles) the location in each of the 16 meteorological sectors (Refer to Note 1, Page 3.12.b-3) of the nearest milk animal, the nearest residence (Refer to Note 2, Page 3.12.b-3), and a enumeration of livestock. For dose calculation, a garden will be assumed at the nearest residence.

APPLICABILITY: At all times.

ACTIONS

NOTES-- ----------------------------

I. TLCO 3.0.c is not applicable.

2. TLCO 3.0.d is not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Calculated dose or A.1 Identify the new 12 months dose commitment location(s) in the greater than the value next Annual currently calculated Radiological in Technical Environmental Requirement 3.11.h.1. Operating Report pursuant to Technical Specification 5.6.2.

(continued)

BYRON - UNITS 1 & 2 3.12.b-1 Revision 1 Technical Requirements Manual

TRM Land Use Census 3.12.b ACTIONS (continued)

CONDITION REQUIRED ACTION COMPLETION TIME B. Identification of a B.1 Add the new 30 days location that yields a location(s) to the calculated dose or Radiological dose commitment (via Environmental the same exposure Monitoring Program pathway) 20% greater (REMP) given in the than at a location OFFSITE DOSE from which samples are CALCULATION MANUAL currently being (ODCM) (Refer to obtained, in Note 3, accordance with Page 3.12.b-3)

Technical Requirement 3.12.a.

SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY TSR 3.12.b.1 The Land Use Census (Refer to Note 4, 12 months Page 3.12.b-3) shall be conducted during the growing season (01 JUN - 01 OCT).

BYRON - UNITS 1 & 2 3.12.b- 2 Revision 1 Technical Requirements Manual

TRM Land Use Census 3.12.b Note 1: This requirement may be reduced according to geographical limitations; e.g. at a lake site where some sectors will be over water.

Note 2: The nearest industrial facility shall also be documented if closer than the nearest residence.

Note 3: The sampling location(s), excluding the control station location, having the lowest calculated dose or dose commitment(s), via the same exposure pathway, may be deleted from this monitoring program after October 31 of the year in which this Land Use Census was conducted. Pursuant to Technical Specification 5.5.1.c, submit in the next Annual Radiological Environmental Operating Report documentation for a change in the ODCM including a revised figure(s) and table(s) for the ODCM reflecting the new location(s) with information supporting the change in sampling locations.

Note 4: The Land Use Census shall use information that will provide the best results, such as by a door-to-door survey, aerial survey, or by consulting local agriculture authorities. The results of the Land Use Census shall be included in the Annual Radiological Environmental Operating Report.

BYRON - UNITS I & 2 3.12.b-3 Revision I Technical Requirements Manual

TRM Interlaboratory Comparison Program 3.12.c 3.12 RADIOLOGICAL ENVIRONMENTAL MONITORING PROGRAM 3.12.c Interlaboratory Comparison Program TLCO 3.12.c Analyses shall be performed on radioactive materials, supplied as part of an Interlaboratory Comparison Program that corresponds to samples required by Table 3.12.a-1.

APPLICABILITY: At all times.

ACTIONS

NOTES--------------------------------

1. TLCO 3.0.c is not applicable.

2. TLCO 3.0.d is not applicable.

CONDITION REQUIRED ACTION COMPLETION TIME A. Analyses NOT being A.1 Report the In accordance performed per corrective actions with Technical Table T3.12.a-l. to preclude Specification I recurrence in the 5.6.2 Annual Radiological Operating Report to the Commission pursuant to Technical Specification 5.6.2 BYRON - UNITS 1 &2 3.12.c-1 Revision 46 Technical Requirements Manual

TRM Interlaboratory Comparison Program 3.12.c SURVEILLANCE REQUIREMENTS SURVEILLANCE FREQUENCY TSR 3.12.c.1 Summarize the results obtained as part In accordance of the Interlaboratory Comparison with Technical Program in the Annual Radiological Specification Environmental Operating Report to the 5.6.2 Commission pursuant to Technical Specification 5.6.2. _

BYRON - UNITS 1 &2 3.12.c-2 Revision 46 Technical Requirements Manual

BYRON 2008-0032, Transmittal of 2007 Annual Radioactive Effluent Release Report & Rev. 5 to Offsite Dose Calculation Manual

Text

Subject:

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

SUMMARY

1.0 INTRODUCTION

1.0 INTRODUCTION

1.4 REFERENCES

Navigation menu

Search